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Abstract
This work outlines the use of Lewis acidic boranes in a variety of different 
reactions, mainly in the activation of unsaturated substrates such as allenes, alkynes, 
ketones, aldehydes and imines. 
The activation of allenes toward frustrated Lewis pairs showed that a formal 1,4-
addition product prevails, trapping the product as the zwitterionic s-cis diene species. 
Conversely, reacting these same substrates with B(C6F5)3 alone allows two distinct 
reactive pathways; either σ-activation to yield the scarcely observed 1,2-
carboboration product or π-activation followed by dealkylation to generate the γ-
lactone. Following this second activation mode, the reaction between propargyl 
esters, amides, carbamates and carbonates with a variety of homo- and hetero-leptic 
boranes as well as borocations promotes the 5-exo-dig cyclisation which, depending 
on the substrate, was either isolated as the oxazolium or dioxaborinine heterocycle. 
In addition, utilising the Lewis acid PhBCl2 in this reaction interestingly produces the 
hitherto unreported 1,3-haloboration of alkynes.
B(C6F5)3 was also shown to be hugely successful in a number of other ring 
closing reactions, specifically the 6-endo-dig cyclisation of alkynyl ester derivatives to 
form various pyrones, isocoumarins and pyryliums. Of particular interest is the 
development of a new methodology for catalytic carbon-carbon bond formation 
through alkyl group transfer. In this case, benzyl, α-methylbenzyl and benzhydryl
functionalised alkynyl esters underwent the expected cyclisation using catalytic 
B(C6F5)3 to form the lactone however, 1,5-migration occurs from oxygen to carbon to 
generate the corresponding γ-functionalised pyrones and isocoumarins.
Finally, a diverse array of reduction chemistry was performed by attenuating the 
Lewis acidity at boron to specialise its function in catalysis. Other work focused on 
the exploitation of novel processing technologies to improve conventional batch-type 
main group reactivity via continuous-flow chemistry. Additionally, biologically inspired 
dihydropyridines were used in the formation of thermally stable borohydrides as well 
as elemental hydrogen surrogates in boron mediated transfer hydrogenation 
pathways.
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Chapter 1
Introduction
1.1 Scope of This Work
As the implementation of boron Lewis acids has exploded over the past few 
decades, new avenues of reactivity that were previously thought to be unobtainable 
have become accessible to the synthetic chemist. The following work described in 
this thesis highlights this fact through the reactions of Lewis acidic boranes and 
borocations in various transformations such as electrophilic cyclisations, 
carboborations, haloborations as well as reduction of unsaturated substrates. 
Chapter 1 gives an introduction to boranes and borocations as Lewis acids including 
their synthesis and reactivity. Chapter 2 shows the rearrangement reactions of allenyl 
ketones and esters when exposed to the Lewis acid tris(pentafluorophenyl) borane. 
These same reagents are then subjected to frustrated Lewis pair chemistry with the 
heterocyclic products being elucidated and studied. Chapter 3 outlines further 
application of the propargyl rearrangement mechanism discovered within the Melen 
group previously. Various homo- and hetero-leptic boranes as well as borocations are 
used in regioselective functional group transfer of a number of propargyl esters, 
amides, carbamates and carbonates. Chapter 4 targets the application of p-block 
Lewis acids in the cyclisation of alkynyl esters and carboxylic acids via π-activation. 
Dialkynyl systems are then explored using two different Lewis acids of differing 
chemical hardness. Finally, Chapter 5 focuses on boron mediated and catalysed 
reduction chemistry across three main themes; attenuating the Lewis acidity at boron 
through aryl group substitution to improve reactivity over perfluorinated counterparts;
the use of novel processing technologies in hydrosilylation reactions and 
comparisons to batch-type reactions; the use of biologically inspired hydride sources 
as potential borohydride precursors as well as their applications in boron mediated 
transfer hydrogenation reactions. 
Chapter 1: Introduction
2
1.2 Background
The concept of Lewis acidity arose in 1923 in opposition to the Brønsted-Lowry 
definition of the time which stated that acids and bases are proton acceptors and 
donors respectively. Lewis proposed an alternative definition whereby the movement 
of a lone pair of electrons describes their basicity and acidity with a Lewis base acting 
as a lone pair donor (1.2a) and a Lewis acid acting as a lone pair acceptor (1.2b, 
Scheme 1.1).[1] Using this parlance, Brønsted-Lowry and Lewis bases are in essence 
the same, with only the definition of the Lewis acidic component changing. This theory
may then be divided further into their hard and soft definitions. For instance, hard 
Lewis acids and bases tend to have small atomic radii with high charge density. This 
results in low polarisability leading to predominantly ionic-type bonding. Conversely, 
softer Lewis acids and bases tend to have lower oxidation states and charge densities 
with larger atomic radii and are therefore more polarisable giving rise to predominantly 
covalent-type bonding. This in turn explains why hard acids tend to bind to hard bases 
and conversely, soft acids tend to bind to soft bases.
Scheme 1.1: General reactivity of boranes with Lewis bases.
Table 1.1: Atomic characteristic according to hard soft acid base (HSAB) theory 
Characteristic Hard Soft
Polarisability low high
Atomic radii small large
Charge density high low
Affinity ionic covalent
As the vast majority of the following work concerns the implementation of highly 
electrophilic boron Lewis acids in various organic transformations, the Lewis acidity 
of such compounds is paramount to their reactivity. Indeed, the reactivity of these 
electron deficient group 13 Lewis acids relies on the availability of a vacant pz orbital 
on boron to accept a lone pair of electrons from a Lewis base (Scheme 1.1). With 
regard to softer Lewis basic centres, specifically alkenes and alkynes, it is proposed 
that an initial encounter complex is formed between the π-electron rich multiple bond 
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and the borane. This hypothesis is supported experimentally by Stephan et al. 
whereby a borane tethered alkene 1.2e is synthesised by exposing Piers’ borane to 
1,4-pentadiene 1.2d with the reaction coordinate being monitored via low temperature 
1H{19F} HOESY NMR spectroscopy.[2] Using this technique, significant through space 
cross-relaxation between the olefinic protons and the ortho-fluorine atoms of B(C6F5)2
was seen indicating a ‘closed’ form of alkenyl borane 1.2f (Scheme 1.2). These cross-
signals in the 2D NMR spectrum disappeared upon heating to ambient temperature 
as the small dissociation energy of the van der Waals encounter complex was 
overcome. The same effect was observed upon addition of acetonitrile as the 
favourable nitrogen-boron adduct is formed preferentially over alkene coordination. 
These experimental findings agree with theoretical work by Guo and Li who also 
found that a similar transitional van der Waals complex is formed between ethylene 
and B(C6F5)3 before nucleophilic attack by phosphorus in an FLP reaction.[3] 
Scheme 1.2: Depiction of closed (1.2e) and open (1.2f) forms in the detection of van der Waals 
interactions via HOESY.
With regard to their synthesis, several paths to generate trivalent boranes 1.2h
exist for example; boron trihalides may undergo salt metathesis reactions via either a 
Grignard[4] or organolithium[5] reagent (1.2g and 1.2i respectively) to form the 
homoleptic borane with elimination of either LiX or MgX2 (Scheme 1.3, top).
Sublimation of the product under reduced pressure and elevated temperatures is a 
convenient method for purification of broad variety of perfluorinated aryl boranes such 
as B(C6F5)3 (Scheme 1.3, inset). Recent work by Ashley and Wildgoose et al. used a 
similar method in pursuit of heteroleptic boranes whereby the diarylated zinc reagent 
1.2j (formed via salt metathesis) was then reacted with excess boron tribromide to 
yield the mono-arylated borane 1.2k. Further reaction with an arylated copper reagent 
1.2l garners the requisite heteroleptic borane with a general structure similar to that 
of 1.2m (Scheme 1.3, bottom). While syntheses to similar heteroleptic boranes are 
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laborious, the final yield was remarkably good at 81%, paving the way for further 
derivatisation using a similar method.[6] 
Scheme 1.3: Salt metathesis routes to homo- and hetero-leptic boranes. Inset shows the 
sublimation of B(C6F5)3.
Other common synthetic methodologies involve the use of routes such as the 
hydroboration of alkenes and alkynes in the analogous reaction seen earlier in 
Scheme 1.2. Some of the more prominent borane reagents used in recent years such 
as those from Erker[7] and Du[8] inter alia[9] have used this technique to garner highly 
electrophilic heteroleptic boranes for use in a plethora of areas of synthetic chemistry
such as small molecule activation as well as highly important enantioselective 
transformations using unsaturated chiral backbones.
Following on from electrophilic boranes, borocations have seen great promise 
over recent years with their implementation in catalysis seeing marked improvements 
since the first structural example of a boronium cation was revealed by Parry et al.[10]
Koelle and Nöth provide an in-depth review of structural aspects of borocations which 
summarise the three types of borocation; the two-coordinate borinium, the three-
coordinate borenium and the four-coordinate boronium.[11] In terms of reactivity, the 
sp hybridised borinium cation is the most reactive, featuring two X-type ligands 
leaving two empty p-orbitals for bonding. These tend to be highly unstable, requiring 
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electronically stabilising π-donors such as amines and significantly bulky ligands to 
sterically protect the vacant orbitals at the boron centre (1.2n–o, Figure 1.1).[12] On 
the other end of the spectrum exists the boronium cations featuring sp3 hybridised 
boron centre with the general formula of [BX2L2]+. In this case, the boron centre still 
features a formal positive charge however, it is coordinatively saturated (1.2r–s,
Figure 1.1). The increase in stability over the borinium cation is mitigated by a partial 
quenching of reactivity due to the two L-type donors. Nevertheless, they are still 
common motifs in borylation chemistry, often being described as ‘masked boreniums’
on account of a weakly bound ligand in the fourth coordination site whose lability 
opens up the boron centre toward reaction.[13] A compromise between the two 
extremes of the borinium and boronium is possible through the use of borenium 
cations, a three coordinate borocation with the general structure [BX2L]+ (1.2p–q, 
Figure 1.1).[14] These offer a highly Lewis acidic boron centre as a result of the formal 
positive charge, as well as the availability of the vacant pz orbital on boron.
Figure 1.1: Trend in borocation reactivity and select examples.
The use of boranes in synthetic chemistry has been a staple for many decades 
now, with a small selection being shown in Figure 1.2. To expand, a vast range of 
reactions are possible using boron reagents with aryl and vinyl boranes proving to be 
powerful precursors for carbon-carbon bond formation through the Suzuki-Miyaura 
cross-coupling reaction.[15] This transformation is of such importance that the 2010 
Nobel Prize in Chemistry was awarded to the pioneers for their contributions to 
organic synthesis, highlighting the influence that boron reagents have in synthetic 
chemistry. Similar reactivity of aryl boronic acids was revealed in the Chan-Lam 
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cross-coupling using a copper (II) acetate catalyst to form oxygen or nitrogen bridged 
diaryl systems under aerobic conditions.[16] Allylboron reagents also have a prominent 
position in allylation reactions, sharing this mantle with other famous main group 
compounds such as allylstannanes as well as metal derivatives, for example organo-
chromium,[17] zinc[18] and indium compounds.[19] This reaction is particularly useful in 
the installation of allylalcohol derivatives, with a surprising amount of molecular 
complexity being possible using synthetically accessible boron reagents.[20] The bulky 
Lewis acid B(C6F5)3 has also been used industrially as a co-catalyst in the Ziegler-
Natta polymerisation of alkenes. In this case, the borane is used an abstraction agent 
to remove a methyl group from the zirconium centre to leave a vacant site at the 
metal. This is then ready for alkene coordination and subsequent propagation to 
generate the requisite polymer. More pertinent to the work outlined within this thesis, 
trivalent boranes have been recently adopted to great effect in carbo- halo- and hydro-
borations which are explored in-depth throughout this work. Therefore, the 
exploitation of commercially available or readily synthesisable boranes in new 
reactivity is of utmost importance to the scientific community. To that end, the 
utilisation of these highly reactive electron-deficient group 13 reagents for use in new 
synthetic methodologies such as carboborations, cyclisations, haloborations,
hydroboration, hydrosilylations and hydrogenations comprise the major focus of this 
thesis (Chapters 2–5).
Figure 1.2: Selection of boron mediated or catalysed reactions.
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Chapter 2
Activation of Allenyl Ketones and Esters using 
Cooperative Lewis Pairs and Boron Lewis Acids
Publications from this work 
1. R. L. Melen,* L. C. Wilkins, B. M. Kariuki, H. Wadepohl, L. H. Gade, A. S. K. 
Hashmi, D. W. Stephan, M. M. Hansmann,* “Diverging Pathways in the 
Activation of Allenes with Lewis Acids and Bases: Addition, 1,2-Carboboration 
and Cyclization”, Organometallics, 2015, 34, 4127.
2.1 Introduction
Two main reactions are discussed within the chapter; frustrated Lewis pair-type 
chemistry and 1,n-carboborations. Regarding the former, frustrated Lewis pair 
chemistry has seen an exponential increase in interest since the initial discovery by 
Stephan et al. in 2006.[9c, 9e, 21] As discussed earlier, the combination of a sterically 
encumbered Lewis acid and base leads to unquenched reactivity. This ‘frustrated’
reactivity has seen particular interest in the activation of small molecule such as N2O, 
SO2, CO2, CO and H2 with molecular hydrogen perhaps being one of the most 
synthetically, and industrially useful.[9g] More pertinent to this work though, the 
application of an FLP system to unsaturated carbon-carbon frameworks, leads to a
1,2-addition reaction across the double- or triple-bond. This has been shown with a 
variety of Lewis acid/base combinations such as boranes, alanes and stannanes as 
the Lewis acid, with amines, phosphines and sulfides amongst others being used as 
the base (Scheme 2.1, top).[9d, 22]
The activation of carbon-element double bonds (C = X where X = N, O) with main 
group compounds has been extensively pursued in a variety of reduction reactions 
such as hydrosilylations,[23] hydroborations[24] and hydrogenations[9a, 25] with the 
activation of carbon-carbon double bonds being slightly less well explored due to the 
inherent lower polarity compared with the heteroatom congeners. In this context, one 
of the earlier examples of metal-free main group reactivity with alkenes was in the 
synthesis of intramolecular FLPs by Erker.[7a, 7c] It was shown that the reaction of 
dimesitylvinylphosphine (2.1a) with Piers’ borane HB(C6F5)2 (2.1b) proceeded to yield 
the selective anti-Markovnikov product as the ethylene-bridged B/P frustrated Lewis 
pair 2.1c.
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Scheme 2.1: Activation of carbon-carbon multiple bonds by FLPs (top) boranes 
(bottom).
This has seen numerous applications as an effective FLP catalyst in a number of 
reactions such as small molecule activation, but also as an alkene activator itself. 
When exposed to norbornene a formal 1,2-addition takes place to garner the exo-2,3-
adduct 2.1d in 72% yield (Scheme 2.2). Other work by Wang et al. showed how Piers’ 
borane can also readily undergo a reduction reaction of an ‘unactivated’ olefin to the 
alkylborane which can then participate in subsequent hydrogenolysis to furnish the 
requisite alkane regenerating the Piers’ borane in a catalytic fashion.[26]
Scheme 2.2: Hydroboration of a vinylphosphine to form an intramolecular FLP with 
subsequent alkene activation.
Some examples exist of borylation reactions of alkenes however, many 
incorporate early transition metals such as copper, nickel or a bimetallic Cu/Pd system 
to yield the alkyl boronate esters.[27] To counter this trend, Erker and Stephan have 
been at the forefront of the movement to utilise metal-free routes to activate alkenes 
such as the cycloamination of o-allyl dimethylaniline derivatives 2.1e–f to yield the 
zwitterionic indoline and quinoline derivatives 2.1g–h (Scheme 2.3).[28]
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Scheme 2.3: Cycloamination of o-allyl anilines using B(C6F5)3.
This is similar in nature to further research conducted by Stephan et al. whereby 
various boranes with pendant olefinic units (2.1i, 2.1k) undergo an FLP-1,2-addition 
reaction upon exposure to the bulky Lewis base PtBu3 to generate either the 
zwitterionic 5- or 6-membered B-heterocycles 2.1j and 2.1l respectively (Scheme 
2.4). In addition, the combination of the bulky amine base pentamethylpiperidine 
(PMP) with the alkoxyborane 2.1m furnished a similar 6-membered heterocyclic ring, 
this time with the incorporation of oxygen to generate the ammonium borate salt 2.1n
(Scheme 2.4).[29] Similar examples exist using 1,3-dienes,[30] 1,3-enynes or 1,3-diynes
also.[31]
Scheme 2.4: Cyclisation of allylboranes by FLP-1,2-addition and hydrogenation.
While alkynes, and to a lesser extent alkenes, have received the majority of the 
attention, there is a surprising lack of interest in the literature regarding the reactivity 
of allenes toward main group compounds. With regard to this, a few examples exist
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such as the hydrostannation of various alkyl allenes to yield the vinyl tin reagents in 
relatively good yields, however, E/Z selectivity of the resulting alkene was poor 
ranging from 1:99 to 42:58.[32] Subsequent work by Alcarazo observed the 
FLP hydrogenation of electron deficient allenyl malonates 2.1o using various amine 
and phosphine bases alongside B(C6F5)3. Pressurising the system with H2 (60 bar) 
showed hydrogenation of the olefinic unit proximal to the malonate functional 
group.[33] Expanding the substrate scope with various electron rich and poor groups 
appended to the terminal carbon of the allene whilst using DABCO as the Lewis base 
garnered the reduced products 2.1p in good to excellent yields however, long reaction 
times of 72 hours were noted (Scheme 2.5). Interestingly, the exposure of these 
allenes to the FLP system in the absence of hydrogen was not trialed.
Scheme 2.5: Hydrogenation of allenyl malonates using FLPs.
Remarkably, carboborations of alkenes appear to be seldom found in the 
literature whilst their alkyne counterparts have found endless success in a variety of 
1,n-carboboration reactions. The topic of carboboration of alkynes is extensively 
covered during the course of this work (see Chapters 3 and 4) therefore extensive 
discussion of alkyne activation can be found in these sections. Nevertheless there
was an interesting report from Ohmiya and Sawamura et al. who demonstrated an 
elegant method to carry out a 1,2-trans-carboboration of ethyl 3-phenylpropiolate
2.1q via an allenyl phosphonium borate intermediate I (Scheme 2.6).[34] This reaction 
proceeds via a 1,4-alkyl migration to the α-carbon to yield the resonance structures 
of the allylide intermediate II and III. This then undergoes a conformational change 
to IV–V with concomitant ring-closing to form the cyclic phosphonium borate VI. 
Subsequent ring-opening with loss of the phosphine fragment generates the trans-
carboboration product 2.1r as a result of molecular templating from the carbonyl 
oxygen.
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Scheme 2.6: 1,2-trans-carboboration of ethylpropiolates via allene intermediates.
2.1.1 Aims of This Chapter
The reaction of allenes with FLPs and boranes to yield various borylated products 
is notably scarce in the literature therefore investigations into these systems are 
incredibly desirable. Additionally, given the high reactivity of these systems it is 
anticipated that interesting reactivity should result from this work. Herein, the reactivity 
of these allene systems toward Lewis acids and bases will be probed with an 
examination of the reaction pathway taking place via spectroscopic, solid-state and 
computational analyses.
2.2 Results and Discussion
2.2.1 Cooperative Lewis Pair Reactions with Allenes
Initial investigations pursued the addition of sterically demanding Lewis acids and 
bases to the various allenyl ketone reagents 2.2 with the preliminary expectation that 
a simple 1,2-trans-addition across the distal olefinic unit would occur, similar to that 
witnessed previously with other unsaturated carbon-carbon frameworks as discussed 
above. The allenyl ketones 2.2 were reacted with a combination of the Lewis acid 
B(C6F3)3 and various tertiary phosphines (P(o-tol)3; P(m-FC6H4)3; P(p-OMeC6H4)3; 
PBn3) in a 1:1:1 ratio. Once mixed, the reaction progress was assessed via in situ
NMR spectroscopy (1H, 19F, 11B, 13C, 31P) which revealed an almost instantaneous
and quantitative conversion to a new product 2.3 which was determined to be the 
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product of a 1,4-addition (Scheme 2.7). The recovered yields were of the crystalline 
products hence lower than the NMR spectroscopic conversions. Diagnostically, the
11B NMR spectra invariably all displayed resonances at ca. δ = -4.0 ppm which is 
synonymous with the formation of an oxygen bound borate moiety.[35]
Scheme 2.7: Reactions of allenyl ketones 2.2 with FLPs to give 2.3.
As expected, all 19F NMR spectra exhibited three multiplet signals in a 2:1:2 ratio 
arising from the ortho (δ = -132.7 to -133.3 ppm), para (δ = -160.1 to -161.2 ppm) and 
meta (δ = -164.9 to -165.9 ppm) fluorine atoms of the perfluorophenyl rings of the 
borane. In addition, the 19F NMR spectra of 2.3f and 2.3g showed resonances at δ = 
-105.5 and -105.2 ppm respectively as a result of the m-fluorine atoms on the 
phosphine derivative that was used. The singlet resonance observed in the 31P{1H} 
NMR spectra varied according to the phosphine that was utilised in the reaction: for 
2.3a–e and 2.3f–g where P(o-tol)3 and P(m-FC6H5)3 were used respectively, the 
chemical shift was observed at ca. δ = 23 ppm. Similarly, for 2.3h–i where P(p-
OMeC6H5)3 was used, a resonance at δ = 22 ppm was seen and finally for 2.3j–k
using PBn3, a singlet shift was observed at ca. δ = 25 ppm.
For many of these addition products, single crystals could be obtained directly 
from the reaction mixture after storing at ambient temperature for 2–8 h. Single crystal 
X-ray diffraction measurements were performed on the crystals 2.3a–c, 2.3f and 2.3j–
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k which confirmed the molecular structure as the result of a 1,4-addition of the boron 
to oxygen, and the phosphine to the β-carbon of the allene unit to form the s-cis
conformer (Figure 2.1). The bond lengths of the solid-state structures are all similar 
regardless of the ketone substituent and phosphine used (Table 2.1). However, 
differences do arise between the structures when comparing the dihedral angles 
C1=C2 and C3=C4 subunits.
Figure 2.1: Solid-state molecular structures of 2.3a–c, 2.3f and 2.3j–k. C: grey, O: red, B: 
yellow-green, F: pink, P: orange, Cl: green. Thermal ellipsoids drawn at 50% probability.
2.3 2.3b
2.3c 2.3f
2.3j 2.3k
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Although a conjugated π-system is present, the two olefinic fragments are out of 
plane by anywhere between 14.2(4)° and 29.5(3)° thus reducing effective orbital 
overlap and reducing the extent of delocalisation across the system. Further to this, 
the R1 phenyl substituent appears to rotate out of the diene plane in the solid-state, 
further hindering the delocalisation of the conjugated π-system which is thought to be 
a combination of steric obstruction as well as an artifact of crystal packing. 
Table 2.1: Experimental bond lengths in 2.3a–c, 2.3f and 2.3j–k.
Mechanistically it is proposed that the reaction is initiated by the formation of the 
hard Lewis acid/base adduct between the borane and carbonyl oxygen via σ-
activation. This initial adduct formation is in-keeping with previous reports whereby 
the borane primarily forms this Lewis adduct however, the relatively facile nature of 
the B–O bond cleavage enables the borane to activate other functional groups.[23a, 23b, 
36] In this instance however, upon coordination there is a build-up of partial positive 
charge on the β-carbon of the allene (I, Scheme 2.8) allowing subsequent conjugate 
addition to occur through nucleophilic attack by the external phosphine (II, Scheme 
2.8) to furnish the diene product 2.3 (Scheme 2.8). Whilst it may be feasible that the 
phosphine addition may occur reversibly in the absence of the borane, in situ NMR 
spectroscopic studies show no indication of activation on an NMR timescale, 
signifying that the borane is necessary to isolate the product.
Bond Length /Å
Bond 2.3a 2.3b 2.3c 2.3f 2.3j 2.3k
C1–C2 1.347(2) 1.352(4) 1.356(2) 1.356(3) 1.359(3) 1.353(2)
C2–C3 1.465(3) 1.468(4) 1.464(2) 1.460(3) 1.463(3) 1.466(2)
C3–C4 1.337(3) 1.332(5) 1.340(2) 1.339(3) 1.337(3) 1.335(2)
C1–O 1.339(2) 1.334(4) 1.336(2) 1.337(3) 1.339(2) 1.335(2)
O–B 1.495(3) 1.493(4) 1.489(2) 1.499(3) 1.490(2) 1.493(2)
C3–P 1.818(2) 1.825(3) 1.811(1) 1.811(2) 1.800(2) 1.804(1)
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Scheme 2.8: Reactions of allenes 2.2 with Lewis acid/base pairs. 
To probe this further, thermodynamic calculations were carried out using the 
allenyl ketone 2.2a as a model in the sequential addition of B(C6F5)3 then PPh3 in 
order to assess the energetics of each reaction step. The enthalpy, entropy and Gibbs 
energy changes were calculated at 298 K alongside NBO analysis to calculate partial 
charges on each atom of the allene substrate.[37] As expected, this supports the 
experimental findings showing a large increase in positive charge on the β-carbon 
upon borane addition in I from +0.12 to +0.21. Additionally, the thermodynamic data 
supports this theory showing favourable energetics upon borane binding with a further 
decrease in G once conjugate addition has taken place (Table 2.2).
Table 2.2: Thermodynamic data and NBO charge distributions (e–) for the reaction of 2.2a with 
B(C6F5)3 and PPh3 using B3LYP/6-311G*+ level of theory.
Compound G (kJ/mol) H (kJ/mol) S (kJ/mol.K)
2.2a -1210463 -1210344 0.398505
B(C6F5)3 -5799279 -5799045 0.785245
PPh3 -2720657 -2720496 0.539788
I -7009704 -7009412 0.977920
II -9730353 -9729963 1.304974
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2.2.2 1,2-Carboration of Allenes using B(C6F5)3
Once it was established that allene reagents will react with cooperative Lewis 
pairs, it was postulated that these reactive functional groups should react directly with 
the Lewis acidic component on its own. Therefore, the same allenyl ketones (2.2) as 
outlined above in Section 2.2 were subjected to a stoichiometric amount of B(C6F5)3. 
Once again, these reactions were complete within a 30 minute timeframe at room 
temperature to yield a single product when observed by NMR spectroscopy. The 11B 
NMR spectra for products 2.4 showed a broad singlet resonance at δ = 2 ppm, 
consistent with chelating heterocyclic adducts observed in the literature.[20, 36b, 36d]
Perhaps more revealing was the presence of a new set of peaks in the 19F NMR 
spectra. Two sets of 2:1:2 resonances were present in a 1:2 ratio indicating the 
presence of two equivalent perfluorophenyl rings and one inequivalent suggesting a 
carboboration reaction had occurred. With the above information to hand, coupled 
with the presence of a vinylic proton at δ = 7.3 ppm and an alkyl CH2 fragment at δ = 
2.7 ppm in the 1H NMR spectra, it was anticipated that the reaction undergoes a 
regioselective formal 1,2-carboboration of the terminal olefinic unit of the allene to 
form the E-isomer of the chelating α,β-unsaturated ketone 2.4 (Scheme 2.9).
Scheme 2.9: Reactions of B(C6F5)3 with allenes 2.2 to give 2.4.
The proposed product was confirmed in the solid-state through X-ray diffraction 
studies of crystals grown from a saturated toluene/hexane solution stored at -40 °C. 
Indeed, the structure was that of a formal 1,2-carboboration whereby a C6F5 has been 
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installed in the β-position with the boron fragment being located at the γ-position to
the carbonyl functionality (Figure 2.2). Metrics are summarised in Table 2.3, showing 
bond lengths are the same within error for the two structural derivatives.
Figure 2.2: Solid-state molecular structures of 2.4a (left) and 2.4b (right). C: grey, O: red, B: 
yellow-green, F: pink. Thermal ellipsoids drawn at 50% probability.
As this chemistry appeared to work well with allenyl ketones, it was posited that
allenyl esters would show similar reactivity (Scheme 2.10). Unfortunately, the reaction 
between B(C6F5)3 and the ester derivatives 2.5a–b did not proceed as smoothly with 
in situ spectroscopic analyses showing and intractable mixture of products. However,
a small crop of crystals suitable for X-ray diffraction could be isolated from a scale-up 
reaction by slow evaporation of either a CH2Cl2/hexane (2.5a) or toluene/hexane 
(2.5b) solution to reveal the solid-state structure of 2.6a–b as the product of a 1,2-
carboboration process (Figure 2.3, Table 2.3). As with the allenyl ketones, the isolated 
structures show σ-activation with a subsequent 1,5-C6F5 migration followed by a 
sigmatropic 1,5-boron migration to form the stable intramolecular 6-membered 
chelate 2.6. This was again confirmed by the 11B NMR spectra of the isolated crystals 
with broad singlet resonances arising at ca. δ = 4.5 ppm, again indicative of these 
intramolecularly coordinated oxaborinine compounds.[20, 36b, 36d]
Scheme 2.10: Reactions of B(C6F5)3 with allenyl esters 2.5.
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Figure 2.3: Solid-state molecular structures of 2.6a (left) and 2.6b (right). C: grey, O: red, B: 
yellow-green, F: pink. Thermal ellipsoids drawn at 50% probability.
Table 2.3: Experimental bond lengths in 2.4a–b and 2.6a–b.
As described earlier, B(C6F5)3 has displayed the proclivity to undergo certain π-
binding modes instead of the traditional σ-activation mode. This was evident when 
combining the trimethylated allenyl ketone 2.5c, in the presence of trace water, which 
afforded the γ-lactone 2.7 as the product of a 5-endo-trig cyclisation with borane 
coordinated to the carbonyl oxygen in a moderately good yield of 56% (Scheme 2.11). 
This was confirmed via X-ray diffraction as seen in Figure 2.4. Of note is the similarity 
of this reaction to others conducted with coinage and platinum group metals such as 
gold or palladium, setting an interesting prospect for boranes to act as transition metal 
mimics.[38]
Bond Length /Å
Bond 2.4a 2.4b 2.6a 2.6b
C1–C2 1.437(4) 1.440(3) 1.4636(3) 1.4655(16)
C2–C3 1.352(3) 1.355(2) 1.3482(3) 1.3565(16)
C3–C4 1.496(3) 1.497(3) 1.5180(3) 1.5235(17)
C1–O 1.268(3) 1.277(2) 1.2557(2) 1.2613(15)
O–B 1.569(3) 1.565(2) 1.5723(3) 1.5660(16)
B–C4 1.604(3) 1.603(3) 1.6148(3) 1.6136(17)
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Scheme 2.11: Reactions of B(C6F5)3 with allenyl ester 2.5c.
Figure 2.4: Solid-state structure of compound 2.7. C: grey, O: red, B: yellow-green, F: pink. 
Thermal ellipsoids drawn at 50% probability.
With regard to possible mechanistic pathways, it is understood that these allenyl 
esters may undergo either a σ-activation mode of the carbonyl oxygen, or π-activation 
of the distal olefinic fragment with each drastically changing the product which is
formed. Whilst no formal η-2-type complex has been isolated showing side-on 
activation of the π-system, recent analyses indicate that weak van der Waals 
interactions may exist between the π-bond and the borane (see Scheme 1.2).[2] This 
is more evident in the case of the allenyl ketones whereby the inherent polarity of the 
carbonyl bond is more pronounced, with significantly more positive charge located on 
the β-carbon. If this is diminished, as is the case with allenyl ester derivatives, then 
alternative π-activation pathways may predominate. If the σ-activation pathway 
prevails, then the activation of the β-carbon occurs through the conjugated system (I
and II, Scheme 2.12) allowing a 1,5-C6F5 migration to occur followed by the 
sigmatropic 1,5-boron migration of the intermediate diene unit III to the α,β-
unsaturated ester 2.6 featuring the chelating O–B motif. Alternatively, if π-activation 
is invoked (IV, Scheme 2.12) then depletion of electron density on the terminal carbon 
of the allene allows for nucleophilic attack to form the furanium borate intermediate 
V. This may be evidenced in the 11B NMR spectrum where a sharp singlet is observed 
at δ = -16 ppm.[39] This step is presumably reversible however, when trace water is 
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present dealkylation of the ester moiety may occur driving the reaction toward the 
lactone 2.7 via concurrent protodeboration, similar in fashion to related chemistry of 
palladium or gold systems through protodemetallation mechanisms.[38]
Scheme 2.12: Proposed mechanism for σ- vs. π-activation of allenyl esters.
Table 2.4: Thermodynamic data and NBO partial charges (e–) for the reaction of I with B(C6F5)3
and its subsequent rearrangement to III.
Compound G (kJ/mol) H (kJ/mol) S (kJ/mol.K)
B(C6F5)3 -5799279 -5799045 0.785245
I -1111010 -1110888 0.410736
II -6910240 -6909945 0.988575
III -6910341 -6910056 0.957191
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To explore this phenomenon further, representative computational analyses 
were conducted of the prototypical allenyl ester (I, Table 2.4). In this case, the 
depletion of electron density on the central carbon of the allene unit is far less 
pronounced upon borane coordination compared to the ketone derivative, increasing 
from +0.13 to only +0.16 according to NBO partial charge analysis. Thermodynamic 
data was also calculated revealing that this process is far less thermodynamically 
favourable than the ketone counterpart with the Gibbs free energy of the cyclised 
chelate product III being essentially iso-energetic to the σ-activated intermediate II.
2.3 Conclusions
The application of cooperative Lewis pairs to allenyl ketones results in the 1,4-
addition product through O–B coordination and nucleophilic attack of the β-carbon by 
the phosphine. If a Lewis base is absent from the reaction, then a net 1,2-
carboboration pathway prevails through a series of steps; 1) borane coordination to 
the carbonyl oxygen; 2) 1,5-C6F5 migration from boron to the β-carbon and; 3) a 
sigmatropic 1,5-boron migration to garner the heterocyclic 6-membered allylboron 
chelate. However, when allenyl esters are used, there are two pathways by which the 
reaction may proceed. Firstly, σ-activation follows the same pathway as before to 
yield the 6-membered heterocycles however, in the presence of water the second 
pathway may proceed via π-activation. In this case activation of the distal olefin 
results in a 1,2-addition followed by dealkylation and protodeboration to reveal the γ-
lactone product. The latter reactivity mimics that of π-Lewis acidic late transition 
metals such as palladium, platinum and gold revealing new applications of boranes 
in carbon-carbon multiple bond activation, a topic that is discussed in the following 
chapters.
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Chapter 3
The Propargyl Rearrangement: Cyclisations, 1,1-
Carboborations and 1,3-Haloborations of Homoleptic 
and Heteroleptic Boranes
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Hansmann*, R. L. Melen,* “The Propargyl Rearrangement to Functionalised 
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3.1 Introduction
One powerful subset of carbon-element bond forming reactions is the 1,n-
carboboration where main group centred reagents have been used extensively with 
many applications in benzannulations[40] and cyclisations,[41] amongst others.[42]
Wrackmeyer’s seminal work, which is also briefly described in Chapter 2, describes 
how an ‘activated’ alkyne undergoes a 1,1-carboboration reaction through π-
activation of the electron rich carbon-carbon triple bond (Scheme 3.1).[43]
Scheme 3.1: General carboboration mechanism.
In light of Wrackmeyer’s discoveries, Erker et al. utilised this powerful method to 
affect benzannulation reactions through a series of carboboration steps using 
dialkynyl precursors in conjunction with B(C6F5)3. In this case, a functionalised indole 
derivative 3.1a, featuring trimethylsilyl groups in the terminal positions of the alkynes, 
undergoes a cascade reaction to garner the 6,5,6-tricyclic 14π Hückel aromatic 
compound 3.1c.[40] This was then extended to thiophene and pyridine backbones to 
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generate the corresponding benzothiophenes and quinoline derivatives. These 
cyclized products were then subjected to oxidative workup using NaOH/H2O2 to 
remove the boron fragment however, this workup also cleaved the adjacent C–Si 
bond to give the resultant benzannulation products such as 3.1d in a modest yield of 
52–58% (Scheme 3.2). This reaction is posited to proceed via the mono-
carboboration of the alkyne proximal to the heteroatom to give the selective Z
intermediate I (thermodynamic pathway). If the distal alkyne is activated (kinetic 
pathway), it was seen through the solid-state structure of 3.1b that the second alkyne 
activation may not proceed due to the boron centre not being in the vicinity of the 
second alkyne π-bond. Nevertheless, once the thermodynamic product I is formed, 
a 1,1-alkenylboration reaction from II takes place to generate the desired carbazole 
product 3.1c. 
Scheme 3.2: Benzannulation reaction of diynes using B(C6F5)3.
Other work in this area from Stephan et al. used telluroethers in a series of 
carboboration reactions to produce a range of 1-telluro-4-boracyclohexadienes. In the 
earliest report, a dialkynyl telluroether 3.1e was combined with a number of boranes 
(B(C6F5)3, PhB(C6F5)2 and BPh3), triggering a double 1,1-carboboration reminiscent 
of the work by Erker above.[44] Following the first 1,1-carboboration (I, Scheme 3.3), 
it appears as though the reaction can follow one of two pathways; the first pathway is 
the reversible intermolecular FLP addition to generate an extensively conjugated 
dizwitterion 3.1f. However, this is in equilibrium and thus collapses back to the native 
carboboration intermediate I that undergoes a second irreversible 1,1-carboboration 
furnishing the 6-membered borotellurocycle 3.1g which were all confirmed 
spectroscopically as well as in the solid-state. Interestingly, it was shown that when 
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tetrasubstituted olefinic substituents are incorporated, a substitution reaction may 
occur upon addition of a terminal alkyne such as phenylacetylene (Scheme 3.3). Due 
to the increased steric crowding afforded by the quaternisation and the substituent 
adjacent to boron (II, Scheme 3.3), the internal alkynyl equivalent is expelled to 
garner the less hindered heterocycle 3.1h.[45] Conversely, if an alcohol is applied to 
the intermediate 3.1g then a substitution reaction ensues that affords a variety of 
unsymmetrically substituted tellurium boron heterocycles 3.1i.[46] Further to this, using 
monofunctionalised telluroethers gave the mono-carboboration products which are 
then susceptible to further FLP-type addition reaction toward alkynes to give the 
zwitterionic borotellurocycle.[22a] This work has particularly interesting prospects as 
tellurium-doped heterocycles possess interesting photophysical properties[47] and 
photo-reactivity[48] as well as applications in optoelectronics[49] and photodynamic 
therapy.[50]
Scheme 3.3: Formation of various boron tellurium heterocycles via 1,1-carboboration.
With regard to the target cyclisation products, specifically oxazoles, oxazolines 
and dioxaborinines, the synthesis of such functionalisable heterocycles are key in 
various areas of chemistry with application in a diverse range of fields such as 
pharmaceuticals,[51] coordination chemistry[52] as well as protecting groups.[53] With 
specific focus on their use in pharmaceuticals, searching for procedures that negate 
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the use of heavy metals and replacing them with less toxic, more abundant main 
group reagents is of particular interest. Traditionally, many of the methods used to 
undergo similar cyclisations to form oxazoles, furans and lactones use late transition 
metals such as gold,[54] palladium[55] or silver[56] as soft π-Lewis acids. One example 
of many is the use of a Pd (II) catalyst in work by Liu et al. whereby an enynyl acetate 
reagent (3.1j) undergoes a 5-endo-dig cyclisation reaction to generate the 2,5-
substituted furans 3.1k through a π-activation process (Scheme 3.4). In this case, the 
formation of an η-2 metal complex (I, Scheme 3.4) activates the alkyne toward 
nucleophilic attack by the acetate moiety. This in turn releases the palladium 
substituted furan (II, Scheme 3.4) through dealkylation of the acetate group to form 
acetic acid with concomitant protodemetallation to give the substituted furan 3.1k. 
Similar work in their group previously found that the same reaction could be 
conducted using elemental iodine to form the iodonium electrophile in situ resulting in 
the substituted furans, thus precluding the use of expensive transition metal 
catalysts.[57]
Scheme 3.4: Palladium catalysed intramolecular cyclisation to form furan derivatives.
This original discovery using main group elements showcases how many 
transformations that are carried out by transition metals may also be effectively 
carried out using more abundant and potentially less toxic p-block elements. With the 
revelation that main group compounds are useful in carbon-carbon triple bond 
activation, contrary to traditional thought, a number of other procedures having been 
put forward using elemental iodine and hypervalent iodine (III) reagents.[58]
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Specifically, work conducted by Du and Zhao et al. utilised the Lewis acidity of 
phenyliodine diacetate,  PhI(OAc)2, in the oxidative intramolecular cyclisation of 
enamides (3.1l) to form the target oxazoles 3.1m (Scheme 3.5).[59] This proceeds 
through a number of complex rearrangement steps with one proposed pathway 
proceeding through alkene activation by the hypervalent iodine with subsequent 
isomerisation (I, Scheme 3.5). This then undergoes substitution at iodine to give the 
iodine-containing heterocycle (III, Scheme 3.5) followed by reductive elimination of 
iodobenzene to form the new carbon-oxygen bond of the oxazole.
Scheme 3.5: Hypervalent iodine mediated cyclisation of enamides to form oxazoles.
Recent work within the Melen group combined both these practices of 
cyclisations and 1,1-carboborations utilising main group compounds in the formation 
of a number of oxazoles, oxazoliums and dioxoliums through the use of boron Lewis 
acids. Some of the earlier research in the area used propargyl amides 3.1n in 
combination with the archetypal bulky Lewis acid B(C6F5)3 producing similar results 
as those utilising π-Lewis acidic gold complexes.[60] In this case, using the borane in 
a stoichiometric manner initiated the 5-exo-dig cyclisation when heated to 45 °C to
yield a range of oxazolium borate zwitterions  (3.1p, Scheme 3.6).[39a] It was noted 
that a reactivity series could be established whereby depletion of electron density of 
the carbonyl through the R1 substituent could enhance reactivity by increasing the 
lability of the boron adduct of 3.1o, resulting in more ‘free’ borane to activate the 
alkyne. This is a trend that holds true with a lot of early main group reactivity, with 
specific mention to reduction reactions whereby hydrosilylation occurs fastest with 
electron deficient carbonyls and conversely, the poorest reactivity is imparted by 
electron rich substrates.[23a, 24a, 61]
Many of the examples used in this early work feature a tertiary amine in the 
backbone however, if a secondary amine is used then catalytic turnover to the oxazole 
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can be observed when a sufficiently bulky adamantyl group is incorporated into the 
R1 position. While the reaction is slow under harsh reaction conditions (10 days at 
100 °C) the oxazole 3.1q could be produced in 83% yield setting an encouraging 
precedent for main group catalysts (Scheme 3.6). When the substrates were 
functionalised with methyl groups in the propargylic position, then an alternative 
reaction pathway prevailed producing a 7-membered chelating 1,1-carboboration 
product 3.1r. This is posited as being the result of allylic strain between the adjacent 
bulky C6F5 groups on boron and the dimethyl backbone in the oxazolium borate 
resulting in the carboboration pathway triumphing over the cyclisation route (Scheme 
3.6).
Scheme 3.6: Varying reactivity of propargyl amides with B(C6F5)3.
In an extension to this, simply switching out the amide unit for an ester drastically 
changes the outcome of the reaction with a complex rearrangement process 
occurring coined as the ‘propargyl rearrangement’ (Pathway A, Scheme 3.7). Early 
examples of this divergent reactivity from Melen et al. used various substitution 
patterns of propargyl esters in conjunction with B(C6F5)3 to form the similar 5-
membered zwitterionic 3.1t however, due to the instability of the dioxolium salt, this 
undergoes a ring-opening reaction with π-bond migration generating a build-up of 
positive charge on the carbon adjacent to the boron centre (II, Scheme 3.7). This is 
followed by a 1,2-C6F5 shift which, upon conformational change, forms a stable 6-
membered dioxaborinine 3.1u. When heated, this may then undergo a 1,3-boron shift 
to give the less hindered product 3.1v. Yet, in a similar vein to the propargyl amides, 
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functionalising the propargyl reagent drastically affects the reactivity as seen when 
the terminal alkyne is altered to an internal variant featuring either Me or nPr groups 
in the R4 position. In this system, instead of the propargyl rearrangement taking place, 
a stable tertiary carbocation (III, Scheme 3.7) is formed which undergoes a new ring-
closing reaction by nucleophilic attack of the carbonyl oxygen. A subsequent 1,3-
boron shift and carbon-carbon double bond migration generates the stable dioxolium 
zwitterions 3.1w (Pathway B, Scheme 3.7). This is particularly interesting as very few 
isolable examples of such dioxoliums exist in the literature owing to their inherent 
instability.[20, 62]
Scheme 3.7: Varying reactivity of propargyl esters with B(C6F5)3.
3.1.1 Aims of This Chapter
Combining the above topics and methodologies to synthesise evermore complex 
and synthetically useful heterocyclic structures is of massive importance to the 
synthetic chemist. Additionally, developing these systems to deliver groups other than 
perfluorinated aryl rings is a challenge that is prime for exploitation. To this end, and 
building on other contemporary works in this area, this chapter aims to expand the 
substrate scope of these propargyl systems to include ureas, carbamates and 
carbonates as well as utilising heteroleptic boranes to deliver synthetically more 
useful R-groups to the heterocyclic products.
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3.2 Results and Discussion
3.2.1 The Propargyl Rearrangement of Amides, Carbamates and
Carbonates 
3.2.1.1 Reactivity of Dipropargyl Amides 
Building on previous work within the group, we aimed to react dipropargyl amides 
with B(C6F5)3 in a bid to promote a cyclisation reaction. Initially it was uncertain as to 
whether the diyne cyclisation would occur to form the carboboration product similar 
to those seen in the synthesis of boroles, phospholes inter alia,[41, 63] or whether it 
would follow the analogous propargyl amide cyclisation pathway seen before with 
gold and boron reagents to form the oxazolium salt.[39a, 64] Indeed, there is the 
prospect for the pendant alkyne fragment to undergo additional tandem reactions 
differing from previous mono-alkyne reagents. 
It was observed that the 1:1 stoichiometric reaction between N,N-dipropargyl 
amides 3.2 with B(C6F5)3 at mild temperatures resulted in a single product being 
formed. Interestingly, it was solely the 5-exo-dig cyclisation pathway that prevailed to 
form the oxazolium zwitterion 3.4 while leaving the second alkyne fragment 
untouched (Scheme 3.8). This presumably follows the same mechanistic pathway 
observed previously whereby the 1,2-trans-addition of the carbonyl oxygen and 
borane to the alkyne occur via the initial Lewis adduct 3.3.[39a] Two examples of this 
Lewis adduct intermediate 3.3a–b could be isolated by crystallisation from a saturated 
toluene solution stored at -40 °C in 77% and 41% yield respectively, which could be 
measured by single crystal X-ray diffraction (vide infra). The ensuing cyclisation to 
form the 5-alkylidene-4,5-dihydrooxazolium borate products 3.4 via π-activation could 
be initiated by heating to 45 °C for 48 hours garnering the products in generally good 
yields of 57–86% (Scheme 3.8). It appears the best conversions were as a result of 
the incorporation of mesomerically electron-withdrawing p-nitrophenyl group (3.4c) 
presumably reducing the nucleophilicity of the carbonyl oxygen. This in turn increases 
the lability of the O–B adduct, leaving more ‘free’ borane available to activate the 
alkyne toward nucleophilic attack. This general trend is congruent with other findings 
within the group.[39a]
The proposed transformation is evidenced by the 11B NMR spectra whereby a 
broad singlet is seen at δ = -0.5 ppm for the B–O adduct which then gives rise to 
another sharp singlet resonance at δ = -17 ppm post cyclisation, which is indicative 
of similar vinyl borate moieties.[39, 62] This is further reinforced by the 19F NMR spectra 
which showed that upon quaternisation of the borane, a diagnostic upfield shift of the 
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p-F atoms are observed revealing the three resonances in a 2:1:2 ratio for ortho (ca. 
δ = -132.8 ppm), para (ca. δ = -160.5 ppm) and meta (ca. δ = -165.0 ppm) fluorine 
atoms of the perfluorophenyl rings.
Scheme 3.8: Reactions of dipropargyl amide derivatives with B(C6F5)3.
Solid-state analysis of the Lewis adducts 3.3a–b reveals that both structures 
present similar bond lengths which are all within anticipated ranges however, a slight 
shortening of the C–N bond is seen as a result of the stabilizing effect of the cationic 
carbonyl fragment (ca. 1.324 Å vs. 1.346 Å for a C–N single bond). The resulting cis
configuration displays a slight bent geometry with regard to the dihedral angle 
between B–O–C–C of 18.71(16)° for 3.3a and 7.88(17)° for 3.3b. Subsequent solid-
state analyses on 3.4c–d reveal as expected, the heterocyclic oxazolium borate. 
Similar in nature to the adduct, the delocalisation of positive charge that is formed 
through the cyclisation step is now more pronounced with further contraction of the 
C–N bond (ca. 1.302 Å) compared to a formal C–N single bond at 1.346 Å.[65]
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Figure 3.1: Solid-state structures of 3.3a–b and 3.4c–d. Toluene solvent omitted for clarity. C: 
grey, B: yellow-green, N: blue, F: pink, O: red. Thermal ellipsoids shown at 50% probablility.
Table 3.1: Experimental bond lengths for 3.4c and 3.4d.
Bond Length /Å
Bond 3.4c 3.4d
C1–C2 1.305(9) 1.315(2)
C2–C3 1.499(8) 1.510(2)
C3–C 1.489(7) 1.475(2)
C4–C 1.306(6) 1.298(2)
C4–N 1.466(7) 1.489(2)
C2–O 1.471(5) 1.459(2)
C4–O 1.303(8) 1.307(2)
C1–B 1.619(8) 1.628(2)
3.3a 3.3b
3.4c 3.4d
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Both structures also display remarkable planarity regardless of the lack of aromaticity 
with root mean square (RMS) deviation values of 0.024 and 0.037 for 3.4c and 3.4d
respectively as a result of four of the five atoms in the ring system being predominantly 
sp2 in character. Additionally, in the solid-state, the oxazoline fragment lies in the 
equatorial position of the cyclohexyl group of 3.4d, theorised to be as a means to 
reduce the steric occlusion between the adjacent unreacted propargyl moiety (Figure 
3.1).
3.2.1.2 Reactivity of Propargyl Ureas 
In an extension to the work conducted previously into the dipropargyl amides and 
the lability of the B–O adduct, attenuation of the carbonyl oxygen donor ability was 
probed through the use of propargyl urea substrates. If this reaction follows the same 
5-exo-dig cyclisation pathway, then it should be expected that 5-alkylidene-4,5-
dihydrooxazol-2-amino borate products will predominate. Indeed, when the 
substrates 3.5 were subjected to one equivalent of B(C6F5)3, a broad singlet was 
observed in the 11B NMR spectrum at δ = -1.9 ppm indicating adduct formation.[66]
Upon heating to 50 °C a new resonance at δ = -17.0 ppm was  observed in the 11B 
NMR after 7 days (3.6a) or 14 days (3.6b) which was attributed to the target vinyl 
borate species (Scheme 3.9). These could both be isolated in 31% yield as crystalline 
solids from the reaction mixtures upon cooling. 
Figure 3.2: In situ 11B NMR spectra of the reaction between 3.5b and B(C6F5)3.
30 min
24 h
6 d
12 d
14 d
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Further support could be offered by the 19F NMR spectra, revealing a similar theme 
in the form of the three resonances in a 2:1:2 ratio for the ortho (δ = -132.4 ppm), para
(δ = -161.2 ppm) and meta (δ = -165.1 ppm) fluorine atoms. This upfield shift of the 
para-fluorine atom is again indicative of a four-coordinate borate which is consistent 
with similar motifs found in the literature.[67] It was also noted that a side product was 
emerging in the 11B NMR at δ = -10.0 ppm which is attributed to the formation of the 
oxazole via a protodeboration and tautomerisation rearrangement with the borane 
coordinating to the imine nitrogen (Figure 3.2, Scheme 3.9).
The reduced reaction rate of the urea derivatives compared to the amide 
precursors may be attributed to the stronger donor character of the carbonyl oxygen 
due to the urea scaffold in addition to poor solubility of the urea reagents. The 
delocalised positive charge about the N2CO fragment is more stabilised than in the 
amide example leading to lower concentrations of ‘free’ borane in solution, therefore 
reduced rates of alkyne activation. These factors may be partially mitigated through 
the use of more harsh reaction conditions to ensure that the oxazoline products 3.6
could be furnished in modest yields.
Scheme 3.9: Proposed mechanistic pathway of the reaction between propargyl ureas and 
B(C6F5)3.
As stated earlier, the positive charge that is delocalised about the N2CO fragment 
is elucidated when addressing the solid-state metrics of the cyclised oxazoline 
products 3.6. The data summarised in Table 3.2 showcases this with a noticeable 
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contraction of both C–N bonds (1.313(3) and 1.317(3) Å) as well as the C–O bond 
(1.304(3) Å) which are all intermediate between formal single and double bonds.[65]
Again, the planarity of the 5-membered oxazoline ring system is almost completely 
planar with a RMS of 0.026. 
Table 3.2: Experimental bond lengths for 3.6a–b.
Figure 3.3: Solid-state molecular structures of 3.6a (left) and 3.6b (right). C: grey, B: yellow-
green, N: blue, F: pink, O: red. Thermal ellipsoids shown at 50% probability.
3.2.1.3 Reactivity of Propargyl Carbamates 
Moving along the series in varying the heteroatoms flanking the carbonyl moiety, 
O-propargyl carbamates 3.7 were used in a stoichiometric amount with B(C6F5)3 to 
affect the propargyl rearrangement to the yield the heterocyclic chelating 1,1-
carboboration product 3.9. While the first part of the mechanism involves the 
formation of the dioxoiminiolium borate 3.8, similar to those seen in Sections 3.2.1 
and 3.2.2, a subsequent rearrangement via a ring-opening/1,2-C6F5 migration 
Bond Length /Å
Bond 3.6a 3.6b
C1-C2 1.309(3) 1.310(4)
C2-C3 1.512(3) 1.508(5)
C3-N1 1.465(2) 1.455(4)
C4-N2 1.313(3) 1.312(5)
C4-N 1.317(2) 1.309(5)
C2-O 1.461(2) 1.460(4)
C4-O 1.304(2) 1.309(4)
C1-B 1.619(3) 1.618(5)
Chapter 3: The Propargyl Rearrangement: Cyclisations, 1,1-Carboborations and 1,3-Haloborations of Homoleptic 
and Heteroleptic Boranes
35
mechanism occurs (I and II, Scheme 3.10) to generate the allylboron 3.9 which is 
analagous to the reaction between propargyl esters with B(C6F5)3. This initial 
cyclisation readily occurs at room temperature, assumedly due to lower 
nucleophilicity of the NCO2 moiety when compared to the urea derivative, which could 
be isolated in 64% and 60% yield respectively. However, to secure the final allylboron 
products 3.9, extended reaction times of 24–120 h were necessary although 
increasing reaction temperature to 50 °C saw the products being furnished in as little 
as 16 h in yields of 66–75% (Scheme 3.10). With regard to mechanistic insight, 
conducting the initial cyclisation step at low temperature precludes the ring-opening 
step, allowing the  2-amino-1,3-dihydrooxolium zwitterions 3.8 to be isolated. Whilst 
other unstabilised dioxolium compounds rapidly undergo the ring-opening step 
making isolation near impossible with a few exceptions,[20] the stabilsation offered by 
the amido nitrogen of the carbamate allowed for easy isolation of these intermediates 
as crystalline solids. 
Scheme 3.10: Reaction between 3.7 and B(C6F5)3 to give 3.8 and 3.9. 
Multinuclear NMR spectroscopic analysis of the intermediates presented the 
characteristic resonance in the 11B NMR spectra at δ = -17.0 ppm for the quaternised 
vinyl borate fragment with a similar motif in the 19F NMR spectra for the ortho- (δ = -
132.8 ppm), para- (δ = -161.1 ppm) and meta- (δ = -165.5 ppm) fluorine atoms of the 
pentafluorophenyl rings in a 2:1:2 ratio. Indeed, when these are then heated to initiate 
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the ring-opening step, the formation of the allylboron products 3.9 are readily 
identified by a broad resonance at δ = ca. 0 ppm in the 11B NMR spectra which is 
indicative of the new chelating B–O adduct. Another diagnostic NMR handle is the 
formation of the exo-alkene moiety. These vinylic protons present as a pair of 
doublets for the unsubstituted propargyl carbamates (3.9a,c) at δ = 4.3–5.0 ppm in 
the 1H NMR, or a doublet and quartet for the methyl derivative (3.9b). Instead of 
observing three resonances in the 19F NMR as is the case with the vinylborate 
intermediates 3.8, the juxtaposition of one of the C6F5 rings as a result of the 
carboboration reaction leads to all three perfluorophenyl rings being inequivalent 
hence nine distinct resonances for 3.9.
From the reactivity so far, a trend can be identified whereby an increase in the 
stabilisation from heteroatoms that flank the carbonyl moiety, the more Lewis basic 
the carbonyl oxygen and hence the slower the cyclisation is due to borane 
sequestration. An argument could be made that a stronger Lewis basic oxygen could 
undergo a more rapid cyclisation due to an increase in nucleophilic behaviour once 
B–O dissociation occurs however, it appears that adduct cleavage is the rate 
determining step leading to slower reaction times and more harsh reaction conditions 
being necessary for appreciable conversion to the heterocyclic product. Additionally, 
the extra stabilisation that is afforded by the amido nitrogen also stabilises the 
intramolecular chelate formed in 3.9 as prolonged heating at 60 °C did not undergo a 
1,3-boron shift to yield the 1,3-carboboration product as seen in Scheme 3.7, which 
requires this O–B bond to be cleaved.[20] Whilst these compounds were fully 
characterised via multinuclear NMR spectroscopy, the solid-state structures could 
also be measured by single crystal X-ray diffraction to unambiguously verify the 
formation of the zwitterionic 5-membered oxazolium borate 3.8 and 6-membered 
allylboron chelate 3.9 (Figure 3.4). The metrics are outlined in Table 3.3. Comparing 
the C–N bond length of the urea product 3.6 to that of 3.8 shows a contraction 
(1.313(3) vs. 1.290(3) Å) which is consistent with the positive charge being located 
primarily on the nitrogen atom hence, a decrease in the number of stabilising nitrogen 
atoms leads to shorter bond lengths of any remaining C–N bonds. Confirmation of 
the molecular structure of 3.9b–c was seen through single crystal X-ray diffraction, 
revealing the heterocyclic 6-membered allylboron product. The metrics in this case 
were as expected with the C2–C3 bond displaying typical double bond sp2 character 
(1.324(7) and 1.309(3) Å) alongside a contracted C4–N bond in agreement with prior 
observations regarding bond order (Table 3.3).
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Figure 3.4: Solid-state molecular structures of 3.8a,c, 3.9b–c. C: grey, B: yellow-green, N: 
blue, F: pink, O: red. Thermal ellipsoids shown at 50% probability.
Table 3.3: Experimental bond lengths for 3.8 and 3.9.
Bond Length /Å Bond Length (Å)
Bond 3.8a 3.8c Bond 3.9b 3.9c
C4-C5 1.302(3) 1.304(4) C5-C6 1.498(6) 1.492(3)
C4-C6 1.509(3) 1.505(4) C6-C7 1.324(7) 1.309(3)
C6-O7 1.468(3) 1.466(4) C6-O8 1.438(5) 1.436(2)
C2-O7 1.309(3) 1.297(3) C2-O3 1.280(6) 1.263(3)
C2-N1 1.290(3) 1.305(3) C2-O8 1.332(6) 1.315(3)
C4-O3 1.440(3) 1.464(3) C2-N1 1.325(6) 1.320(3)
C2-O3 1.307(3) 1.305(3) C5-B4 1.633(7) 1.647(4)
C5-B 1.616(4) 1.627(4) O3-B4 1.570(6) 1.555(2)
3.8a 3.8c
3.9b 3.9c
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While the former carbamate substrates featured the propargyl functionality 
tethered to the oxygen atom, the reverse was then investigated through the use of 
the N-propargyl carbamate 3.10 (Scheme 3.11). Upon exposure to one equivalent of 
B(C6F5)3 the anticipated oxazolium borate was unexpectedly absent when observing 
the in situ multinuclear NMR spectra. Instead, the 11B NMR spectrum showed a 
resonance at δ = 0.7 ppm indicating a coordinative B–O bond. This information,
coupled with the 1H NMR spectrum where resonances at δ = 2.18 ppm and δ = 6.56 
ppm were observed indicating methyl and vinyl environments, suggested that the 
compound was a product of the aforementioned protodeboration/tautomerisation step 
to form the corresponding 5-methyl-2-(3H)-oxazolone borane adduct 3.11. This was 
then reinforced through single crystal X-ray diffraction confirming the molecular 
connectivity as being the oxazolone heterocycle. It is posited that trace amounts of 
water prompt the dealkylation of the benzyl protecting group with concurrent 
protodeboration/tautomerisation to generate the oxazolone 3.11. 
As the product sequesters the borane as the Lewis adduct, it was thought that 
this reaction could be conducted catalytically. Attempting this reaction using 10 mol%
B(C6F5)3 in the presence of one equivalent of water shows the presence of a singlet 
in the 1H NMR spectrum at δ = 4.63 ppm, indicating the formation of benzyl alcohol 
as a result of the dealkylation step. However, the in situ NMR spectroscopic data 
could not reliably confirm the success of this reaction due to a mixture of other 
products being present. This does however demonstrate the potential that the strong 
Lewis acid B(C6F5)3 poses as a transition metal mimic as similar transformations to 
oxazolone products exist using late coinage and platinum group metals such as 
palladium or gold.[68]
Scheme 3.11: Oxazolone synthesis from the reaction between B(C6F5)3 and 3.10.
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Figure 3.5: Solid-state molecular structure of 3.11, C: grey, B: yellow-green, N: blue, F: pink, 
O: red. Thermal ellipsoids shown at 50% probability.
3.2.1.4 Reactivity of propargyl carbonates 
To fully extend the series of flanking heteroatoms, propargyl carbonates were 
subsequently examined. Indeed, the stoichiometric mixture of the propargyl 
carbonate 3.12 with B(C6F5)3 led to the formation of the 6-membered allylboron 
heterocycle in 81% yield via the propargyl rearrangement with relatively long reaction 
times of 72 hours being noted (Scheme 3.12). All NMR spectroscopy revealed the 
expected chemical shifts with the indicative 11B NMR resonance presenting as a 
broad singlet at δ = ca. 0 ppm. Subsequent solid-state analysis through single crystal 
X-ray diffraction again confirmed the molecular structure (Figure 3.6). Additionally, it 
was observed that all three C–O bond lengths were similar in nature, varying by only 
ca. 0.05 Å (1.246(2), 1.298(2) and 1.292(2) Å for C–O1, C–O2 and C–O3 respectively) 
showing the positive charge is delocalised almost equally about the CO3 fragment.
Figure 3.6: Solid-state molecular structure of 3.13, C: grey, B: yellow-green, F: pink, O: red. 
Thermal ellipsoids shown at 50% probability.
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Scheme 3.12: Reactions of propargyl carbonate 3.12 in propargyl rearrangements with 
B(C6F5)3. 
In an interesting turn from the reactivity observed with these types of reagents, a 
completely new avenue was unlocked when the tbutyl derivative 3.14 was used. 
Instead of the anticipated 1,1-carboboration product prevailing, the in situ 1H NMR 
spectrum revealed a more interesting fate. The use of B(C6F5)3 resulted in the 
complete deprotection of the the Boc group to generate isobutylene as well as the 
porpargyl alcohol starting material (Scheme 3.13). Analysis of the 1H NMR spectrum 
over time when using 10 mol% B(C6F5)3 loading at ambient temperature showed 
almost complete deprotection of the Boc group after 17 hours, with the diagnostic 
isobutylene septet at δ = 4.64 ppm being identified (Figure 3.7). In addition to this, the 
methyl groups of the alcohol moiety undergo a slight downfield shift in the 1H NMR 
spectrum from δ = 1.67 to 1.70 ppm. 
Scheme 3.13: Proposed mechanism for Boc deprotection of propargyl carbonate 3.14
using 10 mol% B(C6F5)3. 
Indeed, this deprotection is an incredibly common method in synthetic chemistry, 
more often catalysed by the addition of a strong Brønsted acid e.g. HCl/acetic acid or 
trifluoroacetic acid however, if certain acid sensitive functionalities are present in 
reagent, this method may provide a slightly milder approach to catalytic Boc group 
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deprotection.[69] It is also true that this transformation has been conducted by other 
main group centred compounds[70] nonetheless, according to an exhaustive literature 
survey, this is one of the first examples where B(C6F5)3 has been used for the catalytic 
deprotection of Boc groups.
Figure 3.7: Stacked in situ 1H NMR spectra for the catalytic Boc deprotection of propargyl 
carbonate 3.14 using 10 mol% B(C6F5)3.
3.2.2 Use of Heteroleptic Boranes for Selective Migratory Group 
Transfer
The use of boranes, specifically B(C6F5)3, as a carboboration reagent was 
outlined in the previous section however, the transfer of a C6F5 group is of limited 
synthetic use with only a handful of practical uses, such as their applications in 
biological systems.[71] It would be of greater significance to transfer ‘R’-groups other 
than these perfluorophenyl rings. To this end, other electrophilic boranes were 
synthesised to be utilised in the propargyl rearrangement as a way of installing new 
functionality in a one-pot multistep process. Boranes of the general structure R-
B(C6F5)2 were used for example, those synthesised by Erker through the salt 
metathesis of PhBCl2 and LiC6F5 to yield PhB(C6F5)2[72] (3.18) as well as the 
hydroboration of styrene using Piers’ borane (HB(C6F5)2)[24a] to generate the 
Unreacted 3.14
1 h
3 h
17 h
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phenylethyl borane 3.19.[24b, 73] Additional transfer reagents such as the borenium 
cation 3.21 reported by Ingleson et al. were also utilised in this work as selective 
carboboration reagents (Figure 3.8).[74]
Figure 3.8: Electrophilic borane and borenium Lewis acids used as R-group transfer reagents. 
It was also identified that iodoalkynes of the general structure R-C≡C-I (R = Ph, 
nBu) are excellent candidates to undergo carboboration reactions due to their 
similarity to Wrackmeyer’s ‘activated’ alkynes. Indeed, when exposed to B(C6F5)3, 
such iodoalkynes undergo rapid 1,1-carboboration (<10 mins) to garner the 
iodoalkenylboranes 3.20 quantitatively and in excellent stereoselectivities of ca. 98:2 
E/Z of the product 3.20a as determined by in situ multinuclear NMR spectroscopy. 
Equally, the nBu derivative gave similarly high yields however, slightly lower 
selectivities were noted giving a ca. 80:20 mixture of the E/Z isomers of 3.20b. This 
is a surprisingly high degree of selectivity when compared to ‘normal’ alkynes 
(terminal alkyl/aryl groups), where the E/Z isomers are formed in a ca. 1:1 ratio.[73]
This selectivity, and purity, could be readily assessed through the 19F NMR spectra 
which give rise to six resonances for the ortho (δ = -127.0 (4F), -137.5 (2F) ppm), 
para (δ = ca. -144.5 (2F), -152.6 (1F) ppm) and meta (δ = ca. -160.5 (6F) ppm) fluorine 
atoms. The small number of residual resonances observed in the 19F NMR spectrum 
of 3.20b are attributed to the minor isomer of the carboboration step. Additional 
multinuclear NMR spectroscopic data confirms these findings with 3.20a–b
presenting a broad singlet resonance in the 11B NMR spectrum at δ = 57.9 ppm and 
δ = 58.4 ppm respectively which is congruent with other similar scaffolds.[75] Work in 
the area by Erker showcased how irradiation of the stereoisomeric sample could 
promote photolytic interconversion to a single isomer however, after being irradiated 
with UV light (HPK 125, pyrex filter)[73] a mixture of stereoisomers persisted. Of note 
is the prospect of employing these iodine-functionalised reagents in further reactivity 
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such as the synthetically important carbon-carbon bond forming reactions for 
instance, Sonogashira or Suzuki-Miyaura cross-coupling as well as Heck reactions.
The borane and borenium reagents 3.18–3.21 were then implemented as 
transfer reagents to assess their alkyl, alkenyl and aryl migratory aptitudes when 
subjected to various propargyl esters and carbamates which have to date only seen 
reaction with B(C6F5)3.[20, 36d] The first reagent that was trialed was PhB(C6F5)2 3.18 in 
conjunction with the propargyl ester 3.22f in a stoichiometric ratio. Initial results from 
this reaction were less than impressive with a mixture of products being observed, 
most likely arising from an unselective migration of either a C6F5 or phenyl moiety. 
Similarly, the reaction using the ethylphenylborane 3.19 with the ester 3.22f again 
gave an intractable mixture of products, presumably showing how lability of each 
group (C6F5 vs. alkyl) is similar in this instance, which is interestingly in contradiction
to previous reports.[75] While this reaction proved to be unselective (64:36 alkyl:C6F5 
transfer) single crystals of the major isomer could be obtained which were suitable for 
X-ray diffraction showing transfer of the alkyl group (Figure 3.9).
As a side note, a 1,1-hydroboration reaction was also attempted using Piers’ 
borane to see whether the propargyl rearrangement could be affected with 
subsequent 1,2-hydride shift from boron to carbon however, the clean 1,2-
hydroboration of the alkyne proceeded within minutes thus signifying that the 
hydroboration reaction occurs much more rapidly than the propargyl rearrangement.
Figure 3.9: Solid-state structure of reaction between 3.22f and 3.19. C: grey, H: white, O: red, 
B: yellow-green, F: pink. Thermal ellipsoids drawn at 50% probability.
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Scheme 3.14: General mechanism for the propargyl rearrangement using boron centred 
reagents.
Moving forward with the novel iodoalkenylboranes 3.20 in these carboboration 
reactions, it was observed that the proclivity of the alkene to migrate was superior to 
that of the C6F5 moiety. With these favourable results in hand, the reaction scope was 
expanded to various other substituted aryl esters 3.22e–f, acetyl ester 3.22g and 
carbamate 3.22h to give a range of various highly functionalised allylboron products 
3.23a–e (Scheme 3.15). Through in situ multinuclear NMR spectroscopy, it was 
observed that these reactions had reached completion within approximately 18 hours 
at ambient temperature to yield 3.23. This could be discerned through the 11B NMR 
spectra which showed a broad singlet at δ = 2.0 ppm, which is characteristic of these 
6-membered dioxaborinine derivatives. The selective transfer of the alkene moiety 
was further verified by scrutinising the 19F NMR spectra whereby the introduced 
inequivalence of the perfluorophenyl rings confirms selective transfer. In addition to 
the inequivalence that is noted in previous examples to give six resonances, the 
juxtaposition of the sterically encumbered alkene fragment precludes the free rotation 
of the C6F5 rings further, therefore presenting as ten resonances instead. This is 
rationalised as four ortho-fluorine resonances (δ = ca. -130 to -140 ppm (6F)), three 
para-fluorine resonances (δ = ca. -150 to -160 ppm, (3F)) and a further three meta-
fluorine resonances (δ = ca. -160 to -165 ppm (6F)). Supplementary verification was 
shown through the presence of the proton on the carbon adjacent to boron as a broad 
singlet in the 1H NMR spectra at δ = ca. 5 ppm.
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Scheme 3.15: Rearrangement products (3.23a–f) from vinyl group transfer. 3.24 shows minor 
product from C6F5-migration.
Additionally, the presence of a quartet δ = 5.5 ppm is characteristic of the vinyl group 
exo to the dioxaborinine ring being formed as a result of the cyclisation process. In 
the case where the carbamate precursor 3.22h was used, instead of the methylvinyl 
group being generated, a simple vinylic fragment is noted with the presence of a pair 
of doublets at δ = 4.72 and 5.00 ppm in the 1H NMR for 3.23f.
Storing the samples 3.23a–c and 3.23e–f as saturated CH2Cl2/hexane solutions 
at -40 °C led to the formation of a crop of crystals whose structure could be 
determined by single-crystal X-ray diffraction (Figure 3.10). Using this method 
revealed the iodinated olefinic fragment to be the E-isomer in all structures however, 
the stereochemistry of the adjacent sp3 carbon centre is formed as a racemic mixture 
of the R- and S-enantiomers. In the case of 3.24, a very small number of crystals 
could be collected of the minor product whereby a C6F5 fragment was transferred 
instead of the olefinic unit.
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Figure 3.10:  Solid-state structure of 3.23a–c, 3.23e–f and 3.24. C: grey, H: white, O: red, B: 
yellow-green, F: pink, I: brown, N: blue. Thermal ellipsoids drawn at 50% probability.
The propargyl esters used so far feature a methyl group in the propargylic 
position however, when this is replaced with a proton to give the methylene esters
3.22a–d (Scheme 3.14), an entirely different rearrangement mechanism is observed. 
While a familiar resonance was present in the 11B NMR at δ = 2.0 ppm, indicating 
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adduct formation of a trivalent species, when observing the 1H NMR spectra the 
presence of the vinylic protons were noticeably absent. Fortunately, two sets of single 
crystals could be harvested from the reaction between 3.22d and 3.20 which were 
unambiguously determined as the bis(perfluorophenyl)boranyl ester dimer 3.25 in 
addition to the substituted (pentafluorophenylethynyl)benzene 3.26 as a result of an
elimination reaction (Scheme 3.16, Figure 3.11). Mechanistically, it is presumed that 
the initial B–O Lewis adduct is formed which in turn activates the propargylic position 
to undergo nucleophilic attack via iodine transfer. With the loss of propargyliodide, 
the B–C bond cleavage occurs to produce the (pentafluorophenylethynyl)benzene 
fragment 3.26 alongside the bis(pentafluorophenyl)boranyl ester which dimerises as 
observed in the solid-state (Figure 3.11). To further test this hypothesis, benzyl 
benzoate 3.27 was trialed with the iodovinylborane 3.20a with the corresponding 
borane dimer 3.25a prevailing as determined by X-ray crystallography. This 
alternative reaction pathway is presumed to arise due to the lack of steric 
encumbrance in the propargylic position as the inclusion of a bulkier group in this 
position impedes the intramolecular halide shift.
Scheme 3.16: Alternative reactivity of propargyl esters 3.22a–d with vinyl boranes 3.20.
Scheme 3.17: Reaction of 3.20a with benzyl benzoate to generate the dimeric boranylester 
3.25a. Conversion given as in situ NMR spectroscopic measurement.
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Figure 3.11:  Solid-state structure of 3.25a, 3.25b and 3.26. C: grey, H: white O: red, B: yellow-
green, F: pink, N: blue. Thermal ellipsoids drawn at 50% probability.
As the approaches used so far show varying degrees of successful alkyl, vinyl or 
aryl group transfer, focus was then shifted to the 8-oxy-quinolatoborenium salts 3.21
reported by Ingleson, which have proven to be effective migratory group transfer 
reagents.[74] This was selected due to the bidentate nature of the quinoline backbone 
which promotes the exclusive transfer of the aryl substituent on boron. Monitoring the 
reaction between the propargyl esters 3.22e–f and the borenium cation 3.21 showed 
that indeed the phenyl group was transferred exclusively to garner the allylboronium 
salts 3.28. These were formed in 43% and 75% respectively as measured via in situ
conversions. The resultant 1H NMR spectra for 3.28a–b were perhaps more 
complicated than first assumed due to the formation of a diastereomeric mixture of 
the (R,R) and (R,S) conformers in a 5:1 ratio as a result of the spiro-centre formed at 
boron and adjacent chiral sp3 centre. Single crystals could be grown of the (R,R) 
diastereomer which unequivocally shows molecular connectivity of the boronium 
cation 3.28b (Figure 3.12).
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Scheme 3.18: Propargyl rearrangements with borenium cations 3.21. Conversion to both 
diastereoisomers 3.28 and 3.28’ determined by in situ NMR spectroscopy.
Figure 3.12: Solid-state structure of 3.28b. C: grey, H: white O: red, N: blue, B: yellow-green, 
Al: light grey, Cl: green. Thermal ellipsoids drawn at 50% probability.
3.2.3 Divergent Elementoboration using Heteroleptic Boranes in the 
Propargyl Rearrangement
In the previous sections, various boranes and borocation have been discussed 
as ‘R’-group transfer reagents in a bid to increase molecular complexity in the 
products of the propargyl rearrangement. While both sections outline a powerful 
method of transferring various groups, there are certain pitfalls such as the restrictive 
nature of transferring C6F5 groups using B(C6F5)3, or the synthetically intensive routes 
to form the alkyl, vinyl and aryl boron centred reagents in section 3.3. It was therefore 
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proposed that another commercially available borane could be used to affect the 
same transformation while simultaneously transferring a synthetically more useful R-
group. To this end, dichlorophenyborane PhBCl2 was targeted as a good candidate 
for this transformation. 
To trial this borane in the propargyl rearrangement, the model ester 3.29a was 
mixed with PhBCl2 in a 1:1 ratio to affect what was suspected to be the formation of 
the dioxaborinine heterocycle similar to previous examples however, detailed 2D 
NMR spectroscopy (COSY, HSQC, HMBC) did not correlate with the anticipated 
structure. Instead of the expected 1,1-carboboration product prevailing, it was 
revealed that a formal 1,3-haloboration reaction had taken place to furnish the product 
as the α,β-unsaturated ester 3.31 as indicated by the resonance at δ = 6.6 ppm for 
the vinylic proton, and δ = 4.7 ppm for the methylene protons. Interestingly there are 
no reported 1,3-haloboration reactions of alkynes with only one being reported for 
alkenes.[76] With this alternative reactivity being confirmed, the substrate scope was 
expanded to include a small number of substituted phenyl groups with the target 
products being identified by in situ NMR spectroscopy in generally >90% conversion. 
Figure 3.13: Propargyl ester substrates used in this work.
Scheme 3.19: Reaction between PhBCl2 and 3.29 to give 1,3-haloboration products 3.31. 
Values are given as in situ NMR conversions. 
Chapter 3: The Propargyl Rearrangement: Cyclisations, 1,1-Carboborations and 1,3-Haloborations of Homoleptic 
and Heteroleptic Boranes
51
In the case of the p-nitro derivative 3.31c it was possible to obtain single crystals 
from a saturated CH2Cl2/hexane solution stored at -40 °C which unambiguously 
confirmed the molecular structure to be that of a formal 1,3-haloboration reaction, 
agreeing with conclusions from NMR spectroscopic methods (Figure 3.14). It was 
possible to elucidate the stereochemistry of the resulting olefin to be the trans-
product. Earlier work by Erker showcased similar vinylboranes which may be subject 
to photoinduced isomerisation between the E/Z conformers when irradiated with UV 
light.[73] Attempts to induce this interconversion here to form the intramolecular chelate 
were met with limited success as no clear alteration could be noted when scrutinising 
the 11B NMR spectrum. A brief optimisation of solvent systems was implemented with 
all common halogenated and non-halogenated solvents (chloroform, 
dichloromethane, chlorobenzene, benzene and toluene) garnering the product in 
quantitative conversion in 9 hours. Conversely, when coordinating solvents such as 
diethylether and tetrahydrofuran were used, reactivity was completely quenched with 
a singlet resonance at δ = 15 ppm persisting in the 11B NMR spectra indicating the
favourable O–B Lewis adduct was formed, precluding alkyne activation.
Figure 3.14: Solid-state structure of compound 3.31c, C: grey, H: white, N: blue, O: red, B: 
yellow-green, Cl: green. Thermal ellipsoids shown at 50% probability.
The scope was then expanded to include various propargyl esters featuring 
methyl groups in the propargylic position (3.30) instead of the protons seen in 3.29
(Figure 3.13). Interestingly, once these new reagents were exposed to PhBCl2 in a 
1:1 ratio, the in situ multinuclear NMR spectra were not consistent with the formation 
of structures analogous to 3.31. Instead, new resonances arose in the 1H NMR 
spectrum at δ = 3.8 ppm and the 11B NMR spectra at δ = 8.0 ppm, both indicating the 
generation of a dioxaborinine scaffold via 1,1-carbobroation, similar in nature to those 
outlined earlier in this chapter (Scheme 3.20). This could be confirmed further by 
looking at the 13C NMR spectra whereby the vinyl sp2 carbon of the 1,3-haloboration 
product 3.31 gives rise to a resonance at δ ca. = 120 ppm whereas the sp3 carbon 
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formed in 3.32 is as expected at δ = ca. 40 ppm. This reactivity was then expanded 
to other substituted propargyl esters featuring moderately electron 
withdrawing/donating functionalities. However, it appears that this system suffers 
from decomposition when using strongly electron deficient propargyl systems as an 
intractable mixture of products prevails from the reaction. Fortunately, storing a 
saturated CH2Cl2/hexane solution of 3.32a–c at -40 °C resulted in the formation of a 
crop of crystals suitable for X-ray diffraction which confirmed the 1,1-carboboration 
products (Figure 3.15). From the solid-state structure it was possible to gain insight 
into the regioselectivity of this reaction with the selective transfer of the aryl group 
being preferable to the chloride fragment.[36d] Detailed 2D NMR spectroscopic studies 
could again confirm that the bulk sample is in agreement with the solid-state structure. 
Scheme 3.20: Reaction between PhBCl2 and 3.30 to give 1,1-carboboration products 3.32. 
Yields are given as isolated yields.
Figure 3.15: Solid-state structure of compounds 3.32a–c, C: grey, H: white, O: red, B: yellow-
green, Cl: green, F: pink. Thermal ellipsoids shown at 50% probability.
In order to probe the mechanism of these transformations, the terminal position 
of the alkyne 3.29a was selectively deuterated using a polystyrene immobilised amine 
base (WA50) according to a process proposed by Yamada et al.[77] For the 1H NMR 
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of the unaltered compound 3.31, a resonance is seen at δ = 6.6 ppm for the proton 
of the newly formed olefin however, when conducting this reaction with 3.29aD this 
peak is no longer present although it is seen in the 2H NMR spectrum at the same 
chemical shift of δ = 6.6 ppm (Figure 3.16). 
Figure 3.16: Stacked in situ spectra for the reaction between propargyl ester 3.29a or 3.29aD
with PhBCl2.
Comparison of the diverging elementoboration witnessed in this chapter is 
posited to be as a result of the varying steric encumbrance encountered at the 
propargylic position. Taking into account the deuterium labelling experiments above, 
mechanistically it is proposed that initially a 1,2-trans-oxyboration reaction occurs to 
generate the dioxolium borate intermediate (I, Scheme 3.21).[20, 62] From this point, 
the reaction may proceed one of two ways depending on the group featured on the 
backbone. If hydrogen atoms occupy the propargylic position, then the partial positive 
charge that builds here may be quenched by a 1,4-chloride migration to generate the 
1,3-haloboration product 3.31 (Scheme 3.21). Counter to this, if more sterically 
3.31 (1H)
3.31D (1H)
3.31 (2H)
3.31D (2H)
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demanding methyl groups are featured, then the stabilised positive charge cannot be 
quenched leading to the ring-opening rearrangement leaving a build-up of positive 
charge on the carbon adjacent to boron. In this case, a 1,2-aryl group migration 
occurs to furnish the 1,1-carboboration product as the intramolecular chelate 3.32 
(Scheme 3.21).
Scheme 3.21: Proposed mechanism for the divergent elementoboration of 3.29 or 3.30 using 
PhBCl2.
3.3 Conclusions
The addition of various boranes to propargyl ester and amide derivatives spawn 
a variety of differing reactivities stemming from the simple cyclisation of amide 
derivatives, such as ureas and carbamates, to give oxazolium salts. Alternatively, the 
use of ester variants undergo the propargyl rearrangement via 1,1-carboboration to 
give 6-membered heterocyclic dioxaborinine products. In the case of B(C6F5)3 these 
reactions simply transfer a synthetically benign C6F5 group however, using various 
heteroleptic boranes, other functionalities have been transferred including alkyl, vinyl
and aryl groups. These reagents then possess a multitude of reactive sites including 
allylboron units, vinyliodide fragments as well as boronic ester-type functionality all 
leading to potential further reactivity from allylations, crotylations, Heck couplings or 
Suzuki-Miyaura cross-coupling. Further to this, the use of commercially available 
boranes, specifically PhBCl2, has been shown to effectively carry out the propargyl 
rearrangement to garner the dichloroboronate ester. Slight modification of the 
propargyl reagents that were used completely alters the reactivity with the hitherto 
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unreported 1,3-haloboration pathway prevailing over the traditional 1,1-
carboboration. These reactions show how versatile boron reagents are in the 
transformation of simple alkynyl substrates to much more complex and synthetically 
useful products.
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Activation: Carbon-Element Bond Creation through 
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4.1 Introduction
The use of boron Lewis acids in cyclisation reactions has seen exceptional 
uptake in the synthesis of a vast range of compounds such as many common 
heterocyclic motifs seen in a number of biologically active compounds specifically 
pyrones, isocoumarins and pyryliums. These compounds are of particular interest 
due to their wide-ranging physicochemical properties,[78] making them ideal 
candidates for antimicrobial,[79] anti-inflammatory,[80] antibiotic,[81] antiviral,[82] and 
antispasmodic[83] agents. Additionally, there are many recorded cases where they 
also act as a non-steroidal antagonist to a number of androgen[84] or pregnane X 
receptors.[85] Of equal interest is their use as enzyme inhibitors such as that of serine 
proteases.[86] Due to their plethora of applications, many synthetic methodologies 
have been developed over the past few decades from intermolecular approaches 
such as cascade reactions of alkynes with propiolic acids or esters using late 
transition metal catalysts such as ruthenium[87] catalysts or a more elegant gold/silver 
bimetallic coupling system.[88] Alternative methods involve ring expansion of β-
lactones as well as inverse Diels-Alder-type chemistry based on reports by Boger and 
Mullican,[89] which were subsequently expanded by Yamashita et al.[90]
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Another approach is the intramolecular cyclisation of esters featuring pendant 
alkenes or alkynes using π-Lewis acids, for example the bimetallic system set forth 
by Blum et al. whereby a gold/palladium cooperative system was used to affect a 
tandem cyclisation/alkyl migration to generate complex γ-functionalised isocoumarins 
(Scheme 4.1).[91] In this case the π-Lewis acidic Au (I) centre successfully activates 
the alkyne of 4.1a toward cyclisation by the ester carbonyl to generate the oxonium 
triflate ion pair intermediate II. The activated ester substituent is then primed to 
undergo a carbodeauration mechanism via the η-3 allyl palladium intermediate III to 
furnish the final substituted product 4.1b using a relatively low catalyst loading of 5 
mol% with excellent isolated yields of 83–98%.
Scheme 4.1: Dual catalytic cyclisation/allyl transfer mechanism using a bimetallic catalyst.
While the use of transition metals in this sector has seen extensive application, 
other groups have dedicated their research to main group alternatives. One of the 
prototypical examples is that of Gandour et al. whereby an electrophilic bromonium 
ion is generated in situ which was able to affect a formal 6-endo-dig cyclisation of 
intramolecular alkynyl esters to the corresponding bromo-functionalised 
isocoumarin.[92] This was then extended by Larock et al. where other main group 
electrophiles such phenylselenyl chloride, phenylsulfenylchloride and iodine 
monochloride were used to affect the analogous transformation as that set forth by 
Gandour to generate the respective isocoumarin 4.1d with concomitant loss of the 
ester substituent as an alkyl halide (Scheme 4.2).[93] This reaction was thought to 
proceed via three key steps; 1) activation of the alkyne of 4.1c to form the cationic η-
2 selenonium, sulfonium or iodonium intermediate I followed by; 2) nucleophilic attack 
of the carbonyl oxygen to the activated alkyne through a 6-endo-dig cyclisation 
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pathway resulting in the pyrylium intermediate II and; 3) dealkylation of the ester 
substituent by the generated halide anion to liberate the γ-functionalised isocoumarin 
4.1d with the simultaneous loss of the alkyl halide by-product (Scheme 4.2) 
Scheme 4.2: Proposed general mechanism for electrophilic cyclisation of alkynyl esters.
Katzenellenbogen et al. also implemented a similar methodology using mercury 
(II) acetate to promote the cyclisation with successive addition of two equivalents of 
copper (II) chloride to displace the pendant mercurial group in the γ-position leaving 
the chlorinated isocoumarin.[94] While this work further highlights the use of main 
group compounds in cyclisation reactions, the use of toxic mercury compounds 
combined with the use of superstoichiometric amounts of reagent make this route 
less attractive to the synthetic chemist.
In a bid to focus on metal-free cyclisation methods Blum and co-workers, building 
on work outlined later in this chapter (see Section 4.2.1) and their own previous 
findings,[95] reported the stoichiometric use of B-chlorocatechol borane to promote the 
cyclisation of methyl pent-4-ynoate 4.1e to their respective lactone products 4.1f
(Scheme 4.3, top). In this instance, the 1,2-trans-oxyboration cyclisation forms the 
pyrylium borate zwitterion which provides a suitable nucleophile in the form of a 
chloride ion to undergo alkyl abstraction of the ester substituent (I, Scheme 4.3).[96]
The intermediate catechol boronate ester was then trans-esterified to garner the 
stable γ-functionalised isocoumarin 4.1f which provides an excellent scaffold for 
further derivatisation through Suzuki-Miyaura cross-coupling reactions. The same B-
chlorocatecholborane reagent was then applied to alkynyl thioethers 4.1g to furnish 
the functionalised benzothiophene products 4.1h in generally good to excellent yields 
of 48–96% via a similar zwitterionic intermediate (II, Scheme 4.3).[97]
Chapter 4: Formation of 6-Membered Heterocycles via Alkyne Activation: Carbon-Element Bond Creation through 
Cyclisations
59
Scheme 4.3: Reactivity of alkynyl methyl esters and thioethers with B-chlorocatechol borane.
Ingleson et al. showed in simultaneous work that the commercially available 
boron trichloride was also an extremely useful reagent for the cyclisation of similar 
alkynyl ethers and thioethers to generate a series of benzofurans and 
benzothiophenes respectively.[98] The combination of the alkynyl ethers 4.1i (Scheme 
4.4, Y = O) with this borane led to rapid cyclisation and loss of chloromethane to 
generate the borylated benzofuran in as little as five minutes. This vinylchloroborane 
was then esterified due to the inherent instability of the dichloro species to furnish the 
bench stable vinyl boronate ester (Scheme 4.4), which was subsequently applied to 
further cross-coupling reactions to generate the arylated benzofuran in a one-pot 
reaction. This cyclisation methodology could also be applied to thioethers 4.1i
(Scheme 4.4, Y = S) however, the demethylation step did not occur under the 
standard conditions. In this case, the addition of NEt3 and AlCl3 was necessary to 
drive the reaction forward with the products 4.1k being isolated in 55–82% yield after 
conversion to the pinacol boronate ester. 
Scheme 4.4: Oxy- and thio-boration using boron trichloride.
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Interesting work by Erker et al. further demonstrates the use of boron Lewis acids 
in alkyne activation through annulation reactions of diynes to generate a number of 
dibenzopentalenes. Initial reactions using the tetrafluoro derivative of 4.1l (R1 = R2 = 
F, Scheme 4.5) showed how a 1:1 amount of B(C6F5)3 could induce the intramolecular 
cyclisation reaction to garner the requisite 6,5,5,6-tetracyclic system 4.1m in 
moderately good yields of 58%. Altering the backbone of the diyne to include either 
protons or methyl groups in the R1 position instead of the tetrafluoro motif allowed a 
different reaction pathway to ensue. In these cases, a mixture of products were 
recorded, most notably 4.1m which is the analogous product to that observed before, 
and the monoarylated species 4.1n. Mechanistically it was proposed that the initial 
tandem activation of the diyne leads to the intermediate II (Scheme 4.5), which can 
then follow one of two paths. Either protodeboration occurs to generate the final 
product via the vinylborate intermediate III or double bond migration followed by 
carboboration may occur followed by deborylation to the C6F5 functionalised product 
4.1n.
Scheme 4.5: Synthesis of dibenzopentalenes using B(C6F5)3.
Research outlined earlier in Chapters 2 and 3, as well as examples in the 
literature, have shown how the strong Lewis acid B(C6F5)3 is capable of operating as 
a π-Lewis acid in a range of transformations such as trans-oxyborations,[36d]
annulations[99] and cycloaminations[28a] inter alia,[42, 63, 100] in essence mimicking the 
reactivity of late coinage and platinum group metals. As B(C6F5)3 is characterised as 
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a particularly hard Lewis acid, such high reactivity with both hard Lewis basic 
carbonyls as well as soft π-Lewis basic centres is an interesting phenomena. This 
‘dual activity’ is not too dissimilar from research by Takaki et al. whereby a bismuth 
(III) acetate catalyst is used in similar cyclisations to yield functionalised pyrones 
however, this softer Lewis acid was described as activating the ester and alkyne 
simultaneously in a bifunctional manner however, due to the limited availability of the 
vacant pz orbital on boron, only one activation mode may be in operation at any 
moment.[101]
4.1.1 Aims of This Chapter
There are numerous examples of the strong Lewis acid B(C6F5)3 acting as a hard 
Lewis acid in the activation of various substrates through a σ-binding mode however, 
π-activation was observed less frequently until recent years. This chapter exploits 
new findings where B(C6F5)3 is effective in 1,2-addition reactions across alkynes to 
form new heterocyclic products such as pyryliums, indenes, pyrones and 
isocoumarins. Using this method, this chapter explores new methods to form C–H, 
C–C and C–O bonds as well as demonstrating this boranes application in tandem 
reactivity. As a contrast, softer period 4 Lewis acids will also be compared to the 
reactivity of their lighter group 13 congeners.
4.2 Results and Discussion
4.2.1 Formation of Zwitterionic Pyrylium Borates using B(C6F5)3
Reagents featuring alkynyl and carbonyl functionalities tethered by a vinylic 
backbone were targeted as potentially useful starting materials in cyclisation 
reactions due to the driving force of forming a 6π aromatic pyrylium species. 
Therefore, enynoates 4.2a–c were synthesised by literature methods[102] with 
subsequent reaction with the strong Lewis acid B(C6F5)3 which resulted in a rapid 
colour change from off-yellow to a dark orange/red colour at ambient temperatures.
In situ multinuclear NMR spectroscopic studies indicated that a new product had been 
formed in as little as 1 h in quantitative conversion. Storing a saturated CH2Cl2/hexane 
solution at -40 °C resulted in a crop of colourless crystals that could be isolated in 
65% and 64% yield for 4.3a and 4.3b respectively. Interrogation of the NMR 
spectroscopic data indicated that a 6-endo-dig cyclisation reaction had occurred to 
generate the 6-membered pyrylium borate derivatives (Scheme 4.6). This was 
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evidenced by a distinct downfield shift of the vinylic proton on the β-carbon to the 
ester (δ = 6.37 to 8.65 ppm (4.3a), δ = 6.15 to 8.47 ppm (4.3b)). Due to the sterically 
demanding borane used in this transformation, restricted movement of the R1
substituent is seen upon cyclisation (supported by the solid-state structure, see 
below). This was the most pronounced when looking at the 1H NMR spectrum of 4.3b
whereby the two proximal methylene unit of the nBu unit are inequivalent, presenting 
as two broad 1:1 singlets at δ = 1.43 and 0.64 ppm.
Scheme 4.6: Proposed mechanistic pathway of the reaction between B(C6F5)3 and methyl en-
ynoates.
This restricted movement was also observed in the 19F NMR spectra whereby the 
‘normal’ 2:1:2 o-F:p-F:m-F motif is replaced by a more complex picture (Figure 4.1). 
In the case of 4.3a, eight peaks are witnessed for the respective ortho (δ = -128.6 
(1F), -130.3 (4F) and -131.1 ppm (1F)), para (δ = -159.2 (1F) and -160.0 ppm (2F)) 
and meta (δ = -163.5 (1F), -164.7 (1F) and -165.4 ppm (4F)) fluorine atoms. This 
pattern indicates that two of the perfluorophenyl rings are equivalent and one 
inequivalent which contrasts with the nBu derivative which is far more complex. For 
4.3b, fifteen resonances are seen in total for the ortho (δ = -128.2 to -135.0 ppm (6F)), 
para (δ = -158.9 to -159.9 ppm (3F)) and meta (δ = -162.8 to -165.3 ppm (6F)) fluorine 
atoms with each fluorine atom being chemically inequivalent. Perhaps the most 
indicative evidence for the formation of the pyrylium borate scaffold was the sharp 
singlet resonance seen in the 11B NMR at δ = -14.4 and -14.5 ppm for 4.3a and 4.3b
respectively which is indicative of the formation of formally four-coordinate vinyl 
borate species.[39a, 103] Attempts to use variable temperature NMR experiments to 
overcome the rotational energy barrier were unfortunately met with little success as 
heating a d8-toluene solution of 4.3b to 80 °C resulted in no coalescence of the 
proximal methylene protons in the 1H NMR spectrum.
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Figure 4.1: Stacked 19F NMR spectra of 4.3a (top) and 4.3b (bottom).
Additionally, no coalescence of the fluorine resonances in the 19F NMR spectrum was 
apparent indicating that a substantial energy barrier is present in the rotation of the 
C6F5-groups and the R1 substituent. With regard to steric occlusion in the R1 position, 
if a more sterically demanding tBu group is included, then reactivity is completely 
quenched as the Lewis acid/base adduct between the carbonyl and borane 
predominates.
As stated, both structures could be isolated as single crystals which could be 
measured via X-ray diffraction to unambiguously verify the formation of the 6-
membered heterocyclic pyrylium borate 4.3a–b (Figure 4.2). As seen in the solid-
state structure for 4.3a where R1 = Ph, an extended conjugated system is prevented 
as the phenyl unit rotates out of the plane of aromatic pyrylium ring by 58.4(2)°. This 
is in contrast to the cationic 5-membered dioxolium examples whereby coplanar 
orbital overlap is necessary between the [CO2]+ fragment and the adjoining aromatic 
substituent to stabilise the positive charge.[62] As proposed earlier it is presumed that 
steric congestion about the boron centre is the chief factor for this phenyl group 
rotation, which is clearly evident in the space-filling models (Figure 4.3). In the solid-
state there appears to be a displaced π-stacking interaction between this rotated 
phenyl substituent and one of the perfluorophenyl groups on boron with a 
centroid···centroid distance of 3.6421(10) Å. This stacking leads to an eclipsed 
geometry of the B–C6F5 bond and the adjacent C–C6H5 bond which deviate by a mere 
0.11(14)°. Conversely, 4.3b displays lower symmetry, consistent with the NMR 
ortho-F 
ortho-F 
para-F 
para-F meta-F 
meta-F 
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spectroscopic data, giving a B–C6F5/C–nBu deviation of 49.9(2)° showing the 
intersection of the nBu group between two perfluorophenyl rings which is again, more 
evident in the space filling model (Figure 4.3). Other metric parameters of the two 
structures 4.3a–b are similar to one another with C–C bond lengths in the main 
residue of 1.372(3)–1.410(3) Å (Table 4.1) being intermediate between formal single 
(ca. 1.53 Å) and double (ca. 1.33 Å) bonds, and consistent with aromatic systems (ca.
1.38 Å).[65] Additionally, both C–O bonds exo and endo to the ring system are 
statistically equivalent within error (1.303(2)–1.316(2) Å), again intermediate to formal 
single and double C–O bond lengths  (ca. 1.42 and 1.23 Å respectively).[65] Further to 
this, the planarity of the heterocycle could be examined through root mean square 
(RMS) deviation calculations which show the 6-membered cyclic structure being near 
perfectly planar with RMS values of 0.023 (4.3a) and 0.013 (4.3b). 
Figure 4.2: Solid-state structures of 4.3a (left) and 4.3b (right). C: grey, O: red, B: yellow-
green, F: pink, H: white. Thermal ellipsoids shown at 50% probability.
Figure 4.3: Space-filling representation of structures 4.3a (left) and 4.3b (right). C: grey, O: 
red, B: yellow-green, F: pink, H: white. 
Computational studies were then undertaken to further investigate these pyrylium 
structures through natural bond order (NBO)[37] and nucleus independent chemical 
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shift analysis (NICS(0)) using the B3LYP/6-311G* level of theory.[104] The converged 
energy minima structure agrees well with metrics obtained through experimental 
means with similar bond lengths being observed between theoretical and 
experimental methods (Table 4.1). NBO analysis shows clear delocalisation about 
the heterocyclic ring however, a more localised cationic motif is observed about the 
CO2 fragment with Wiberg bond indices for each C–O bond being similar (Figure 4.4). 
Due to the increased electronegativity of the oxygen atoms, a strong bond polarisation 
of the σ-system is observed through large partial charge build up on the carbon atoms 
bonded to oxygen in addition to the oxygen atoms themselves. This accumulation of 
positive charge is predominantly based on the carbon bonded to both oxygens 
however, second order perturbation analysis indicates how some of this effect is 
mitigated through π-back donation to the carbocationic centre. NICS(0) calculations 
clearly demonstrated that 4.3a (-3.93 ppm) and 4.3b (-4.86 ppm) are both aromatic 
although, are both markedly less aromatic in character compared to the benzene with 
a NICS(0) chemical shift of -8.91 ppm (Figure 4.5). This clearly indicates that the 
inclusion of a secondary oxygen atom external to the pyrylium ring disturbs the overall 
aromaticity, which is congruent with other similar systems.[105]
Figure 4.4: Wiberg bond indices for 4.3a and NBO charges for the pyrylium cations 4.3a and 
4.3b. 
Figure 4.5: Aromaticity of compounds 4.3 relative to benzene using NICS(0) calculations.
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Table 4.1: Experimental and calculated bond lengths for 4.3a and 4.3b
This reaction is assumed to proceed via a 1,2-addition of the Lewis basic 
carbonyl oxygen and the Lewis acidic borane to the alkyne in a 6-endo-dig cyclisation 
mechanism reminiscent to that observed in the literature. [20, 39a, 62, 95-96, 106] It was seen 
that the formation of the 6-membered, planar, 6π Hückel aromatic system is preferred 
over the alternative 5-exo-dig cyclisation and the 1,1-carboboration pathways which 
are also prevalent in the literature.[75] Indeed, the resultant furanium derivative as a 
result of a potential 5-exo-dig cyclisation is considered to be less stable than the 
pyrylium counterpart however, examples of such cationic motifs do exist (vide 
infra).[107]
4.2.2 Divergent Reactivity of Hard and Soft Lewis Acids: 6-endo-dig vs.
5-exo-dig
With the previous work into cyclisations of enynyl esters to hand, similar reactivity 
was applied to the conjugated diynyl methyl ester 4.4. Upon mixing this substrate with 
B(C6F5)3 in a 1:1 ratio, an immediate colour change was noted, changing from a 
yellow/orange solution to dark green from which a crop of red block-shaped crystals 
could be harvested in very good yields of 84%. Single crystal X-ray diffraction studies 
of these crystals uncovered the solid-state structure to be that of the extensively 
Bond Length /Å
4.3a 4.3b
Bond Experimental Calculated Experimental Calculated
C2–C3 1.371(3) 1.386 1.374(3) 1.378
C3–C4 1.362(3) 1.384 1.382(3) 1.390
C4–C5 1.430(2) 1.423 1.410(3) 1.410
C5–C6 1.361(2) 1.377 1.372(3) 1.384
C2–O1 1.316(2) 1.319 1.316(3) 1.320
C6–O1 1.404(2) 1.391 1.370(3) 1.370
C2–O7 1.306(2) 1.316 1.311(3) 1.316
C5–B 1.665(2) 1.671 1.657(3) 1.673
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conjugated olefin bridged indene-benzofuranium zwitterion product 4.5 (Scheme 4.7, 
Figure 4.6). It is posited that, contrary to the pyrylium scaffolds witnessed in Section 
4.2, a tandem 5-exo-dig/5-endo-dig tandem cyclisation reaction occurs through π-
activation of the sterically less encumbered alkyne distal to the ester. This triggers 
the nucleophilic attack of the proximal alkyne by the carbonyl oxygen, which then itself 
acts as the nucleophile, undergoing a 1,2-trans addition to the distal alkyne (Scheme 
4.7). It is of note that while a gamut of cascade reactions are known within the 
biomedical field, the use of Lewis acidic boranes in similar domino annulation 
reactions are more rare with only a few examples existing in the literature.[108]
Scheme 4.7: Reaction of 4.4 with B(C6F5)3.
When scrutinising the solid-state structure, it is seen that while the indene and 
furan subunits are adjoined through an olefin bridge and are thus conjugated, they 
are not coplanar in the solid-state with a twist angle of 17.99(11). Interestingly, a 
similar trope to the pyrylium borate products (see Section 4.2.1) is observed in this 
structure whereby the steric occlusion brought about by the juxtapostion of the borane 
and olefin phenyl substituent causes a loss of symmetry as observed in the 19F NMR 
spectrum. Alongside this, π-stacking of the phenyl substituent and one of the C6F5
rings occurs adopting a near coplanar geometry with a fold angle of just 12.52(9)°. 
This π-stacking is shown to have a centroid···centroid distance of 3.4785(16) Å which 
is slightly shorter than that exhibited by 4.3a mentioned in Section 4.2.1.[39b]
Bulk sample analysis via multinuclear NMR spectroscopy agreed with the 
proposed structure of 4.5 with the 11B NMR spectrum displaying a sharp singlet 
resonance at δ = -15.8 ppm, typical of such four-coordinate vinyl borates.[36b] As 
indicated with the solid-state structure, the steric encumbrance brought about by the 
bulky Lewis acid causes restricted rotation of the perfluorophenyl groups leading to 
chemical inequivalence hence, a more complex 19F NMR spectrum than initially 
anticipated. Three discrete resonances are observed in the 19F NMR spectrum for 
both the para- (δ = -160.8 – -162.7 ppm (3F)) and meta- (δ = -164.9 – - 166.6 ppm 
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(6F)) fluorine atoms with each of the ortho-fluorine atoms also being inequivalent, 
resulting in six distinct signals (δ = -123.0 – -136.2 ppm (6F)). In a similar fashion to 
the pyrylium borate products 4.3, the space-filling model elucidates the steric 
encumbrance about the lower part of the molecule where the indene subunit 
interlocks between two of the C6F5-rings as well as the π-stacking motif of the 
remaining C6F5-ring and the phenyl substituent (Figure 4.6).
Figure 4.6: Solid-state structure of 4.5 (left). C: grey, H: white, O: red, B: yellow-green, F: pink. 
Thermal ellipsoids shown at 50% probability. Space-filling model of 4.5 (right).
To contrast the reactivity of the archetypal hard Lewis acid, B(C6F5)3, the softer 
phenylselenylchloride was used as it has been utilised in similar cyclisations to form 
the corresponding selenolactones through a selenirenium intermediate.[109] Upon 
mixing the same diynye starting material 4.4 with PhSeCl in a 1:1 ratio, instead of the 
cascade reaction observed with B(C6F5)3, the monocyclisation reaction with the 
alkyne proximal to the ester took place, garnering the isocoumarin appended selenyl 
ether in 68% yield, leaving the distal alkyne untouched (Scheme 4.8). This could be 
verified by the loss of the diagnostic methyl group of the ester moiety which appears 
in the 1H NMR spectrum at δ = 3.89 ppm in 4.6 alongside the downfield shift of the 
aromatic protons on the phenyl backbone. In an attempt to incorporate both Lewis 
acidic centres into the product, the isocoumarin 4.6 was then reacted with one 
equivalent of B(C6F5)3 to promote π-activation of the second alkyne subunit. 
Unfortunately, this second activation was not observed with the simple hard Lewis 
adduct between the carbonyl oxygen and borane prevailing (4.7, Scheme 4.8). This 
could be readily identified through the 11B NMR spectrum revealing a broad singlet at 
δ = -0.5 ppm alongside a pattern in the 19F NMR spectrum in which the para- and 
Chapter 4: Formation of 6-Membered Heterocycles via Alkyne Activation: Carbon-Element Bond Creation through 
Cyclisations
69
meta-fluorine resonances do not indicate formal quaternisation as Δδp-m = ca. 8 ppm
rather than that of Δδp-m = ca. 3 ppm for formal anionic borate species.[67]
This was further corroborated through X-ray crystallographic studies which 
clearly identified the structure to be that of the Lewis adduct (Figure 4.7). This is not 
dissimilar to other systems whereby extended chain alkynyl benzoates prefer this 
adduct formation over alkyne activation.[36c] Interestingly though, heating a toluene 
solution of 4.6 to reflux for several days still did not produce any indication of alkyne 
activation with the 77Se NMR spectrum retaining the singlet resonance at δ = 289.5 
ppm which is comparable to similar selanyl compounds reported in the literature.[110]
Figure 4.7: Solid-state structure of 4.6. C: grey, H: white, O: red, B: yellow-green, F: pink, Se: 
orange. Thermal ellipsoids shown at 50% probability.
In light of this reluctance to react with a hard Lewis acid, a further two equivalents 
of PhSeCl were added to the isocoumarin intermediate 4.6 (Scheme 4.8). Fortunately, 
the solid-state structure could be elucidated by X-ray crystallography of crystals which 
were isolated in 37% yield by slow evaporation of the solvent (Figure 4.8). The 
structure was that of a tetracyclic conjugated salt 4.7 which comprised a selenium 
atom in three separate environments; 1) a cationic selenonium; 2) neutral selane and 
3) anionic selenate counterion. Due to poor solubility of the salt, the 77Se NMR 
spectrum could not be measured however, both high resolution mass spectrometry 
and elemental analysis support the proposed product. 
With regard to the solid-state structure of 4.7, while the isocoumarin scaffold is 
essentially planar, the selenocycle disrupts this planarity through the adoption of a 
tetragonal geometry consisting of C–Se–C bond angles of 96.57(12)° and 
100.86(12)°. This is further evidenced when looking at the intracyclic C–Se bond 
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lengths of 1.912(2)–1.939(3) Å which are consistent with Se–C single bonds, 
indicating that although the tetracyclic unit is fully conjugated, the aromaticity does 
not extend across the entire structure. Remarkably, there have been very few reports 
of the [PhSeCl2]– counterion in the literature however, the metrics that are observed 
in this work are similar to those encountered previously with the counterion adopting 
a T-shape geometry featuring axial chloride atoms.[111] As expected, the C–Se–Cl 
bond angles are near perpendicular (90.47(10)° and 90.72(10)°) with Se–Cl bond 
lengths of lengths 2.445(1) and 2.457(1) Å. 
Figure 4.8: Solid-state structure of 4.7. Chloroform solvate molecule omitted for clarity. C: 
grey, H: white, O: red, Se: orange. Thermal ellipsoids shown at 50% probability.
It was then seen as to whether the tetracyclic salt 4.7 could be formed in a single 
step through the addition of three equivalents of PhSeCl to the diyne precursor 4.4. 
Indeed, multinuclear spectroscopy could confirm the formation of 4.7 along with the 
concomitant loss of chloromethane (δH = 3.05 ppm, δC = 21.5 ppm).[112] Mechanistic 
considerations propose that the selenium reagent initially acts as the electrophile to 
activate the alkyne forming the aforementioned selenirenium cation intermediate 
which undergoes nucleophilic attack by the carbonyl oxygen. Once the intermediate 
salt is formed (I, Scheme 4.8), the chloride ion then dealkylates the ester forming 
chloromethane and the selenyl isocoumarin 4.6. This type of reactivity has been 
applied more recently to other cyclisation reactions, such as those highlighted by 
Blum and Ingleson in the formation of benzofurans and benzothiophenes.[97-98] A 
second PhSeCl equivalent then activates the distal alkyne with the isocoumarin 
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tethered selenyl ether acting as the nucleophile in an FLP-type 1,2-trans-addition step 
with the third equivalent of PhSeCl accepting the chloride ion to generate the 
[PhSeCl2]– anion alongside the tetracyclic product 4.8 (Scheme 4.8).
Scheme 4.8: Reactions of 1 with phenylselenyl chloride (PhSeCl) to generate 4.6–4.8.
4.2.3 Stoichiometric and Catalytic Pyrone and Isocoumarin Formation 
via C–H and C–C Bond Formation 
The substitution of different groups in the R1 position of various alkynyl acids (4.9) 
and esters (4.10) was then tested to see whether the requisite pyrone or isocoumarin 
product could be formed. To that end, various alkynyl carboxylic acid and esters 
(Figure 4.9) which were prepared by literature methods[101] were exposed to B(C6F5)3
to promote the 6-endo-dig cyclisation, similar to that observed earlier with the pyrylium 
borates (see section 4.2.1). Indeed, the exposure of neutral and electron rich alkynyl 
carboxylic acids 4.9a–c produced the pyrones 4.11a–c in near quantitative 
conversions within 30 minutes as noted in the in situ NMR spectra with excellent 
isolated yields between 93% and 96% (Scheme 4.9). When the dimethyl backbone 
was altered to include a phenyl scaffold, the reactivity was hindered with the 
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corresponding isocoumarins 4.11d–e being isolated in only 45 and 52% yield 
respectively. Nevertheless, storing a saturated CH2Cl2/hexane solution of 4.11a and 
4.11d–e at -40 °C resulted in a crop of colourless crystals which were suitable for 
single crystal X-ray diffraction (Figure 4.10) 
Figure 4.9: Substrates 4.9 and 4.10 used in this study. 
The results from the carboxylic acid reagents were particularly noteworthy as 
boranes, B(C6F5)3 in particular, tend to undergo various decomposition pathways 
such as protonolysis when exposed to Brønsted acids. There are however a very 
limited number of examples of their successful reactivity, for example B(C6F5)3
catalysed deoxygenations in addition to structural investigations.[113] Unfortunately, 
electron poor or ortho-substituted alkynyl carboxylic acids 4.9d–h were less 
successful with the target molecule only being observed as the minor component of 
an otherwise intractable mixture of products.
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Figure 4.10: Solid-state structure of compound 4.11a, 4.11d and 4.11e. C: grey, H: white, B: 
yellow-green, O: red, F: pink. Thermal ellipsoids shown at 50% probability.
With this, the R1 substituent was then exchanged for various ester groups which 
led to more intricate pyrone and isocoumarin products resulting from the cyclisation 
process (Scheme 4.9). Whilst it was hoped that simple isopropyl or allyl groups 
appended to the ester could be transferred (4.10a–b), no cyclised product was formed 
with the Lewis adduct prevailing in the reaction mixture. Fortuitously, altering the ester 
substituent for a benzyl, α-methylbenzyl or benzhydryl derivative spurred the same 
cyclisation witnessed with the carboxylic acids whereby the ester substituent is 
transferred to the γ-position of the lactone with the borane being bound to the carbonyl 
oxygen. While the majority of products featuring a phenyl or p-tolyl group in the R2
position produced the pyrone and isocoumarin derivatives in very good to excellent 
yields (81–97%) in as little as 30 minutes, the formation of 4.11f and 4.11k took 
considerably longer at 24 h however, excellent yields were also reported at 91% and 
92% respectively. To confirm the anticipated structure, the solid-state structures could 
be elucidated for 4.11h–i, 4.11m and 4.11v clearly showing the γ-functionalised 
heterocycle (Figure 4.11). Identifiable spectroscopic changes include the upfield shift 
of the benzhydryl proton from δ = ca. 6.8 ppm to δ = 5.0 ppm consistent with the 
migration away from the electron withdrawing ester oxygen. Additionally, the 11B NMR 
spectra showed the characteristic broad singlet at δ = 0.0 ppm for the B–O adduct 
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formation. One of the most indicative changes was the loss of the alkyne resonances 
in the 13C NMR between δ = ca. 81–89 ppm alongside the appearance of new vinylic 
signals in the region between δ = ca. 115-140 ppm.
Figure 4.11: Solid-state structure of compound 4.11h, 4.11i, 4.11m and 4.11v. Disordered F 
and Cl atoms modelled over two sites. C: grey, H: white, B: yellow-green, O: red, F: pink, Cl: 
green. Thermal ellipsoids shown at 50% probability.
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Scheme 4.9: Substrate scope for the cyclisation reaction of 4.9 or 4.10 with B(C6F5)3. In situ
NMR conversion (isolated yield). a 24 h reaction time.
As noted earlier, the final products of the stoichiometric reactions result in the 
sequestration of the borane as the Lewis adduct with the carbonyl oxygen therefore, 
it was proposed that this weak boron-oxygen bond could be thermolytically cleaved 
to allow the borane to activate other alkynyl precursors in a catalytic fashion. 
Fortuitously, when using the substrate 4.10d in CDCl3 and 10 mol% B(C6F5)3, the 
product 4.12c could be observed in >95% conversion after 6 h at 70 °C. This protocol 
then underwent optimisation viz. solvent, catalyst loading and borane catalyst (Table 
4.2). Through these optimisations it was seen that less Lewis acidic boranes (BPh3, 
B(2,6-F2C6H3)3 and B(2,4,6-F3C6H2)3)[114] were ineffective, with no conversion being 
noted after 24 h (entries 1–3, Table 4.2). The slightly less Lewis acidic,[19] and less 
bulky BF3·OEt2 also showed very little reactivity giving 4.12c in only 7% conversion 
(entry 4, Table 4.2). On the other hand, it was noted that B(C6F5)3 was an extremely 
effective catalyst even when used in only 1 mol%, giving almost quantitative 
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conversion within 6 hours however, 5 mol% was used for the proceeding experiments 
to ensure maximum conversion for the least active reagents as well as for use in 
tandem reactivity explored later in this chapter (entries 5–7, Table 4.2). This reaction 
appears to be tolerant of most common solvents such as CDCl3, CH2Cl2, Et2O and 
toluene generating the product in >95% conversions however, strongly coordinating 
solvents (THF and 1,4-dioxane) fared less well presumably due to catalyst 
deactivation through borane-solvent coordination (entries 5, 8–12, Table 4.2). These 
optimised conditions were then applied to the electron-rich carboxylic acid substrate 
4.9c which found that the same trend is followed whereby 4.12a was formed 
quantitatively (entry 13, Table 4.2). To examine whether this reaction is Brønsted acid 
catalysed as a result of borane coordination to the carboxylic acid carbonyl oxygen, 
trifluoroacetic acid and the stronger trifluoromethanesulfonic acid were trialled with 
little success (entries 14–15, table 4.2).
Table 4.2: Optimisation for the catalytic cyclisation of 4.9c and 4.10d to give 4.12c and 4.12a.
Entry Catalyst Solvent Loading (mol%) Conv. (%)a Product
1 BPh3 CDCl3 10 <5 4.12c
2 B(2,6-F2C6H3)3 CDCl3 10 <5 4.12c
3 B(2,4,6-F3C6H2)3 CDCl3 10 <5 4.12c
4 BF3∙OEt2 CDCl3 10 7 4.12c
5 B(C6F5)3 CDCl3 10 >95 4.12c
6 B(C6F5)3 CDCl3 5 >95 4.12c
7 B(C6F5)3 CDCl3 1 >95 4.12c
8 B(C6F5)3 THF 10 52 4.12c
9 B(C6F5)3 1,4-Dioxane 10 54 4.12c
10 B(C6F5)3 Toluene 10 >95 4.12c
11 B(C6F5)3 Et2O 10 >95 4.12c
12 B(C6F5)3 CH2Cl2 10 >95 4.12c
13 B(C6F5)3 CDCl3 5 >95 4.12a
14 CF3CO2H CDCl3 5 0 4.12a
15 CF3SO3H CDCl3 5 Tracesb 4.12a
a In situ NMR conversion after 6 hours at 70 °C. b Multiple products observed.
Using these optimised conditions, various alkynyl carboxylic acids and esters 
were then reacted to obtain the respective pyrone or isocoumarin products. As before, 
the most electron-rich carboxylic acid 4.12a could be isolated in an excellent yield of 
91% however, all other less electron-rich derivatives 4.9a–b, and the sterically 
encumbered variants 4.9d–e showed no appreciable conversion. Nevertheless, when 
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using the ester substrates, the vast majority could be isolated in excellent yields 
although lower conversions were noted for the benzyl derivative 4.12b and the 
electron-poor alkyne variant 4.12f which were isolated in 33% and 27% respectively 
(Scheme 4.10). An increase in catalyst loading to 10 mol% was necessary in the 
conversion of the conjugated substrates 4.12h–j garnering the products in reasonably 
good yields of 71–78%. Confirmation of these lactone products could be gathered 
from the solid-state structure by storing saturated CH2Cl2/hexane solutions at -40 °C 
to yield a crop of colourless crystals (Figure 4.12) 
Scheme 4.10: Catalytic formation of 4.12 using B(C6F5)3. In situ NMR conversion (isolated 
yield). a Isolated yield after 120 h. b 10 mol% catalyst. c 16 h reaction time. d 24 h reaction time. 
e 48 h reaction time.
Further to this work, it was anticipated that the borane may act as a dual catalyst 
for the one-pot tandem cyclisation/hydrosilylation from the alkynyl ester reagent 4.10d
through to the γ-functionalised cyclic silylacetals (Scheme 4.11). Indeed, the latter 
hydrosilylation step is well-known in the literature, hence it was expected that this 
reduction reaction should proceed in a facile manner.[23c-e, 115] It was found that after 
using the optimised conditions to form the lactone 4.12, the addition of one equivalent 
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of silane (HSiPh3 or HSiEt3) and heating to 70 °C for 6 h showed quantitative 
conversion to the reduced silylacetal 4.13a–f, which could be isolated in excellent 
yields of 90–95%.
Figure 4.12: Solid-state structure of compound 4.12a, 4.12c and 4.12f. Disordered F and Br 
atoms modelled over two sites. C: grey, H: white, B: yellow-green, O: red, F: pink, Br: brown. 
Thermal ellipsoids shown at 50% probability.
Scheme 4.11: Catalytic tandem one-pot cyclisation/hydrosilylation to yield 4.13.
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This was evident by the new resonance in the 29Si NMR spectra at δ = ca. 11.8 ppm 
(SiPh3) and δ = ca. 19.8 ppm (SiEt3). This was seen alongside the new singlet 
resonance at δ = ca. 5.0 ppm in the 1H NMR spectrum corresponding to the newly 
introduced hydride to the CO2 unit. Whilst there is the opportunity to reduce at different 
sites within the lactone, this reaction appears to be regioselective for the carbonyl 
over the alkene which was confirmed through the solid-state structure (Figure 4.13).
Figure 4.13: Solid-state structure of compound 4.13a. Disordered F atoms modelled over two 
sites. C: grey, H: white, B: yellow-green, O: red, F: pink, Si: light grey. Thermal ellipsoids 
shown at 50% probability.
One mechanistic aspect that was investigated was whether the 1,5-migration of 
the ester moiety proceeds via an intra- or inter-molecular pathway. To probe this, a 
1:1 mixture of 4.10f and 4.10h was combined with two equivalents of B(C6F5)3 with 
the reaction being monitored through multinuclear NMR spectroscopy (Figure 4.14, 
crossover A). It was seen that a mixture of all four possible products prevailed 
indicating a scrambling of the cationic benzhydryl fragment occurred by way of an 
intermolecular pathway. To confirm this, a second crossover was performed using 
4.10d and 4.10j again with two equivalents of borane. Indeed, a similar scrambling 
pattern was observed, supporting the previous findings whereby a transient 
carbenium ion is generated leading to intermolecular transfer (Figure 4.14, crossover 
B). On further inspection, crossover A showed essentially even formation of the four 
products 4.11h, 4.11j, 4.11l and 4.11n whereas crossover B showed that 4.11h
predominated over the other three products. It is assumed that the more electron-rich 
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alkyne 4.10d reacts preferentially over the electron-poor variant 4.10j, which also 
explains the lowered reactivity of the CF3 substituted alkynyl esters earlier. In addition, 
the Hammet parameter for para-F is greater than that of para-Br suggesting a more 
stable carbenium is formed with the fluorinated substrate, resulting in faster reaction 
of the substrate 4.10d.[116]
Figure 4.14: Crossover reactions to probe inter- vs. intra-molecular pathway. 
As mentioned in Chapters 2 and 3, there are two independent modes by which 
the borane may activate these types of alkynyl esters, either σ- or π-activation. With 
the former, activation of the carbonyl by the borane promotes the elimination of the 
carbenium ion with concomitant 6-endo-dig cyclisation (Pathway I, Scheme 4.12). 
Conversely, π-activation promotes the 1,2-trans-addition of the borane and carbonyl 
oxygen across the triple bond with subsequent proto- or carbo-deboration (Pathway 
II, Scheme 4.12). Both such pathways have precedence in the literature and other 
work mentioned in Chapters 2 and 3. For instance, the catalytic deprotection of Boc 
groups using B(C6F5)3 outlined in Chapter 3 follows a very similar premise to that 
proposed here,[36b] while the 6-endo-dig mechanism posited in Pathway II has been 
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elucidated earlier in Section 4.2.1 as well as by others in the literature in the synthesis 
of pyryliums, lactones inter alia.[39b, 96]
It may be assumed that the hard Lewis acid/base adduct between the carbonyl 
and borane is preferred over the softer alkyne site as described by hard soft acid base 
(HSAB) theory. While this initial activation mode undoubtedly takes place as indicated 
by a broad singlet resonance at δ = ca. 40 ppm in the 11B NMR spectrum, a transient 
sharp singlet is also observed at δ = -15 ppm indicating that Pathway II is also taking 
place. Further evidence for the reaction proceeding via Pathway II may be inferred 
from the lack of reactivity of the ortho-substituted carboxylic acid derivatives 4.9d–h 
as other electronically similar para-substituted derivatives were shown to react. This 
increased steric crowding about the alkyne may preclude this activation pathway 
leading to reduced reactivity. The assumption that the reaction proceeds via a 
carbenium ion intermediate is reinforced by the lack or lower reactivity of less 
stabilised carbeniums (i.e. iPr, allyl, benzyl) compared to the more stable ethyl phenyl 
or benzhydryl derivatives. Other mechanistic observations include the lack of 
reactivity with the Brønsted acids trifluoroacetic acid and trifluoromethylsulfonic acid. 
If σ-activation does take place then presumably this would create a fairly potent 
Brønsted acid source which could in turn affect the cyclisation. Both catalytic and 
stoichiometric amounts of Brønsted acid failed to form the desired heterocycle 
perhaps indicating that the latter π-activation pathway may predominate in the 
formation of the pyrone and isocoumarin products.
Scheme 4.12: Proposed mechanistic pathways for the catalytic formation of 4.12. 
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4.3 Conclusions
Within this chapter it has been shown how the strong Lewis acid B(C6F5)3 can 
undergo π-activation of alkynes to affect 5-exo-dig and 6-endo-dig cyclisations to 
form various pyryliums, pyrones and isocoumarins as well as promote annulation 
reactions. Indeed, the synthesis of such compounds have extensive uses as synthetic 
intermediates as well as in biologically active agents therefore are of great importance 
to the synthetic chemist. It is also important to note the divergent reactivity between 
soft and hard Lewis acids, altering the electrophile in this instance has a dramatic 
influence on the proceeding reaction. Additionally, the use of softer Lewis acids in 
these FLP-type 1,2-addition reactions is comparatively rare in the literature with this 
work providing much needed exposure. Additionally, the use of electron deficient 
boranes in new C–H and C–C bond forming reactions as well as tandem catalysis is 
an area of main group chemistry that is now beginning to expand, with work 
showcased above displaying excellent atom efficiency in a range of transformations. 
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Chapter 5
Boron Mediated and Catalysed Reduction Reactions: 
Emerging Catalysts, Novel Processing Techniques 
and Transfer Hydrogenation
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L. Melen,* “Exploring Multistep Continuous Flow Hydrosilylation Reactions 
Catalyzed by Tris(pentafluorophenyl)borane”, Adv. Synth. Catal., 2017, 359, 
2580. 
3. L. C. Wilkins, N. Santi, L. Y. P. Luk, R. L. Melen,* “Reactions of Biologically 
Inspired Hydride Sources with B(C6F5)3”, Phil. Trans. R. Soc. A, 2017, 375, 
20170009.
5.1 Introduction
The hydroboration reaction is one of the most well-known applications for 
boranes dating back to the 1950’s, with H. C. Brown being awarded the Nobel Prize 
in Chemistry for his work in the synthesis of organoboranes through the hydroboration 
of alkenes.[117] One of the many advantages of the hydroboration reaction is the atom-
efficiency, rendering the borylated product with little to no side-products with good 
control over regioselectivity as well as the variability in the borane that can be used; 
e.g. pinacol borane (HBPin),[118] 9-BBN[119] or the strongly Lewis acidic Piers’ borane 
[HB(C6F5)2].[24a, 24b] The hydroboration of alkenes and alkynes using boranes (R2BH) 
tend to proceed via a concerted syn-addition giving the anti-Markovnikov product on 
account of the greater electronegativity of hydrogen over boron. More recently, a bevy 
of examples have included transition metals such as rhodium, palladium and platinum 
as the active catalyst in the hydroboration of unsaturated substrates.[120] For example, 
work by Miyaura et al. described how the catalyst [Rh(cod)Cl]2 could affect the 
alternative 1,1-hydroboration of various alkynes to the (Z)-alkene in up to 99% 
yield.[120a] This follows a proposed mechanism that is perhaps more complex than first 
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envisaged. Initial oxidative addition of the alkyne to the metal (I, Scheme 5.1) is 
followed by tautomerisation to the alkylidene intermediates (II, Scheme 5.1). A 
subsequent second oxidative addition of the borane to the metal, with the borane 
moiety occurs to undergo a 1,2-migration furnishing the vinyl intermediate IV. 
Reductive elimination of the product 5.1c garners the (Z)-stereoisomer with 
concomitant regeneration of the metal catalyst. 
Scheme 5.1: Isotope labelled mechanism for the transition metal catalysed hydroboration of 
alkynes.
In recent years however, metal-free catalysts have been developed for this 
purpose from both s-block[121] and p-block[122] elements to great effect. Indeed, this 
success has proliferated over the last few decades in a bid to compete with transition 
metal catalysts, particularly in the development of pharmaceutical precursors where 
trace-metal impurities are heavily restricted.[123] One interesting example reported by 
Ingleson et al. shows how using a borenium-based system, initiated by B(C6F5)3, the 
stereoselective trans-1,2-addition of alkynes can occur vs. the conventional syn-1,2-
addition (Scheme 5.2).[124] In this case, it is proposed that the NHC stabilised 9-BBN 
undergoes hydride abstraction by the B(C6F5)3 initiator leaving the borenium borate 
ion pair 5.1e. Activation of an alkyne substrate by 5.1e forms the unstable vinylic 
cation I which is then reduced by a hydride from another equivalent of 5.1d to give 
the borylated product 5.1g, whilst reforming the borenium cation to enter the cycle 
again. 
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Scheme 5.2: Mechanism for the metal-free 1,2-trans-hydroboration of alkynes. [HB(C6F5)3]–
counterion omitted for clarity.
A series of products could be synthesised using this methodology to include a large 
number of styrene derivatives as well as vinylthiophene, vinylcyclohexenyl and 
isoprene-type moieties in generally excellent yields (56–97%). As stated throughout 
this work, such borylated products are excellent candidates for further 
functionalisation such as cross-coupling reactions to more complex polyaromatic 
compounds.[15] Indeed, Ingleson showed that the vinylic boranes 5.1h–j (where R = 
p-tol or p-anisole) were susceptible to a Suzuki-Miyaura cross-coupling reaction to 
provide the cis-stilbene derivative in 81% and 73% yield respectively in a one-pot 
synthesis.
Additionally, reduction of unactivated alkenes has been shown by Oestreich and 
co-workers using the highly Lewis acidic borane tris[3,5-bis(trifluoromethyl)phenyl] 
borane (BArF3).[125] In this case, the reduction capability of BArF3 was found to be even 
greater than that of the archetypal Lewis acid B(C6F5)3. Whilst initial observations may 
indicate the simple hydroboration via catalytic hydride shuttling by BArF3, the 
proposed mechanism, supported by literature precedence and kinetic experiments 
indicated a more complex mechanism was occurring.[24a, 126] The BArF3 in this case 
may be thought of as a precatalyst as the combination with HBPin results in ligand 
exchange through σ-bond metathesis to generate the active catalyst 5.1k (Scheme 
5.3). This active catalyst, similar to Piers’ borane, then undergoes the expected 1,2-
hydroboration to generate the alkyl borane 5.1l. A second ligand metathesis reaction 
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occurs upon reaction with another equivalent of HBPin, regenerating 5.1k while 
garnering the requisite pinacol boronate ester 5.1m. Whilst transition metal catalysts 
have been used in the hydroboration of other unsaturated moieties such as imines[127]
and aldehydes,[128] the incorporation of metal-free variations are seldom reported 
however, traction has certainly built in this area over the past decade.[24c, 129]
Scheme 5.3: Proposed mechanism for the hydroboration of alkenes using BArF3 via ligand 
redistribution through σ-bond metathesis.
Another common reaction in the reduction of unsubstituted scaffolds is the 
hydrosilylation reaction. Silanes of the general structure R3SiH as well as others such 
as tetramethyldisiloxane (TMDS) are commonly used in this transformation as the 
reductant to form silyl protecting groups en route to liberation of the free alcohol or 
amine. Whilst the most popular is the simple 1,2-addition to C=X bonds such as 
carbonyls, other addition patterns are routine such as the 1,4-addition to α,β-
unsaturated ketones, in a conjugate addition reaction. The common Lewis acid 
B(C6F5)3 has once again shown prominence in the catalytic formation of new O–Si,[23a]
C–Si[130] as well as N–Si bonds (en route to various hydrogenation products by 
hydrolysis).[23b, 131]
Seminal work in this field by Piers et al. using B(C6F5)3 showed how aldehydes, 
ketones and esters could be readily reduced in the presence of various silanes.[23a] In 
these initial reactions a number of carbonyl containing substrates could be converted 
to the corresponding silylether, which underwent hydrolysis to form the alcohol in 
good to excellent yields (ca. 80%). Further studies by Piers uncovered how the 
conventional reactivity series whereby aldehydes are the most reactive, and esters 
are the least reactive is in fact reversed.[23b] [132] Extensive kinetic work described how 
the reaction proceeds via the initial silane-borane encounter complex (Si–H···B) with 
subsequent nucleophilic attack of the silane by the carbonyl followed by hydride 
delivery by B(C6F5)3. To reason this inverse reactivity, it was posited that the more 
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basic the functional group (aldehyde>ketone>ester) the stronger the adduct formation 
with the Lewis acid. Therefore, it is necessary to have an electron-deficient 
heteroatom to increase the availability of ‘free’ borane in solution to abstract the 
hydride upon coordination of the silane to the carbonyl. These findings were 
supported in further work by Oestreich and co-workers using a chiral silane reagent, 
and tracking the final configuration (and purity) of the product by chiral HPLC and 
optical rotation measurements.[115b] Employing this methodology, it was found that 
using an enantioenriched silane (SiR)-5.1n (90% enantiomeric excess (ee)) in the 
hydrosilylation of the prochiral acetophenone resulted in the almost complete 
inversion of the silane producing (SiS)-5.1n (84% ee), as well as generating the 
alcohol in 38% ee. This complete inversion at silicon is only possible if the reaction 
proceeds through a Walden inversion transition state in an overall SN2 reaction. If this 
reaction were to occur by the formation of a silylium intermediate as a result of an SN1 
reaction, then presumably a racemic mixture would result. This hypothesis was 
reinforced by theoretical work carried out by Fujimoto et al. confirming this SN2 
reaction at silicon reaction by initial Si–H activation by the borane.[115c]
Scheme 5.4: SN2 silylation reaction mechanism proposed by Oestreich.
Interestingly, while contemporary main group chemistry, including borane 
catalysed hydrosilylation, has become more mainstream over the past two decades, 
there appears to be little crossover with other fields or processing technologies. In 
nearly all cases other than very recent reports by Stephan et al.[133] the use of p-block 
Chapter 5: Boron Mediated and Catalysed Reduction Reactions: Emerging Catalysts, Novel Processing Techniques 
and Transfer Hydrogenation
88
catalysts in continuous-flow chemistry has been all but ignored. Indeed, flow 
chemistry has seen increased adoption across many diverse fields[134] in both industry 
and academia however, main group chemistry appears to be behind this trend.[135]
The need to expand implementation of continuous-flow chemistry is paramount 
to many processes as the symbiotic relationship of traditional methods coupled with 
novel processing methods often leads to increased conversion, reaction rates and 
selectivities. Perhaps more significantly, flow chemistry allows for a modular and 
adaptable approach to synthesis thus increasing automation[136] and sanctioning 
multistep processes in a single reaction setup.[137] Using these new methods, 
expansive libraries of compounds may be synthesised whilst reducing manual 
intervention.[138] Another facet to continuous-flow processing is the ability to conduct 
reactions at significantly higher temperatures and pressures than is normally allowed 
when using a traditional batch-type setup. By incorporating other fixtures such as 
back-pressure regulators (BPR), the superheating of solvents at high pressure almost 
invariably leads to increased reaction rates, providing a very attractive methodology 
for rapid throughput to the synthetic chemist (Figure 5.1).[139] Using such fixtures also 
explicates one of the other critical benefits to using flow chemistry; the increased 
safety profile. Using this technology increases the safety profile through increased 
thermal control, lower risk of concentration hotspots of reactive intermediates as well 
as working with smaller volumes during the active step, e.g. the reactive step is 
contained to a continuously-fed 5 ml reactor coil rather than a static larger volume 
flask. This means that more capricious reactions may be conducted in a laboratory 
setting with a vastly increased safety profile.[140]
Figure 5.1: General flow set-up for a multi-step synthesis.
Another area of main group chemistry that has seen great expansion in the past 
decade has been that of small molecule activation, specifically hydrogenation. This 
was mainly promulgated through frustrated Lewis pair chemistry in seminal work by 
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Stephan et al. using both intra- and inter-molecular phosphine/borane combinations 
to heterolytically cleave dihydrogen.[9a-c, 21, 141] While dihydrogen has received massive 
amounts of attention, alternative dihydrogen and hydride sources have been 
overlooked in the literature with only a handful of reports in this area. Hantzsch esters 
are great hydrogen equivalents due to its ease of manipulation when compared to 
gaseous hydrogen, with access to both the protic and hydridic components being 
possible through simple activation by a Lewis acid.[142] Other routes have been 
implemented to access the H2 equivalent stored in Hantzsch esters, such as the 
organocatalytic method introduced by Rueping et al. whereby a phosphoric acid 5.1q
is used as the proton source to form the iminium intermediate 5.1s with subsequent 
reduction by the hydride on the Hantzsch ester to garner the secondary amine 5.1u. 
The pyridinium 5.1v that is formed reprotonates the phosphate anion to regenerate 
the organocatalyst while garnering the aromatic pyridine 5.1n as a by-product
(Scheme 5.5).[143]
Scheme 5.5: Work by Rueping into organocatalytic reduction of imines using Hantzsch esters 
as hydrogen storage mediums.
Other than the above examples or those catalysed by transition metals, only a 
couple of studies exist of inorganic main group chemistry being applied to this 
area.[144] One of these few examples is reported by Stephan and Crudden et al. who 
used these Hantzsch esters as a hydride source to form borohydrides for subsequent 
reduction reactions (Scheme 5.6).[145] In this case, when traditional Hantzsch esters 
are used (R1 = OEt), an equilibrium is established between the carbonyl/borane Lewis 
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adduct 5.1y and the pyridinium hydridoborate 5.1z via hydride abstraction. Whilst this 
could be isolated at low temperatures and characterised by single crystal X-ray 
diffraction, it was found that above -20° C a secondary reduction reaction may occur. 
In this case the hydridoborate moiety reduces the pyridinium at the α-position to 
furnish the 2,3-dihydropyridine 5.1aa. This was deemed to be as a result of the B–O 
adduct formation being the energetically more favourable product. Further to this, 
when a ketone was used (R1 = Me) instead of an ester, then the adduct 5.1ab was 
the sole product of the reaction with no hydride abstraction taking place. The reason 
for this relates to similar observations outlined in chapters 2 and 3, as well as by Piers 
and Oestreich whereby the stronger Lewis basic ketone sequesters the borane 
preferentially over other reactivity.  
Scheme 5.6: Recent work from Stephan and Crudden using Hantzsch ester and derivatives 
as hydride sources for borohydride formation.
Oestreich pursued similar reactivity through the reaction of cyclohexa-1,4-diene 
derivatives with B(C6F5)3 in the transfer-hydrogenation of alkenes (Scheme 5.7).[146]
With 1,1-diphenylethylene being selected as a model substrate, a series of 
substituted cyclohexa-1,4-dienes were trialled for reactivity with the optimal hydrogen 
source being determined as 1,3,5-trimethylcyclohexa-1,4-diene 5.1ac garnering the 
reduced product 5.1ag in 97% yield after just 1 h using 5 mol% borane loading. 
Following this, an extensive substrate scope was tested with generally excellent 
yields being recovered across the board however, smaller substituents in the R1 and 
R2 position tended to give lower conversions due to competitive side-reactions such 
as dimerisation with another equivalent of 5.1ad. Increasing the steric bulk about the 
alkene terminus reduces the possibility for this dimerisation to occur hence garnering 
higher yields with bulkier substituents. Regarding the posited mechanism for this 
Chapter 5: Boron Mediated and Catalysed Reduction Reactions: Emerging Catalysts, Novel Processing Techniques 
and Transfer Hydrogenation
91
reaction, it is believed that initial borohydride formation occurs to form the Wheland 
intermediate I which then protonates the alkene substrate generating the aromatised 
mesitylene as a side-product. At this point, the carbenium intermediate II may then 
undergo the dimerisation to form 5.1af or reduction by the hydridoborate to garner 
the desired alkane 5.1ag however, according to in silico studies, the former pathway 
is energetically less favoured due to the steric encumbrance about the cationic centre. 
Scheme 5.7: Proposed mechanism for catalytic transfer hydrogenation of alkenes using 
cyclohexa-1,4-dienes.
5.1.1 Aims of This Chapter
This chapter explores new reactivity in boron mediated reduction reactions using 
several new approaches. Firstly, attenuation of the Lewis acidity has been shown as 
an effective way of modulating reactivity to suit a certain purpose. To that end, 
adapting boranes for the reduction of unsaturated substrates is an area of main group 
catalysis that is currently being exploited to increase their effectiveness and 
competitiveness. Secondly, novel processing methods are a fascinating competitor to 
conventional batch-type reactions, with there being more adoption across several 
fields in academia and industry of late. However, the combination of main group 
catalysis and continuous-flow processing technologies has rarely been investigated, 
hence studies in this topic will provide much-needed insight into this synergistic 
pairing. This drive to pair such technologies are spurred by the adaptability of 
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continuous-flow methodologies to undergo reactions at far higher temperatures and 
pressures than those seen in batch-type reactions, allowing main group catalysts to
be applied to a wider range of substrates with greater success. Finally, the use of 
borohydrides are ubiquitous in organic synthesis with their syntheses relying mainly 
on salt metathesis reactions however, very few examples are presented in the 
literature whereby biological analogues are used as hydride donors. Analogues of the 
biologically sourced nicotinamide adenine dinucleotide phosphate (NADPH), such as 
1-benzyl-1,4-dihydronicotinamide, are considered to be artificial mimics with similar 
hydride donor properties to NADPH. Reactions of these mimics, and derivatives 
thereof, should provide an interesting basis for merging main group and biological 
chemistry. 
5.2 Results and Discussion
5.2.1 Tempering Lewis Acidity of Boranes for General Hydroboration 
Reactions
As stated earlier, the use of boranes and other main group compounds for 
reduction reactions has been exploited to great effect in recent years, with one of the 
most established being the hydroboration of carbon-element multiple bonds. Herein 
the focus of this work was to find a highly Lewis acidic borane that was capable of 
reducing C–X (X = C, N, O) multiple bonds in a facile manner with high functional 
group tolerance. It is well known that both tris(3,5-bis(trifluoromethyl)phenyl) borane 
and tris(pentafluorophenyl) borane are prime examples of strongly electrophilic 
boranes that are capable of catalysing the swift reduction of unsaturated systems 
however, in certain circumstances such examples shown earlier (see chapters 2–4),
B(C6F5)3 specifically is prone to react with such unsaturated systems in carboboration 
reactions. To this end, the less Lewis acidic borane tris(2,4,6-trifluorophenyl)borane 
(2,4,6-BArF9) was targeted as a good candidate for this reaction owing in part to its 
lower Lewis acidity while retaining a sufficiently encumbered boron centre.[114]
Fortuitously, the 1:1 stoichiometric combination of 2,4,6-BArF9 and the model 
alkyne, phenylacetylene, displayed no reactivity even when heated to 60 °C for five 
days. This is in distinct contrast to B(C6F5)3 which undergoes a 1,1-carboboration 
reaction with the same substrate at ambient temperature within minutes.[75, 147] Work 
by Alcarazo outlined the relative Lewis acidity of these common Lewis acids via 
Child’s method showing that B(C6F5)3 (100%) > 2,4,6-BArF9 (70%) > 2,6-BArF9 (56%) 
which may in part help explain the reactivity observed here.[114] In addition to the lack 
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of reactivity of 2,4,6-BArF9 toward alkynes, no ligand scrambling occurred when 
exposed to equimolar amounts of HBPin presumably as a result of the ortho-fluorine
atoms blocking this redistribution.[125a] The reaction conditions were then optimised 
viz. borane substrate, solvent and reaction time as well as control reactions of other 
more and less Lewis acidic boranes with the conversion of phenylacetylene to the 
corresponding pinacol boronate ester 5.2a being measured via in situ NMR 
spectroscopy. It was observed that tuning the Lewis acidity was essential to the 
general applicability of the borane with more and less electrophilic boranes (2,6-
BArF6, B(C6F5)3, BPh3) performing poorly in comparison (entry 1–3, Table 5.1) 
whereas 2,4,6-BArF9 showed complete conversion to 5.2a within 5 hours at 5 mol% 
catalyst loading (entry 4, Table 5.1). 
Altering the solvent from CH2Cl2 to toluene had no effect on reactivity whereas 
the use of coordinating ethereal solvents completely quenched the reaction 
presumably due to borane sequestration (entries 4–7, Table 5.1). The final 
parameters that were optimised were borane catalyst and reagent loading. Reducing 
the catalyst loading to 1 mol% could still garner the product 5.2a in 99% conversion 
however, an extended reaction time of 18 h was noted. 
Table 5.1: Optimisation of reaction conditions.
Entry Catalyst Loading (mol%)
Borane 
(equiv.) Solvent
Time 
(h)
Conversiona
(%)
1 B(C6F5)3 5 HBPin (1) CH2Cl2 18 59
2 2,6-BArF6 5 HBPin (1) CH2Cl2 18 62
3 BPh3 5 HBPin (1) CH2Cl2 18 31
4 2,4,6-BArF9 5 HBPin (1) CH2Cl2 5 99
5 2,4,6-BArF9 5 HBPin (1) Toluene 5 99
6 2,4,6-BArF9 5 HBPin (1) THF 18 0
7 2,4,6-BArF9 5 HBPin (1) Et2O 18 0
8 2,4,6-BArF9 1 HBPin (1) CH2Cl2 18 99
9 2,4,6-BArF9 2 HBPin (1) CH2Cl2 6 99
10 2,4,6-BArF9 10 HBPin (1) CH2Cl2 4 99
11 2,4,6-BArF9 2 HBPin (1.2) CH2Cl2 6 99
12 2,4,6-BArF9 2 HBPin (2) CH2Cl2 6 99
13 2,4,6-BArF9 2 HBPin (5) CH2Cl2 5 99
14 2,4,6-BArF9 2 HBCat (1.2) CH2Cl2 6 85
a Conversion measured via in situ 1H NMR spectroscopy.
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Conversely, increasing the catalyst loading to 10 mol% had a negligible positive effect 
on conversion giving quantitative conversions in 4 h. It was therefore decided that 2 
mol% represented a good compromise between low catalyst loading and appreciably 
swift reaction times (entry 8-10, Table 5.1). Changing the stoichiometry of the borane 
reagent between 1 and 5 equivalents showed almost no difference in reaction rate 
therefore, a slight excess of 1.2 equivalents was used to furnish maximum conversion 
as any excess borane was readily removed under reduced vacuum (entry 11–13, 
Table 5.1). Catecholborane (HBCat) was also tested as an alternative to 
pinacolborane however, its performance was subpar, generating the boronate ester 
in conversions of only 85% after 6 h (entry 14, Table 5.1)
Once the optimised conditions had been realised, other alkyne substrates were 
then trialled such as terminal aryl and alkyl substrates which generated the reduced 
products 5.2a–d in excellent yields of 71–99%. Propargyl esters were then reacted 
which revealed the selective hydroboration of the alkyne moiety over the ester 
carbonyl giving the expected anti-Markovnikov product in 55–77% yield (5.2e–h). 
Propargyl acrylate also shows the same regioselectivity as neither the olefin or ester 
were reduced, leading to the alkyne being the sole reduction site garnering the 
borylated product 5.2i in 87% yield. It was observed that selective reduction of 
terminal alkynes occurs when a combination of both terminal and internal alkynes are 
featured in the same substrate furnishing the styryl derivative 5.2l in 56% yield. With 
this in mind, other internal alkynes were then trialled to find any limitations of this 
catalytic system. Fortunately, all cases where either aryl, alkyl or silyl termini are 
present on the internal alkyne, the hydroborated products 5.2m–p could be formed in 
generally excellent yields ranging between 80 to 96%. Interestingly, when asymmetric 
internal alkynes were utilised, in situ NMR spectroscopic studies indicate the two 
regioisomers are formed in a ca. 10:1 ratio with the borane and phenyl substituent 
lying trans to one another in 5.2m, and trans to the methyl group in 5.2o. It was 
possible to isolated single crystals of 5.2k and 5.2p by storing a saturated CH2Cl2
solution at -40 °C. Measuring the solid-state structure by X-ray diffraction 
unambiguously determined the structure to be the product of the expected syn-
hydroboration (Figure 5.2).
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Scheme 5.8: Hydroboration of various terminal and internal alkynes. Conditions for given 
isolated yield noted.
Figure 5.2: Solid-state structure of 5.2k and 5.2p. C: grey, H: white, O: red, B: yellow green, 
Si: grey. Thermal ellipsoids shown at 50% probability.
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Using the same optimised reaction conditions from before, the hydroboration of 
various aldehydes was then undertaken. Through in situ NMR spectroscopic studies, 
it was observed that benzaldehyde was converted to the borate ester 5.3a 
quantitatively within 1 h. Confirmation of 5.3a was possible through multinuclear NMR 
spectroscopy by removing the volatiles under reduced pressure and redissolving in 
CDCl3. Following this successful result, the substrate scope was expanded to 
incorporate a broad spectrum of functional groups (Scheme 5.9). It was shown that 
benzaldehyde derivatives which included either electron withdrawing or donating 
groups e.g. NO2, CN, F, CF3, OMe, Me in the para- or ortho-position could be 
quantitatively converted to the borate esters 5.3a–m in as little as 3 h however, –M 
electronic functionalities required increased reaction times of 48 h. 
Scheme 5.9: Hydroboration of aldehydes. Conditions indicated to reach quantitative 
conversion by in situ 1H NMR spectroscopy.
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The inclusion of heteroarenes also posed few obstacles with pyridine and furan 
derivatives furnishing the reduced products 5.3o–p within 24 h showing that 
coordinating substrates may reversibly sequester the borane catalyst and/or reagent 
with little impingement on reactivity. Various other functionalities such as fused aryl 
moieties (5.3n) alkyl groups (5.3q–s) in addition to cyclic aliphatics all performed well 
producing the hydroborated species quantitatively in as little as 1 h at ambient 
temperature. This methodology is extremely portable to many different substituted 
aldehydes with quantitative conversion being seen in all cases however, in certain 
instances slightly elevated temperatures are required with somewhat increased 
reaction times being observed.
Moving on to other unsaturated frameworks, aldimines were then targeted for 
hydroboration using the same procedure. Initial tests using N-benzylideneaniline 
again showed very favourable results with the resulting borolanamine 5.4a being 
formed rapidly in quantitative conversions. To expand the substrate scope, a number 
of other aldimines were synthesised according literature procedures to include 
various substitution patterns at both the nitrogen and carbon centres.[148] Facile 
hydroboration of these imines was achieved using the standard conditions, with the 
exception of some examples which required mild heating, to produce the tertiary 
amines quantitatively within 4 to 24 h. C-functionalisation with electron-poor 
aromatics appeared to slow the reaction slightly taking the full 24 h (5.4g), while the 
electron-rich derivatives 5.4b–e were formed in slightly shorter times of between 4 
and 18 h. Additionally, sterically encumbered groups were also tolerated nicely as 
well as o-functionalised aromatic systems (5.4c, 5.4e). N-functionalisation also 
showed little impediment to reactivity with both derivatised aromatics and aliphatic 
groups giving optimal conversions 5.4i–l. Again, sterically demanding groups are also 
tolerated well in this position with no impact on reactivity showing the general 
applicability of this catalyst and procedure toward reduction reactions. For the 
purpose of complete characterisation, some borolanamine products were converted 
to the secondary amines taking advantage of their proclivity to undergo 
protodeborative decomposition during work-up (5.4d–g, 5.4p).
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Scheme 5.10: Hydroboration of imines. Conditions indicated to reach quantitative conversion 
by in situ 1H NMR spectroscopy.
5.2.2 Novel Processing Methods in the Hydrosilylation of Aldehydes, 
Ketones and Imines
The synthetically useful B(C6F5)3 catalysed hydrosilylation process was used in 
this section to reduce various aldehydes and ketones to their constituent silylethers, 
as well as in the tandem reductive amination of aldehydes and amines to their 
respective secondary amines under continuous-flow conditions. A benchmark for the 
hydrosilylation reaction conditions were established using a conventional batch 
reaction methodology. In this reaction, acetophenone was used as the model 
substrate with stoichiometric amounts of the commercially available triphenylsilane 
and 2 mol% borane catalyst loading. This was conducted at concentrations of 0.2 M 
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in toluene as reactions at higher concentrations and/or using CH2Cl2 as a solvent 
resulted in precipitate formation which may lead to failure of the injection apparatus 
when adapted to the flow procedure. Using this system, the silylether 5.5a could be 
isolated in 78% yield after 30 minutes at ambient temperatures.
In order to replicate these conditions for use under continuous-flow conditions, a 
0.4 M ketone/aldehyde solution and an 8 mM (2 mol%) B(C6F5)3 solution were 
prepared with 5 ml aliquots of each being used for the reaction. The reagent streams 
were injected using syringe pumps and mixed using a T-piece at a flow rate of 0.083 
ml/min giving a combined flow rate of 0.166 ml/min at the requisite concentration of 
0.2 M. The combined reagents continued to a 5 ml reactor coil giving a residence time 
of 30 minutes, then to the quench reagent. Once the reaction had commenced, it was 
allowed to reach steady-state conditions for 6 minutes then allowed to flow for the 
designated residence time before collection commenced. Analysing the collected 
product upon dissolution in CDCl3 via 1H NMR spectroscopy showed that the 
silylether 5.5a was present in very good conversions of 85%, a slight improvement 
over the batch reaction. Increasing the reaction temperature to 60 °C showed the 
reduced product 5.5a in essentially quantitative conversions of 98%. With these 
encouraging results, the method to quench the reaction was optimised to ensure that 
the conversion that was measured was as a result of the flow process alone, rather 
than a combination of the flow process and the continued reaction in the collection 
flask.
Three possible quench methods were proposed to deactivate irreversibly the 
borane catalyst; 1) dropping the product stream into water; 2) dropping into a 
MeCN/CsF slurry or; 3) filtration through a short silica gel plug (Figure 5.3). 
Interestingly, the reaction appeared to continue while using the first two quench 
methods with time-dependent NMR studies showing continued product formation 
post-quench. This is perhaps not unexpected as recent reports by Ingleson and 
Ashley explicated how B(C6F5)3 shows surprising stability and cooperative reactivity 
when in the presence of water in certain instances.[149] Conversely, when filtering 
through a short silica gel plug, all remnants of the borane catalyst had been removed 
per 11B and 19F NMR spectroscopy with no further catalytic activity being recorded. 
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Figure 5.3: Quenching protocols to terminate catalytic activity.
Once the optimised conditions had been established, including the quench 
protocol, a range of ketones and aldehydes featuring various electronic and steric 
differentiated aryl substituents as well as aliphatic groups were then tested under 
these continuous-flow conditions. Generally the silylethers 5.5 and 5.6 could be 
generated in conversions greater than 90% with few exceptions. As noted in earlier 
work by Piers, ketones undergo the reduction reaction faster than the aldehydes 
hence the slightly lower conversions noted for compound 5.6 compared to 5.5. This 
is reasoned as the effect of the more Lewis basic carbonyl sequestering the borane 
catalyst hence reducing catalytic activity. Conversely, the least Lewis basic derivative 
allows there to be more ‘free’ borane to activate the silane in an SN2 reaction with the 
carbonyl. This difference in reactivity between aldehydes and ketones is more 
pronounced in the mesityl examples where identical reaction conditions gave the 
ketone derivative 5.5d in 87% conversion whereas the aldehyde variant 5.6d only 
reached 62% (Figures 5.4 and 5.5). Furthermore, lower conversions of 78% and 58% 
were noted for the electron rich para-methoxy functionalised systems 5.5g and 5.6g 
respectively, agreeing with the premise that electron poor carbonyl units, or 
significantly increased borane concentrations, are required for facile hydride 
transfer.[23a]
Quench Reagent Quench Protocol Outcome
H2O Dropped into water Reaction continues
Fluoride Dropped into CsF/MeCN Slurry Reaction continues
Silica Gel Filtered through silica plug Reaction quenched
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Figure 5.4: Continuous-flow hydrosilylation of ketones. Conversion measured via 1H NMR 
spectroscopy. a Using the same reaction conditions with 2 equivalents of silane.
Figure 5.5: Continuous-flow hydrosilylation of aldehydes. Conversion measured via 1H NMR 
spectroscopy.
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Whilst these results are certainly encouraging as there are very few reports of using 
electron rich acetophenone or benzaldehyde derivatives in borane catalysed hydrosilylation 
due to their poor reactivity, it was decided to attempt to push these results further by embracing 
more facets of this novel processing technology. Therefore, simple modifications to the setup 
such as the use of high pressure HPLC pumps and a back-pressure regulator (BPR) allowed 
higher temperatures and pressures to be reached. Using this adapted apparatus the most 
problematic substrate, p-anisaldehyde, could form the silylether 5.6g in a conversion of 67% 
in just 5 minutes at 150 °C and 130 PSI (Figure 5.6)
Figure 5.6: Comparison between low pressure/temperature and high pressure/temperature 
systems. a Using a back-pressure regulator, HPLC pumps and stainless steel reactor coil.
Combining ideas from Chapter 4 regarding tandem reactivity (see 4.2.3), as well 
as observations made earlier on the surprising observation that B(C6F5)3 may remain 
catalytically active when exposed to water, it was proposed that the tandem imine 
formation and reductive hydrosilylation reaction could be conducted in flow.[149] To 
affect this reaction, more adaptations were made to the setup to include a third 
reagent stream.[137] The rationale being that the combination of the silane, amine and 
aldehyde should form the aldimine in situ alongside one equivalent of water in the first 
reactor coil, followed by the injection of the borane to carry out the hydrosilylation of 
the imine to the secondary amine in the second reactor coil (Figure 5.7). In this 
instance, the less sterically demanding silane Me2PhSiH was utilised to reduce the 
steric occlusion between the silane and the substituent on nitrogen upon 
coordination.[23c, 150] The reaction setup followed the general scheme; a combination 
of aldehyde (0.4 M) and silane (0.48 M) in toluene was mixed with the aniline 
derivative (0.48 M) in toluene using a T-piece adapter. Following a short residence 
time in the first reactor coil (40 s), the borane catalyst (8 mM) was injected, which 
then proceeded the second reactor coil. This was heated to 150 °C for 10 minutes 
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before passing through a cooling coil to leave the product stream at ambient 
temperature which could then pass through a silica gel plug before being collected. 
The target amines 5.7 could be produced in good yields up to 89% with various 
arylated substituents on either the C or N terminus (Scheme 5.7). Notable exceptions 
to this are where strongly electron donating or withdrawing functionalities are installed 
at nitrogen such as p-OMe (5.7f) and p-CF3 (5.7g) which gave the secondary amine 
in yields of 45% and 34% respectively (Figure 5.7). In this latter case, hydrosilylated 
aldehyde was also detected in the product stream as a result of poor imine formation. 
Due to the modular and adaptable format of continuous-flow chemistry, this trait could 
easily be remedied in future by increasing residence time or temperature of reactor 
coil 1 to ensure complete conversion to the imine takes place. As mentioned earlier, 
regardless of the formation of water as a side-product, the borane suffers no 
deleterious effects during this process opening more avenues for a merger between 
main group chemistry and this emergent processing technology. As can be seen 
below, comparison of results between the batch and flow methodologies clearly show 
advantages to using latter process (Figure 5.8). This radial diagram shows a number 
of comparative parameters by which to judge the effectiveness of each approach. 
Evidently, the continuous-flow method allows modularity and easy access to more 
forcing reaction conditions such as high pressures and temperatures thus leading to 
product formation in much faster times whilst greatly increasing the yield with the 
same catalyst loading. 
Figure 5.7: Tandem B(C6F5)3 catalysis to give 5.7. Conversion measured via 1H NMR 
spectroscopy in parenthesis with isolated yields indicated for 5.7a and 5.7d. 
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Batch
Flow
Figure 5.8: Radial chart comparing batch and flow systems in the synthesis of 5.7c.
5.2.3 Biologically Inspired Borohydride Sources and Subsequent 
Transfer Hydrogenation Reactions
Initial bids to form borohydrides from biologically inspired hydride donors involved 
the reaction of B(C6F5)3 with the NADPH analogue, 1-benzyl-1,4-dihydropyridine 
5.8a. Monitoring the reaction progress via in situ NMR spectroscopy revealed the 
formation of an aromatic pyridinium motif within 10 mins. This was evidenced by the 
1H NMR spectrum with new diagnostic peaks observed at δ = 8.65, 8.43 and 7.97 
ppm for the ortho-, para- and meta-protons of the newly formed aromatic ring. This 
was corroborated in the 11B NMR spectrum whereby a sharp doublet resonance was 
observed at δ = -25.2 ppm (1JBH = 66 Hz), synonymous with the 
tris(pentafluorophenyl)hydridoborate anion, [HB(C6F5)3]–.[151] This rapid quantitative 
conversion, taking less than 10 minutes, to the pyridinium borate was accompanied 
by a stark colour change from an off yellow solution to a dark crimson once the 
reaction had completed with the product being isolated in 94% yield. Conversely, the 
use of the less Lewis acidic 2,4,6-BArF9 showed much slower reactivity in forming the 
hydridoborate species however, much lower conversions were measured with a 
number of other by-products persisting. Additionally, BPh3 was also trialled with very 
little success, with barely any activation being observed.
Unfortunately, repeated efforts to obtain single crystals of 5.9 were met with little 
success with a red oil resulting from each attempt. Interestingly, the pyridinium borate 
salt 5.9 was stable in solution at elevated temperatures of 70 °C for over 3 hours 
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which is in contrast to similar systems reported recently whereby warming the 
Hantzsch ester ion pair to room temperature results in the reduction of the pyridinium 
ring at the ortho-position furnishing the 1,2-dihydropyridine borane adduct (see 
Scheme 5.6).[145] According to these reports, this is posited to be driven by the 
formation of a favourable hard Lewis adduct between the borane and the ester 
carbonyl oxygen. This particular reversible reduction pathway is avoided through the 
exclusion of such coordinating functional groups alongside the slight steric congestion 
brought about by the amine substituent, thus allowing the equilibrium to favour the 
formation of the pyridinium borate. 
Scheme 5.11: Synthesis of pyridinium borate 5.9.
Further investigations sought to compare the results from the native 
dihydropyridine 5.8a with that of the C3-functionalised amidodihydropyridine 5.8b. 
The proceeding 1:1 reaction between 5.8b and B(C6F5)3 shows that initially a strong 
amide-borane adduct is formed as evidenced by the in situ 11B NMR spectrum, 
presenting a broad singlet resonance at δ = -2.4 ppm, which is similar in nature to 
others reported previously.[36b] Monitoring the 11B NMR spectrum after 1 h showed a 
new sharp resonance emerging at δ = -10.9 ppm indicating a new tetrahedral borate 
species. Heating the reaction to 70 °C for 12 h produced a white crystalline solid that 
could be isolated in 44% yield. 
Solid-state analyses via X-ray diffraction showed the product of the reaction to 
be the zwitterionic pyridinium amidoborate 5.10 which supports the chemical shift 
seen in the 11B NMR spectrum as well as the downfield shift of the dihydropyridine 
backbone protons as a result of aromatisation (Scheme 5.12). Initial speculation 
regarding the mechanism proposed that the reaction proceeds via a dehydrogenative 
pathway through hydride abstraction by the borane, followed by dehydrocoupling to 
form the pyridinium amidoborane 5.10. However, closer inspection of the multinuclear 
NMR spectra of the mother liquor exposed a new boron-containing compound in the 
11B NMR spectrum as well as newly formed aliphatic proton signals in the 1H NMR 
spectrum. The new resonances were ascribed to the partially hydrogenated 
amidotetrahydropyridine borane adduct 5.11 which could be isolated as a pale green 
solid in a moderate yield of 42% to give a combined total yield for the reaction of 86%. 
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A deshielding effect is observed through the conjugated system as a result of borane 
coordination resulting in a downfield shift of the vinylic proton to δ = 7.92 ppm in the 
1H NMR spectrum. Additionally, the newly formed aliphatic sp3 signals arise as triplets 
at δ = 3.15 and 2.11 ppm as well as a pentet at δ = 1.91 ppm.
Scheme 5.12: Reaction between 5.8b and B(C6F5)3 to give 1:1 mixture of 5.10 and 5.11.
Analysing the solid-state structure of 5.10 unambiguously confirmed the 
formation of the pyridinium heterocycle. With regard to the metric parameters, the C–
C bonds lengths (1.369(5)–1.389(3) Å) and C–N bond lengths (1.345(3)–1.351(3) Å) 
of the heterocycle are consistent with literature values of similar nitrogen containing 
heterocyclic structures (Figure 5.9, Table 5.2).[65] Other traits include the rotation of 
the amide fragment out of the plane of the heterocyclic ring by 34.3(3)° thus reducing 
the effective orbital overlap and hindering conjugation. This is thought to arise as a 
result of the repulsion between the amide N–H proton and the aromatic C–H proton 
which features a distance of only 2.23(17) Å in the solid-state. When observing 
packing features in the solid-state, short intermolecular contacts are seen between 
the carbonyl oxygen and the electron deficient ortho-H atom of the pyridinium ring 
and one of the benzylic protons (Figure 5.10).
Figure 5.9: Solid-state structure of 5.10. C: grey, H: white, N: blue, O: red, B: yellow-green, F: 
pink. Thermal ellipsoids shown at 50% probability. 
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Figure 5.10: Solid-state packing of 5.10 depicting close intermolecular contacts. C6F5-groups 
omitted from boron atom for clarity. C: grey, O: red, N: blue, B: yellow-green. Thermal 
ellipsoids shown at 50% probability.
Theoretical studies at the B3LYP/6-31G* level of theory[152] showed that the 
geometry optimised structure agreed well for the most part with the experimental 
solid-state structure as all calculated bond lengths were the same within error as the 
experimental data (Table 5.2). A slight difference arose when comparing the rotation 
of the nitrogen appended benzyl group, as the solid-state twist angle between the 
pyridinium ring and phenyl group was measured at 11.1(7)° whereas the in silico
study calculated this to be more pronounced at 64.6° (Figure 5.11) presumed to be 
an artefact of packing effects in the solid-phase vs. gas-phase calculations.
Table 5.2. Calculated and experimental bond distances for 5.10.
Bond lengths (Å)
Bond Experimental Calculated
C1-C2 1.389(4) 1.399
C2-C3 1.369(5) 1.382
C3-N4 1.345(3) 1.358
C5-N4 1.351(3) 1.348
C5-C6 1.379(4) 1.389
C6-C1 1.390(3) 1.398
C6-C7 1.516(4) 1.528
C7-O 1.228(3) 1.234
C7-N8 1.329(3) 1.333
N8-B 1.557(4) 1.570
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Figure 5.11: Overlay of experimental structure (blue) and calculated structure (red) of 5.10.
With regard to the mechanism, it was posited that the initial adduct formation 
between the amide oxygen atom and boron causes the NH2 protons to become more 
acidic. This in turn protonates the alkenyl functionality distal to the amide of another 
dihydropyridine equivalent with boron migration from oxygen to nitrogen to garner the 
intermediate I. Subsequent hydride migration from I to the iminium intermediate II
generates the tetrahydropyridine borane adduct 5.11 and the zwitterionic pyridinium 
borate 5.10 in a 1:1 molar ratio (Scheme 5.13). It was hoped that using half an 
equivalent of the borane could also produce the desired product as half the supplied 
borane forms the simple Lewis adduct 5.11 which may be recycled upon heating. 
Unfortunately, a mixture of products were observed according to in situ NMR 
spectroscopy when using this new 1:2 borane to substrate stoichiometry. This result 
indicates that ‘free’ borane is essential for the desired reactivity to proceed via borane 
mediated hydride shuttling (Scheme 5.13). Alternatively, coordination of B(C6F5)3 to 
the carbonyl oxygen of intermediate II promotes reduction of the iminium by an 
equivalent of I.
Scheme 5.13: Proposed mechanistic pathway for the disproportionation reaction between 
5.8b and B(C6F5)3.
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To understand further the reaction mechanism, isotopic labelling of the amide 
protons was conducted in a bid to ascertain what, if any, regiocontrol this reaction 
follows. The deuterated amide 5.8c, synthesised by exposing 5.8b to MeOD, was 
exposed to B(C6F5)3 in a 1:1 Stoichiometric ratio and heated to 70 °C in CDCl3 for 12 
h. The resulting NMR spectra showed that a single regioisomer was formed for the 
isolated compounds of 5.12 and 5.13 with selective deuteration at the β-position to 
the nitrogen of the heterocyclic ring (Scheme 5.14). Instead of the previously 
observed triplets, doublets now prevailed at δ = 3.15 ppm and 2.10 ppm for the 
methylene protons adjacent to the deuterated position. Further to this, the pentet that 
was observed previously endured however, with an integral of 1 at δ = 1.91 ppm. 
Scheme 5.14: Deuterium labelling studies into the hydrogen transfer reaction of 5.8c.
This reaction was then repeated in the presence of a reducible reagent (4-
fluorobenzaldehyde) however, no alcoholic product was observed with the aldehyde 
resonance remaining completely unaltered. Following the reaction coordinate by in 
situ NMR spectroscopy indicated that the reaction proceeds as seen in Scheme 5.12, 
with the two compounds 5.10 and 5.11 being observed, albeit amongst a small 
amount of side products. 
Further work altered the functional group on the dihydropyridine backbone to a 
carboxylic acid in a bid to affect the same transformation as seen before. Indeed, 
applying the same conditions to the reaction with 5.8d garnered the expected product 
5.14, which could be isolated in 36% yield (Scheme 5.15). Confirmation could be 
obtained by the presence of the aromatic motif in the 1H NMR spectrum alongside the 
diagnostic sharp singlet resonance of δ = -4.0 ppm in the 11B NMR spectrum. 
Unfortunately, the reduced product could not be isolated from the reaction mixture as 
a number of side reactions occurred according to spectroscopic analysis of the 
mother liquor. This reaction further reinforces new ground-breaking group 13 Lewis 
acid chemistry as carboxylic acids are not normally tolerated by similar highly 
electrophilic boranes, as set out in Chapter 4. These new examples of previously 
forbidden chemistry continue to push the boundaries of main group compounds and 
their applications in more diverse fields.
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Scheme 5.15: Reaction between 1-benzyl-1,4-dihydronicotinic acid 5.8d and B(C6F5)3.
5.3 Conclusions
This chapter has shown how tailoring the Lewis acidity at boron can vastly 
change the reactivity and effectiveness in reduction reactions, specifically 
hydroborations. By attenuating the electrophilicity of the Lewis acid it was 
demonstrated that side reactions may be precluded while still remaining catalytically 
active in the hydroboration of a vast number of unsaturated reagents, such as 
alkynes, aldehyde and aldimines with tolerance to a plethora of electronic and steric 
functional groups. Pleasingly, low catalyst loading is required to produce the majority 
of these pinacol boronate esters in quantitative yields using only mild reaction 
conditions and relatively short reaction times. In addition to this, simple purification 
via either removal of volatiles under reduced pressure and/or filtering through a silica 
gel plug rendered this catalytic system incredibly useful in the hydroboration of a 
range of unsaturated substrates.
With regard to the continuous-flow aspect, this work has shown how there is
significant benefit through the synergistic combination of novel processing methods 
and main group catalysis to affect hydrosilylation reactions. This has not only allowed 
the hydrosilylation of more problematic electron rich substrates which are not possible 
under traditional batch-type conditions, but also permitted the multi-step synthesis of 
secondary amines via a B(C6F5)3 catalysed condensation reaction in a single 
procedure.
Finally, with only a small number of examples where biological inspired systems 
have been merged with main group chemistry, this work built upon this premise to 
develop thermally stable borohydrides from nicotinamide adenine dinucleotide 
phosphate (NADPH) mimics. Functionalisation of these dihydropyridines with either 
an amide or carboxylic acid moiety leads to a transfer hydrogenation-type reaction 
whereby one equivalent undergoes an oxidation to form the pyridinium borate 
whereas the second equivalent is reduced to the tetrahydropyridine. It was 
hypothesised that in this case the borane acts in a bifunctional manner, not only acting 
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as an initiator to promote the protonation of the alkene, but also to promote hydride 
transfer to reduce one equivalent of the dihydropyridine. 
This chapter has shown how the combination of different fields can effectively 
overcome many hurdles in main group chemistry, paving the way for further bridging 
themes to tackle current pitfalls in early p-block reactivity. 
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Chapter 6
Experimental
6.1 General Experimental
With the exception of the synthesis of starting materials, all reactions and 
manipulations were carried out under an atmosphere of dry, O2-free nitrogen using 
standard double-manifold techniques with a rotary oil pump. A nitrogen-filled glove 
box (MBraun) was used to manipulate solids including the storage of starting 
materials, room temperature reactions, product recovery and sample preparation for 
analysis. All solvents (toluene, CH2Cl2, hexane, pentane, THF, 1,4-dioxane, Et2O) 
were dried by employing a Grubbs-type column system (Innovative Technology) or a 
solvent purification system MB SPS-800 and stored under a nitrogen atmosphere. 
Deuterated solvents were distilled and/or dried over molecular sieves before use. 
Chemicals were purchased from commercial suppliers and used as received. 1H, 11B,
13C, 19F, 27Al, 29Si and 77Se NMR spectra were recorded on a Bruker Avance 300, 
Bruker Avance II 400 or Bruker Avance 500 spectrometers. 13C NMR spectra were 
recorded as 1H decoupled. Chemical shifts are expressed as parts per million (ppm, 
δ) downfield of tetramethylsilane (TMS) and are referenced to CDCl3 (7.26/77.16 
ppm) as internal standards. NMR spectra were referenced to CFCl3 (19F), 
BF3·Et2O/CDCl3 (11B), Al(NO2)3 (27Al), TMS/CDCl3 (29Si) and Me2Se (77Se). The 
description of signals include: s = singlet, d = doublet, t = triplet, q = quartet, pent. = 
pentet, sext. = sextet, sept. = septet, m = multiplet and br. = broad. All coupling 
constants are absolute values and are expressed in Hertz (Hz). Yields are given as 
isolated yields unless otherwise states. All spectra were analysed assuming a first 
order approximation. IR-Spectra were measured on a Shimadzu IRAffinity-1 
photospectrometer where intensity is denoted by s = strong, m = medium, w = weak 
and br. = broad. Mass spectra were measured on a Waters LCT Premier/XE or a 
Waters GCT Premier. Elemental Analysis was performed by Mr Stephen Boyer of 
London Metropolitan University. 
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6.2 Activation of Allenyl Ketones and Esters using 
Cooperative Lewis Pairs and Boron Lewis Acids
6.2.1 Synthesis of Starting Materials
Allenyl ketones and esters 2.2 and 2.5 respectively were synthesised by Dr. Max. 
M. Hansmann using literature procedures.[153]
6.2.2 Synthesis of Products
General Procedure 1: PR3 (0.1 mmol, 1 equiv.) in CDCl3 (0.5 ml) was added to 
B(C6F5)3 (51 mg, 0.1 mmol, 1 equiv.) to give a pale yellow solution which was then 
transferred to 2.2 (0.1 mmol, 1 equiv.) to give a red solution. The mixture was 
transferred to an NMR tube and the 1H, 13C 11B, 31P and 31P{1H} NMR spectra were 
measured. Multinuclear in situ NMR reaction spectra for 2.3a were not recorded due 
to rapid crystal formation upon reaction, similarly in situ 13C NMR spectrum was not 
recorded for 2c for the same reason. Crystals of 2.3a, 2.3b, 2.3c, 2.3f, 2.3j and 2.3k
suitable for X-ray diffraction were grown from CDCl3. The remaining solid was washed 
with hexane (3 x 2 ml) and dried in vacuo to give the pure product with isolated yields 
indicated. For 2.3d, 2.3e, 2.3g, 2.3h and 2.3i, the volatiles were removed under 
reduced pressure to yield a solid which was washed with hexane (3 x 2 ml) and dried 
in vacuo to give the product with isolated yields indicated.
2.3a: Synthesised according to General Procedure 1 using 2.2a (14 
mg, 0.1 mmol) tri(o-tol)phosphine (30 mg, 0.1 mmol). Yield: 58.3 
mg, 88.9 μmol, 89%. IR ʋmax (cm-1): 3054, 2987, 2685, 2412, 2305, 
1642, 1558, 1515, 1466, 1423, 1266, 1087, 980, 896, 747, 735, 
706. HRMS (ES–) m/z calculated for [M-H]– [C49H28BF15OP]–: 958.1768, found: 
958.1782. 
2.3b: Synthesised according to General Procedure 1 using 2.2b
(16 mg, 0.1 mmol) tri(o-tol)phosphine (30 mg, 0.1 mmol). Yield: 65 
mg, 66.7 μmol, 67%. Melting point: 178-193 °C. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.37-7.07 (m, 12H, phosphine C-H), 
7.37-7.07 (m, 4H, Ar-H), 5.40 (d, 3JHP = 53 Hz, 1H, C-H), 5.22 (d, 
3JHP = 26 Hz, 1H, =C-H), 4.34 (d, 3JHP = 11 Hz, 1H, =CH) 2.45 (br. s, 3H, Ar-CH3), 
2.25 (br. s, 3H, phosphine CH3), 1.78 (br. s, 3H, phosphine CH3), 1.59 (br. s, 3H, 
phosphine CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 165.2 (s), 151.5 (s), 148.9 
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(s), 146.9 (s), 138.4 (s), 137.5 (s), 134.9 (s), 133.6 (s), 132.2 (s), 130.9 (s), 129.7 (s), 
127.7 (s), 93.7 (s), 22.6 (s), 21.5 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -4.0 
(br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -132.7 (m, 2F, o-F), -161.1 (t, 3JFF
= 20 Hz, 1F, p-F), -165.9 (m, 2F, m-F). 31P NMR (202 MHz, CDCl3, 298 K) δ/ppm: 22.9 
(br. s). 31P{1H} NMR (202 MHz, CDCl3, 298 K) δ/ppm: 23.0 (s). IR ʋmax (cm-1): 3055, 
2987, 2925, 2853, 2687, 2412, 2306, 1643, 1586, 1558, 1513, 1465, 1423, 1390, 
1373, 1266, 1202, 1137, 1114, 1087, 997, 980, 927, 897, 836, 809, 742, 707. HRMS
(ES–) m/z calculated for [M-H]– [C50H30BF15OP]–: 972.1924, found: 972.1971. 
Elemental analysis (%) calculated for C50H31BF15OP: C 61.62, H 3.21, found: C 
61.68, H: 3.14.
2.3c: Synthesised according to General Procedure 1 using 2.2c
(17 mg, 0.1 mmol) tri(o-tol)phosphine (30 mg, 0.1 mmol). Yield: 
47 mg, 47.4 μmol, 47%. Melting point: 176-187 °C. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 8.28-7.14 (m, 12H, phosphine C-H), 
7.52 (d, 3JHH = 8.7 Hz, 2H, o-H), 6.89 (d, 3JHH = 8.7 Hz, 2H, m-
H), 5.54 (d, 3JHP = 52 Hz, 1H, C-H), 5.35 (d, 3JHP = 26 Hz, 1H, 
=C-H), 4.42 (d, 3JHP = 11 Hz, 1H, =C-H), 3.79 (s, 3H, Ar-OCH3), 2.45 (br. s, 3H, 
phosphine CH3), 1.85 (br. s, 3H, phosphine CH3), 1.65 (br. s, 3H, phosphine CH3). 
11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -4.0 (br. s). 19F NMR (282 MHz, CDCl3, 
298 K) δ/ppm: -132.7 (m, 2F, o-F), -161.1 (t, 3JFF = 21 Hz, 1F, p-F), -165.9 (m, 2F, m-
F). 31P NMR (202 MHz, CDCl3, 298 K) δ/ppm: 22.7 (br. s). 31P{1H} NMR (202 MHz, 
CDCl3, 298 K) δ/ppm: 22.8 (s). IR ʋmax (cm-1): 3055, 2988, 2931, 2856, 2687, 2524, 
2411, 2306, 1713, 1643, 1610, 1587, 1557, 1513, 1465, 1423, 1390, 1373, 1267, 
1175, 1138, 1088, 1032, 980, 925, 908, 897, 842, 808, 756, 724, 706. HRMS (ES–) 
m/z calculated for [M-H]– [C50H30BF15O2P]–: 988.1873, found 988.1891. Elemental 
analysis (%) calculated for C50H31BF15O2P·CDCl3. C 55.14, H: 2.99, found: C 55.07, 
H 2.26.
2.3d: Synthesised according to General Procedure 1 using 2.2d
(18 mg, 0.1 mmol) tri(o-tol)phosphine (30 mg, 0.1 mmol). Yield: 
98 mg, 98.5 μmol, 99%. Melting point: 186-194 °C. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 8.15-7.17 (m, 12H, phosphine C-H), 
7.53 (d, 3JHH = 8.5 Hz, o-H), 7.34 (d, 3JHH = 8.5 Hz, m-H), 5.52 (d, 
3JHP = 52 Hz, 1H, =C-H), 5.38 (d, 3JHP = 25 Hz, 1H, =C-H), 4.48 (d, 3JHP = 10 Hz, 1H, 
C-H), 2.44 (br. s, 3H, phosphine CH3), 1.83 (br. s, 3H, phosphine CH3), 1.66 (br. s, 
3H, phosphine CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 163.8 (m), 149.1 (s), 
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147.2 (s), 143.9 (s), 143.2 (s), 143.2 (s), 139.0 (s), 137.8 (s), 135.3 (s), 134.7 (s), 
134.0 (s), 133.5 (s), 130.0 (s), 129.7 (s), 129.5 (s), 129.3 (s), 126.6 (s), 113.5 (s), 94.6 
(m), 26.0 (s), 22.8 (br. s), 21.5 (s), 19.4 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 
-3.9 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -132.9 (m, 2F, o-F), -160.8 (t, 
3JFF = 20 Hz, 1F, p-F), -165.6 (m, 2F, m-F). 31P NMR (202 MHz, CDCl3, 298 K) δ/ppm: 
23.0 (br. s). 31P{1H} NMR (202 MHz, CDCl3, 298 K) δ/ppm: 23.1 (s). IR ʋmax (cm-1):
3055, 2987, 2685, 2412, 2308, 1644, 1585, 1556, 1515, 1488, 1466, 1422, 1390, 
1371, 1296, 1267, 1202, 1171, 1136, 1122, 1088, 1032, 1016, 996, 979, 926, 910, 
898, 844, 808, 750, 729, 706. HRMS (ES–) m/z calculated for [M-H]–
[C49H27BClF15OP]–: 992.1378, found: 992.1411.
2.3e: Synthesised according to General Procedure 1 using 2.2d
(24 mg, 0.1 mmol) tri(o-tol)phosphine (30 mg, 0.1 mmol). Yield: 
100 mg, 88.1 μmol, 88%. Melting point: 98-115 °C. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.59-6.84 (m, 12H, phosphine C-H), 
7.59-6.84 (m, 4H, Ar-H), 7.59-6.84 (br. m, 2H, furan C-H), 5.87 (d, 
3JHP = 50 Hz, 1H, C-H), 5.63 (d, 3JHP = 23 Hz, 1H, =C-H), 4.36 (d, 
3JHP = 7.4 Hz, 1H, =C-H), 2.30 (s, 3H, phosphine CH3), 1.79 (s, 3H, phosphine CH3), 
1.58 (s, 3H, phosphine CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 151.5 (s), 
150.7 (m), 148.3 (s), 147.7 (s), 145.8 (s), 138.6 (s), 136.5 (s), 133.9 (s), 129.8 (s), 
128.1 (s), 127.4 (s), 126.8 (s), 125.3 (s), 114.1 (s), 112.2 (s), 95.2 (m), 21.6 (s), 20.0 
(m). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -3.6 (br. s). 19F NMR (282 MHz, CDCl3, 
298 K) δ/ppm: -132.9 (m, 2F, o-F), -161.2 (t, 3JFF = 21 Hz, 1F, p-F), -165.7 (m, 2F, m-
F). 31P NMR (202 MHz, CDCl3, 298 K) δ/ppm: 23.7 (s), 19.7 (br. s). 31P{1H} NMR (202 
MHz, CDCl3, 298 K) δ/ppm: 23.6 (s), 19.7 (br. s). IR ʋmax (cm-1): 3055, 2988, 2686, 
2522, 2412, 2306, 1712, 1645, 1593, 1566, 1555, 1514, 1466, 1424, 1368, 1265, 
1223, 1170, 1137, 1087, 1025, 978, 897, 808, 753, 723, 705. HRMS (ES–) m/z
calculated for [M-H]– [C53H29BClF15O2P]–: 1058.1484, found: 1058.1536.
2.3f: Synthesised according to General Procedure 1 using 2.2c
(17 mg, 0.1 mmol) tris(m-FC6H4) phosphine (32 mg, 0.1 mmol). 
Yield: 55 mg, 54.9 μmol, 55%. Melting point: 151-164 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.51-7.48 (m, 3H, 
phosphine C-H), 7.39 (br. t, 3JHH = 8.1 Hz, 3H, phosphine C-H), 
7.34 (d, 3JHH = 8.2 Hz, 2H, o-H), 7.16 (m, 3H, phosphine C-H), 7.05 (m, 3H, phosphine
C-H), 6.74 (d, 3JHH = 8.2 Hz, 2H, m-H), 5.63 (d, 3JHP = 53 Hz, 1H, =C-H), 5.06 (d, 3JHP
= 25 Hz, 1H, =C-H), 4.45 (d, 3JHP = 9.8 Hz, 1H, =C-H), 3.67 (s, 3H, OCH3). 13C NMR
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(126 MHz, CDCl3, 298 K) δ/ppm: 166.0 (m), 163.8 (m), 161.9 (m), 160.0 (s), 148.6 
(s), 139.6 (s), 137.5 (m), 135.4 (m), 132.9 (s), 132.6 (m), 131.1 (s), 129.7 (s), 129.7 
(s), 129.4 (s), 123.1 (m), 120.6 (m), 119.4 (s), 118.8 (s), 114.0 (s), 92.3 (m), 55.1 (s). 
11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -3.8 (br. s). 19F NMR (282 MHz, CDCl3, 
298 K) δ/ppm: -105.5 (m, 1F, phosphine), -133.2 (d, 3JFF = 22 Hz, 2F, o-F), -160.8 (t, 
3JFF = 21 Hz, 1F, p-F), -165.6 (t, 3JFF = 21 Hz, 2F, m-F). 31P NMR (202 MHz, CDCl3, 
298 K) δ/ppm: 22.6 (s). 31P{1H} NMR (202 MHz, CDCl3, 298 K) δ/ppm: 22.7 (s). IR
ʋmax (cm-1): 3055, 2987, 2686, 2411, 2306, 1644, 1610, 1585, 1556, 1514, 1480, 
1465, 1423, 1270, 1262, 1237, 1175, 1098, 1090, 1033, 999, 981, 925, 897, 844, 
794, 757, 723, 706. HRMS (AP+) m/z calculated for [M]+ [C47H22BF18O2P]+: 
1002.1163, found: 1002.1166. Elemental analysis (%) calculated for 
C47H22BF18O2P: C 56.31, H 2.21, found: C 56.27, H 2.18.
2.3g: Synthesised according to General Procedure 1 using 
2.2d (18 mg, 0.1 mmol) tris(m-FC6H4)phosphine (32 mg, 0.1 
mmol). Yield: 93 mg, 92.4 μmol, 92%. Melting point: 119-141 
°C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.02-7.54 (m, 
12H, phosphine C-H) 7.02-7.54 (m, 4H, Ar-H), 5.62 (d, 3JHH = 
53 Hz, 1H, =C-H), 5.11 (d, 3JHH = 25 Hz, 1H, =C-H), 4.52 (d, 3JHH = 9.4 Hz, 1H, =CH). 
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 165.3 (m), 164.4 (m), 162.3 (m), 149.1 
(m), 147.2 (m), 140.2 (m), 137.9 (m), 137.7 (s), 135.8 (m), 135.2 (s), 134.2 (m), 133.1 
(m), 130.8 (m), 130.0 (m), 129.4 (m), 127.9 (s), 127.3 (s), 123.8 (m), 121.2 (m), 119.7 
(m), 119.0 (m), 117.0 (m), 93.6 (m). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -3.8 
(br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -105.2 (m, 1F, P(m-FC6H4)3), -133.3 
(m, 2F, o-F), -160.4 (t, 3JFF = 20.3 Hz, 1F, p-F), -165.4 (m, 2F, m-F). 31P NMR (202 
MHz, CDCl3, 298 K) δ/ppm: 22.9 (br. s). 31P{1H} NMR (202 MHz, CDCl3, 298 K) δ/ppm:
22.8 (s). IR ʋmax (cm-1): 3055, 2988, 2964, 2932, 2874, 2861, 2686, 2411, 2307, 1720, 
1682, 1644, 1585, 1556, 1514, 1480, 1465, 1424, 1370, 1267, 1235, 1100, 1056, 
1015, 998, 979, 966, 926, 898, 843, 794, 752, 731, 707. HRMS (ES–) m/z calculated 
for [M-H]– [C46H18BClF18OP]–: 1004.0626, found: 1004.0672.
2.3h: Synthesised according to General Procedure 1 using 
2.2c (17 mg, 0.1 mmol) tris(p-OMeC6H4)phosphine (35 mg, 
0.1 mmol). Yield 70 mg, 67.4 μmol, 67%. Melting point: 110-
122 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.32 (d, 
3JHH = 8.4 Hz, 2H, Ar o-H), 7.24 (m, 6H, phosphine m-H), 
6.89 (dd, 3JHH = 8.8 Hz, 4JHH = 2.5 Hz, 6H, phosphine o-H), 6.70 (d, 3JHH = 8.7 Hz, 2H, 
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Ar m-H), 5.47 (d, 3JHP = 50 Hz, 1H, =C-H), 5.00 (d, 3JHP = 24 Hz, 1H, =C-H), 4.47 (d, 
3JHP = 9.0 Hz, 1H, =CH), 3.77 (s, 9H, phosphine CH3), 3.66 (s, 3H, OCH3). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 164.8 (s), 164.11 (m), 159.9 (s), 149.0 (br. s), 147.1 
(br. s), 137.7 (m), 135.8 (m), 132.0 (s), 131.7 (s), 130.8 (s), 129.9 (s), 115.8 (m), 113.9 
(s), 109.2 (s), 108.4 (s), 94.0 (m), 55.7 (s), 55.3 (s). 11B NMR (160 MHz, CDCl3, 298 
K) δ/ppm: -3.8 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -133.0 (m, 2F, o-F), 
-161.2 (t, 3JFF = 21 Hz, 1F, p-F), -165.8 (t, 3JFF = 21 Hz, 2F, m-F). 31P NMR (202 MHz, 
CDCl3, 298 K) δ/ppm: 21.8 (br. s). 31P{1H} NMR (202 MHz, CDCl3, 298 K) δ/ppm: 21.7 
(s). IR ʋmax (cm-1): 3055, 2988, 2845, 2687, 2410, 2307, 1713, 1643, 1596, 1568, 
1513, 1505, 1464, 1443, 1423, 1364, 1297, 1267, 1184, 1170, 1112, 1084, 1026, 
966, 897, 834, 805, 753, 728, 705. HRMS (ES–) m/z calculated for [M-H]–
[C50H30BF15O5P]–: 1036.1721, found: 1036.1725.
2.3i: Synthesised according to General Procedure 1 using 
2.2d (18 mg, 0.1 mmol) tris(p-OMeC6H4)phosphine (35 mg, 
0.1 mmol). Yield: 100 mg, 95.9 μmol, 96%. Melting point: 
87-99 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.30 
(d, 3JHH = 8.8 Hz, 2H, Ar o-H), 7.24-7.20 (m, 6H, phosphine
C-H), 7.12 (d, 3JHH = 8.4 Hz, 2H, Ar m-H), 6.92-6.91 (m, 6H, phosphine C-H), 5.47 (d, 
3JHP = 49 Hz, 1H, =C-H), 5.06 (d, 3JHP = 23 Hz, 1H, =C-H), 4.54 (d, 3JHP = 8.6 Hz, 1H, 
=CH), 3.78 (s, 9H, phosphine CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 164.6 
(m), 148.8 (m), 146.7 (m), 136.0 (m), 135.5 (m), 129.8 (s), 129.1 (s), 128.9 (s), 128.5 
(s), 128.1 (s), 125.2 (s), 116.6 (m), 115.7 (m), 108.6 (m), 107.9 (m), 55.6 (m), 31.5 
(s), 22.6 (s), 21.3 (s), 14.0 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -3.8 (br. s). 
19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -133.1 (m, 2F, o-F), -160.9 (t, 3JFF = 20.7 
Hz, 1F, p-F), -165.6 (m, 2F, m-F). 31P NMR (202 MHz, CDCl3, 298 K) δ/ppm: 21.6 (s). 
31P{1H} NMR (202 MHz, CDCl3, 298 K) δ/ppm: 21.7 (s). IR ʋmax (cm-1): 3054, 2988, 
2846, 2685, 2309, 1713, 1644, 1594, 1567, 1514, 1504, 1465, 1422, 1366, 1300, 
1265, 1223, 1184, 1113, 1088, 1024, 979, 965, 896, 835, 806, 739, 706. HRMS (ES–
) m/z calculated for [M-H]– [C49H27BClF15O4P]–: 1040.1225, found: 1040.1245.
2.3j: Synthesised according to General Procedure 1 using 2.2c (17 
mg, 0.1 mmol) tribenzylphosphine (30 mg, 0.1 mmol). Yield: 62 mg, 
62.6 μmol, 63%. Melting point: 168-181 °C. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 7.34-7.39 (m, 9H, phosphine C-H), 7.34-7.39 
(m, 2H, Ar o-H) 6.89 (m, 6H, phosphine C-H), 6.80 (d, 3JHH = 8.8 
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Hz, 2H, Ar m-H), 5.58 (d, 3JHP = 47 Hz, 1H, =C-H), 5.19 (d, 3JHP = 20 Hz, 1H, =C-H), 
4.87 (d, 3JHP = 8.3 Hz, 1H, =CH), 3.78 (s, 3H, OCH3), 3.20 (d, 3JHP = 13 Hz, 6H, 
phosphine CH2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 196.9 (s), 164.5 (m), 
149.1 (br. s) 147.2 (br. s) 137.9 (br. s), 137.3 (s), 135.9 (m), 134.7 (s), 133.3 (s), 130.3 
(m), 129.2 (m), 128.7 (m), 126.1 (s), 91.3 (m), 28.6 (m), 26.0 (m). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: -3.57 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -132.9 
(m, 2F, o-F), -160.3 (t, 3JFF = 21.1, 1F, p-F), 165.1 (m, 2F, m-F). 31P NMR (202 MHz, 
CDCl3, 298 K) δ/ppm: 25.1 (m). 31P{1H} NMR (202 MHz, CDCl3, 298 K) δ/ppm: 25.0 
(s). IR ʋmax (cm-1): 3055, 2987, 2961, 2926, 2855, 2687, 2411, 2359, 2308, 1716, 
1643, 1609, 1588, 1565, 1514, 1498, 1465, 1423, 1365, 1266, 1175, 1088, 1032, 
980, 925, 896, 865, 845, 808, 751, 730, 706. HRMS (ES–) m/z calculated for [M-H]–
[C50H30BF15O2P]–: 988.1873, found: 988.1896. Elemental analysis (%) calculated for 
C50H31BF15O2P: C 60.63, H 3.15, found: C 60.48, H 2.94.
2.3k: Synthesised according to General Procedure 1 using 2.2d
(18 mg, 0.1 mmol) tribenzylphosphine (30 mg, 0.1 mmol).Yield: 87 
mg, 87.4 μmol, 87%. Melting point: 91-103 °C. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 7.29-7.21 (m, 9H, phosphine C-H), 7.29-7.21 
(m, 2H, Ar o-H), 7.14 (m, 2H, Ar m-H), 6.77 (m, 6H, phosphine C-
H), 5.42 (d, 3JHP = 47 Hz, 1H, =C-H), 5.09 (d, 3JHP = 20 Hz, 1, =C-H), 4.8 (d, 3JHP = 
8.1 Hz, 1H, =CH), 3.13 (d, 3JHP = 13 Hz, 6H, phosphine CH2). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 186.7 (s), 167.5 (s), 155.9 (s), 148.3 (s), 139.8 (s), 138.1 (s), 
130.3 (m), 129.6 (m), 128.8 (m), 126.2 (s), 93.6 (s), 34.5 (m), 22.4 (m). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: -3.5 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -
132.9 (m, 2F, o-F), -160.1 (t, 3JFF = 20.6 Hz, 1F, p-F), -164.9 (m, 2F, m-F). 31P NMR
(202 MHz, CDCl3, 298 K) δ/ppm: 25.4 (m). 31P{1H} NMR (202 MHz, CDCl3, 298 K) 
δ/ppm: 25.2 (s). IR ʋmax (cm-1): 3055, 2987, 2927, 2854, 2687, 2412, 2361, 2307, 
1714, 1678, 1645, 1589, 1515, 1464, 1423, 1364, 1266, 1222, 1088, 978, 964, 897, 
751, 728, 707. HRMS (ES–) m/z calculated for [M-H]– [C49H27BClF15OP]–: 992.1378, 
found: 992.1357. Elemental analysis (%) calculated for C49H28BClF15OP: C 59.15, 
H 2.84, found: C 59.02, H 2.86.
General procedure 2: B(C6F5)3 (51 mg, 0.1 mmol, 1 equiv.) in CDCl3 (0.5 ml) was 
added to 2.2 (0.1 mmol, 1 equiv.) and transferred to an NMR tube and the 1H, 11B, 
13C and 19F NMR spectra were measured. Upon completion, the solvent was removed 
under reduced pressure yielding an oil which was washed with hexane (3 x 2 ml) and 
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dried in vacuo to give a solid with isolated yields indicated. Crystals of 2.4a and 2.4b 
suitable for X-ray diffraction were obtained by dissolving in a few drops of toluene with 
the addition of 1 drop of hexane and leaving at -40 °C.
2.4a: Synthesised according to General Procedure 2 using 2.2a (14 
mg, 0.1 mmol). Yield: 26 mg, 39.6 μmol, 40%. Melting point: 48-51 
°C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.26 (d, 3JHH = 7.7 
Hz, 2H, o-H), 7.88 (t, 3JHH = 7.6 Hz, 1H, p-H), 7.67 (t, 3JHH = 7.7 Hz, 
2H, m-H), 7.33 (s, C-H), 2.74 (s, 2H, CH2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm:
192.6 (s), 169.1 (s), 147.9 (dm, 1JCF = 255 Hz), 144.3 (dm, 1JCF = 245 Hz), 140.2 (dm, 
1JCF = 255 Hz) , 140.0 (dm, 1JCF = 255 Hz), 138.6 (s), 138.3 (dm, 1JCF = 245 Hz), 137.3 
(dm, 1JCF = 258 Hz), 132.9 (s), 131.9 (s), 130.1 (s), 121.2 (s), 27.2 (m). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 2.7 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -
135.1 (m, 4F, o-F), -138.2 (m, 2F, o-F), -149.1 (t, 3JFF = 20.5 Hz, 1F, p-F), -157.6 (t, 
3JFF = 20.7 Hz, 2F, p-F), -159.7 (m, 2F, m-F), -163.6 (m, 4F, m-F). IR ʋmax (cm-1): 3055, 
2988, 2689, 2365, 2307, 1736, 1719, 1651, 1520, 1473, 1422, 1270, 1262, 1096, 
982, 897, 759, 721, 708. HRMS (ES–) m/z calculated for [M-H]– [C28H7BF15O]–: 
654.0387, found: 654.0378.
2.4b: Synthesised according to General Procedure 2 using 
2.2b (16 mg, 0.1 mmol). Yield: 64 mg, 95.5 μmol, 96%. Melting 
point: 48-52 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.19 
(d, 3JHH = 8.4 Hz, 2H, o-H), 7.46 (d, 3JHH = 8.4 Hz, 2H, m-H), 
7.29 (s, C-H), 2.71 (s, 2H, CH2), 2.54 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 191.8 (s), 168.1 (s), 151.7 (s), 148.1 (dm, 1JCF = 242 Hz), 144.5 (dm, 1JCF
= 250 Hz), 142.7 (dm, 1JCF = 253 Hz), 140.1 (dm, 1JCF = 255 Hz), 138.7 (dm, 1JCF = 
245 Hz), 137.7 (dm, 1JCF = 255 Hz), 132.4 (s), 131.2 (s), 130.6 (s), 121.4 (s), 116.4 
(m), 22.8 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 2.2 (br. s). 19F NMR (282 
MHz, CDCl3, 298 K) δ/ppm: -135.1 (m, 4F, o-F), -138.5 (m, 2F, o-F), -149.6 (t, 3JFF = 
20.1 Hz, 1F, p-F), -157.8 (t, 3JFF = 20.6 Hz, 2F, p-F), -159.9 (m, 2F, m-F), -163.7 (m, 
4F, m-F). IR ʋmax (cm-1): 3055, 2983, 2686, 2411, 2360, 2343, 2307, 1714, 1650, 
1606, 1520, 1486, 1422, 1364, 1319, 1268, 1264, 1223, 1184, 1093, 980, 896, 754, 
726, 704. HRMS (ES–) m/z calculated for [M-H]– [C29H9BF15O]–: 668.0543, found: 
668.0535. Elemental analysis (%) calculated for C29H10BF15O: C 51.97, H 1.50, 
found: C 51.86, H 1.46.
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2.4c: Synthesised according to General Procedure 2 using 
2.2c (17 mg, 0.1 mmol). Yield: 68 mg, 99.1 μmol, 99%. Melting 
point: 64-71 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.30 
(d, 3JHH = 8.6 Hz, 2H, o-H), 7.23 (s, C-H), 7.11 (d, 3JHH = 8.6 
Hz, 2H, m-H), 4.00 (s, 3H, CH3), 2.66 (s, 2H, CH2). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 189.0 (s), 168.8 (s), 165.8 (s), 148.0 (dm, 1JCF = 248 Hz), 144.2 (dm, 1JCF
= 251 Hz), 140.1 (dm, 1JCF = 248 Hz), 139.8 (dm, 1JCF = 250 Hz), 138.2 (dm, 1JCF = 
248 Hz), 137.2 (dm, 1JCF = 255 Hz), 135.2 (s), 125.5 (s), 120.9 (s), 115.8 (s), 56.4 (s), 
26.9 (br. s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 1.7 (br. s). 19F NMR (282 MHz, 
CDCl3, 298 K) δ/ppm: -135.2 (m, 4F, o-F), -138.9 (m, 2F, o-F), -150.3 (t, 3JFF = 20.9 
Hz, 1F, p-F), -158.2 (t, 3JFF = 21.0 Hz, 2F, p-F), -160.2 (m, 2F, m-F), -163.9 (m, 4F, 
m-F). IR ʋmax (cm-1): 3056, 2989, 2687, 2413, 2361, 2308, 1713, 1649, 1593, 1572, 
1518, 1496, 1465, 1427, 1384, 1271, 1264, 1178, 1095, 1050, 1019, 993, 978, 922, 
897, 845, 758, 722, 706. HRMS (ES–) m/z calculated for [M-H]– [C29H9BF15O2]–: 
684.0605, found: 684.0624.
2.4d: Synthesised according to General Procedure 2 using 2.2d
(18 mg, 0.1 mmol). Yield: 58 mg, 84.0 μmol, 84%. Melting point: 
61-66 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.22 (d, 3JHH
= 8.5 Hz, 2H, o-H), 7.64 (d, 3JHH = 8.5 Hz, 2H, m-H), 7.28 (s, 1H, 
C-H), 2.75 (s, 2H, CH2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 191.4 (s), 170.1 
(s), 148.0 (dm, 1JCF = 260 Hz), 146.1 (s), 144.3 (dm, 1JCF = 252 Hz), 142.8 (dm, 1JCF
= 245 Hz), 140.0 (dm, 1JCF = 248 Hz), 138.4 (dm, 1JCF = 259 Hz), 137.3 (dm, 1JCF = 
256 Hz), 133.0 (s), 131.2 (s), 130.6 (s), 120.8 (s), 27.3 (s). 11B NMR (160 MHz, CDCl3, 
298 K) δ/ppm: 2.1 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -135.2 (m, 4F, 
o-F), -138.0 (m, 2F, o-F), -148.7 (t, 3JFF = 21.1 Hz, 1F, p-F), -157.4 (t, 3JFF = 20.7 Hz, 
2F, p-F), -159.6 (m, 2F, m-F), -163.5 (m, 4F, m-F). IR ʋmax (cm-1): 3055, 2988, 2686, 
2362, 2343, 2307, 1712, 1669, 1651, 1520, 1484, 1423, 1363, 1320, 1266, 1223, 
1093, 980, 896, 749 732, 706. HRMS (ES–) m/z calculated for [M-H]– [C28H6BClF15O]–
: 687.9997, found: 687.9984.
2.4e: Synthesised according to General Procedure 2 using 
2.2e (24 mg, 0.1 mmol). Yield: 46 mg, 60.8 μmol, 61%. Melting 
point: 58-63 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.04 
(br. s, 1H, C-H), 7.81 (m, 1H, C-H), 7.47 (m, 2H, Ar-H), 7.36 
(m, 2H, Ar-H), 7.16 (s, 1H, C-H), 2.60 (s, 2H, CH2). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 176.1 (br. s), 166.5 (br. s), 161.9 (br. s), 148.0 (dm, 
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1JCF = 262 Hz), 144.2 (dm, 1JCF = 254 Hz), 140.3 (dm, 1JCF = 247 Hz), 139.9 (dm, 1JCF
= 255 Hz), 138.2 (dm, 1JCF = 260 Hz), 137.3 (dm, 1JCF = 256 Hz) , 134.4 (s), 133.0 (s), 
132.6 (s), 132.3 (s), 132.1 (s), 131.7 (s), 129.8 (s), 127.7 (br. s), 126.6 (s), 120.5 (s), 
27.3 (br. s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 1.9 (br. s). 19F NMR (282 MHz, 
CDCl3, 298 K) δ/ppm: -135.1 (m, 4F, o-F), -138.3 (m, 2F, o-F), -149.9 (t, 3JFF = 21 Hz, 
1F, p-F), -158.1 (t, 3JFF = 21 Hz, 2F, p-F), -160.1 (m, 2F, m-F), -163.9 (m, 4F, m-F). 
IR ʋmax (cm-1): 3055, 2987, 2686, 2411, 2361, 2343, 2307, 1714, 1651, 1519, 1493, 
1482, 1422, 1365, 1320, 1266, 1186, 1093, 1029, 982, 897, 752, 728, 706. Elemental 
analysis (%) calculated for C32H9BClF15O2: C 50.80, H 1.20, found: C 50.74, H 1.12.
2.6a: B(C6F5)3 (103 mg, 0.2 mmol) was dissolved in toluene (1 ml) 
and was added to ethyl 2,5-dimethylhexa-2,3-dienoate (2.5a) (34 
mg, 0.2 mmol) in toluene (1 ml). The reaction was left to stand at 
room temperature for 24 h giving an orange solution. Removal of 
the solvent afforded a dark orange oil. Addition of hexane (2 ml) and a small amount 
of DCM (ca. 0.5 ml to solubilise the oil) followed by slow evaporation of the solvent 
afforded colourless crystals of the product. The remaining solution was decanted off 
and the solid product washed with pentane (3 x 2 ml) and dried in vacuo to give the 
crude mixture. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 4.2 (br. s). (Due to 
intractable mixture of products analysis via 1H, 13C and 19F NMR spectroscopy was 
not possible, however 11B NMR spectra has been identified to show the desired broad 
singlet of the chelating boron). 
2.6b: B(C6F5)3 (103 mg, 0.2 mmol) was dissolved in toluene (1 ml) 
and was added to ethyl 2-methyl-5-phenylpenta-2,3-dienoate (2.5b) 
(43 mg, 0.2 mmol) in toluene (1 ml) giving a yellow solution upon 
addition. The reaction was left to stand at room temperature for 24 
h. Removal of the solvent afforded a dark orange oil. Addition of hexane (2 ml) and a 
small amount of toluene (ca. 0.5 ml to solubilise the oil) followed by slow evaporation 
of the solvent afforded colourless crystals of the product. The remaining solution was 
decanted off and the solid product washed with pentane (3 x 2 ml) and dried in vacuo
to give the pure product (13.7 mg, 9%, 0.02 mmol). 1H NMR (400 MHz, C6D6, 298 K) 
δ/ppm: 7.08-7.07 (m, 3H, o-H and p-H), 6.95 (d, 3JHH = 6.6 Hz, 2H, m-H), 4.68 and 
4.43 (m, 2H, CH2 diastereotopic), 3.08 and 2.65 (m, 2H, CH2 diastereotopic), 1.78 (d, 
4JHH = 2 Hz, 3H, CH3), 1.51 (t, 3JHH = 7.1 Hz, 3H, CH3), 0.88 (t, 3JHH = 7.1 Hz, 1H, CH). 
11B NMR (128 MHz, C6D6, 298 K) δ/ppm: 4.5 (br. s). 19F NMR (282 MHz, C6D6, 298 
K) δ/ppm: -132.9 (m, 2F, o-F), -133.2 (m, 1F, o-F), -137.5 (br. s, 2F, o-F), -139.3 (m, 
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1F, o-F), -152.2 (t, 3JFF = 21 Hz, 1F, p-F), -157.2 (t, 3JFF = 21 Hz, 1F, p-F), -157.8 (t, 
3JFF = 20 Hz, 1F, p-F), -160.4 (m, 1F, m-F), -161.5 (m, 1F, m-F), -163.3 (m, 2F, m-F), 
-163.6 (m, 2F, m-F).
2.7: B(C6F5)3 (102 mg, 0.2 mmol) was dissolved in toluene (2 ml) 
and added to ethyl 2,4-dimethylpenta-2,3-dienoate (2.5c) (31 mg, 
0.2 mmol) to give a brown solution. After the addition of 1 equiv. 
H2O the reaction was left at room temperature for 72 h. Slow 
evaporation of the solvent gave large brown crystals that were suitable for X-ray 
diffraction. The remaining solid was washed with hexane (3 x 2 ml) and dried in vacuo
to give the pure product. (72 mg, 0.12 mmol, 56%). 1H NMR (500 MHz, CDCl3, 298 
K) δ/ppm: 7.42 (s, 1H, =CH), 2.03 (s, 3H, CH3), 1.43 (s, 6H, (CH3)2). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 160.9 (s), 148.8 (s), 146.8 (s), 138.9 (s), 137.8 (s), 135.8 
(s), 128.7 (s), 23.7 (s), 17.0 (s), 9.6 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm:
40.4 (br. s), 26.2 (br. s), 1.1 (br. s, B–O adduct), -3.6 (br. s). 19F NMR (282 MHz, 
CDCl3, 298 K) δ/ppm: -134.7 (d, 3JFF = 21 Hz, 2F, o-F), -157.3 (t, 3JFF = 21 Hz, 1F, p-
F), -164.2 (t, 3JFF = 21 Hz, 2F, m-F). HRMS (ES+) m/z calculated for [M-B(C6F5)3]+
[C7H10O2]+: 126.0681, found: 126.0683.
6.2.3 Computational Studies 
All geometry optimisations were undertaken using the B3LYP functional[152a] and 6-
31G* basis set[154] within Jaguar.[155] Subsequent single point calculations were 
undertaken using the B3LYP functional and larger 6-311G*+ basis set. 
6.2.4 Crystallographic Studies
Single crystals of 2.3, 2.4, 2.6 and 2.7 were grown under an inert atmosphere. 
Intensity data sets were collected at low temperature with an Agilent Dual SuperNova 
diffractometer using monochromatic Cu-Kα radiation (1.54184 Å) and a CCD area 
detector. The data was collected at Data collection and processing implemented 
CrysalisPro[156] and a gaussian absorption correction applied within the CrysalisPro 
suite. The structures were solved by direct methods and refined against F2 using the 
SHELXTL package.[157] The structures have been deposited with the Cambridge 
Structural Database (CCDC deposition numbers 1062326-1062327 and 1062523-
1062531).
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Table 6.2.1 Crystallographic data for compounds 2.3, 2.4, 2.6 and 2.7.
Compound 2.3a 2.3b 2.3c 2.3f
Empirical Formula C50H30BCl3F15OP C50H31BF15OP C50H31BF15O2P C47H22BF18O2P
Crystal System Monoclinic Monoclinic Monoclinic Monoclinic
Space Group P21/n P21/n P21/n P21/n
a/Å 13.00937(15) 12.9285(2) 11.7467(2) 12.68853(19)
b/Å 20.5826(2) 20.8057(3) 22.3776(4) 18.3742(3)
c/Å 17.61995(18) 20.3530(3) 17.2697(3) 17.9394(3)
α/o 90 90 90 90
β/o 102.1504(10) 107.5893(18) 105.0260(18) 99.2369(16)
γ/o 90 90 90 90
V/Å3 4612.34(9) 5218.72(15) 4384.36(13) 4128.17(12)
Z 4 4 4 4
T /K 150(2) 150(2) 150(2) 150(2)
Dc/g.cm-3 1.555 1.544 1.501 1.613
Crystal size/mm 0.400 x 0.220 x 0.110 0.280 x 0.100 x 0.090 0.240 x 0.1.00 x 0.070 0.270 x 0.080 x 0.050
Total data 18570 21771 18384 17523
Unique data 8002 10346 8680 8156
Rint 0.0212 0.0385 0.0268 0.0290
R1[F2>2 σ(F2)] 0.0424 0.0651 0.0357 0.0450
wR2 (all data) 0.1131 0.1931 0.0950 0.1326
GoF 1.044 1.040 1.021 1.033
ρmin/ρmax/eÅ-3 -0.534/0.732 -1.147/1.287 -0.344/0.377 -0.292/0.662
CCDC code 1062523 1062524 1062525 1062526
Compound 2.3j 2.3k 2.4a 2.4b
Empirical Formula C50H31BF15O2P C49H28BClF15OP C28H8BF15O C36H18BF15O
Crystal System Monoclinic Monoclinic Monoclinic Triclinic
Space Group P21/n P21/n P21/c P-1 
a/Å 13.0028(3) 13.0092(2) 11.1762(5) 11.3113(4)
b/Å 15.1522(3) 15.1502(2) 15.7904(6) 11.5408(5)
c/Å 23.0392(5) 22.7586(3) 14.5984(6) 12.6612(5)
α/o 90 90 90 105.469(4)
β/o 103.336(2) 104.4200(16) 109.641(5) 96.466(3)
γ/o 90 90 90 91.745(3)
V/Å3 4416.79(16) 4344.22(12) 2426.40(19) 1579.64(11)
Z 4 4 4 2
T /K 150(2) 151(2) 150(2) 150(2)
Dc/g.cm-3 1.490 1.521 1.796 1.603
Crystal size/mm 0.290 x 0.050 x 0.030 0.190 x 0.130 x 0.070 0.280 x 0.160 x 0.080 0.360 x 0.110 x 0.070
Total data 18440 17446 11576 14168
Unique data 8711 8580 5768 7467
Rint 0.0442 0.0224 0.0454 0.0582
R1[F2>2 σ(F2)] 0.0421 0.0312 0.0546 0.0499
wR2 (all data) 0.1127 0.0820 0.1439 0.1388
GoF 1.023 1.032 1.046 1.078
ρmin/ρmax/eÅ-3 -0.318/0.330 -0.343/0.259 -0.247/0.292 -0.306/0.330
CCDC code 1062527 1062528 1062529 1062530
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Compound 2.6ad1363 2.6b 2.7
Empirical Formula C28H16BF15O2 C32H16BF15O2 C25H10BF15O2
Crystal System Monoclinic Orthorhombic Monoclinic
Space Group P21/c P bca P21/c
a/Å 14.643(7) 14.550(8) 16.8686 (3)
b/Å 18.428(8) 14.952(7) 11.05869 (18)
c/Å 19.621(9) 7.128(13) 27.6059 (4)
α/o 90 90 90
β/o 90.098(14) 90 105.3765 (18)
γ/o 90 90 90
V/Å3 5295(4) 5902(5) 4965.39
Z 8 8 8
T /K 100(1) 100(1) 150(2)
Dc/g.cm-3 1.707 1.639 1.707
Crystal size/mm 0.240 x 0.180 x 0.090 0.260 x 0.190 x 0.120 0.270 x 0.200 x 0.140
Total data 117383 145467 21050
Unique data 13680 10197 9823
Rint 0.0645 0.0549 0.0266
R1[F2>2 σ(F2)] 0.0386 0.0396 0.0339
wR2 (all data) 0.0915 0.1056 0.0945
GoF 1.015 1.030 1.015
ρmin/ρmax/eÅ-3 -0.234/0.314 -0.234/0.457 -0.223/0.261
CCDC code 1062326 1062327 1062531
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6.3 The Propargyl Rearrangement: Cyclisations and 1,1-
Carboborations of Homoleptic and Heteroleptic 
Boranes
6.3.1 The Propargyl Rearrangement of Esters, Amides, Carbamates 
and Carbonates
6.3.1.1 Synthesis of Starting Materials
General Procedure 1. N,N-Dipropargylcarboxamides were prepared according to 
literature methods.[64] Et3N (1.39 ml, 10 mmol, 2 equiv.) and 4-DMAP (12 mg, 98 μmol, 
2 mol%) were added to a solution of N,N-dipropargylamine hydrochloride (0.645 g, 5 
mmol, 1 equiv.) in CH2Cl2 at room temperature under a nitrogen atmosphere and the 
resulting solution was stirred for 15 min. The solution was then cooled to 0 °C and the 
corresponding acyl chloride (5 mmol, 1 equiv.) was added dropwise and stirred for 30 
min at this temperature. The reaction mixture was then allowed to warm to room 
temperature and was stirred for a further 3 h. The reaction was then quenched with 
water and the aqueous layer extracted with CH2Cl2 (x2) and the combined organic 
phases washed with brine. The organic phase was then dried with Na2SO4 and 
filtered. Removal of the solvent yielded the crude product which was purified by 
column chromatography.
3.2a: Synthesised according to General Procedure 1 using 3,4-
dimethoxybenzoyl chloride (1.0 g, 5 mmol, 1 equiv.). The crude 
product was purified by column chromatography (SiO2, Pet. 
ether/ethyl acetate, 6:4). Yield: 0.926 g, 3.6 mmol, 72%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm:  7.22 (dd, 3JHH = 8.2 Hz, 4JHH = 1.9 Hz, 1H, Ar-H), 7.17 (d, 4JHH = 1.9 
Hz, 1H, Ar-H), 6.89 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 4.33 (br. s, 4H, N-CH2), 3.91 (s, 3H, 
OCH3), 3.91 (s, 3H, OCH3), 2.33 (br. s, 2H, ≡CH). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm:  170.8 (s), 151.0 (s), 148.8 (s), 126.7 (s), 120.8 (s), 111.0 (s), 110.6 (s), 78.6 
(br. s), 72.8 (br. s), 56.1 (s). 
3.2b: Synthesised according to General Procedure 1 using 3-
methylbut-2-enoyl chloride (0.590 g, 5 mmol, 1 equiv.). The crude 
product was purified by column chromatography (SiO2, Pet. 
ether/ethyl acetate, 7:3). Yield: 0.578 g, 3.3 mmol, 65%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm:  5.82 (m, 1H, =CH), 4.33 (s, 2H, N-CH2), 4.21 (s, 2H, N-CH2), 2.28 (s, 
1H, ≡CH), 2.21 (s, 1H, ≡CH), 1.93 (d, 4JHH = 1.1, 3H, CH3), 1.86 (d, 4JHH = 1.1 Hz, 3H, 
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CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  167.6 (s), 149.6 (s), 116.8 (s), 78.6 
(s), 78.1 (s), 73.0 (s), 72.1 (s), 36.8 (br. s), 33.3 (br. s), 26.6 (br. s), 20.5 (br. s).
3.2c: Synthesised according to General Procedure 1 using 4-
nitrobenzoyl chloride (0.925 g, 5 mmol, 1 equiv.). The crude 
product was purified by column chromatography (SiO2, Pet. 
ether/ethyl acetate, 7:3). Yield: 1.02 g, 4.2 mmol, 84%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm:  8.31 (d, 3JHH = 8.8 Hz, 2H, Ar-H), 7.74 (d, 3JHH = 8.6 Hz, 2H, Ar-H), 
4.50 (br. s, 2H, N-CH2), 4.10 (br. s, 2H, N-CH2), 2.40 (br. s, 1H, ≡CH), 2.32 (br. s, 1H, 
≡CH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  168.7 (s), 150.0 (s), 140.7 (s), 128.4 
(s), 124.1 (s), 77.4 (s), 74.2 (s), 73.2 (s), 38.3 (s), 34.0 (s). 
3.2d: Synthesised according to General Procedure 1 using 
cyclohexanecarbonyl chloride (0.730 g, 5 mmol, 1 equiv.). The 
crude product was purified by column chromatography. (SiO2, Pet. 
ether/ethyl acetate, 7:3). Yield: 548 mg, 2.7 mmol, 54%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm:  4.31 (d, 4JHH = 2.1 Hz, 2H, N-CH2), 4.23 (d, 4JHH = 2.1 Hz, 2H, N-CH2), 
2.50 (m, 1H, ≡CH), 2.30 (br. s, 1H, ≡CH), 2.20 (m, 1H, cyclohex.), 1.84-1.72 (m, 4H, 
cyclohex.), 1.86 (m, 1H, cyclohex.), 1.48 (m, 2H, cyclohex.), 1.34-1.16 (m, 3H, 
cyclohex.). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  175.6 (s), 78.8 (s), 78.3 (s), 
72.9 (s), 72.2 (s), 41.0 (s), 36.1 (s), 33.9 (s), 29.4 (s), 25.8 (s). HRMS (EI+) m/z
calculated for [M]+ [C13H17NO]+: 203.1306, found 203.1310. IR ʋmax (cm-1): 3281, 3223, 
2926, 2922, 2855, 1728, 1643, 1452, 1435, 1418, 1343, 1310, 1290, 1273, 1265, 
1244, 1204, 1175, 1136, 953, 922, 893, 856, 640.
General Procedure 2. Propargyl ureas were prepared according to similar literature 
methods.[158] To the amine (1 equiv.) dissolved in water (ca. 50 ml) at 4 °C was added 
carbonyldiimidazole (CDI) (2 equiv.) and the resulting mixture stirred for 1 h at this 
temperature. The solution was then allowed to warm up to room temperature and 
after complete formation of the carbonylimidazolide, propargyl amine (1 equiv.) was 
added and the mixture stirred at room temperature for ca. 2 h until the reaction was 
complete. The product was isolated by filtration, washed with cold water and dried in 
vacuo to give a white solid.
3.5a: Synthesised according to General Procedure 2 using 
propargylamine (1.1 g, 20.2 mmol, 2 equiv.). Yield: 1.4 g, 10.3 
mmol, 51%. Melting point: 178-184 ºC. 1H NMR (500 MHz, DMSO-d6, 298 K) δ/ppm:  
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6.32 (t, 3JHH = 5.8 Hz, 2H, NH), 3.78 (dd, 3JHH = 5.8 Hz, 4JHH = 2.5 Hz, 4H, CH2), 3.04 
(t, 4JHH = 2.5 Hz, 2H, ≡CH). 13C NMR (126 MHz, DMSO-d6, 298 K) δ/ppm:  156.9 (s), 
82.3 (s), 72.5 (s), 28.8 (s). HRMS (EI+) m/z calculated for [M]+ [C7H9N2O]+: 137.0715, 
found: 137.0711.
3.5b: Synthesised according to General Procedure 2 using 
benzylamine (1.1 g, 10.2 mmol, 1 equiv.) and propargylamine 
(0.55 g, 10.2 mmol, 1 equiv.). Yield: 3.4 g, 18 mmol, 91%, 
Melting point: 117–120 °C. 1H NMR (500 MHz, DMSO-d6, 298 K) δ/ppm:  7.29-7.17 
(m, 5H, Ar-H), 6.39 (t, 3JHH = 5.4 Hz, 1H, NH), 6.20 (t, 3JHH = 5.4 Hz, 1H, NH), 4.22 (d, 
3JHH = 5.9 Hz, 2H, CH2), 3.82 (m, 2H, CH2), 2.81 (s, 1H, ≡CH). 13C NMR (126 MHz, 
DMSO-d6, 298 K) δ/ppm:  157.4 (s), 140.3 (s), 127.9 (s), 126.9 (s), 126.4 (s), 82.0 (s), 
71.9 (s), 42.9 (s), 28.8 (s). HRMS (EI+) m/z calculated for [M]+ [C11H12N2O]+: 188.0950, 
found: 188.0941.
General procedure 3. Propargyl carbamates were synthesised by the following 
method. Carbamoyl chloride (1 equiv.) and 4-DMAP (0.05 equiv.) were added to a 
solution of propargyl alcohol (1 equiv.) in pyridine (5 ml) and the resulting mixture 
heated overnight at 80 °C. The reaction mixture was quenched with saturated NH4Cl 
solution (10 ml) and the aqueous phase extracted with diethyl ether (3 x 20 ml). The 
combined organic phases were then washed further with saturated NH4Cl solution (3 
x 20 ml), dried over sodium sulfate, filtered and the solvent removed in vacuo. 
3.7a: Synthesised according to General Procedure 3 using N,N-
diisopropylcarbamoyl chloride and propargyl alcohol. Purification 
by column chromatography gave a colourless oil. (SiO2, Pet. 
ether/EtOAc, 95:5). Yield: 0.35 g, 1.64 mmol, 67%. Rf = 0.44 (SiO2, Pet. ether/EtOAc,
80:20). 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm:  4.70 (d, 4JHH = 2.5 Hz, 2H), 4.92 
(br. s, 2H), 2.42 (t, 4JHH = 2.5 Hz, 1H), 1.22 (d, 3JHH = 6.8 Hz, 12H). 13C NMR (75 MHz, 
CDCl3, 298 K) δ/ppm:  154.8 (s), 79.1 (s), 74.1 (s), 52.2 (s), 46.2 (br. s), 21.1 (br. s). 
IR ʋmax (cm-1): 3247, 2971, 1702, 1443, 1370, 1310, 1294, 1219, 1160, 1136, 1069, 
960, 771, 719, 624, 606. MS-EI: 183.1 (13), 169.1 (11), 168.1 (100), 161.9 (6), 151.0 
(6), 126.1 (39), 102.1(5), 82.1 (11), 70.0 (11). HRMS (EI+) m/z calculated for [M+H]+
[C10H17NO2]+: 183.1259, found: 183.1239.
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3.7b: Synthesised according to General Procedure 3 using N,N-
diisopropyl carbamoyl chloride and but-3-yn-2-ol. Purification by 
column chromatography gave a colourless oil. (SiO2, Pet. 
ether/EtOAc, 95:5). Yield: 0.61 g, 3.10 mmol, 62%. Rf = 0.33 (SiO2, Pet. ether/EtOAc, 
95:5). 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm:  5.42 (dq, 3JHH = 6.7 Hz, 4JHH = 2.1 
Hz, 1H), 4.28-3.55 (m, 2H), 2.40 (d, 4JHH = 2.1 Hz, 1H), 1.50 (d, 3JHH = 6.7 Hz, 3H), 
1.21-1.18 (m, 12H). 13C NMR (75 MHz, CDCl3, 298 K) δ/ppm:  154.6 (s), 83.3 (s), 
72.3 (s), 60.2 (s), 46.0 (br. s), 21.8 (s), 21.1 (br. s). IR ʋmax (cm-1): 3312, 3248, 2972, 
2937, 2876, 2121, 1694, 1437, 1370, 1344, 1319, 1284, 1210, 1191, 1158, 1133, 
1091, 1045, 918, 768, 661. MS ESI: 197.1 (31), 183.1 (12), 182.1 (100), 161.9 (5), 
150.9 (5), 138.1 (5), 130.0 (35), 128.1 (11), 102.0 (11), 96 (18), 88.0 (17), 86.1 (23), 
86.0 (19). HRMS (EI+) m/z calculated for [M+H]+ [C11H19NO2]+: 197.1416, found: 
197.1422.
3.7c: Synthesised according to General Procedure 3 using N,N-
diphenyl carbamoyl chloride and propargyl alcohol. Purification by 
recrystallisation from petroleum ether 40-60 with a few drops of 
Et2O to solubilise the solid at -40 °C gave a pale yellow solid. Yield: 1.07 g, 4.26 mmol, 
71%. Melting point: 128–133 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm:  7.28–
7.13 (m, 10H, Ar-H), 4.68 (s, 2H, CH2), 2.37 (s, 1H, ≡CH). 13C NMR (126 MHz, CDCl3, 
298 K) δ/ppm:  154.1 (s), 142.4 (s), 129.1 (s), 127.1 (s), 126.5 (s), 78.2 (s), 74.9 (s), 
53.5 (s). IR ʋmax (cm-1): 3087, 3062, 3027, 2950, 2922, 2870, 1944, 1861, 1803, 1730, 
1605, 1495, 1461, 1379, 1304, 1210, 1180, 1083, 1059, 1031, 896, 735. HRMS (AP+) 
m/z calculated for [M+H]+ [C16H14NO2]+: 252.1025, found: 252.1017.
3.10: The propargyl carbamate was synthesised by the following 
method. Propargylamine (0.51 ml, 8 mmol) was added to a solution 
of chloroformate (1.2 ml, 8 mmol) and NaHCO3 (0.67 g, 8 mmol) in 
10 ml EtOH/H2O (1:1) at 0 ºC. The solution was allowed to warm up to room 
temperature and stirred overnight. The solution was diluted with EtOH/H2O and the 
aqueous phase extracted with diethyl ether (3 x 20 ml). The combined organic phases 
were then washed with saturated NH4Cl solution (3 x 20 ml), dried over sodium 
sulfate, filtered and the solvent removed in vacuo. The crude product was purified by 
recrystallisation from petroleum ether 40-60 with a few drops of Et2O to solubilise the 
solid left at -40 °C. Yield: 1.48 g, 7.82 mmol, 98%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm:  7.36 (m, 5H, Ar-H), 5.13 (s, 2H, CH2–O), 4.98 (br. s, 1H, NH), 4.00 (s, 2H, N-
CH2), 2.24 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm:  
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156.0 (s), 136.2 (s), 128.6 (s), 128.3 (m), 127.1 (s), 79.8 (s), 71.7 (s), 67.2 (s), 30.9 
(s). IR ʋmax (cm-1): 3421, 3308, 3087, 3064, 3030, 2982, 2922, 2875, 2739, 2123, 
1950, 1864, 1811, 1732, 1606, 1511, 1457, 1381, 1353, 1325, 1227, 1176, 1141, 
1085, 1047, 987, 939, 908, 870, 775. HRMS (EI+) m/z calculated for [M]+
[C11H11NO2]+:189.0785, found: 189.0790.
3.12a: nBuLi (2.00 ml, 2.5 M in hexane, 5.00 mmol) was added to a 
solution of 1-pentyne-3-ol (0.43 ml, 5.00 mmol) in THF (10-20 ml) at 
-78 °C and the resulting solution stirred for 1 h. Diethyl-
pyrocarbonate (0.73 ml, 5.00 mmol) in 20 ml THF was then added to the cooled 
solution and the mixture allowed to warm to room temperature and subsequently 
stirred for 12-24 h. The reaction mixture was quenched with saturated NH4Cl solution 
(20 ml) and the aqueous phase extracted with diethyl ether (3 x 20 ml). The combined 
organic phases were then washed with saturated NH4Cl solution (3 x 20 ml), dried 
over NaSO4, filtered and the solvent removed in vacuo. The product was purified by 
column chromatography using SiO2 (SiO2, pet. ether/EtOAc 95:5 to 80:20) to give the 
pure product. Yield: 0.57 g, 5.00 mmol, 100%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm:  5.09 (dt, 3JHH = 6.5 Hz, 4JHH = 1.3 Hz, 1H, CH), 4.22 (q, 3JHH = 7.2 Hz, 2H, 
CH2), 2.50 (d, 4JHH = 1.3 Hz, 1H, ≡CH), 1.88-1.81 (m, 2H, CH2), 1.32 (t, 3JHH = 7.2 Hz, 
3H, CH3), 1.04 (t, 3JHH = 7.4 Hz, 3H, CH3). 13C NMR (125 MHz, CDCl3, 298 K) δ/ppm:  
154.7 (s), 80.8 (s), 74.7 (d), 69.0 (d), 64.7 (t), 28.2 (t), 14.6 (q), 9.5 (q). IR ʋmax (cm-1): 
3293, 2979, 2940, 2882, 2358, 2125, 1756, 1515, 1465, 1396, 1373, 1342, 1302, 
1275, 1177, 1094, 1062, 1046, 1007, 948, 932, 893, 857, 791, 670. MS-EI: 128.0 
(39), 127.0 (8), 91.0 (12), 84.1 (7), 83.1 (51), 69.0 (30), 67.1 (82), 66.0 (100), 63.0 
(20). HRMS (EI+) m/z calculated for [M-C2H4]+ [C6H8O3]+: 128.0473, found: 128.0487.
3.14: Synthesised according to a similar literature method.[28]
Propargyl alcohol (1.7 ml, 30 mmol) was dissolved in 
dichloromethane in combination with Hünig’s base (13.1 ml, 75 
mmol) alongside 4-DMAP (10 mol%). After cooling to 0 °C, Boc anhydride (8.51 g, 39 
mmol) was added portionwise ensuring reaction is not allowed to reflux, then stirred 
until completion. The resultant solution was quenched with saturated NH4Cl solution 
(20 ml) and the aqueous phase extracted with dichloromethane (3 x 20 ml). The 
combined organic phases were then washed with 1M HCl, sat. NaHCO3 solution and 
brine (all 2 x 20 ml) then dried over MgSO4, filtered and the solvent removed in vacuo
to give a colourless oil. The product was sufficiently pure for subsequent reactions. 
Yield: 3.4 g, 21.8 mmol, 73%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm:  2.53 (s, 1H, 
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≡CH), 1.68 (s, 6H, CH3), 1.48 (s, 9H, CH3). 13C NMR (125 MHz, CDCl3, 298 K) δ/ppm:  
151.5 (s), 84.6 (s), 82.4 (s), 73.0 (s), 72.5 (s), 29.0 (s), 28.0 (s).
6.3.1.2 Synthesis of Products
3.3a: 3,4-dimethoxy-N,N-di(prop-2-yn-1-yl)benzamide 3.2a (52 
mg, 0.2 mmol) was dissolved in toluene (2 ml) and added to 
B(C6F5)3 (102 mg, 0.2 mmol) to give a yellow solution. After 1 h 
small crystals formed which were redissolved by briefly warming 
the solution slightly and adding a few drops of CH2Cl2. Upon cooling large colourless 
blocks of the adduct formed which were suitable for X-ray diffraction. The crystals 
were washed with petroleum ether 40-60 (3 x 3 ml) to give the adduct 3.3a. Yield: 119 
mg, 77%, 0.15 mmol. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm:  6.70 (dd, 3JHH = 8.4 
Hz, 4JHH = 1.9 Hz, 1H, Ar-H), 6.63 (d, 3JHH = 8.4 Hz, 1H, Ar-H), 6.50 (d, 4JHH = 1.9 Hz, 
1H, Ar-H), 4.64 (br. s, 2H, N-CH2), 4.17 (d, 4JHH = 2.3 Hz, 2H, N-CH2), 3.79 (s, 3H, 
OCH3), 3.61 (s, 3H, OCH3), 2.46 (t, 4JHH = 2.3 Hz, 1H, ≡CH), 2.40 (t, 4JHH = 2.4 Hz, 
1H, ≡CH). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm:  0.5 (br. s). 19F NMR (283 MHz, 
CDCl3, 298 K) δ/ppm:  -133.6 (d, 3JFF = 20.6 Hz, 2F, o-F), -157.5 (t, 3JFF = 20.5 Hz, 
1F, p-F), -164.1 (m, 2F, m-F). The product could not be fully characterised in solution 
as subsequent dissociation of boron from the amide oxygen atom followed by 
cyclisation to yield 3.4a occurs. IR ʋmax (cm-1): 2359, 2340, 2322, 1647, 1560, 1560, 
1516, 1464, 1456, 1273, 1258, 1240, 1099, 978. Elemental analysis (%) calculated 
for C33H15BF15NO3: C 51.52, H 1.97, N 1.82, found: C 51.49, H 1.85, N 1.82. 
3.3b: 3-methyl-N,N-di(prop-2-yn-1-yl)but-2-enamide 3.2b (36 mg, 
0.2 mmol) was dissolved in toluene (ca. 2 ml) and added to 
B(C6F5)3 (102 mg, 0.2 mmol) to give a yellow solution. The reaction 
was left at room temperature without stirring for 30 min. Slow 
evaporation of the solvent yielded large colourless blocks of the product which could 
be characterised by X-ray diffraction. The remaining solvent was decanted off and 
the product washed with petroleum ether (3 x 3 ml) and dried in vacuo to give pure 
3.3b. Yield: 57 mg, 0.08 mmol, 41%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm:  5.32 
(br. s, 1H, =CH), 4.49 (d, 4JHH = 2.2 Hz, 2H, N-CH3), 4.28 (d, 4JHH = 2.2 Hz, 2H, N-
CH3), 2.38 (t, 4JHH = 2.2 Hz, 1H, ≡CH), 2.24 (t, 4JHH = 2.2 Hz, 1H, ≡CH), 1.48 (s, 3H, 
CH3), 1.24 (s, 3H, CH3). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm:  -0.5 (br. s). 19F 
NMR (283 MHz, CDCl3, 298 K) δ/ppm:  -134.1 (d, 3JFF = 20.1 Hz, 2F, o-F), -157.4 (t, 
3JFF = 20.5 Hz, 1F, p-F), -164.0 (m, 2F, m-F). The product could not be fully 
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characterised in solution as subsequent dissociation of boron from the amide oxygen 
atom followed by cyclisation to yield 3.4b occurs. IR ʋmax (cm-1): 2361, 2340, 2322, 
1647, 1559, 1516, 1456, 1281, 1257, 1092, 980, 868, 806, 766, 729, 690, 682. 
Elemental analysis (%) calculated  for C29H13BF15NO: C 50.68, H 1.91, N 2.04, 
found: C 50.83, H 1.82, N 2.11. 
3.4a: 3,4-dimethoxy-N,N-di(prop-2-yn-1-yl)benzamide 3.2a 
(52 mg, 0.2 mmol) was dissolved in toluene (8 ml) and added 
to B(C6F5)3 (102 mg, 0.2 mmol) to give a yellow solution. The 
reaction was heated to 45 ºC for 2 days without stirring 
whereupon CH2Cl2 (ca. 0.5 ml) was added. Upon cooling small 
colourless crystals of the product formed. The remaining solvent was decanted off 
and the crystals washed with petroleum ether (3 x 3 ml) and then dried under vacuum 
to give colourless crystals of the pure product Yield: 89 mg, 58%, 0.12 mmol. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm:  7.59 (dd, 3JHH = 8.6 Hz, 4JHH = 2.2 Hz, 1H, Ar-H), 
7.35 (d, 4JHH = 2.2 Hz, 1H, Ar-H), 7.10 (d, 3JHH = 8.6 Hz, 1H, Ar-H), 6.64 (br. s, 1H, 
=CH), 4.54 (d, 4JHH = 2.6 Hz, 2H, N-CH2), 4.38 (d, 4JHH = 2.6 Hz, 2H, CH2), 4.04 (s, 
3H, OCH3), 3.98 (s, 3H, OCH3), 2.75 (t, 4JHH = 2.2 Hz, 1H, ≡CH). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm:  -16.9 (s). 19F NMR (283 MHz, CDCl3, 298 K) δ/ppm:  -132.7 
(d, 3JFF = 22.4 Hz, 2F, o-F), -160.8 (t, 3JFF = 20.8 Hz, 1F, p-F), -165.0 (m, 2F, m-F). 
Elemental analysis (%) calculated  for C33H15BF15NO3: C 51.52, H 1.97, N 1.82, 
found: C 51.50, H 1.89, N 1.91. IR ʋmax (cm-1): 2357, 2342, 1613, 1597, 1512, 1458, 
1437, 1396, 1348, 1284, 1271, 1080, 961, 810, 768.
3.4b: 3-methyl-N,N-di(prop-2-yn-1-yl)but-2-enamide 3.2b (36 mg, 
0.2 mmol) was dissolved in toluene (8 ml) and added to B(C6F5)3
(102 mg, 0.2 mmol) to give a yellow solution. The reaction was 
heated to 45 ºC for 2 days without stirring giving an orange 
solution. Upon cooling small colourless acicular crystals of the product formed. The 
remaining solvent was decanted off and the crystals washed with petroleum ether (3 
x 3ml) and dried under vacuum to give colourless crystals of the pure product. Yield: 
79 mg, 57%, 0.11 mmol. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm:  6.53 (br. s, 2H, 
=CH), 5.96 (br. s, 1H, =CH), 4.32 (d, 4JHH = 2.4 Hz, 2H, N-CH2), 4.15 (d, 4JHH = 2.4 
Hz, 2H, CH2), 2.62 (t, 4JHH = 2.5 Hz, 1H, ≡CH), 2.39 (s, 3H, CH3), 2.27 (s, 3H, CH3). 
11B NMR (160 MHz, CDCl3, 298 K) δ/ppm:  -16.9 (s). 19F NMR (283 MHz, CDCl3, 298 
K) δ/ppm:  -132.7 (d, 3JFF = 21.9 Hz, 2F, o-F), -160.9 (t, 3JFF = 20.8 Hz, 1F, p-F), -
165.1 (m, 2F, m-F). HRMS (EI+) m/z calculated for [M-H]– [C29H12BF15NO]–: 686.0772, 
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found: 686.0799. IR ʋmax (cm-1): 2359, 2334, 2322, 1636, 1512, 1456, 1271, 1262, 
1080, 974, 963, 806.
3.4c: 4-nitro-N,N-di(prop-2-yn-1-yl)benzamide 3.2c (48 mg, 
0.2 mmol) was dissolved in toluene (3 ml) and was added to 
B(C6F5)3 (102 mg, 0.2 mmol) to give a yellow solution. The 
reaction was left at room temperature for 1 h and CH2Cl2 (ca. 
1ml) was added and the solvent was allowed to evaporate slowly to give small 
acicular colourless crystals of the product which were suitable for X-ray diffraction. 
The remaining solvent was decanted off and the crystals washed with petroleum ether 
(3 x 3ml) and then dried under vacuum to give colourless crystals of the pure product. 
Yield: 130 mg, 86%, 0.17 mmol. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.51 (d, 
3JHH = 8.9 Hz, 2H, Ar-H), 8.08 (d, 3JHH = 8.9 Hz, 2H, Ar-H), 6.69 (s, 1H, =CH), 5.23 (s, 
2H, CH2), 4.47 (br. d, 4JHH = 2.4 Hz, 2H, N-CH2), 2.78 (t, 4JHH = 2.4 Hz, 1H, ≡CH). 11B 
NMR (160 MHz, CDCl3, 298 K) δ/ppm:  -16.9 (s). 19F NMR (283 MHz, CDCl3, 298 K) 
δ/ppm:  -132.7 (d, 3JFF = 22.5 Hz, 2F, o-F), -160.3 (t, 3JFF = 21.1 Hz, 1F, p-F), -164.7 
(m, 2F, m-F). Elemental analysis (%) calculated  for C31H10BF15N2O3: C 49.37, H 
1.34, N 3.71, found: C 52.50, H 1.64, N 3.52. IR ʋmax (cm-1): 2361, 2341, 1653, 1636, 
1597, 1533, 1512, 1456, 1445, 1400, 1358, 1296, 1267, 1258, 1084, 978, 961, 928, 
891, 866, 808, 770, 739, 716, 692, 669.
3.4d: N,N-di(prop-2-yn-1-yl)cyclohexanecarboxamide 3.2d (40 
mg, 0.2 mmol) was dissolved in toluene (2 ml) and added to 
B(C6F5)3 (102 mg, 0.2 mmol) to give a cloudy yellow solution. 
Leaving the solution to stand for 10 min resulted in the formation 
of a white precipitate which was redissolved by gentle heating with the addition of a 
few drops of CH2Cl2. The reaction was left for 2 days and then the solvent was allowed 
to evaporate slowly to give colourless crystals of the product which were suitable for 
X-ray diffraction. The remaining solvent was decanted off and the crystals washed 
with petroleum ether (3 x 3 ml) and then dried under vacuum to give colourless 
crystals of the pure product. Yield: 114 mg, 80%, 0.15 mmol. 1H NMR (400 MHz, 
DMSO-d6, 298 K) δ/ppm:  6.31 (s, 1H, =CH), 4.51 (s, 2H, CH2), 4.06 (s, 2H, CH2), 
2.78 (t, 4JHH = 2.5 Hz, 1H, ≡CH), 1.90-1.68 (m, 5H, cyclohex.), 1.53-1.45 (m, 2H, 
cyclohex.), 1.33-1.17 (m, 4H, cyclohex.). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm:  
-17.0 (s). 19F NMR (283 MHz, CDCl3, 298 K) δ/ppm:  -132.8 (d, 3JFF = 22.4 Hz, 2F, o-
F), -160.9 (t, 3JFF = 20.4 Hz, 1F, p-F), -165.3 (m, 2F, m-F). Elemental analysis (%) 
calculated  for C31H17BF15NO: C 52.06, H 2.40, N 1.96, found: C 51.94, H 2.24, N 
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1.94. HRMS (EI+) m/z calculated for [M]+ [C31H16BF15NO]–: 714.1085, found: 
714.1079. IR ʋmax (cm-1): 2363, 2342, 2322, 1630, 1512, 1454, 1437, 1304, 1260, 
1233, 1180, 1138, 1113, 1078, 978, 961, 883, 841, 818, 806, 768, 669.
3.6a: B(C6F5)3 (51 mg, 0.1 mmol) was dissolved in CDCl3 (ca.
0.5 ml) and added to 1,3-di(prop-2-yn-1-yl)urea 3.5a (14 mg, 
0.1 mmol). The reaction was heated at 50 ºC for 7 d to give a 
yellow solution and a crop of needle shaped crystals which 
were suitable for X-ray diffraction. The remaining solvent was decanted off and the 
product was washed with hexane (4 x 2 ml) and dried in vacuo to give pure 9a. Yield: 
20 mg, 0.03 mmol, 31%. Melting point: 178–184 °C. 1H NMR (500 MHz, DMSO-d6, 
298 K) δ/ppm:  10.01 (br. s, 1H, NH), 5.91 (s, 1H, NH), 5.65 (s, 1H, =CH), 4.07 (d, 
4JHH = 2.0 Hz, 2H, CH2), 3.64 (s, 2H, CH2), 3.30 (br. s, 1H, CH). 11B NMR (160 MHz, 
DMSO-d6, 298 K) δ/ppm:  -17.0 (s). 19F NMR (283 MHz, DMSO-d6, 298 K) δ/ppm:  
132.1 (d, 3JFF = 22.2 Hz, 2F, o-F), 161.3 (t, 3JFF = 22.2 Hz, 1F, p-F), 165.2 (t, 3JFF = 
22.2 Hz, 2F, m-F). IR ʋmax (cm-1): 3085, 3061, 3029, 2922, 2876, 1708, 1672, 1643, 
1607, 1572, 1545, 1514, 1495, 1460, 1380, 1280, 1082, 1030, 977, 729, 695. HRMS
(ES–) m/z calculated for [M-H]– [C25H7BN2OF15]–: 646.0448, found: 646.0445.
3.6b: B(C6F5)3 (51 mg, 0.1 mmol) was dissolved in CDCl3 (ca.
0.5 ml) and added to 1-benzyl-3-(prop-2-yn-1-yl)urea 3.5b
(19 mg, 0.1 mmol). The reaction was heated to 50 ºC for 14 
d to give a pale yellow solution. The solvent was removed in 
vacuo, leaving a white solid, which was recrystallised from hexane with a drop of 
toluene at -40 °C to give colourless crystals of 9b. Yield: 43 mg, 0.06 mmol, 31%. 
Melting point:182-190 °C. 1H NMR (500 MHz, DMSO-d6, 298 K) δ/ppm:  10.11 (br. s, 
1H, NH), 7.39-7.30 (m, 5H, Ar-H), 5.90 (br. s, 1H, NH), 5.74 (s, 1H, =CH), 4.43 (br. s, 
2H, CH2), 3.65 (br. s, 2H, CH2). 11B NMR (160 MHz, DMSO-d6, 298 K) δ/ppm:  -16.9 
(br. s). 19F NMR (283 MHz, DMSO-d6, 298 K) δ/ppm:  -132.1 (d, 3JFF = 21.3 Hz, 2F, 
o-F), -161.1 (t, 3JFF = 21.0 Hz, 1F, p-F), -165.1 (t, 3JFF = 21.0 Hz, 2F, m-F). IR ʋmax
(cm-1): 3088, 3062, 3029, 2923, 2783, 1944, 1865, 1808, 1648, 1605, 1519, 1495, 
1469, 1380, 1287, 1101, 1067, 1032, 981, 872, 819, 771, 733, 695, 616. HRMS (ES–)
m/z calculated for [M-H]– [C29H11BN2OF15]–: 698.0761, found: 698.0790.
3.8a: Prop-3-yn-2-yl-diisopropylcarbamate 3.7a (18.3 mg, 0.1 
mmol) and B(C6F5)3 (51.2 mg, 0.1mmol) were dissolved in CD2Cl2
(0.5 ml) and the mixture left for 24 h. The progress of the reaction 
was monitored by 1H-, 11B- and 19F-NMR spectroscopy. The 
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solution was concentrated and when complete, layered with pentane and stored at -
20 °C, whereby the product crystallised out. The remaining solution was decanted off 
and the resulting solid washed with cold pentane (3 x 2ml). Drying in vacuo afforded 
the product as a white crystalline solid. Yield: 44.5 mg, 0.06 mmol, 64%. 1H NMR (500 
MHz, CD2Cl2, 298 K) δ/ppm: 6.46 (s, 1H, =CH), 4.85 (d, 4JHH = 2.1 Hz, 2H, CH2), 4.22 
(sept., 3JHH = 6.9 Hz, 1H, CH iPr), 4.07 (sept., 3JHH = 6.9 Hz, 1H, CH iPr), 1.39 (d, 3J
HH = 6.9 Hz, 6H, CH3 iPr), 1.36 (d, 3JHH = 6.9 Hz, 6H, CH3 iPr). 11B NMR (96 MHz, 
CD2Cl2, 298 K) δ/ppm:  -17.0 (s). 19F NMR (282 MHz, CD2Cl2, 298 K) δ/ppm: -133.0 
(d, 3JFF = 22 Hz, 6F, o-F), -161.9 (t, 3JFF = 20 Hz, 3F, p-F), -166.2 (m, 6F, m-F). 13C 
NMR (125 MHz, CD2Cl2, 298 K) δ/ppm:  160.9 (s), 148.7 (dm, 1JCF = 245 Hz), 140.5 
(m), 139.1 (dm, 1JCF = 245 Hz), 137.2 (dm, 1JCF = 245 Hz), 119.4 (m), 71.6 (s), 51.7 
(s), 20.2 (s). IR ʋmax (cm-1): 1716, 1663, 1643, 1512, 1457, 1442, 1404, 1379, 1363, 
1264, 1144, 1079, 1066, 978, 959, 902, 867, 844, 804, 763, 747, 736, 704, 675, 658, 
642, 607. HRMS (ES+) m/z calculated for [M+H]+ [C28H18BF15NO2]+: 696.1191, found: 
696.1183.
3.8c: Prop-2-yn-1-yl diphenylcarbamate 3.7c (50 mg, 0.2 mmol) 
and B(C6F5)3 (102 g, 0.2 mmol) were dissolved in toluene (2 ml) 
to give a clear colourless solution. This was immediately cooled 
to -40 °C and left for 5 days to give a crop of small pale yellow 
crystals suitable for X-ray diffraction. The solution was decanted and the solid was 
washed with hexane (3 x 2 ml) and dried in vacuo to afford the product as a white 
solid. Yield: 91 mg, 0.12 mmol, 60%. Melting point: 65-72 °C. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm:  7.46-7.25 (m, 10H, Ar-H), 6.43 (s, 1H, =CH), 4.9 (s, 2H, CH2). 
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.3 (s), 148.2 (dm, 1JCF = 252 Hz), 139.9 
(m), 140.3 (s), 138.9 (dm, 1JCF = 255 Hz), 136.9 (dm, 1JCF = 247 Hz), 130.1 (s), 129.9 
(s), 126.7 (s), 110.2 (s), 73.0 (s). 11B NMR (160 MHz, CDCl3, 298 K), -17.1 (s) 19F 
NMR (282 MHz, CDCl3, 298 K) δ/ppm:  -132.6 (d, 3JFF = 21.3 Hz, 2F, o-F), -160.5 (t, 
3JFF = 21.2 Hz, 1F, p-F), -164.9 (t, 3JFF = 21.2 Hz, 2F, m-F). IR ʋmax (cm-1): 3088, 3046, 
3016, 2915, 2873, 2739, 1946, 1861, 1806, 1737, 1616, 1584, 1518, 1476, 1381, 
1319, 1287, 1251, 1212, 1179, 1101, 1088, 1029, 973, 898, 774, 739, 719, 702, 689. 
HRMS (EI-) m/z calculated for [M-H]– [C34H12BNO2F15]–: 761.0785, found: 761.0775.
3.9a: Prop-3-yn-2-yl-diisopropylcarbamate 3.7a (18 mg, 0.1 mmol) 
and B(C6F5)3 (51 mg, 0.1 mmol) were dissolved C6D6 (0.5 ml) and 
the reaction left at 60 °C for 15 h. The progress of the reaction was 
monitored by 1H-, 11B- and 19F-NMR spectroscopy. The solution was concentrated, 
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when complete and layered with pentane then stored at -20 °C whereby the product 
crystallised out. The remaining solution was decanted off and the resulting solid 
washed with cold pentane (3 x 2 ml). Drying in vacuo afforded the product as a white 
crystalline solid. Yield: 50.4 mg, 0.07 mmol, 72%. 1H NMR (600 MHz, C6D6, 298 K) 
δ/ppm:  4.55 (d, 4JHH = 2.6 Hz, 1H, =CH), 4.48 (br. s, 1H, CH), 4.38 (d, 4JHH = 2.6 Hz, 
1H, =CH), 3.06 (br. s, 2H, CH iPr), 0.89 (d, 3JHH = 6.8 Hz, 3H, CH3), 0.86 (d, 3JHH = 
6.6 Hz, 3H, CH3), 0.83 (d, 3JHH = 6.8 Hz, 3H, CH3), 0.80 (d, 3JHH = 6.8 Hz, 3H, CH3). 
11B NMR (96 MHz, C6D6, 298 K) δ/ppm:  0.8 (br. s). 19F NMR (282 MHz, C6D6, 298 K) 
δ/ppm:  -134.8 (br. d, 2F, o-F), -136.0 (m, 2F, o-F), -143.0 (m, 2F, o-F), -156.8 (m, 
2F, p-F), -157.6 (t, 3JFF = 21.7 Hz, 1F, p-F), -162.9 (br. s, 2F, m-F), -163.4 (m, 2F, m-
F), -163.7 (m, 2F, m-F). 13C NMR (150 MHz, C6D6, 298 K) δ/ppm: 156.4 (s), 155.8 
(s), 148.4 (dm, 1JCF = 245 Hz), 147.9 (dm, 1JCF = 245 Hz), 145.3 (dm, 1JCF = 245 Hz), 
140.4 (dm, 1JCF = 245 Hz), 139.3 (dm, 1JCF = 245 Hz), 137.7 (dm, 1JCF = 245 Hz), 98.9 
(s), 49.7 (s), 47.3 (s), 29.0 (br. s), 20.6 (s), 20.1 (s).
3.9b: But-3-yn-2-yl-diisopropylcarbamate 3.7b (19.7 mg, 0.1 
mmol) and B(C6F5)3 (51.2 mg, 0.1 mmol) were dissolved in CD2Cl2
(0.5 ml) and the reaction left for 24 h. The completion of the 
reaction was monitored by 1H-, 11B- and 19F-NMR spectroscopy. 
The solution was concentrated, and when complete layered with pentane and stored 
at -20 °C resulting in crystallisation on the product. The remaining solution was 
decanted off and the solid was washed with cold pentane (3 x 2 ml). Drying in vacuo
afforded the product as a white crystalline solid. Yield: 54.7 mg, 0.08 mmol, 75%. 1H 
NMR (300 MHz, CD2Cl2, 298 K) δ/ppm:  5.04 (q, 3JHH = 6.9 Hz, 1H, =CH), 4.68-4.64 
(m, 1H, CH), 4.34 (s, 1H, CH), 4.00-3.91 (m, 1H, CH), 1.70 (d, 3JHH = 6.9 Hz, 3H, 
CH3), 1.44-1.30 (m, 12H, CH3). 13C NMR (125 MHz, CD2Cl2, 298 K) δ/ppm:  156.7 (s), 
149.1 (m), 148.4 (dm, 1JCF = 245 Hz), 147.8 (dm, 1JCF = 245 Hz), 145.4 (dm, 1JCF = 
245 Hz), 140.4 (dm, 1JCF = 245 Hz), 140.1 (s), 139.3 (dm, 1JCF = 245 Hz) 137.9 (s), 
137.6 (dm, 1JCF = 245 Hz), 137.3 (s), 110.2 (s), 50.1 (s), 48.1 (s), 29.4 (br. s), 21.1 
(s), 20.5 (s), 11.0 (s). 11B NMR (96 MHz, CD2Cl2, 298 K) δ/ppm:  0.0 (br. s). 19F NMR
(282 MHz, CD2Cl2, 298 K) δ/ppm: -135.0 (br. s, 2F, o-F), -136.3 (m, 2F, o-F), -143.1 
(d, 3JFF = 20.6 Hz, 2F, o-F), -158.7 (t, 3JFF = 20.7 Hz, 1F, p-F), -159.0 (t, 3JFF = 20.0 
Hz, 1F, p-F), -159.7 (t, 3JFF = 20.8 Hz, 1F, p-F), -163.9 (m, 2F, m-F), -164.8 (m, 2F, 
m-F), -165.0 (m, 2F, m-F), all C6F5-rings are inequivalent. IR ʋmax (cm-1): 2993, 2978, 
1702, 1644, 1614, 1517, 1494, 1464, 1393, 1374, 1284, 1250, 1215, 1182, 1157, 
1091, 1068, 1039, 993, 974, 956, 934, 904, 873, 860, 824, 777, 751, 737, 720, 699, 
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686, 663, 629, 617. HRMS (ES+) m/z calculated for [M+NH4]+ [C29H23BF15N2O2]+: 
727.1613, found: 727.1601.
3.9c: Prop-2-yn-1-yl diphenylcarbamate 3.7c (50 mg, 0.2 mmol)
and B(C6F5)3 (102 mg, 0.2 mmol) were dissolved in toluene (0.5 
ml) to give a clear colourless solution. After 5 d at room 
temperature a few drops of CH2Cl2 were added and the solvent left to evaporate to 
give large pale yellow blocks suitable for X-ray diffraction. The solution was decanted 
and the solid washed with hexane (3 x 2 ml). This was then dried in vacuo to yield the 
pure product as a white solid. Yield: 101 mg, 0.13 mmol, 66%. Melting point: 137-
146 °C. 1H NMR (500 MHz, CDCl3, 298 K) 7.50-7.35 (m, 10H, Ar-H), 4.73 (d, 2JHH = 
2.5 Hz, 1H, =C–H), 4.66 (d, 2JHH = 2.5 Hz, 1H, =C–H), 4.39 (s, 1H, B-C–H). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm:  157.2 (s), 155.6 (s), 130.1 (s), 129.9 (s), 129.4 (s), 
129.5 (s), 126.7 (s), 126.6 (s), 100.5 (s), note: carbon environments of C6F5 groups 
not reported due to extensive line broadening. 11B NMR (160 MHz, CDCl3, 298 K) 
δ/ppm: 1.4 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm:  -134.0 (d, 3JFF = 21.5 
Hz, 2F, o-F), -135.5 (d, 3JFF = 21.5 Hz, 2F, o-F), -141.4 (br. s, 1F, o-F), -143.2 (br. s, 
1F, o-F), -156.6 (t, 3JFF = 21.2 Hz, 1F, p-F), -157.0 (t, 3JFF = 21.2 Hz, 2F, p-F), -161.2 
(br. s, 1F, m-F), -162.0 (br. s, 1F, m-F), -163.0 (m, 2F, m-F) -163.8 (m, 2F, m-F). All 
C6F5 rings are inequivalent. IR ʋmax (cm-1): 3055, 2987, 2686, 2359, 2307, 1673, 1647, 
1618, 1582, 1519, 1496, 1487, 1465, 1423, 1384, 1289, 1273, 1260, 1209, 1161, 
1107, 1092, 1026, 998, 972, 896, 759, 738, 717, 699. HRMS (EI+) m/z calculated for 
[M+Na]+ [C34H13BF15NO2Na]+: 785.0734, found 785.0711.
3.11: With less stringent exclusion of water, benzyl-prop-2-yn-1-
ylcarbamate 3.10 (38 mg, 0.2 mmol) was added to B(C6F5)3 (102 
mg, 0.2 mmol) in 2 ml toluene to give a slight yellow solution. After 
reaction for 4 d at room temperature the solution was concentrated in vacuo, layered 
with hexane and left at -40 °C to produce yellow/orange blocks suitable for X-ray 
diffraction. Yield: 55 mg, 0.09 mmol, 45%. Melting point: 95-102 °C. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 8.29 (br. s, 1H, NH), 6.56 (s, 1H, =CH), 2.18 (s, 3H, CH3). 
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 157.9 (s), 148.0 (br. s), 147.1 (br. s), 141.3 
(m), 139.3 (m), 138.2 (m), 136.2 (m), 108.8 (s), 53.6 (s), 11.2 (s). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: 0.7 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm:  -134.7 
(m, 2F, o-F), -156.8 (m, 1F, p-F), -163.7 (s, 2F, m-F). IR ʋmax (cm-1): 3380, 3088, 3062, 
3028, 2922, 2873, 1943, 1863, 1806, 1731, 1697, 1674, 1648, 1604, 1519, 1496, 
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1470, 1379, 1291, 1105, 1085, 1033, 979, 774, 736, 725, 697, 625. HRMS (EI–) m/z
calculated for [M-H]– [C22H4BNO2F15]–: 609.0132, found: 609.0142.
3.13: Ethyl-pent-1-yn-3-yl-carbonate 3.12 (15.6 mg, 0.1 mmol) and 
B(C6F5)3 (51.2 mg, 0.1 mmol) were dissolved in 0.6 ml CD2Cl2 and 
left for 66 h at room temperature. The completion of the reaction 
was monitored by 1H-, 11B- and 19F-NMR spectroscopy. Removal 
of the solvent in vacuo afforded the crude product as a brown solid. Product was 
recrystallised by slow evaporation of toluene to yield a small crop of colourless plates. 
Yield: 53.9 mg, 0.08 mmol, 81%. 1H NMR (400 MHz, CD2Cl2, 298 K) δ/ppm:  5.20 (t, 
3JHH = 7.5 Hz, 1H), 4.80 (dq, 3JHH = 7.1 Hz, 4JHH = 1.4 Hz, 2H), 4.48 (s, 1H), 2.23-2.04 
(m, 2H), 1.55 (t, 3JHH = 7.1 Hz, 3H), 0.93 (t, 3JHH = 7.5 Hz, 3H); 11B NMR (96 MHz, 
CD2Cl2, 298 K) δ/ppm: -0.9 (br. s).  19F NMR (282 MHz, CD2Cl2, 298 K) δ/ppm:  -139.2 
(m, 2F, o-F), -139.8 (m, 2F, o-F), -147.0 (br. s, 2F, o-F), -161.2 (t, 3JFF = 20.2 Hz, 1F, 
p-F), -161.7 (t, 3JFF = 20.6 Hz, 1F, p-F), -162.2 (t, 3JFF = 20.6 Hz, 1F, p-F), -166.7 (br. 
m, 2F, m-F), -168.2 (m, 4F, m-F). 13C NMR (100 MHz, CD2Cl2, 298 ) δ/ppm:  159.4 
(s), 148.5 (dm, 1JCF = 245 Hz), 147.8 (dm, 1JCF = 245 Hz), 145.5 (dm, 1JCF = 245 Hz), 
140.9 (dm, 1JCF = 245 Hz), 140.6 (dm), 139.8 (dm, 1JCF = 245 Hz), 138.3 (s), 138.1 
(s), 137.7 (dm, 1JCF = 245 Hz), 120.6 (s), 117.6 (t), 117.1 (m), 71.8 (s), 27.9 (br. s), 
18.8 (s), 14.2 (s), 13.6 (s). IR ʋmax (cm-1): 3293, 2979, 2940, 2882, 2358, 2125, 1756, 
1515, 1465, 1396, 1373, 1342, 1302, 1275, 1177, 1094, 1062, 1007, 948, 939, 893, 
857, 7901, 670.
6.3.2 Use of Heteroleptic Boranes for Selective Migratory Group 
Transfer
6.3.2.1 Synthesis of Starting Materials
3.18: nBuLi (7.5 ml, 1.6 M in hexanes, 12 mmol) was added drop wise 
to a solution of C6F5Br (1.5 ml, 12 mmol) in hexane (45 ml) at -78 °C. 
The reaction mixture was stirred for 40 minutes before 
dichlorophenylborane (0.78 ml, 6 mmol) was added, and the mixture warmed to 25 
°C over a period of 12 h, at which point the generated LiCl was removed via cannula 
filtration. Evaporation of the filtrate afford a white solid, which was then sublimed at 
100 °C (1 x 10-3 mbar) over 12 h to afford the desired triarylborane as white crystals 
(750 mg, 1.8 mmol, 30%). 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.68 – 7.62 (m, 
3H, Ar-H), 7.43 (t, 3JHH = 7.6 Hz, 2H, Ar-H). Partial 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 139.5 (s), 136.8 (s), 128.6 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm:  
64.6 (br. s). 19F NMR (470 MHz, CDCl3, 298 K) δ/ppm: -128.6 (dd, 3JFF = 24.0 Hz, 4JFF
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= 8.6 Hz, 4F, o-F), -148.3 (t, 3JFF = 20.0 Hz, 2F, p-F), -160.6 (td, 3JFF = 22.4 Hz, 4JFF
= 8.5 Hz, 4F, m-F). Analytical data agrees with values previously reported.[72]
HB(C6F5)2: B(C6F5)3 (0.77 g, 1.50 mmol, 1.0 equiv.) and triethylsilane 
(0.24 ml, 1.50 mmol, 1.0 equiv.) were dissolved in toluene (10 ml). The 
solution was heated at 60 °C for 5 days and then cooled to -20 °C upon 
which the desired product HB(C6F5)2 crystallised as colourless needles. The 
remaining solvent was removed via cannula and the crystals washed with cold 
toluene (3 x 2 ml). Drying in vacuo afforded the desired product as a colourless 
crystalline solid (164 mg, 0.47 mmol, 32%). 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
4.10 (br. s, 1H). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 19.7 (br. s). 19F NMR (376 
MHz, CDCl3, 298 K) δ/ppm: -132.3 (d, 3JFF = 15.1 Hz, 4F, o-F), -147.2 (t, 3JFF = 20.2 
Hz, 2F, p-F), -158.9 (td, 3JFF = 21.0 Hz, 4JFF = 7.6 Hz, 4F, m-F). The spectral data is 
in accordance with literature reports.[24a]
3.19: HB(C6F5)2 (35 mg, 0.1 mmol) and styrene (10 mg, 0.1 mmol) 
were dissolved in toluene (2 ml). After 30 minutes the solvent was 
removed in vacuo to yield a white solid, which was washed with 
hexane and dried to give 2. Yield: 26 mg, 0.057 mmol, 57%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.29 – 7.25 (m, 2H, Ar-H), 7.20 – 7.13 (m, 3H, Ar-H), 2.89 (t, 
3JHH = 7.8 Hz, 2H, CH2), 2.47 (t, 3JHH = 7.8 Hz, 2H, CH2). 11B NMR (128 MHz, CDCl3, 
298 K) δ/ppm: 74.0 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -129.6 (dt, 3JFF
= 21.2 Hz, 4JFF = 6.6 Hz, 4F, o-F), -147.0 (t, 3JFF = 19.8 Hz, 2F, p-F), -160.6 (m, 4F, 
m-F). Spectral data is in accordance with literature reports.[159]
General procedure 4: Synthesised in a similar procedure set out Lal et al.[160] Terminal 
alkyne (20 mmol, 1 equiv.) dissolved in 50 ml of THF was cooled to -78 °C in a flame-
dried Schlenk flask. To this nBuLi 1.6 M in hexane solution (13.1 ml, 21 mmol, 1.05 
equiv.) was added dropwise and left to stir at this temperature for 30 minutes. A 
solution of I2 (5.33 g, 21 mmol, 1.05 equiv.) in 30 ml of THF was added portionwise 
to give an orange solution. Once warmed to room temperature, the mixture was 
immediately washed with H2O, extracted with hexane (iodoethynyl-benzene) or 
diethyl ether (1-iodohex-1-yne) and the organic fractions combined and washed with 
10% Na2S2O3 solution then saturated NaCl solution. Volatiles were removed in vacuo
to give a yellow/orange oil which were suitably pure for subsequent reactions.
3.20a’: Synthesised according to General Procedure 4 using phenyl 
acetylene (2.19 ml, 20 mmol, 1 equiv.) as terminal alkyne. Yield: 4.39 g, 19.26 mmol, 
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96%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.46-7.41 (m, 2H, Ar-H), 7.34-7.29 
(m, 3H, Ar-H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 132.4 (s), 128.9 (s), 128.3 
(s), 123.4 (s), 94.2 (s), 6.7 (s). Analytical data agrees with previously reported 
values.[161]
3.20b’: Synthesised according to General Procedure 4 using 1-
hexyne (2.3 ml, 20 mmol, 1 equiv.) as terminal alkyne. Yield: 3.46 
g, 16.7 mmol, 83%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 2.36 (t, 3JHH = 7.0 Hz, 
2H, CH2), 1.55-1.47 (m, 2H, CH2), 1.44-1.38 (m, 2H, CH2), 0.91 (t, 3JHH = 7.3 Hz, 3H, 
CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 95.0 (s), 30.7 (s), 22.0 (s), 20.7 (s), 
13.7 (s), -7.6 (s). Analytical data agrees with previously reported values.[162]
General Procedure 5: The iodoalkyne reagent 3.20’ (0.2 mmol, 1 equiv.) was 
dissolved in CH2Cl2 (2 ml) with the subsequent addition of B(C6F5)3 (102 mg, 0.2 
mmol, 1 equiv.). Removal of solvent in vacuo gave the pure product as a dark orange-
brown oil within 10 minutes at room temperature as confirmed by multinuclear NMR 
spectroscopy. 
3.20a: Synthesised using General Procedure 5 with 3.20a’ (45 mg, 
0.2 mmol, 1 equiv.) Yield: 147 mg, 0.2 mmol, quant. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.22 – 7.16 (m, 5H, Ar-H). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 149.1 (dm, 1JCF = ~250 Hz) 143.9 (dm, 1JCF = ~250 
Hz), 143.9 (dm, 1JCF = 250 Hz), 143.1 (s), 137.7 (dm, 1JCF = ~250 Hz) 130.4 (s), 129.2 
(s), 128.4 (s), 119.7 (s), 116.4 (m), 112.8 (m). 11B NMR (160 MHz, CDCl3, 298 K) 
δ/ppm: 57.9 (br. s). 19F NMR (283 MHz, CDCl3, 298 K) δ/ppm: -127.2 (d, 3JFF = 21.7 
Hz, 4F, o-F), -137.3 (d, 3JFF = 18.5 Hz, 2F, o-F), -144.0 (t, 3JFF = 21.0 Hz, 2F, p-F), -
152.6 (t, 3JFF = 21.6 Hz, 1F, p-F), -160.2 (td, 3JFF = 21.7 Hz, 4JFF = 8.9 Hz, 4F, m-F), -
160.6 (t, 3JFF = 18.5 Hz, 2F, m-F). Elemental analysis (%) calculated  for C26H5BF15I:
C 42.20, H 0.68, found: C 41.97, H 0.72.
3.20b: Synthesised using General Procedure 5 with3.20b’ (42 mg, 
0.2 mmol, 1 equiv.). Yield 144 mg, 0.2 mmol, quant. Major 
stereoisomer reported: 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
2.52 (t, 3JHH = 7.3 Hz, 2H, CH2), 1.70 – 1.56 (m, 2H, CH2), 1.37 – 1.29 (m, 2H, CH2), 
0.88 (t, 3JHH = 7.3 Hz, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 148.6 
(dm, 1JCF = ~250 Hz), 145.7 (dm, 1JCF = ~250 Hz), 144.7 (dm, 1JCF = ~250 Hz), 142.7 
(dm, 1JCF = ~250 Hz), 137.7 (dm, 1JCF = ~250 Hz), 127.9 (s), 114.8 (m), 113.3 (m), 
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47.6 (s), 43.3 (s), 34.0 (s), 31.8 (s), 21.7 (s), 21.5 (s), 13.8 (s), 13.6 (s). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 58.4 (br. s). 19F NMR (283 MHz, CDCl3, 298 K) δ/ppm: -
127.1 (d, 3JFF = 19.6 Hz, 4F, o-F), -137.7 (m, 2F, o-F), -144.9 (t, 3JFF = 21.1 Hz, 2F, 
p-F), -152.8 (t, 3JFF = 21.1 Hz, 1F, p-F), -160.73 – -160.55 (m, 6F, m-F). Elemental 
analysis (%) calculated  for C24H9BF15I: C 40.04, H 1.26, found: C 39.95, H 1.20.
8-((trimethylsilyl)oxy)quinoline: Prepared according to literature 
methods.[163] To a solution of 8-hydroxyquinoline (4.79 g, 33.0 mmol) and 
imidazole (2.36 g, 34.7 mmol) in 50 ml CH2Cl2, trimethylsilyl chloride 
(4.62 ml, 36.4 mmol) was added and stirred overnight at room temperature. The 
resulting cloudy orange solution was diluted with diethyl ether (100 ml) and filtered. 
The organic layer was dried with Na2SO4 and the volatiles removed in vacuo. The 
resulting brown oil was left to stand for 24 h whereby the resulting orange/brown oil 
was decanted from the brown crystalline solid to give the pure product as a brown oil. 
Yield: 3.33 g, 15.3 mmol, 46%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.89 (dd, 
3JHH = 4.2 Hz, 4JHH = 1.7 Hz, 1H, quinoline Ar-H), 8.12 (dd, 3JHH = 8.1 Hz, 4JHH = 1.7 
Hz, 1H, quinoline Ar-H), 7.42 (s, 1H, Ar-H), 7.41 (d, 3JHH = 2.6 Hz, 1H, Ar-H), 7.37 (q, 
3JHH = 4.1 Hz, 1H, Ar-H), 7.16 (dd, 3JHH = 5.7 Hz, 3JHH = 3.2 Hz, 1H, Ar-H), 0.36 (s, 
9H, SiMe3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 152.2 (s), 148.7 (s), 142.0 (s), 
135.8 (s), 129.7 (s), 126.8 (s), 121.2 (s), 120.5 (s), 117.6 (s), 1.1 (s). HRMS (EI+) m/z 
calculated for [C12H15NOSi]+ [M]+: 217.0923 , found: 217.0922. Characterisation 
agrees with previous literature findings.[74]
3.21’: Prepared in a procedure set out by Ingleson et al.[74] To a solution 
of 8-((trimethylsilyl)oxy)quinoline (1 ml, 4.6 mmol, 1 equiv.) in 10 ml of 
CH2Cl2, dichlorophenyl borane (PhBCl2) (0.73 ml, 4.6 mmol, 1 equiv.) 
was added dropwise to give an instant colour change from an orange to 
a dark green solution. This was left at room temperature for 1 h whereby bright yellow 
crystals formed. The remaining solution was decanted and the resulting solid dried in 
vacuo. The crude product was washed with cold CH2Cl2 (1 x 2 ml) then hexane (3 x 
2 ml) and dried under reduced pressure to afford the pure product as a bright yellow 
crystalline solid. Yield: 1.20 g, 4.49 mmol, 98%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 8.64 (dd, 3JHH = 5.2 Hz, 4JHH = 0.9 Hz, 1H, Ar-H), 8.53 (dd, 3JHH = 8.3 Hz, 4JHH
= 0.9 Hz, 1H, Ar-H), 7.76-7.71 (m, 4H, Ar-H), 7.42 (d, 3JHH = 8.4 Hz, 1H, Ar-H), 7.38-
7.29 (m, 4H, Ar-H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 156.3 (s), 140.5 (s), 
140.4 (s), 136.2 (s), 133.0 (s), 131.8 (s), 128.3 (s), 128.1 (s), 127.9 (s), 123.4 (s), 
114.4 (s), 111.2 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 12.3 (br. s). HRMS
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(EI+) m/z calculated for [C15H11BClNO]+ [M]+: 266.0659, found: 266.0658. 
Characterisation agrees with previous literature findings.[74]
3.21: Prepared in a procedure set out by Ingleson et al.[74] The 
oxazoboroloquinoline precursor 3.21’ (0.60 g, 2.25 mmol, 1 equiv.) 
was dissolved in CH2Cl2 (25 ml) with subsequent addition of AlCl3
(0.30 g, 2.25 mmol, 1 equiv.) instantly yielding a yellow-green 
precipitate. The mixture was stirred for a further 20 minutes then left to settle. The 
solution was decanted with the solid residue being washed with hexane (3 x 5 ml) to 
give the product (3.21) as a bright yellow powder. Yield: 653 mg, 1.68 mmol, 73%. 1H 
NMR (500 MHz, CH2Cl2 d6-DMSO insert, 298 K) δ/ppm: 9.79 (br. s, 1H, Ar-H), 9.43 
(d, 3JHH = 6.8 Hz, 1H, Ar-H), 8.53 (br. s, 1H, Ar-H), 8.35 (br. d, 3JHH = 6.1 Hz, 2H, Ar-
H), 8.2 (br. d, 3JHH = 7.6 Hz, 1H, Ar-H), 8.12 – 8.07 (m, 2H, Ar-H), 7.84 (br. s, 1H, Ar-
H), 7.71 (t, 3JHH = 7.5 Hz, 2H, Ar-H). 11B NMR (160 MHz, CH2Cl2 d6-DMSO insert, 298 
K) δ/ppm: 34.5 (br. s). HRMS (EI+) m/z calculated for [C15H11BNO]+ [M]+: 231.0970, 
found: 231.0960. Characterisation agrees with previous literature findings.[74]
General Procedure 6: Synthesised using an adapted procedure from Lam et al.[164]
Propargyl alcohol (0.72 ml, 12.5 mmol, 1 equiv.) was dissolved in 100 ml CH2Cl2 and 
cooled to -78 °C. Tetramethylethylenediamine (TMEDA) (1.12 ml, 7.5 mmol, 0.6 
equiv.) was added followed by dropwise addition of acyl chloride (13.8 mmol, 1.1 
equiv.). After stirring at this temperature for 30 minutes the reaction was warmed to 
room temperature and quenched with saturated NH4Cl solution. The aqueous phase 
was extracted with CH2Cl2 (3 x 30 ml) with the combined organic phases being 
washed with H2O then dried over K2CO3 and Na2SO4. Removal of volatiles under 
reduced pressure gave the crude product as a pale yellow oil. This was purified by 
either recrystallisation or column chromatography.
General Procedure 7: Synthesised using a procedure similar to that reported by 
Stephan et al.[20] The acyl chloride (15 mmol, 1.2 equiv.) and triethylamine (TEA) (3.5 
ml, 25 mmol, 2 equiv.) were dissolved in 50 ml CH2Cl2 and cooled to 0 °C. Propargyl 
alcohol (12.5 mmol, 1 equiv.) was added dropwise at this temperature and the mixture 
stirred at room temperature for 10 h. The resulting solution was washed with 100 ml 
H2O with the aqueous phase being extracted with CH2Cl2 (3 x 50 ml). The combined 
organic fractions were washed with saturated NaCl solution (100 ml) and dried over 
MgSO4 with the volatiles being removed in vacuo. The crude product was purified by 
either recrystallisation or column chromatography.
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General procedure 8: Synthesised using a procedure adapted from Stephan et al.[20]
Triethylamine (1.0 equiv.) and 4-dimethylaminopyridine (4-DMAP) (0.02 equiv.) were 
added to a solution of the propargyl alcohol (1.0 equiv.) in CH2Cl2 (ca. 20 ml) and was 
stirred for 5 min. The solution was cooled to 0 °C and the acyl chloride (1.0 equiv.) 
added dropwise. The resulting mixture was stirred at this temperature for 30 min and 
was then allowed to warm to room temperature and was stirred for a further 3-48 h. 
The reaction was quenched with water and the aqueous layer extracted twice with 
CH2Cl2. The collective organic phases were washed with brine, dried with MgSO4, 
filtered, and the solvent was removed under vacuum and the product purified by 
column chromatography or recrystallisation as necessary.
3.22a: Synthesised according to General Procedure 6 using benzoyl 
chloride (1.60 ml, 13.8 mmol, 1.1 equiv.). Purification via column 
chromatography (hexane/ethyl acetate, 20:1) gave the pure product as 
a colourless oil. Yield: 1.82 g, 11.4 mmol, 91%. Spectroscopic data agrees with 
literature values.[165] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.09 – 8.07 (m, 2H, 
Ar-H), 7.58 (tt, 3JHH = 7.5 Hz, 4JHH = 1.3 Hz, 1H, Ar-H), 7.45 (t, 3JHH = 7.6 Hz, 2H, Ar-
H), 4.93 (d, 4JHH = 2.5 Hz, 2H, CH2), 2.52 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 165.9 (s), 133.5 (s), 130.0 (s), 129.6 (s), 128.6 (s), 77.9 
(s), 75.1 (s), 52.6 (s). 
3.22b: Synthesised according to General Procedure 6 using p-
toluoyl chloride (1.82 ml, 13.8 mmol, 1.1 equiv.). Recrystallisation 
from hexane by slow evaporation afforded the product as a white 
crystalline solid. Yield: 2.17 g, 12.5 mmol, 100%. Spectroscopic 
data agrees with literature values.[20] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.96 
(d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.25 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 4.91 (d, 4JHH = 2.5 Hz, 
2H, CH2), 2.51 (t, 4JHH = 2.5 Hz, 1H, ≡CH), 2.41 (s, 3H, Ar-Me). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 166.3 (s), 144.5 (s), 130.3 (s), 129.6 (s), 127.1 (s), 78.3 (s), 
75.2 (s), 52.7 (s), 22.1 (s). 
3.22c: Synthesised according to General Procedure 7 using p-
anisoyl chloride (2.03 ml, 15 mmol, 1.2 equiv.). Purification via
column chromatography (hexane/ethyl acetate, 5:1) gave the 
pure product as a colourless oil. Yield: 1.98 g, 10.4 mmol, 83%). 
Spectroscopic data agrees with literature values.[166] 1H NMR (500 MHz, CDCl3, 298 
K) δ/ppm: 8.02 (dt, 3JHH = 9.0 Hz, 4JHH = 2.2 Hz, 2H, Ar-H), 6.92 (dt, 3JHH = 9.0 Hz, 
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4JHH = 2.2 Hz, 2H, Ar-H), 4.89 (d, 4JHH = 2.4 Hz, 2H, CH2), 3.86 (s, 3H, OMe), 2.50 (t, 
4JHH = 2.4 Hz, 1H, ≡CH). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 165.7 (s), 163.9 
(s), 132.0 (s), 122.0 (s), 113.9 (s), 78.2 (s), 74.9 (s).
3.22d: Synthesised according to General Procedure 7 using p-
nitrobenzoylchloride (2.77 g, 15 mmol, 1.2 equiv.). 
Recrystallisation via slow evaporation of CH2Cl2 gave the pure 
product as a yellow crystalline solid. Yield: 2.36 g, 11.5 mmol, 96%. 
Spectroscopic data agrees with literature values.[167] 1H NMR (500 MHz, CDCl3, 298 
K) δ/ppm: 8.30 (dt, 3JHH = 9.0 Hz, 4JHH = 2.2 Hz, 2H, Ar-H), 8.23 (dt, 3JHH = 9.0 Hz, 
4JHH = 2.2 Hz, 2H, Ar-H), 4.97 (d, 4JHH = 2.5 Hz, 2H, CH2), 2.56 (t, 4JHH = 2.5 Hz, 1H, 
≡CH). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 164.0 (s), 151.0 (s), 134.9 (s), 131.1 
(s), 123.8 (s), 77.1 (s), 75.8 (s), 53.4 (s). 
3.22e:Synthesised according to General Procedure 7 using benzoyl 
chloride (1.74 ml, 15 mmol, 1.2 equiv.) and but-3-yn-2-ol (0.92 ml, 
12.5 mmol). Purification via column chromatography (hexane/ethyl 
acetate, 10:1) gave the product as a white solid. Yield: 1.54 g, 8.9 
mmol, 71%. Spectroscopic data agrees with literature values.[20] 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.07 (d, 3JHH = 7.8 Hz, 2H, Ar-H), 7.57 (t, 3JHH = 7.8 Hz, 1H, Ar-
H), 7.45 (t, 3JHH = 7.8 Hz, 2H, Ar-H), 5.68 (q, 3JHH = 6.8 Hz, 1H, OCH(Me)), 2.49 (s, 
1H, ≡CH), 1.65 (d, 3JHH = 6.8 Hz, 3H, OCH(Me). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 165.6 (s), 133.3 (s), 129.9 (s), 129.9 (s), 128.5 (s), 82.3 (s), 73.1 (s), 60.8 (s), 
21.5 (s). 
3.22f: Synthesised according to General Procedure 8, but-3-
yn-2-ol (1.56 ml, 19.8 mmol), 4-DMAP (488 mg), NEt3 (2.72 ml, 
31.4 mmol) and p-toluoyl chloride (2.60 ml, 19.5 mmol) were 
reacted in 50 ml CH2Cl2. Purification by column 
chromatography on SiO2 (hexane:EtOAc, 19:1) afforded the product as a white 
crystalline solid Yield: 2.67 g, 14.2 mmol, 73%. Spectroscopic data agrees with 
literature values.[20] 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.96 (d, 3JHH = 8.30 Hz, 
2H, o-H), 7.24 (d, 3JHH = 8.30 Hz, 2H, m-H), 5.67 (qd, 3JHH = 6.68 Hz, 4JHH = 2.18 Hz, 
1H, -CH), 2.48 (d, 4JHH = 2.18 Hz, 1H, -C≡CH), 2.41 (s, 3H, -CH3), 1.64 (d, 3JHH = 6.68 
Hz, 3H, -CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 156.7 (s), 144.1 (s), 130.0 
(s), 129.2 (s), 127.2 (s), 82.5 (s), 73.1 (s), 60.6 (s), 21.9 (s), 21.5 (s). 
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3.22g: But-3-yn-2-ol (0.8 ml, 10 mmol, 1 equiv.) dissolved in 10 ml 
of CH2Cl2 along with triethylamine (2.1 ml, 15 mmol, 1.5 equiv.). 
Subsequent addition of acetic anhydride (1.04 ml, 11 mmol, 1.1 
equiv.) and 4-dimethylamino pyridine (0.12 g, 1 mmol, 0.1 equiv.) gave a pale yellow 
solution. This was left to stir at rt for 12 h. The resulting solution was washed with 
saturated NH4Cl solution (10 ml) then saturated NaCl solution (10 ml). The solution 
was dried over MgSO4 and volatiles removed in vacuo to give the pure product as an 
off yellow oil which was suitable pure without any further purification. Yield: 0.84 g, 
7.5 mmol, 75%. Spectroscopic data agrees with literature values.[168] 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 5.42 (q, 3JHH = 6.7 Hz, 1H, OCH(Me)), 2.45 (s, 1H, ≡CH), 
2.08 (s, 3H, CO2Me), 1.50 (d, 3JHH = 6.7 Hz, 3H, OCH(Me)). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 169.8 (s), 82.2 (s), 72.9 (s), 60.0 (s), 21.2 (s). 
3.22b: Diphenyl carbamoyl chloride (1.15 g, 5 mmol 1 equiv.) and 4-
dimethylamino pyridine (0.05 equiv.) were added to a solution of 
propargyl alcohol (0.29 ml, 5 mmol, 1 equiv.) in pyridine (5 ml) and the 
resulting mixture heated overnight at 80 °C. The reaction mixture was quenched with 
saturated NH4Cl solution (10 ml) and the aqueous phase extracted with diethyl ether 
(3 x 20 ml). The combined organic phases were then washed with saturated NH4Cl 
solution (3 x 20 ml), dried over sodium sulfate, filtered and the solvent removed in 
vacuo. Purification by recrystallisation from petroleum ether with a few drops of Et2O 
to solubilise the solid at -40 °C gave a pale yellow solid. Yield: 1.07 g, 4.26 mmol, 
71%. Spectroscopic data agrees with literature values.[36b] 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.28–7.13 (m, 10H, Ar-H), 4.68 (s, 2H, CH2), 2.37 (s, 1H, ≡CH). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 154.1 (s), 142.4 (s), 129.1 (s), 127.1 (s), 126.5 
(s), 78.2 (s), 74.9 (s), 53.5 (s). 
6.3.2.2 Synthesis of Products
HB(C6F5)2 (35 mg, 0.1 mmol) and styrene (10 mg, 0.1 mmol) 
were dissolved in toluene (2 ml). After 35 minutes but-3-yn-
2-yl 4-methylbenzoate (3.22f) (19 mg, 0.1 mmol) was 
added. The reaction was stirred for 40 h, and volatiles 
removed in vacuo to give a white solid. Yield: 60 mg, 0.09 mmol, 94%. (combined 
mixture regioisomers in 2:1 ratio, (CH2)2Ph vs. C6F5 migration). 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.17 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.43 (d, 3JHH = 8.1 Hz, 2H, 
Ar-H), 7.24 – 7.20 (m, 2H, Ar-H), 7.09 (d, 3JHH = 7.3 Hz, 3H, Ar-H), 5.06 (q, 3JHH = 7.0 
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Hz, 1H, =CH), 2.73 – 2.69 (m, 2H, CH2), 2.53 (s, 3H, Ph-Me), 2.63 – 2.59 (m, 1H, 
BCH), 1.79 (d, 3JHH = 7.0 Hz, 3H, =CMe), 1.41 – 1.27 (m, 2H, CH2). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 172.1 (s), 152.9 (s), 149.6 (s), 147.1 (dm, 1JCF = 237 Hz, 
o-C, C6F5), 142.2 (s), 140.0 (dm, 1JCF = 248 Hz, p-C, C6F5), 137.3 (dm, 1JCF = 247 Hz, 
m-C, C6F5), 131.5 (s), 130.5 (s), 128.5 (s), 126.0 (s), 122.5 (s), 109.5 (s), 35.3 (s), 
29.7 (s), 22.4 (s), 10.4 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 3.5 (br. s). 19F 
NMR (376 MHz, CDCl3, 298 K) δ/ppm: -134.7 – -135.0 (m, 4F, o-F), -157.6 (dt, 3JFF = 
20.4 Hz, 1F, p-F), -157.9 (dt, 3JFF = 20.3 Hz, 1F, p-F), -163.7 (tdd, 3JFF = 22.8 Hz, 4JFF
= 9.1 Hz, 4F, m-F). Note: Overlapping of both rearrangement products present (C6F5
vs. (CH2)2Ph) leading to split patterns observed particularly for p-F of C6F5 rings. Clear 
major/minor peaks identified in a ratio of ca. 2:1. Elemental analysis (%) calculated 
for C32H21BF10O2: C 60.21, H 3.32, found: C 60.30, H 3.28.
3.23a: B(C6F5)3 (102 mg, 0.2 mmol, 1.0 equiv.) was dissolved in 
CH2Cl2 (5 ml) and 1-iodohex-1-yne (42 mg, 0.2 mmol, 1.0 equiv.) 
added at room temperature. After 10 min but-3-yn-2-yl benzoate 
(3.22e) (34 mg, 0.2 mmol, 1.0 equiv.) was added and the 
reaction stirred for 18 h. The solvent was partially removed, layered with hexane and 
stored at -40 °C to give colourless crystals. The remaining solvent was removed and 
the crystals washed with cold hexane (3 x 2 ml). Drying in vacuum affords the desired 
product as an off-white solid. Yield: 70 mg, 0.071 mmol, 36%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.04 (d, 3JHH = 7.7 Hz, 2H, Ar-H), 7.86 (t, 3JHH = 7.6 Hz, 1H, Ar-
H), 7.61 (t, 3JHH = 7.6 Hz, 2H, Ar-H), 5.59 (q, 3JHH = 7.4 Hz, 1H, =CH), 4.90 (s, 1H, 
BCH), 2.08 (t, 3JHH = 7.4 Hz, 2H, CH2), 1.80 (d, 3JHH = 7.1 Hz, 3H, =CMe), 1.38 (pent., 
3JHH = 7.4 Hz, 2H, CH2), 1.08 (sxt, 3JHH = 7.3 Hz, 2H, CH2), 0.74 (t, 3JHH = 7.2 Hz, 3H, 
CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 172.3 (s), 151.2 (s), 138.2 (s), 130.8 
(s), 129.8 (s), 128.5 (s), 124.2 (s), 116.1 (s), 112.6 (s), 45.3 (s), 42.9 (s), 31.7 (s), 21.4 
(s), 13.9 (s), 10.4 (s). note: carbons of C6F5 groups not reported due to extensive line 
broadening. 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: δ/ppm 2.7 (br. s). 19F NMR 
(376 MHz, CDCl3, 298 K) δ/ppm: -132.0 (br. s, 2F, o-F), -134.1 (d, 3JFF = 26.3 Hz, 1F, 
o-F), -135.5 (br. s, 2F, o-F), -137.5 (d, 3JFF = 24.0 Hz, 1F, o-F), -153.8 (t, 3JFF = 20.7 
Hz, 1F, p-F), -156.8 (t, 3JFF = 20.7 Hz, 1F, p-F), -157.4 (t, 3JFF = 20.7 Hz, 1F, p-F), -
160.8 – -161.0 (m, 2F, m-F), -162.8 – -162.9 (m, 2F, m-F), -164.1 – - 164.3 (m, 2F, 
m-F). Elemental analysis (%) calculated for C35H19BF15IO2: C 47.01, H 2.14, found: 
C 46.98, H 2.22.
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3.23b: B(C6F5)3 (51 mg, 0.1 mmol, 1.0 equiv.) was dissolved in 
CH2Cl2 (0.6 ml) and (iodoethynyl)benzene (23 mg, 0.1 mmol, 1.0 
equiv.) added at room temperature. After 10 min but-3-yn-2-yl 4-
methylbenzoate (3.22f) (19 mg, 0.1 mmol, 1.0 equiv.) was 
added and the reaction stirred for 18 h. The solvent was partially removed, layered 
with pentane and stored at -20 °C to give colourless crystals. The remaining solvent 
was removed via cannula, the crystals washed with cold pentane (3 x 2 ml). Drying in 
vacuum affords the desired product as a white solid. Yield: 27.0 mg, 0.029 mmol,
29%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 7.88 (d, 3JHH = 8.2 Hz, 2H), 7.35 (d, 
3JHH = 8.2 Hz, 2H), 7.11-7.01 (m, 3H), 6.95 (d, 3JHH = 7.3 Hz, 2H), 5.62 (q, 3JHH = 7.1 
Hz, 1H), 4.92 (s, 1H), 2.49 (s, 3H), 1.83 (d, 3JHH = 7.1 Hz, 3H). 11B NMR (96 MHz, 
CDCl3, 298 K) δ/ppm: 2.22 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -131.9 
(br. s., 2F, o-F), -133.4 (dm, 3JFF = 25.3 Hz, 1F, o-F), -135.9 (m, 2F, o-F), -137.5 (dm, 
3JFF = 26.0 Hz, 1F, o-F), -154.1 (t, 3JFF = 20.8 Hz, p-F), -156.9 (t, 3JFF = 19.5 Hz, p-F), 
-157.3 (t, 3JFF = 20.3 Hz, p-F), -161.9 (m, 2F, m-F), -162.9 (m, 2F, m-F), -164.1 (m, 
2F, m-F). 13C NMR (150 MHz, CDCl3, 298 K) δ/ppm: 172.4 (s), 150.8 (s), 150.7 (s), 
147.8 (dm, 1JCF = 250 Hz), 147.4 (dm, 1JCF = 250 Hz), 144.3 (s), 143.0 (dm, 1JCF = 
250 Hz), 140.1 (dm, 1JCF = 250 Hz), 137.3 (dm, 1JCF = 250 Hz), 132.5 (s),  130.9 (s),  
130.4 (s), 128.3 (s),  128.2 (s), 126.6 (s), 121.3 (s), 118.7 (m), 116.1 (m), 112.5 (s), 
112.6 (m), 107.2 (s), 45.2 (br. s), 22.4 (s), 10.4, (s). HRMS (ES+) m/z calculated for 
[C38H21BF15INO2]+ [M+NH4]+, calculated for 946.0471; found, 946.0460.
3.23c: B(C6F5)3 (51 mg, 0.1 mmol, 1.0 equiv.) was dissolved in 
CD2Cl2 (0.6 ml) and 1-iodohex-1-yne (21 mg, 0.1 mmol, 1.0 
equiv.) added at room temperature. After 10 min but-3-yn-2-yl 
4-methylbenzoate (3.22f) (19 mg, 0.1 mmol, 1.0 equiv.) was 
added and the reaction stirred for 18 h. The solvent was partially removed, layered 
with pentane and stored at -20 °C to give colourless crystals. The remaining solvent 
was removed via cannula, the crystals washed with cold pentane (3 x 2 ml). Drying in 
vacuum affords the desired product as white solid. Yield: 22 mg, 0.025 mmol, 25%. 
1H NMR (600 MHz, CDCl3, 298 K) δ/ppm: 7.91 (d, 3JHH = 8.1 Hz, 2H), 7.38 (d, 3JHH = 
8.1 Hz, 2H), 5.54 (q, 3JHH = 7.00 Hz, 1H), 4.88 (s, 1H), 2.53 (s, 3H), 2.08 (t, 3JHH = 7.1 
Hz, 2H), 1.78 (d, 3JHH = 7.1 Hz, 3H), 1.43-1.35 (m, 2H), 1.11-1.03 (m, 2H), 0.75 (t, 
3JHH = 7.8 Hz, 3H). 13C NMR (150 MHz, CDCl3, 298 K) δ/ppm: 172.2 (s), 151.0 (s), 
150.6 (s), 147.7 (dm, 1JCF =  246 Hz), 147.3 (dm, 1JCF = 239 Hz), 143.2 (dm, 1JCF = 
241 Hz), 140.1 (dm, 1JCF = 250 Hz), 137.2 (dm, 1JCF = 250 Hz), 131.6 (s), 130.9 (s), 
130.5 (s), 128.6 (s), 121.3 (s), 118.5 (m), 115.8 (s), 116.2 (m), 112.44 (m), 112.2 (s), 
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45.4 (br. s), 42.9 (s), 31.7 (s), 22.5 (s), 21.4 (s), 13.9 (s), 10.4 (s). 11B NMR (96 MHz, 
CDCl3, 298 K) δ/ppm: 1.92 (br. s). 19F NMR (282 MHz, CDCl3, 298 K) δ/ppm: -132.0 
(br. s, 2F, o-F), -134.1 (d, 3J FF = 24.7 Hz, 1F, o-F), -135.5 (m, 2F, o-F), -137.5 (d, 3J
FF = 24.7 Hz, 1F, o-F), -154.1 (t, 3J FF = 21.0 Hz, p-F), -157.0 (t, 3J FF = 21.2 Hz, p-F), 
-157.7 (t, 3J FF = 20.6 Hz, p-F), -161.1 (m, 2F, m-F), -163.0 (m, 2F, m-F), -164.3 (m, 
2F, m-F). HRMS (ES+) m/z calculated for [C36H25BF15INO2]+ [M+NH4]+: 926.0784; 
found, 926.0770.
3.23d: B(C6F5)3 (102 mg, 0.2 mmol, 1.0 equiv.) was dissolved in 
CH2Cl2 (5 ml) and 1-iodohex-1-yne (42 mg, 0.2 mmol, 1.0 equiv.) 
added at room temperature. After 10 min but-3-yn-2-yl acetate 
(3.22g) (22 mg, 0.2 mmol, 1.0 equiv.) was added and the 
reaction stirred for 18 h. The solvent was partially removed, layered with hexane and 
stored at -40 °C to give colourless crystals. The remaining solvent was removed and 
the crystals washed with cold hexane (3 x 2 ml). Drying in vacuum affords the desired 
product as an off-white solid. Yield: 50 mg, 0.06 mmol, 30%. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 5.53 (q, 3JHH = 7.0 Hz, 1H, =CH), 4.70 (s, 1H, CH), 2.20 (s, 3H, 
MeCO2), 2.10 (t, 3JHH = 8.3 Hz, 2H, CH2), 1.67 (d, 3JHH = 7.1 Hz, 3H, =CMe), 1.40 
(pent., 3JHH = 7.6 Hz, 2H, CH2), 1.10 (sext., 3JHH = 7.3 Hz, 2H, CH2), 0.77 (t, 3JHH = 7.2 
Hz, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 180.6 (s), 151.0 (s), 128.0 
(s), 117.8 (s), 112.9 (s), 77.4 (s), 43.0 (s), 31.8 (s), 21.6 (s), 21.5 (s), 13.9 (s), 10.3 
(s). Note: Partial spectrum, Carbon resonances of C6F5-groups unobserved due to 
extensive line broadening as a result of C–F coupling.  11B NMR (160 MHz, CDCl3, 
298 K) δ/ppm: 2.4 (br. s). 19F NMR (378 MHz, CDCl3, 298 K) δ/ppm: -131.98 (br. s, 
2F, o-F), -133.9 (d, 3JFF = 23.4 Hz, 1F, o-F), -136.1 (d, 3JFF = 17.3 Hz, 2F, o-F), -136.9 
(d, 3JFF = 23.0 Hz, 1F, o-F), -152.3 (t, 3JFF = 21.0 Hz, 1F, p-F), -156.6 (t, 3JFF = 21.1 
Hz, 1F, p-F), -157.0 (t, 3JFF = 21.1 Hz, 1F, p-F), -159.5 (td, 3JFF = 22.6 Hz, 4JFF = 8.1 
Hz, 1F, m-F), -161.3 (td, 3JFF = 22.6 Hz, 4JFF = 8.3 Hz, 1F, m-F), -162.7 (td, 3JFF = 22.1 
Hz, 4JFF = 9.2 Hz, 2F, m-F), -164.2 (td, 3JFF = 22.1 Hz, 4JFF = 9.1 Hz, 2F, m-F). 
Elemental analysis (%) calculated for C30H17BF15IO2: C 43.30, H 2.06, found: C 
43.16, H 1.96.
3.23e: B(C6F5)3 (102 mg, 0.2 mmol, 1.0 equiv.) was dissolved in 
CH2Cl2 (5 ml) and 1-(iodoethynyl)benzene (46 mg, 0.2 mmol, 1.0 
equiv.) added at room temperature. After 10 min but-3-yn-2-yl 
acetate (3.22g) (22 mg, 0.2 mmol, 1.0 equiv.) was added and the 
reaction stirred for 18 h. The solvent was partially removed, layered with hexane and 
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stored at -40 °C to give colourless crystals. The remaining solvent was removed and 
the crystals washed with cold hexane (3 x 2 ml). Drying in vacuum affords the desired 
product as an off-white solid. Yield: 52 mg, 0.06 mmol, 31%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.06 – 7.00 (m, 3H, Ar-H), 6.92 – 6.90 (m, 2H, Ar-H), 5.55 (q, 
3JHH = 7.0 Hz, 1H, =CH), 4.70 (s, 1H, CH), 2.10 (s, 3H, Me), 1.65 (d, 3JHH = 7.0 Hz, 
3H, =CMe). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 180.8 (s), 150.6 (s), 144.2 (s), 
128.5 (s), 128.3 (s), 128.1 (s), 126.6 (s), 125.9 (s), 114.6 (s), 113.2 (s), 21.5 (s), 10.4 
(s). Note: Partial spectrum, Carbon resonances of C6F5-groups unobserved due to 
extensive line broadening due to C–F coupling. 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 2.4 (br. s). 19F NMR (378 MHz, CDCl3, 298 K) δ/ppm: -132.1 (br. s, 2F, o-F), -
134.2 (d, 3JFF = 22.0 Hz, 1F, o-F), -135.6 (br. s, 2F, o-F), -137.6 (d, 3JFF = 25.5 Hz, 
1F, o-F), -153.8 (t, 3JFF = 21.2 Hz, 1F, p-F), -156.9 (t, 3JFF = 20.5 Hz, 1F), -157.5 (t, 
3JFF = 21.1 Hz, 1F, p-F), -160.8 – -161.1 (m, 2F, m-F), -162.9 (td, 3JFF = 22.0 Hz, 4JFF
= 8.8 Hz, 2F, m-F), -164.3 (td, 3JFF = 21.9 Hz, 4JFF = 8.9 Hz, 2F, m-F). Elemental 
analysis (%) calculated for C32H13BF15IO2 0.5 equiv. CH2Cl2: C: 43.63, H: 1.58. 
Found: C: 43.39, H: 1.66.
3.23f: B(C6F5)3 (102 mg, 0.2 mmol, 1.0 equiv.) was dissolved 
in CH2Cl2 (5 ml) and 1-iodohex-1-yne (42 mg, 0.2 mmol, 1.0 
equiv.) added at room temperature. After 10 min prop-2-yn-1-
yl diphenylcarbamate (3.22h) (50 mg, 0.2 mmol, 1.0 equiv.) 
was added and the reaction stirred for 18 h. The solvent was partially removed, 
layered with hexane and stored at -40 °C to give colourless crystals. The remaining 
solvent was removed and the crystals washed with cold hexane (3 x 2 ml). Drying in 
vacuum affords the desired product as an off-white solid. Yield: 44 mg, 0.05 mmol, 
23%. 1H NMR (500 MHz, CD2Cl2, 298 K) δ/ppm: 7.52 – 7.22 (m, 9H, Ar-H), 7.06 (d, 
3JHH = 7.4 Hz, 1H, Ar-H), 5.00 (d, 2JHH = 2.4 Hz, 1H, =CH2), 4.72 (s, 1H, CH), 4.64 (d, 
2JHH = 2.4 Hz, 1H, =CH2), 2.17 (t, 3JHH = 6.8 Hz, 2H, CH2), 1.46 (pent., 3JHH = 7.3 Hz, 
2H, CH2), 1.15 (sext., 3JHH = 7.3 Hz, 2H, CH2), 0.81 (t, 3JHH = 7.2 Hz, 3H, CH3). 13C 
NMR (126 MHz, CD2Cl2, 298 K) δ/ppm: 158.0 (s), 157.2 (s), 138.9 (s), 138.8 (s), 130.5 
(s), 130.0 (s), 129.7 (s), 129.5 (s), 128.9 (s), 126.8 (s), 126.5 (s), 118.3 (s), 99.6 (s), 
46.4 (s), 43.4 (s), 32.3 (s), 21.9 (s), 14.0 (s). Note: Partial spectrum, Carbon 
resonances of C6F5-groups unobserved due to extensive line broadening due to C–F 
coupling. 11B NMR (160 MHz, CD2Cl2, 298 K) δ/ppm: 2.0 (br. s). 19F NMR (282 MHz, 
CD2Cl2, 298 K) δ/ppm: -131.8 (s, 2F, o-F), -134.5 (d, 3JFF = 23.7 Hz, 1F, o-F),  -136.1 
– -136.2 (m, 3F, o-F), -154.0 (t, 3JFF = 21.2 Hz, 1F, p-F), -158.4 (t, 3JFF = 20.2 Hz, 1F, 
p-F), -158.9 (t, 3JFF = 20.2 Hz, 1F, p-F), -161.1 (td, 3JFF = 22.5 Hz, 4JFF = 6.2 Hz, 1F, 
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m-F), -161.3 (td, 3JFF = 22.5 Hz, 4JFF = 6.2 Hz, 1F, m-F), -164.0 (dt, 3JFF = 22.2 Hz, 
4JFF = 8.4 Hz, 2F, m-F), -165.7 (td, 3JFF = 22.2 Hz, 4JFF = 8.2 Hz, 2F, m-F). Elemental 
analysis (%) calculated for C40H22BF15INO2: C 49.46, H 2.28, N 1.44, found: C 49.36, 
H 2.31, N 1.49.
3.24: B(C6F5)3 (102 mg, 0.2 mmol, 1.0 equiv.) was dissolved in 
CH2Cl2 (5 ml) and (iodoethynyl)benzene (46 mg, 0.2 mmol, 1.0 
equiv.) added at room temperature. After 10 min but-3-yn-2-yl 
benzoate (3.22e) (34 mg, 0.2 mmol, 1.0 equiv.) was added and the 
reaction stirred for 18 h. The solvent was partially removed, layered 
with hexane and stored at -40 °C to give a few colourless crystals which could be 
characterised by X-ray diffraction. 
Reactions of methylene propargyl esters 3.22a–d with vinyl borane 3.20a
General Procedure 9: B(C6F5)3 (51 mg, 0.1 mmol, 1.0 equiv.) was dissolved in CH2Cl2
(0.6 ml) and (iodoethynyl)benzene (23 mg, 0.1 mmol, 1.0 equiv.) added at room 
temperature. After 10 min the propargyl ester 3.22a–d (0.1 mmol, 1.0 equiv.) was 
added and the reaction stirred for up up to 7 days. A mixture of products were 
produced as observed by in situ NMR spectroscopic experiments, however o-, p-, m-
fluorine atoms of Ph-C≡C-C6F5 were clearly visible. The solvent was partially 
removed, layered with pentane and stored at -20 °C to give a very small crop of 
colourless crystals of the bis(perfluorophenyl)boranyl ester 3.25 and/or 
(perfluorphenylethynyl)benzene 3.26 suitable for X-ray diffraction. 
Reaction of benzyl benzoate with 3.20a
B(C6F5)3 (51 mg, 0.1 mmol) was added to (iodoethynyl)benzene 3.20a’ (46 mg, 0.1 
mmol) in CDCl3 (0.5 ml) and left at ambient temperature for 10 minutes. Benzyl 
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benzoate (21 mg, 0.1 mmol) was then added with the mixture then being transferred 
to an NMR tube. Multinuclear NMR spectroscopy (1H, 11B and 19F) was conducted in 
situ over the course of 5 days.
3.28a: To a solution of 3.21 (40 mg, 0.1 
mmol, 1 equiv.) in CD2Cl2 (0.6 ml) in CD2Cl2
(0.6 ml) but-3-yn-2-ylbenzoate 3.22e (17 mg, 
0.10 mmol, 1.0 equiv.) was added upon which 
after 40 h at room temperature a 
diastereomer mixture of 3.28a and 3.28a’ is generated (based on in situ monitoring 
by NMR). The remaining solution was removed under reduced vacuum and the 
residue washed with cold hexane (3 x 2 ml) and dried in vacuo to give the desired 
product as yellow solid. Conversion calculated using in situ ratio between integral of 
starting material and combined diastereoisomers. Diastereoisomers of 3.28a formed 
in approximately a 5:1 ratio with the major diastereoisomer being reported. 
Conversion: 75%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 9.29 (d, 3JHH = 5.0 Hz, 
1H, Ar-H), 8.74 (d, 3JHH = 8.0 Hz, 1H, Ar-H), 8.26 (dd, 3JHH = 9.6 Hz, 4JHH = 1.2 Hz, 
2H, Ar-H), 8.08 – 8.05 (m, 1H, Ar-H), 7.86 (tt, 3JHH = 7.4 Hz, 4JHH = 1.2 Hz, 1H, Ar-H), 
7.73 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.60 (t, 3JHH = 7.6 Hz, 2H, Ar-H), 7.44 (t, 3JHH = 7.9 
Hz, 1H, Ar-H), 7.35 (d, 3JHH = 7.1 Hz, 2H, Ar-H), 7.30 (d, 3JHH = 7.6 Hz, 1H, Ar-H), 
7.15 (t, 3JHH = 7.7 Hz, 2H, Ar-H), 7.07 (t, 3JHH = 7.1 Hz, 1H, Ar-H), 5.20 (qd, 3JHH = 7.1 
Hz, 4JHH = 2.2 Hz, 1H, =CH), 4.01 (br. t, 4JHH = 2.2 Hz, 1H, BCH), 2.0 (dd, 3JHH = 7.1 
Hz, 4JHH = 2.4 Hz, 3H, =CMe). 11B NMR (160 MHz, CD2Cl2, 298 K) δ/ppm: 10.1 (br. 
s). 27Al NMR (104 MHz, CDCl3, 298 K) δ/ppm: 104.0 (s, AlCl4). Elemental analysis
(%) calculated for C26H21AlBCl4NO3: C 54.31, H 3.68, N 2.44, found C 54.13, H 3.72, 
N 2.36.
3.28b: To a solution of 3.21 (40 mg, 0.1 
mmol, 1 equiv.) in CD2Cl2 (0.6 ml) but-3-yn-
2-yl 4-methylbenzoate 3.22f (18.8 mg, 0.10 
mmol, 1.0 equiv.) was added upon which 
after 40 h at room temperature a 
diastereomer mixture of 3.28a and 3.28a’ is generated (based on in situ monitoring 
by NMR). The solvent was partially removed to give a saturated solution which was 
layered with pentane. Crystals of diastereoisomer 3.28a were formed from the 
solution at -20 °C. The remaining solution was removed and the crystals washed with 
cold pentane (3 x 2 ml) and dried in vacuo to give the desired product a yellow 
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crystalline solid. Conversion calculated using in situ ratio of integrals of starting 
material and combined diasteroisomers. Conversion calculated using in situ ratio 
between integral of starting material and combined diastereoisomers.
Diastereoisomers of 3.28b formed in approximately a 5:1 ratio with the major 
diastereoisomer being reported. Conversion: 49%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 9.29 (d, 3JHH = 5.0 Hz, 1H, Ar-H), 8.73 (d, 3JHH = 8.0 Hz, 1H, Ar-H), 8.15 (d, 
3JHH = 8.4 Hz, 2H, Ar-H), 7.72 (m, 2H, Ar-H), 7.52 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 7.39 
(d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.34 (d, 3JHH = 7.1 Hz, 2H, Ar-H), 7.29 (d, 3JHH = 7.3 Hz, 
2H, Ar-H), 7.15 (t, 3JHH = 7.4 Hz, 2H, Ar-H), 5.18 (qd, 3JHH = 7.1 Hz, 4JHH = 2.2 Hz, 1H, 
=CH), 4.01 (br. t, 4JHH = ~2 Hz, 1H, BCH), 2.49 (s, 3H, Ph-Me), 1.98 (dd, 3JHH = 7.1 
Hz, 4JHH = 2.3 Hz, 3H, =CMe). 11B NMR (160 MHz, CD2Cl2, 298 K) δ/ppm: 10.4 (br. 
s). 27Al NMR (104 MHz, CDCl3, 298 K) δ/ppm: 104.0 (s, AlCl4). Elemental analysis
(%) calculated for C27H23AlBCl4NO3: C 55.05, H 3.94, N: 2.38, found: C 54.87, H 4.06, 
N 2.52.
6.3.3 Divergent Elementoboration using Heteroleptic Boranes in the 
Propargyl Rearrangment
6.3.3.1 Synthesis of Starting Materials
General Procedure 10: Synthesised using a procedure similar to that reported by 
Stephan et al.[20] The acyl chloride (15 mmol, 1.2 equiv.) and triethylamine (TEA) (3.5 
ml, 25 mmol, 2 equiv.) were dissolved in 50 ml CH2Cl2 and cooled to 0 °C. Propargyl 
alcohol (0.73 ml, 12.5 mmol, 1 equiv.) or 2-methylbut-3-yn-2-ol (1.21 ml, 12.5 mmol, 
1 equiv.) was added dropwise at this temperature and the mixture stirred at room 
temperature for 10 h. The resulting solution was washed with 100 ml H2O with the 
aqueous phase being extracted with CH2Cl2 (3 x 50 ml). The combined organic 
fractions were washed with saturated NaCl solution (100 ml) and dried over MgSO4
with the volatiles being removed in vacuo. The crude product was purified by either 
recrystallisation or column chromatography.
3.29d: Synthesised according to General Procedure 10 using m-
nitrobenzoyl chloride (2.78 g, 15 mmol, 1.2 equiv.). Yield: 1.67 g, 
8.13 mmol, 65%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.90 (dd, 
4JHH = 2.9, 4JHH = 1.1 Hz, 1H, Ar-H), 8.45 (ddd, 3JHH = 8.2, 4JHH = 2.3, 4JHH = 1.1 Hz, 
1H, Ar-H), 8.43 – 8.38 (m, 1H, Ar-H), 7.72 – 7.65 (m, 1H, Ar-H), 4.99 (d, 4JHH = 2.5 
Hz, 2H, CH2), 2.57 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 13C NMR (101 MHz, CDCl3, 298 K) 
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δ/ppm: 163.9 (s), 148.4 (s), 135.6 (s), 131.3 (s), 129.9 (s), 127.9 (s), 125.0 (s), 77.1 
(s), 75.9 (s), 53.4 (s). 
3.29aD: Synthesised using similar methods to that reported in the 
literature[77] whereby the proto-derivative 3.29a (0.336 g, 2.1 mmol) 
was dissolved in D2O at which point the WA30 resin (38 mg) was 
added and stirred under ambient conditions for 18 h. At this point the 
resin was filtered off, and the filtrate was extracted with Et2O (10 ml). This was washed 
with water (10 ml) with the aqueous phase being extracted with Et2O (3 x 10 ml). The 
combined organic phases were dried over MgSO4 with the volatiles then being 
removed in vacuo to give the pure deuterated compound. The 1H and 13C NMR data 
agree with the literature reported values.[77] Yield: 0.267 g, 1.87 mmol, 88%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm: 8.02 – 7.97 (m, 2H, Ar-H), 7.53 – 7.48 (m, 1H, Ar-
H), 7.40 – 7.34 (m, 2H, Ar-H), 4.85 (s, 2H, CH2). 2H NMR (61 MHz, CDCl3, 298 K) 
δ/ppm: 2.53 (s, 1H, ≡CD). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.9 (s), 133.5 
(s), 130.0 (s), 129.5 (s), 128.6 (s), 77.5 (s), 74.9 (t, 1JCD = 38.9 Hz), 52.6 (s).
3.30a: Synthesised according to General Procedure 10 using 
benzoyl chloride (1.74 ml, 15 mmol, 1.2 equiv.). Yield: 0.352 g, 1.89 
mmol, 15%. Spectroscopic data agrees with literature known 
values.[169] 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.05 – 8.01 (m, 1H, Ar-H), 7.57 
– 7.52 (m, 1H, Ar-H), 7.46 – 7.40 (m, 1H, Ar-H), 2.59 (s, 1H, ≡CH), 1.82 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.0 (s), 133.1 (s), 130.9 (s), 129.8 (s), 
128.4 (s), 84.8 (s), 72.7 (s), 72.4 (s), 29.2 (s). 
3.30b: Synthesised according to General Procedure 10 using 4-
toluoyl chloride (1.98 ml, 15 mmol, 1.2 equiv.). Yield: 1.31 g, 6.5 
mmol, 52%. Spectroscopic data agrees with literature known 
values.[20] 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.90 (d, 3JHH
= 8.2 Hz, 1H, Ar-H), 7.21 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 2.57 (s, 1H, ≡CH), 2.38 (s, 3H, 
Ar-CH3), 1.80 (s, 6H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 164.0 (s), 142.6 
(s), 128.7 (s), 128.0 (s), 127.1 (s), 83.9 (s), 71.5 (s), 71.0 (s), 28.1 (s), 20.7 (s).
3.30c: Synthesised according to General Procedure 10 using 4-
fluorobenzoyl chloride (1.77 ml, 15 mmol, 1.2 equiv.). Yield:  1.78 
g, 8.62 mmol, 69%. 1H NMR (400 MHz, CDCl3, 298 K) 8.05 – 8.01 
(m, 2H, Ar-H), 7.11 – 7.06 (m, 2H, Ar-H), 2.59 (s, 1H, ≡CH), 1.81 
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(s, 6H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) 165.8 (d, 1JCF = 253.7 Hz), 164.0 (s), 
132.3 (d, 3JCF = 9.3 Hz), 127.1 (d, 4JCF = 3.0 Hz), 115.5 (d, 2JCF = 22.0 Hz), 84.7 (s), 
72.8 (s), 72.5 (s), 29.1 (s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -105.8 (s).
6.3.3.2 Synthesis of Products
General Procedure 11: Terminal alkyne 3.29 (0.2 mmol, 1 equiv.) was added to 
PhBCl2 (32 mg, 0.2 mmol, 1 equiv.) in CDCl3 (0.5 ml) in an NMR tube, with the 
progress being monitored via in situ multinuclear NMR spectroscopy. Connectivity 
was confirmed through HSQC and HMBC spectroscopy due to difficulty in obtaining 
HRMS or elemental analysis in spite of repeated attempts. In addition other 
spectrocopic data such as IR were inaccessible due to stability issues.
General Procedure 12: Terminal alkyne 3.30 (0.2 mmol, 1 equiv.) was added to 
PhBCl2 (32 mg, 0.2 mmol, 1 equiv.) in CDCl3 (0.5 ml) in an NMR tube, with the 
progress being monitored via in situ multinuclear NMR spectroscopy. At the point the 
reaction was complete, the solvents were removed in vacuo with the residue being 
washed with cold hexane (3 x 1 ml). This was then dissolved in a CH2Cl2/hexane 
solution and stored at -40 °C overnight to yield a crop of white crystals suitable for X-
ray diffraction. The solid was isolated and dried to yield the pure product as a white 
solid. 
3.31a: Synthesised according to General Procedure 11 using 3.29a
(37 mg, 0.2 mmol). Conversion: 94%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 8.12 – 8.00 (m, 3H, Ar-H), 7.59 – 7.51 (m, 2H, Ar-
H), 7.46 – 7.36 (m, 5H, Ar-H), 6.44 (s, 1H, =CH), 4.55 (s, 2H, CH2).
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 164.3 (s), 160.0 (s), 
137.2 (s), 136.6 (s), 134.7 (s), 134.1 (s), 130.4 (s), 128.8 (s), 128.4 (s), 128.0 (s), 
119.1 (br. s), 41.8 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 59.0 (br. s). 
3.31b: Synthesised according to General Procedure 11 using 
3.29b (41 mg, 0.2 mmol). Conversion: 92%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.11 – 8.06 (m, 2H, Ar-H), 8.02 – 7.99 (m, 
2H, Ar-H), 7.55 – 7.50 (m, 1H, Ar-H), 7.41 – 7.36 (m, 2H, Ar-H), 
7.11 – 7.06 (m, 2H, Ar-H), 6.42 (s, 1H, =CH), 4.53 (s, 2H, CH2). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 166.5 (d, 1JCF = 255.9 Hz), 163.3 (s), 159.7 
(s), 136.9 (s), 136.6 (s), 134.7 (s), 133.1 (d, 3JCF = 9.6 Hz), 128.4 (s), 125.3 (d, 4JCF = 
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3.0 Hz), 116.1 (d, 2JCF = 22.1 Hz), 41.8 (s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: 
-103.5 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 59.33 (br. s).
3.31c: Synthesised according to General Procedure 11 using 
3.29c (47 mg, 0.2 mmol). Conversion: 87%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 8.27 – 8.25 (m, 4H, Ar-H), 8.12 –
8.10 (m, Hz, 2H, Ar-H), 7.67 – 7.63 (m, 1H, Ar-H), 7.53 – 7.48 
(m, 2H, Ar-H), 6.55 (s, 1H, =CH), 4.63 (s, 2H, CH2). 13C NMR
(101 MHz, CDCl3, 298 K) δ/ppm: 162.4 (s), 158.7 (s), 151.1 (s), 136.6 (s), 134.9 (s), 
131.5 (s), 128.4 (s), 123.9 (s), 119.6 (s), 41.6 (s). 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 59.9 (br. s). 
3.31d: Synthesised according to General Procedure 11 using
3.29d (47 mg, 0.2 mmol). Conversion: 89%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 9.03 – 8.94 (m, 1H, Ar-H), 8.52 – 8.48 (m, 
2H, Ar-H), 8.14 – 8.10 (m, 2H, Ar-H), 7.77 – 7.73 (m, 1H, Ar-H), 
7.68 – 7.63 (m, 1H, Ar-H), 7.54 – 7.49 (m, 2H, Ar-H), 6.55 (s, 1H, 
=CH), 4.65 (s, 2H, CH2). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 162.2 (s), 158.8 (s), 148.5 (s), 137.0 (s), 136.7 (s), 135.9 (s), 134.9 (s), 130.8 
(s), 130.2 (s), 128.5 (s), 128.3 (s), 125.3 (s), 119.7 (s), 41.6 (s). 11B NMR (128 MHz, 
CDCl3, 298 K) δ/ppm: 60.0 (br. s). 
3.32a: Synthesised according to General Procedure 12 using 
3.30a (37 mg, 0.2 mmol, 1 equiv.). Yield: 57 mg, 0.16 mmol, 
82%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm:  8.23 (d, 3JHH = 
7.5 Hz. 2H, Ar-H), 7.79 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.56 (t, 3JHH
= 7.9 Hz, 2H, Ar-H), 7.13 (t, 3JHH = 7.5, 2H, Ar-H), 7.06 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 
6.98 (d, 3JHH = 7.4 Hz, 2H, Ar-H), 3.84 (s, 1H, CH), 1.97 (s, 3H, CH3), 1.78 (s, 3H, 
CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 171.4 (s), 147.8 (s), 141.1 (s), 138.1 
(s), 131.6 (s), 129.8 (s), 128.4 (s), 127.5 (s), 125.9 (s), 124.7 (s), 122.5 (s), 39.51 (br. 
s), 18.7 (s), 17.7 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm:  8.7 (s). IR ʋmax (cm-
1): 3201 (w), 2993 (w), 2916 (w). 1689 (m), 1597 (m), 1535 (s), 1496 (m), 1450 (m), 
1404 (s), 1311 (m), 1242 (m), 1180 (s), 1056 (m), 1026 (w), 987 (w), 933 (w), 879 
(w), 833 (w), 802 (m), 740 (s), 694 (s).
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3.32b: Synthesised according to General Procedure 12 using 
3.30b (40 mg, 0.2 mmol, 1 equiv.). Yield: 67 mg, 0.17 mmol, 
87%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm:  8.20 (d, 3JHH
= 8.3 Hz, 2H, Ar-H), 7.44 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.21 (t, 
3JHH = 7.5 Hz, 2H, Ar-H), 7.14 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 7.06 (d, 3JHH = 7.4 Hz, 2H, 
Ar-H), 3.90 (s, 1H, CH), 2.53 (s, 3H, Ar-CH3), 2.03 (s, 3H, CH3), 1.86 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  171.3 (s), 150.4 (s), 147.6 (s), 141.2 (s), 
131.7 (s), 130.6 (s), 128.4 (s), 127.5 (s), 125.9 (s), 122.0 (s), 121.8 (s), 39.6 (br. s), 
22.5 (s), 18.6 (s), 17.7 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm:  8.64 (s). IR
ʋmax (cm-1): 2160 (w), 1666 (w), 1605 (w), 1581 (w), 1527 (s), 1504 (m), 1412 (s), 
1296 (m), 1249 (m), 1172 (m), 1134 (m), 1080 (m), 1049 (m), 972 (w), 933 (w), 910 
(w), 879 (w), 833 (m), 763 (s), 740 (s), 648 (m).
3.32c: Synthesised according to General Procedure 12 using 
3.30c (41 mg, 0.2 mmol, 1 equiv.). Yield: 58 mg, 0.16 mmol, 79%. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm:  8.37 – 8.34 (m, 2H,
Ar-H), 7.33 (t, 3JHF = 8.5 Hz, 2H, Ar-H), 7.22 (t, 3JHH = 7.4 Hz, 2H, 
Ar-H), 7.15 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 7.05 (d, 3JHH = 7.3 Hz, 1H, Ar-H), 3.91 (s, 1H, 
Ar-H), 2.03 (s, 3H, CH3), 1.86 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  
170.3, (s), 168.9 (d, 1JCF = 264.1 Hz), 147.9 (s), 140.9 (s), 134.8 (d, 3JCF = 10.6 Hz), 
128.5 (s), 127.5 (s), 126.0 (s), 122.6 (s), 121.0 (d, 4JCF = 2.7 Hz), 117.6 (d, 2JCF = 22.6 
Hz), 39.6 (br. s), 18.7 (s), 17.7 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm:  8.8 (s). 
19F NMR (376 MHz, CDCl3, 298 K) δ/ppm:  -94.5 (dt, 3JHF = 8.5 Hz, 4JHF = 5.4 Hz, 1F, 
p-F). IR ʋmax (cm-1): 3201 (w), 3086 (w), 2916 (w), 1697 (w), 1597 (m), 1535 (m), 1504 
(m), 1404 (s), 1311 (m), 1242 (s), 1157 (s), 1049 (m), 972 (w), 933 (w), 910 (w), 879 
(w), 833 (m), 763 (s), 725 (s), 695 (s), 648 (m).
6.3.4 Crystallographic Studies 
Crystallographic studies were undertaken on single crystal mounted in paratone and 
studied on an Agilent SuperNova Dual three-circle diffractometer using Cu-Kα or Mo-
Kα radiation and a CCD detector. Measurements were typically made at 150(1) K with 
temperatures maintained using an Oxford cryostream. Data were collected and 
integrated and data corrected for absorption using a numerical absorption correction 
based on gaussian integration over a multifaceted crystal model within 
CrysAlisPro.[156] The structures were solved by direct methods and refined against F2
within SHELXL-2013.[170] The structures have been deposited with the Cambridge 
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Structural Database (CCDC deposition numbers 1413179-1413189, 1429175, 
1475828-1475835,147641715-1476417, 1582714-1582717). 
Table 6.3.1 Crystallographic data for compounds 3.3–3.32.
Compound 3.3a 3.3b 3.4c 3.4d
Empirical Formula C36.5H19BF15NO3 C32.5H17BF15NO C38H18BF15N2O3 C31H17BF15NO
Crystal System Triclinic Triclinic Monoclinic Monoclinic
Space Group P-1 P-1 P21/c P21/n
a/Å 10.1170(3) 9.7542(3) 14.4138(10) 11.92043(19)
b/Å 11.1727(3) 12.6233(4) 12.2486(7) 11.60613(16)
c/Å 15.4493(4) 13.5710(5) 20.8864(15) 21.1674(3)
α/o 85.231(2) 69.527(3) 90 90
β/o 81.224(2) 78.068(3) 110.0.78(8) 105.0293(15)
γ/o 88.399(3) 85.081(3) 90 90
V/Å3 1719.66(9) 1531.47(9) 3463.4(4) 2828.33(7)
Z 2 2 4 4
T /K 150(2) 150(2) 150(2) 150(2)
Dc/g.cm-3 1.575 1.590 1.623 1.680
Crystal size/mm 0.200 x 0.100 x 0.050 0.200 x 0.100 x 0.050 0.558 x 0.386 x 0.030 0.370 x 0.150 x 0.100
Total data 12184 10274 10549 10705
Unique data 6754 6006 5514 5571
Rint 0.0189 0.0157 0.0457 0.0234
R1[F2>2 σ(F2)] 0.0379 0.0358 0.0436 0.0347
wR2 (all data) 0.0976 0.0913 0.1075 0.0934
GoF 1.026 0.965 1.045 1.035
ρmin/ρmax/eÅ-3 -0.385/0.514 -0.294/0.232 -0.316/0.314 -0.307/0.306
CCDC code 1413182 1413181 1413189 1413183
Compound 3.6a 3.6b 3.8a 3.8c
Empirical Formula C25H8BF15N2O C30.5H15BCl3F15N2O C28H17BF15NO2 C41H21BF15NO2
Crystal System Monoclinic Monoclinic Triclinic Monoclinic
Space Group P21/n P21/c P-1 P21/c
a/Å 9.2926(2) 12.6397(5) 8.3006(6) 13.4550(5)
b/Å 10.8449(3) 12.0585(4) 12.1237(8) 12.8454(4)
c/Å 24.2433(7) 21.4952(7) 14.8933(10) 21.5470(7)
α/o 90 90 99.1451(17) 90
β/o 99.850(3) 105.440(4) 98.9427(16) 106.721(4)
γ/o 90 90 107.2389(16) 90
V/Å3 2407.17(12) 3158.0(2) 1380.26(16) 3566.6(2)
Z 4 4 2 4
T /K 150(2) 150(2) 200(2) 151(2)
Dc/g.cm-3 1.788 1.741 1.673 1.593
Crystal size/mm 0.250 x 0.060 x 0.040 0.160 x 0.160 x 0.030 0.130 x 0.080 x 0.040 0.250 x 0.180 x 0.090
Total data 8952 20172 13263 20811
Unique data 4723 7650 4928 8638
Rint 0.0357 0.0440 0.0979 0.0365
R1[F2>2 σ(F2)] 0.0477 0.0664 0.0468 0.0574
wR2 (all data) 0.1423 0.1889 0.1200 0.1600
GoF 1.035 1.026 1.063 1.071
ρmin/ρmax/eÅ-3 -0.262/0.440 -1.285/0.667 -0.312/0.287 -0.312/0.385
CCDC code 1413184 1413188 1413180 1413186
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Compound 3.9b 3.9c 3.11 3.13
Empirical Formula C29H19BF15NO2 C34H13BF15NO2 C22H5BF15NO2 C26H12BF15O3
Crystal System Triclinic Monoclinic Triclinic Triclinic
Space Group P-1 P21/c P-1 P-1 
a/Å 9.254(3) 8.7141(5) 8.2180(5) 9.6463(4)
b/Å 11.596(4) 31.5529(12) 10.6283(8) 12.1922(5)
c/Å 14.792(6) 11.7474(5) 13.5393(7) 12.2500(5)
α/o 102.195(8) 90 92.431(5) 96.542(3)
β/o 93.271(9) 109.032(5) 100.822(5) 91.236(3)
γ/o 108.528(8) 90 108.692(6) 97.100(3)
V/Å3 1457.9(9) 3053.4(3) 1093.56(12) 1419.43(10)
Z 2 4 2 2
T /K 200(2) 150(2) 150(2) 150(2)
Dc/g.cm-3 1.616 1.660 1.856 1.563
Crystal size/mm 0.150 x 0.150 x 0.150 0.300 x 0.180 x 0.110 0.290 x 0.160 x 0.030 0.308 x 0.213 x 0.079
Total data 8328 16328 9676 13642
Unique data 4035 7195 5157 6742
Rint 0.1076 0.0581 0.0635 0.0378
R1[F2>2 σ(F2)] 0.0632 0.0511 0.0545 0.0452
wR2 (all data) 0.1222 0.1134 0.1366 0.1170
GoF 1.019 1.031 1.043 0.991
ρmin/ρmax/eÅ-3 -0.247/0.230 -0.237/0.299 -0.327/0.484 -0.250/0.301
CCDC code 1413179 1413185 1413187 1429175
Compound 3.22 major 3.23a 3.23b 3.23c
Empirical Formula C32H21BF10O2 C35H19BF15IO2 C38H17BF15IO2 C37.25H24BF15IO2
Crystal System Triclinic Monoclinic Monoclinic Triclinic
Space Group P-1 P21/n P21/n P-1 
a/Å 10.0350(10) 18.1962(7) 11.5090(4) 9.1636(7)
b/Å 12.4428(12) 18.0826(7) 18.3922(9) 18.4314(14)
c/Å 13.2197(13) 21.6291(11) 16.6568(6) 22.5357(16)
α/o 70.067(2) 90 90 79.537(2)
β/o 68.606(3) 103.640(5) 95.446(3) 78.435(2)
γ/o 73.250(2) 90 90 89.862(5)
V/Å3 1419.3(2) 6916.0(5) 3509.9(3) 3664.7(5)
Z 2 8 4 4
T /K 200(2) 150(2) 150(2) 200(2)
Dc/g.cm-3 1419.3(2) 1.718 1.757 1.679
Crystal size/mm 0.170 x 0.110 x 0.100 0.259 x 0.177 x 0.137 0.368 x 0.197 x 0.051 0.260 x 0.050 x 0.030
Total data 4991 31196 19770 33796
Unique data 4991 12137 8421 12051
Rint 0.0478 0.0773 0.0451 0.1300
R1[F2>2 σ(F2)] 0.0575 0.0771 0.0359 0.0613
wR2 (all data) 0.1387 0.2067 0.0876 0.1543
GoF 1.108 1.069 1.024 1.016
ρmin/ρmax/eÅ-3 -0.236/0.214 -0.763/1.957 -0.617/0.494 -0.588/0.727
CCDC code 1476417 1475828 1475829 1476415
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Compound 3.23e 3.23f 3.24 3.25a
Empirical Formula C32H13BF15IO2 C40H22BF15INO2 C37H15BF15IO2 C39H10B2C12F20N2O8
Crystal System Triclinic Monoclinic Monoclinic Triclinic
Space Group P-1 P21/n P21/n P-1 
a/Å 9.3179(14) 9.1197(4) 11.5171(5) 11.3389(5)
b/Å 10.4144(4) 14.8775(8) 18.0090(9) 12.9856(6)
c/Å 32.2014(13) 27.7753(12) 16.5168(6) 15.3040(7)
α/o 91.978(3) 90 90 111.693(4)
β/o 93.889(7) 98.246(4) 94.905(4) 92.064(3)
γ/o 90.052(8) 90 90 102.822(4)
V/Å3 3115.8(5) 3729.5(3) 3413.2(3) 2024.17(16)
Z 4 4 4 2
T /K 150(2) 150(2) 150(2) 150(2)
Dc/g.cm-3 1.817 1.730 1.779 1.816
Crystal size/mm 0.284 x 0.138 x 0.082 0.291 x 0.055 x 0.042 0.241 x 0.179 x 0.147 0.283 x 0.117 x 0.034
Total data 21940 17237 15712 20253
Unique data 21940 6541 6000 9562
Rint 0.0747 0.0744 0.0469 0.0568
R1[F2>2 σ(F2)] 0.0563 0.0438 0.0437 0.0732
wR2 (all data) 0.1528 0.0916 0.1301 0.1882
GoF 1.059 1.038 0.924 1.074
ρmin/ρmax/eÅ-3 -1.587/1.395 -0.681/0.715 -1.098/1.236 -0.718/0.526
CCDC code 1475830 1475831 1475832 1475833
Compound 3.25b 3.26 3.28b 3.31d
Empirical Formula C38H10B2F20O4 C14H5F5 C28.50H26AlBCl7NO3 C16H12BCl2NO4
Crystal System Monoclinic Triclinic Triclinic Triclinic
Space Group P21/c P-1 P-1 P-1 
a/Å 11.7827(5) 6.1216(7) 9.6723(7) 7.1918(4)
b/Å 25.3378(13) 7.2354(5) 12.0596(10) 10.3441(6)
c/Å 12.0166(5) 12.7503(10) 16.3280(12) 13.0804(7)
α/o 90 85.263(6) 89.278(2) 96.791(4)
β/o 102.193(4) 84.938(9) 74.351(2) 100.323(5)
γ/o 90 85.921(8) 66.729(2) 92.295(4)
V/Å3 3506.6(3) 559.45(9) 1675.2(2) 948.75(9)
Z 4 2 2 2
T /K 150(2) 150(2) 200(2) 150(2)
Dc/g.cm-3 1.766 1.592 1.420 1.274
Crystal size/mm 0.385 x 0.311 x 0.104 0.353 x 0.094 x 0.079 0.120 x 0.110 x 0.090 0.413 x 0.324 x 0.274
Total data 18566 4678 14673 6804
Unique data 8387 2563 5144 4012
Rint 0.0555 0.0806 0.0797 0.0401
R1[F2>2 σ(F2)] 0.0526 0.0594 0.0565 0.0381
wR2 (all data) 0.1359 0.1747 0.1261 0.0930
GoF 1.060 1.000 1.038 1.022
ρmin/ρmax/eÅ-3 -0.270/0.272 -0.284/0.374 -0.512/0.579 -0.291/0.266
CCDC code 1475834 1475835 1476416 1582714
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Compound 3.32a 3.32b 3.32c
Empirical Formula C18H17BCl2O2 C19H19BCl2O2 C18H16BCl2FO2
Crystal System Monoclinic Monoclinic Monoclinic
Space Group P21/n P21/n P21/n
a/Å 13.1814(5) 10.8458(4) 10.4734(3)
b/Å 8.4219(4) 13.8708(5) 14.0452(4)
c/Å 15.3446(8) 12.3961(5) 12.0480(4)
α/o 90 90 90
β/o 97.278(4) 103.821(4) 100.970(3)
γ/o 90 90 90
V/Å3 1689.71(13) 1810.89(12) 1739.88(9)
Z 4 4 4
T /K 150(2) 150(2) 150(2)
Dc/g.cm-3 1.364 1.324 1.393
Crystal size/mm 0.232 x 0.203 x 0.055 0.257 x 0.182 x 0.154 0.237 x 0.217 x 0.096
Total data 5940 6210 6325
Unique data 3173 3409 3073
Rint 0.0460 0.0253 0.0233
R1[F2>2 σ(F2)] 0.0457 0.0336 0.0296
wR2 (all data) 0.1304 0.0954 0.0787
GoF 1.043 1.033 1.045
ρmin/ρmax/eÅ-3 -0.408/0.446 -0.349/0.349 -0.253/0.291
CCDC code 1582715 1582716 1582717
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6.4 Formation of 6-Membered Heterocycles via Alkyne 
Activation: Carbon-Element Bond Creation through 
Cyclisations
6.4.1 Formation of Zwitterionic Pyrylium Borates using B(C6F5)3.
6.4.1.1 Synthesis of Starting Materials.
4.2a: Synthesised using a literature known procedure.[102] The 1H and 13C 
NMR data agree with the literature reported values confirming the 
isolation of the product.[102] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm:
7.55-7.53 (m, 2H, Ar-H), 7.35 (m, 3H, Ar-H), 6.37 (d, 3JHH = 11.4 Hz, 1H, 
=CH), 6.15 (d, 3JHH = 11.4 Hz, 1H, =CH), 3.80 (s, 3H, OCH3).  13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 165.3 (s), 132.2 (s), 129.3 (s), 128.5 (s), 127.9 (s), 123.3 (s), 
122.8 (s), 101.5 (s), 86.5 (s), 51.6 (s).
4.2b: synthesised using similar methods to that reported in the 
literature.[102] The 1H and 13C NMR data agree with the literature reported 
values confirming the isolation of the product.[102] 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 6.16-6.13 (dt, 3JHH = 11.4 Hz, 4JHH = 2.4 Hz, 1H, 
=CH), 6.02 (d, 3JHH = 11.4 Hz, 1H, =CH), 3.74 (s, 3H, OCH3), 2.45 (td, 
3JHH = 7.0 Hz, 4JHH = 2.4 Hz, 2H, CH2), 1.60-1.54 (m, 2H, CH2), 1.49-1.43 (m, 2H, 
CH2), 0.92 (t, 3JHH = 7.2 Hz, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm:
165.5 (s), 127.1 (s), 124.3 (s), 104.5 (s), 77.8 (s), 51.4 (s), 30.6 (s), 22.1 (s), 19.9 (s), 
13.7 (s). 
4.2c: Compound 1c was synthesised using similar methods to that 
reported in the literature.[102] The 1H NMR data agrees with the literature 
reported values confirming the isolation of the product.[102] 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 6.14 (d, 3JHH = 11.5 Hz, 1H, =CH), 6.01 (d, 
3JHH = 11.5 Hz, 1H, =CH), 3.75 (s, 3H, OCH3), 1.30 (s, 9H, tBu).
6.4.1.2 Synthesis of Products
4.3a: (Z)-methyl 5-phenylpent-2-en-4-ynoate (4.2a) (37 mg, 0.2 mmol) 
was dissolved in toluene (ca. 2 ml) and was added to B(C6F5)3 (102 mg, 
0.2 mmol) to give a yellow solution. The reaction was left at room 
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temperature without stirring for 12 h. Slow evaporation of the solvent yielded 
colourless crystals of the product which could be characterised by single crystal X-
ray diffraction. The remaining solvent was decanted off and the product was washed 
with petroleum ether (3 x 3 ml) and dried in vacuo. Yield: 91 mg, 0.13 mmol, 65%. 
Melting point: 194–198 ºC. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.65 (br. s, 1H, 
pyrylium CH), 7.44-7.40 (m, 1H, Ar-H), 7.27-7.25 (m, 2H, Ar-H), 7.23-7.20 (m, 2H, Ar-
H), 7.06 (d, 3JHH = 9.0 Hz, 1H, pyrylium CH), 4.34 (s, 3H, CH3). 13C NMR partial (126 
MHz, CDCl3, 298 K) δ/ppm: 168.8 (s), 167.9 (s),167.1 (s), 131.4 (s), 130.9 (s), 128.7 
(s), 127.8 (s), 106.4 (s), 58.3 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -14.4. 
19F NMR (565 MHz, CDCl3, 298 K) δ/ppm: -128.6 (d, 3JFF = 20.6 Hz, 1F, o-F), -130.3 
(br. s, 4F, o-F), -131.1 (d, 3JFF = 20.6 Hz, 1F, o-F), -159.2 (t, 3JFF = 20.3 Hz, 1F, p-F), 
-160.0 (t, 3JFF = 20.3 Hz, 2F, p-F), -163.5 (br. t, 1F, 3JFF = 18.8 Hz, m-F), -164.7 (br. t, 
3JFF = 18.8 Hz, 1F, m-F), -165.4 (t, 3JFF = 18.8 Hz, 4F, m-F). IR ʋmax (cm-1): 1643, 
1616, 1599, 1550, 1515, 1492, 1436, 1385, 1346, 1273, 1242, 1192, 1081, 965, 841, 
833, 792, 771, 761, 703, 694, 679, 664, 640, 629. Elemental analysis (%) calculated 
for C30H10BF15O2: C 51.61, H 1.44, found: C 51.64 H 1.44.
4.3b: (Z)-methyl non-2-en-4-ynoate (4.2b) (33 mg, 0.2 mmol) was 
dissolved in toluene (2 ml) and added to B(C6F5)3 (102 mg, 0.2 mmol) to 
give an orange solution. The reaction mixture was left at room 
temperature for 30 min before being cooled to -40 ºC for 18 h. The 
product could be recrystallised from the slow evaporation of a toluene/petroleum ether 
solution to give small colourless crystals of the product suitable for X-ray diffraction. 
The remaining solvent was removed and the crystals were washed with petroleum 
ether 40-60 (3 x 3ml) to give the product as a pale green solid. Yield: 87 mg, 64%, 
0.13 mmol. Melting point: 191–194 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.47 
(s, 1H, =CH), 6.90 (d, 3JHH = 8.8 Hz, 1H, =CH), 4.36 (s, 3H, O-CH3), 2.92-2.80 (m, 2H, 
CH2), 1.43 (br. s, 1H, CH), 1.31-1.19 (m, 2H, CH2), 0.80 (t, 3JHH = 7.3 Hz, 3H, CH3) 
0.64 (br. s, 1H, CH) (two α-protons of nBu are diastereotopic). 13C NMR partial (126 
MHz, CDCl3, 298 K) δ/ppm: 175.8 (s), 168.5 (s), 165.0 (s), 104.4 (s), 58.2 (s), 33.4 
(s), 29.2 (s), 22.5 (s), 13.4 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -14.5. 19F 
NMR (565 MHz, CDCl3, 298 K) δ/ppm: -128.2 (br. s, 1F, o-F), -128.6 (br. s, 1F, o-F), 
-130.8 (br. d, 3JFF = 19.3 Hz, 1F, o-F), -132.3 (br. s, 1F, o-F), -134.4 (br. d, 3JFF = 19.3 
Hz, 1F, o-F), -135.0 (br. s, 1F, o-F), -159.0 (t, 3JFF = 20.3 Hz, 1F, p-F), -159.6 (t, 3JFF
= 20.3 Hz, 1F, p-F), -159.8 (t, JFF = 20.3 Hz, 1F, p-F), -162.9 (br. t, 3JFF = 22.9 Hz, 1F, 
m-F), -164.2 (br. dt, 3JFF =  23.1 Hz, 4JFF = 8.3 Hz, 1F, m-F), -164.39 (br. t, 3JFF = 19.6 
Hz, 1F, m-F), -164.6 (m, 1F, m-F), -164.8 (m, 1F, m-F), -165.3 (br. t, 3JFF = 19.6 Hz, 
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1F, m-F). IR ʋmax (cm-1): 2957, 2936, 2877, 2863, 1643, 1606, 1551, 1515, 1498, 
1453, 1346, 1276, 1081, 1002, 966, 864, 824, 794, 771, 760, 749, 679, 632, 557. 
HRMS (ES–) m/z calculated for [M-H]– [C28H13BF15O2]–: 676.0805, found: 676.0806. 
Elemental analysis (%) calculated for C28H14BF15O2: C 49.59, H 2.08, found: C 
49.64, H 1.97. Note: Partial 13C NMR spectra recorded for 4.3a,b due to broad 
resonances observed for fluorine coupled carbon nuclei of C6F5-rings.
6.4.2 Divergent Reactivity of Hard and Soft Lewis Acids: 6-endo-dig vs.
5-exo-dig.
6.4.2.1 Synthesis of Starting Materials.
Methyl 2-((trimethylsilyl)ethynyl)benzoate: Prepared according to 
literature methods.[171] To a solution of methyl 2-iodobenzoate (2.52 
g, 9.60 mmol), copper iodide (73.3 mg, 385 μmol) and PdCl2(PPh3)2
(135 mg, 193 μmol) in THF (25 ml) was added triethylamine (2.67 
ml, 19.3 mmol). A solution of ethynyltrimethylsilane (1.42 g, 14.5 mmol) in THF (5 ml) 
was added dropwise and the reaction mixture was stirred for 19 h at 23 °C. The 
mixture was filtered through Celite and diluted with water (150 ml). The phases were 
separated and the aqueous layer was extracted with diethyl ether (3 x 50 ml). The 
combined organic layers were washed with aq. NaCl solution (3 x 50 ml) and dried 
over MgSO4. The solvent was removed in vacuo yielding methyl 2-
((trimethylsilyl)ethynyl)benzoate as a brown oil. The NMR data is in agreement with 
that reported in the literature.[171] Yield: 2.13 g, 9.18 mmol, 95%. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 7.90 (dd, 3JHH = 7.7 Hz, 4JHH = 1.2 Hz, 1H), 7.58 (dd, 3JHH = 7.7 
Hz, 4JHH = 1.2 Hz, 1H), 7.44 (td, 3JHH = 7.7 Hz, 4JHH = 1.2 Hz, 1H), 7.37 (td, 3JHH = 7.7 
Hz, 4JHH = 1.2 Hz, 1H), 3.92 (s, 3H), 0.27 (s, 9H).
Methyl 2-ethynylbenzoate: Prepared according to literature methods.[171]
To a solution of methyl 2-((trimethylsilyl)ethynyl)benzoate (2.13 g, 9.18 
mmol) in MeOH (20 ml) and CH2Cl2 (10 ml) was added K2CO3 (3.86 g, 
27.60 mmol). The reaction mixture was stirred for 13 h at 23 °C, upon completion the 
reaction mixture was diluted with water (50 ml). The layers were separated and the 
aqueous phase was extracted with diethyl ether (3 x 30 ml). The combined organic 
layers were washed with saturated aq. NaCl solution (3 x 30 ml) and dried over 
MgSO4. The solvent was removed in vacuo yielding methyl 2-ethynylbenzoate as a 
brown oil. Yield: 1.19 g, 7.40 mmol, 81%. The NMR data is in agreement with that 
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reported in the literature.[171] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.94 (dd, 3JHH
= 7.8 Hz, 4JHH = 1.1 Hz, 1H), 7.63 (dd, 3JHH = 7.8 Hz, 4JHH = 1.1 Hz, 1H), 7.48 (td, 3JHH
= 7.7 Hz, 4JHH = 1.4 Hz, 1H), 7.41 (td, 3JHH = 7.7 Hz, 4JHH = 1.3 Hz, 1H), 3.93 (s, 3H), 
3.40 (s, 1H).
1-bromo-2-(phenylethynyl)benzene: Prepared according to 
literature methods.[171] To a solution of 1-bromo-2-iodobenzene 
(1.40 g, 4.93 mmol), copper iodide (37.6 mg, 197 μmol) and 
PdCl2(PPh3)2 (69.2 mg, 98.6 μmol) in THF (15 ml) was added 
triethylamine (1.37 ml, 9.86 mmol). A solution of phenylacetylene (756 mg, 7.40 
mmol) in THF (3 ml) was added dropwise and the reaction mixture was stirred for 16 
h at 23 °C. The mixture was filtered through Celite and diluted with water (150 ml). 
The phases were separated and the aqueous layer was extracted with diethyl ether 
(3 x 50 ml). The combined organic layers were washed with saturated aq. NaCl 
solution (3 x 50 ml) and dried over MgSO4. The solvent was removed in vacuo with 
the crude oil being purified by column chromatography (silica, eluent: n-hexane), 
yielding 1-bromo-2-(phenylethynyl)benzene as a brown oil. Yield: 0.83 g, 3.20 mmol, 
65%. The NMR data is in agreement with that reported in the literature.[171] 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: = 7.52 – 7.63 (m, 4H), 7.36 – 7.37 (m, 3H), 7.30 (td, 
3JHH = 7.4 Hz, 4JHH = 1.2 Hz, 1H), 7.18 (td, 3JHH = 7.8 Hz, 4JHH = 1.6 Hz, 1H).
4.4: Prepared according to literature methods.[171] To a solution of 
1-bromo-2-(phenylethynyl)benzene (829 mg, 3.22 mmol), copper 
iodide (12 mg, 64.4 μmol), Pd(PPh3)4 (74 mg, 64.4 μmol) and 
nbutylamine (1.29 ml, 13.0 mmol) in dry diethyl ether (10 ml) was 
added methyl 2-ethynylbenzoate (516 mg, 3.22 mmol). The 
resulting mixture was heated to 60 °C and stirred for 17 h. After 
cooling to rt, the mixture was quenched with saturated aq. NH4Cl 
solution (20 ml). The layers were separated and the aqueous layer was extracted with 
diethyl ether (3 x 10 ml). The combined organic layers were dried over MgSO4, filtered 
and concentrated in vacuo. The crude oil was purified by column chromatography to 
give 4.4. Yield: 396 mg, 0.97 mmol, 30%. The NMR data is in agreement with that 
reported in the literature.1 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.99 (dd, 3JHH = 
7.9 Hz, 4JHH = 1.4 Hz, 1H), 7.71 (dd, 3JHH = 7.7 Hz, 4JHH = 1.4 Hz, 1H), 7.61 – 7.63 (m, 
1H), 7.55 – 7.59 (m, 3H), 7.47 (td, 3JHH = 7.6 Hz, 4JHH = 1.4 Hz, 1H), 7.39 (td, 3JHH = 
7.8 Hz, 4JHH = 1.4 Hz, 1H), 7.32 – 7.35 (m, 5H), 3.89 (s, 3H).
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6.4.2.2 Synthesis of Products
4.5: Methyl-2-((2-(phenylethynyl)phenyl)ethynyl)benzoate (4.4) 
(67 mg, 0.2 mmol) and B(C6F5)3 (102 mg, 0.2 mmol) were 
dissolved in toluene (1 ml) to give a yellow solution, which quickly 
changed colour to a very dark green. The reaction mixture was 
left at room temperature for 4 h. During this time crystals were 
formed, which were suitable for X-ray diffraction. The solvent was 
evaporated and the remaining crystals were washed with hexane (6 x 2 ml) to give 
the product 4.5 as a dark green solid. Yield: 142 mg, 0.17 mmol, 84%. Melting point:
175 – 180 °C (dec.).1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.99 (d, 3JHH = 7.8 Hz, 
1H), 7.75 (d, 3JHH = 7.4 Hz, 1H), 7.53 (t, 3JHH = 7.7 Hz, 1H), 7.45 (d, 3JHH = 7.7 Hz, 
1H), 7.40 (t, 3JHH = 7.8 Hz, 1H), 7.12 – 7.29 (m, 5H), 7.01 – 7.07 (m, 2H), 4.91 (s, 3H). 
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 175.0 (s), 144.9 (s), 140.7 (s), 140.0 (s), 
139.8 (s), 137.6 (s), 136.7 (s), 135.0 (s), 134.2 (s), 132.3 (s), 132.1 (s), 131.8 (s), 
130.6 (s), 128.6 (s), 128.5 (s), 128.2 (s), 127.4 (s), 127.3 (s), 127.1 (s), 126.2 (s), 
126.1 (s), 125.5 (s), 117.4 (s), 63.4 (s). Note: carbon atoms of C6F5 groups not 
reported due to extensive line broadening. 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 
-15.8 (s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -123.03 (br. s, 1F, o-F), -125.19 
(br. d, 3JFF = 20.3 Hz, 1F, o-F), -129.18 (br. d, 3JFF = 20.3 Hz, 1F, o-F), -129.62 (br. s, 
1F, o-F), -131.98 (br. m, 1F, o-F), -136.14 (br. s, 1F, o-F), -160.78 (t, 3JFF = 20.7 Hz, 
1F, p-F), -161.72 (t, 3JFF = 20.8 Hz, 1F, p-F), -162.68 (t, 3JFF = 20.8 Hz, 1F, p-F), -
164.87 (t, 3JFF = 24.2 Hz, 1F, m-F), -165.49 (m, 1F, m-F), -166.58 (m, 4F, m-F). HRMS
(ES+) m/z calculated for [M]+ [C42H16BF15O2]+: 848.1004; observed: 848.1016.
4.6: A solution of phenylselenyl chloride (38 mg, 0.2 mmol) in toluene 
(1 ml) was added to methyl-2((2-phenylethynyl)phenylethynyl) 
benzoate (4.4) (67 mg, 0.2 mmol) and the reaction left overnight at 
room temperature. The solvent was then removed and the crude 
product washed with hot n-hexane. Drying in vacuo afforded the pure 
product. Yield: 65 mg, 0.14 mmol, 68%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm:
8.39 (dd, 3JHH = 7.7 Hz, 4JHH = 1.0 Hz, 1H), 8.05 (d, 3JHH = 8.0 Hz, 1H), 7.71 (td, 3JHH
= 8.0 Hz, 4JHH = 1.3 Hz, 1H), 7.64 (dd, 3JHH = 7.7 Hz, 4JHH = 1.0 Hz, 1H), 7.55 (t, 3JHH
= 7.7 Hz, 1H), 7.51 (dd, 3JHH = 7.4 Hz, 4JHH = 1.0 Hz, 1H), 7.45 (td, 3JHH =7.6 Hz, 4JHH
= 1.6 Hz, 1H), 7.39 (td, 3JHH = 8.0 Hz, 4JHH = 1.2 Hz, 1H), 7.33 – 7.31 (m, 2H), 7.27 –
7.22 (m, 5H), 7.09 – 7.04 (m, 3H). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.8 
(s), 158.5 (s), 138.0 (s), 137.9 (s), 136.7 (s), 135.3 (s), 132.0 (s), 131.6 (s), 131.4 (s), 
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129.9 (s), 129.9 (s), 129.8 (s), 129.7 (s), 129.1 (s), 128.8 (s), 128.5 (s), 128.3 (s), 
128.2 (s), 128.1 (s), 127.9 (s), 126.6 (s), 125.3 (s), 123.9 (s), 122.8 (s), 121.2 (s), 
107.7 (s), 94.3 (s), 87.4 (s). 77Se NMR (95 MHz, CDCl3, 298 K) δ/ppm: 289.5. HRMS 
(ES+) m/z calculated [C29H18O2Se]+ [M]+: 478.0472, found: 478.0475.
4.7: A solution of phenylselenyl chloride (19 mg, 0.1 mmol) in 
CDCl3 (0.5 ml) was added to methyl-2((2-
phenylethynyl)phenylethynyl) benzoate (4.4) (34 mg, 0.1 mmol). 
After 3 h tris(pentafluorophenyl)borane (51 mg, 0.1 mmol) was 
added which was accompanied by a colour change from an orange 
solution to dark red/black. The reaction mixture was heated to 40 
°C for 3 d. The dark red solution was concentrated in vacuo, washed with n-hexane 
and concentrated again in vacuo. Recrystallisation from CH2Cl2 and n-hexane yielded 
the product as red-brown crystals which could be characterised by single crystal X-
ray diffraction. Yield: 41 mg, 0.4 mmol, 41%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm:
8.60 (d, 3JHH = 8.2 Hz, 1H), 8.23 (d, 3JHH = 8.2 Hz, 1H), 8.00 (t, 3JHH = 7.7 Hz, 1H), 
7.79 (t, 3JHH = 7.7 Hz, 1H), 7.54 (d, 3JHH = 7.2 Hz, 1H), 7.45 (t, 3JHH = 8.2 Hz, 1H), 7.29 
(t, 3JHH = 7.7 Hz, 1H), 7.20 (t, 3JHH = 8.2 Hz, 1H), 6.92 – 7.15 (m, 10H). 13C NMR
partial (126 MHz, CDCl3, 298 K) δ/ppm: 170.2 (s), 156.4 (s), 148.0 (m), 140.0 (s), 
139.9 (s), 137.3 (m), 133.0 (s), 132.4 (s), 131.5 (s), 131.2 (s), 131.1 (s), 129.8 (s), 
129.4 (s), 129.2 (s), 129.1 (s), 129.1 (s), 128.5 (s), 128.4 (s), 128.0 (s), 124.0 (s), 
121.9 (s), 117.7 (s), 116.5 (m), 95.1 (s), 85.7 (s). 11B NMR (160 MHz, CDCl3, 298 K) 
δ/ppm: -0.51 (br. s). 19F NMR (283 MHz, CDCl3, 298 K) δ/ppm: - 135.0 (d, 3JFF = 20.5 
Hz, 6F, o-F), - 157.3 (t, 3JFF = 18.8 Hz, 3F, p-F), - 163.8 (t, 3JFF = 21.7 Hz, 6F, m-F). 
77Se NMR (95 MHz, CDCl3, 298 K) δ/ppm: 289.4 (s). IR ʋmax (cm-1): 2916 (w, br.), 
1493 (m), 725 (s), 698 (s) cm-1. HRMS (ES+) m/z calculated for [C47H18BF15O2Se]+ 
[M]+: 990.0326, found: 990.0338.
4.8: A solution of phenylselenyl chloride (29.1 mg, 150 
μmol, 3 equiv.) in CDCl3 (0.5 ml) was added to methyl-2((2-
phenylethynyl) phenylethynyl)benzoate (4.4) (17 mg, 50.0 
μmol, 1 equiv.). Slow evaporation of the solvent yielded 
orange crystals which could be characterised by single 
crystal X-ray diffraction. The crystals were washed with n-
hexane (2 x 3 ml) and dried in vacuo to give the pure product. Yield: 16 mg, 18.6 
μmol, 37%. Melting point: 128 – 133 °C. 1H NMR (400 MHz, CD2Cl2, 298 K) δ/ppm:
8.39 (d, 3JHH = 7.8 Hz, 1H), 8.16 (dd, 3JHH = 7.0 Hz, 4JHH = 1.4 Hz, 1H), 8.09 (dd, 3JHH
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= 7.3 Hz, 4JHH = 1.8 Hz, 1H), 7.84 (t, 3JHH = 7.3 Hz, 1H), 7.77 (d, 3JHH = 7.8 Hz, 2H), 
7.69 (t, 3JHH = 7.5 Hz, 1H), 7.59 – 7.56 (m, 2H), 7.54 – 7.38 (m, 11H), 7.30 (d, 3JHH = 
7.3 Hz, 2H), 7.21 – 7.20 (m, 4H), 7.06 (t, 3JHH = 7.6 Hz, 2H). 13C NMR (101 MHz, 
CD2Cl2, 298 K) δ/ppm: 163.5 (s), 159.2 (s), 153.3 (s), 137.8 (s), 137.5 (s), 136.6 (s), 
136.3 (br. s), 134.0 (s), 133.3 (s), 133.0 (s), 132.1 (s), 132.0 (s), 132.0 (s), 131.9 (s), 
131.8 (s), 131.5 (s), 130.4 (s), 130.3 (s), 130.1 (s), 130.1 (s), 129.8 (s), 129.9 (s), 
129.7 (s), 129.7 (s), 129.6 (s), 129.0 (br. s), 128.6 (br. s), 127.9 (s), 127.9 (s), 127.7 
(s), 127.4 (s), 124.7 (s), 120.8 (s), 114.1 (s), 104.9 (s). IR ʋmax (cm-1): 3052 (w), 1263 
(s), 1263 (s), 895 (w), 746 (s), 702 (s) cm-1. HRMS (ES+) m/z calculated for 
[C35H23O2Se2]+ [M-PhSeCl2]+: 635.0028, found 635.0037. Note: Sparse solubility of 
selenocyclic salt 2 resulted in a very weak 77Se NMR spectrum. Trials in many 
different deuterated solvents did not lead to a sample sufficiently concentrated 
enough to carry out this spectroscopic method.  
6.4.3 Stoichiometric and Catalytic Pyrone and Isocoumarin Formation 
via C–H and C–C Bond Formation
6.4.3.1 Synthesis of Starting Materials
Tris(pentafluorophenyl)borane: Synthesised in a procedure 
adapted from Lancaster et al.[4] whereby magnesium turnings (1.1 
g, 45 mmol, 3 equiv.) was suspended in Et2O (100 ml). C6F5Br 
(5.6 ml, 45 mmol, 3 equiv.) was added dropwise over the course 
of 30 minutes whilst stirring, without allowing the mixture to reach 
reflux. After stirring at ambient temperature for 30 mins, this mixture was transferred 
via filter cannula to a stirred solution of BF3·OEt2 (1.9 ml, 15 mmol, 1 equiv.) in toluene 
(100 ml). The excess Et2O solvent was removed under vacuum leaving the mixture 
as a toluene solution. The reaction was then set to react at 100 °C for 1 h then left to 
cool to ambient temperature. The remaining solvent was removed under reduced 
pressure whilst gently heating in an oil bath until a brown cake remains. This was the 
subject to a two-fold sublimation (110 °C, 1 x 10-3 mbar) whereupon the pure B(C6F5)3
was collected as a white microcrystalline solid. Yield: 6.7 g, 13.2 mmol, 88%. The 
spectroscopic data agrees with literature established values.[4] 11B NMR (128 MHz, 
CDCl3, 298 K) δ/ppm: 59.6 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -127.73 
(br. s, 6F, o-F), -142.46 (br. s, 3F, p-F), -159.83 (br. s, 6F, m-F).
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General Procedure 1: According to the literature,[114] the corresponding di- or tri-
fluoro-substituted bromobenzene (3 equiv.) was dissolved in freshly distilled THF 
(100 ml) and cooled to -20 °C. At this temperature iPrMgCl (3 equiv., 2.0 M in THF) 
was added dropwise. The reaction mixture was then allowed to reach 0 °C and after 
1 h at this temperature cooled again to -50 °C. Subsequently, BF3•Et2O (1 equiv.) was 
added dropwise and after 1 h the cooling bath was removed and the reaction mixture 
warmed to room temperature within another hour. Removal of all volatiles and a two-
fold sublimation of the remaining solid (120 °C, 1 x 10-3 mbar) afforded the desired 
boranes as white solids.
Tris(2,6-difluorophenyl)borane: Synthesised in accordance with 
General Procedure 1 using 1-bromo-2,6-difluorobenzene (3.39 ml, 
30 mmol, 3 equiv.), iPrMgCl (15 ml, 30 mmol, 3 equiv.) and BF3•Et2O 
(1.23 ml, 10 mmol, 1 equiv.) to give the pure product (2.14 g, 6.1 
mmol, 61%). Spectroscopic analyses agree with literature established values.[114] 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.59–7.20 (m, 3H, aryl), 6.87 (t, 3JHH = 7.8 Hz, 
6H, aryl). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: -62.8 (br. s). 19F NMR (471 MHz, 
CDCl3, 298 K) δ/ppm: -99.05.
Tris(2,4,6-trifluorophenyl)borane: Synthesised in accordance with 
General Procedure 1 using 1-bromo-2,4,6-trifluorobenzene (3.50 
ml, 30 mmol, 3 equiv.), iPrMgCl (15 ml, 30 mmol, 3 equiv.) and 
BF3·Et2O (1.23 ml, 10 mmol, 1 equiv.) to give the pure product 
(3.35 g, 8.3 mmol, 83%). Spectroscopic analyses agree with 
literature established values.[114] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 6.64 (t, 
3JHH = 8.3 Hz, 6H, aryl). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 58.4 (br. s). 19F 
NMR (471 MHz, CDCl3, 298 K) δ/ppm: -95.75 (d, 3JHF = 10.4 Hz, 6F, o-F), -100.31 
(t, 3JHF = 10.4 Hz, 3F, p-F).
General Procedure 2: In accordance with the literature,[172] magnesium turnings (1 
equiv.) were stirred in THF (15 ml) with 1,2-dibromoethane (0.1 ml) being added and 
the solution was cooled to 0 °C. After stirring for 5 minutes, a solution of a halo-
benzene (0.9 equiv.) in THF (20 ml) was added through a dropping funnel. The ice 
bath was removed and the mixture was stirred for 1 h. After cooling the reaction down 
to 0 °C again, a solution of a benzaldehyde derivative (0.8 equiv.) in THF (20 ml) was 
added through a dropping funnel and the reaction mixture was stirred overnight. The 
reaction was then quenched with saturated NH4Cl solution (50 ml) and the organic 
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phase was separated. The aqueous phase was extracted with Et2O (3 x 15 ml). The 
combined organic layers were dried in vacuo yielding the desired compound which 
was sufficiently pure for subsequent use.
4-Fluorobenzhydrol: Synthesised by General Procedure 2 using 
magnesium (0.8 g, 32.9 mmol), 1-bromo-4-fluoro-benzene (5.3 g, 
3.3 ml, 30.3 mmol,) and benzaldehyde (2.69 g, 2.6 ml, 25.3 mmol). 
The spectroscopic data agrees with literature established values.[172] Yield: 4.36 g, 
21.6 mmol, 83%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.39–7.32 (m, 4H, Ar-H), 
7.31–7.27 (m, 3H, Ar-H), 7.02 (t, 3JHH = 8.6 Hz, 2H, Ar-H), 5.83 (s, 1H, C(H)Ar2), 2.26 
(br. s, 1H, OH). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -115.05 – -115.11 (br. m, 
1F, Ar-F).
4-Bromobenzhydrol: Synthesised by General Procedure 2 using 
magnesium (0.5 g, 22.3 mmol), bromobenzene (3.49 g, 22.3 mmol, 
3.3 ml) and 4-bromo-benzaldehyde (3.2 g, 17.1 mmol). The 
spectroscopic data agrees with literature established values.[172] Yield: 3.52 g, 13.4 
mmol, 78%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 7.46 (d, 3JHH = 8.4 Hz, 2H, Ar-
H), 7.37–7.28 (m, 5H, Ar-H), 7.26 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 5.80 (s, 1H, C(H)Ar2), 
2.23 (br. s, 1H, OH).
Methyl 2,2-dimethylpent-4-ynoate: Diisopropylamine (20 ml, 0.14 
mol) was cooled to -78 °C in THF (40 ml), at which point nBuLi (1.6 M 
in hexanes, 79.2 ml, 0.13 mol) was added and the reaction was stirred 
for 1 h. The freshly prepared lithium diisopropylamide was then added 
to a solution of methyl isobutyrate (13.2 ml, 0.12 mol) in THF (30 ml) through a 
dropping funnel over 2 h whilst stirring at 0 °C. After complete addition, the reaction
mixture was stirred for 1 h at room temperature before cooling back to 0 °C. A solution 
of propargyl bromide (80 wt% in toluene, 12.2 ml, 0.12 mmol) in THF (10 ml) was then 
added dropwise. The mixture was warmed to room temperature and then stirred for 
18 h. After quenching with water, the organic phase was separated and the aqueous 
layer extracted with Et2O (3 x 20 ml). The combined organic layers were washed with 
a saturated aqueous NaCl solution, dried over MgSO4, filtered and concentrated in 
vacuo. The obtained oil was distilled (50 °C, 15 mmHg) to give the desired product 
as a colourless oil. The spectroscopic data agrees with literature established 
values.[101, 173] Yield: 12.9 g, 42 mol, 84%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 
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3.70 (s, 3H, OCH3), 2.44 (d, 4JHH = 2.6 Hz, 2H, CH2), 2.00 (t, 4JHH = 2.6 Hz, 1H, ≡CH), 
1.28 (s, 6H, C(CH3)2).
Methyl 2-iodobenzoate: 2-Iodo-benzoicacid (15 g, 60.5 mmol, 1 equiv.) 
was dissolved in methanol (50 ml). The mixture was stirred for 10 min 
to dissolve the acid. After cooling the clear solution to 0 °C, 
concentrated sulphuric acid (2.5 ml, 46.9 mmol, 0.8 equiv.) was added. The mixture 
was allowed to warm to room temperature and was refluxed over-night. The reaction 
mixture was cooled to room temperature and neutralised with saturated aqueous 
NaHCO3 solution (150 ml) and the product was extracted with hexane (3 x 50 ml). 
The combined organic phases were dried over MgSO4, filtered over a short silica plug 
and dried in vacuo to yield the product as a yellow oil. The spectroscopic data agrees 
with literature established values.[174] Yield: 15.4 g, 58.7 mmol, 97%. 1H NMR (300 
MHz, CDCl3, 298 K) δ/ppm: 7.99 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.80 (d, 3JHH = 7.8 Hz, 
1H, Ar-H), 7.40 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.15 (t, 3JHH = 7.7 Hz, 1H, Ar-H), 3.93 (s, 
3H, OCH3).
General Procedure 3: Methyl 2,2-dimethylpent-4-ynoate (0.8 g, 5.7 mmol, 1 equiv.) 
was added to a solution of THF (10 ml), NEt3 (6 ml, 42 mmol, 7 equiv.) and 
iodobenzene derivative (1 equiv.). Pd(PPh3)2Cl2 (58 mg, 1 mol%), CuI (23 mg, 2 
mol%) and PPh3 (60 mg, 4 mol%) were added. The reaction mixture was set to reflux 
for 10 h. After cooling and quenching with water, the organic layer was separated and 
extracted with Et2O (3 x 20 ml). The combined organic layers were washed with 
saturated aqueous NaCl solution, dried over MgSO4, filtered and dried in vacuo. The 
obtained material was purified by column chromatography to afford the product as an 
oil.[101]
4.9a’: Synthesised according to General Procedure 3 using 
iodobenzene (0.63 ml, 5.7 mmol, 1 equiv.) The spectroscopic data 
agrees with literature established values.[101] Rf value: 0.11 (SiO2, 
2:1 hexane/CHCl3). Yield: 1.16 g, 5.4 mmol, 95%. 1H NMR (300 
MHz, CDCl3, 298 K) δ/ppm: 7.43–7.23 (m, 5H, Ar-H), 3.71 (s, 3H, 
OCH3), 2.66 (s, 2H, CH2), 1.34 (s, 6H, C(CH3)2).
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4.9b‘: Synthesised according to General Procedure 3 using 4-
iodotoluene (1.24 g, 5.7 mmol, 1 equiv).  Rf value: 0.13 (SiO2, 
2:1 hexane/CHCl3). Yield: 670 mg, 2.91 mmol, 49%. 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 7.27 (d, 3JHH = 8.0 Hz, 2H, Ar-
H), 7.08 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 3.71 (s, 3H, OCH3), 2.64 (s, 2H, CH2), 2.33 (s, 
3H, Ar-Me), 1.33 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 177.5 
(s), 137.9 (s,  (s),131.6 (s), 129.1 (s), 120.7 (s), 85.9 (s), 82.9 (s), 52.2 (s), 42.7 (s), 
30.7 (s), 24.8 (s), 21.6 (s). HRMS (EI+) m/z calculated for [C15H18O2]+ [M]+: 230.1307, 
found: 230.1306.
4.9c‘: Synthesised according to General Procedure 3 using 4-
(methoxy)iodobenzene (1.32 g, 5.7 mmol, 1 equiv). Rf value: 
0.19 (SiO2, 2:1 hexane/CHCl3). Yield: 532 mg, 2.17 mmol, 32%. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.32 (d, 3JHH = 7.6 
Hz, 2H, Ar-H), 6.81 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 3.80 (s, 3H, 
OCH3), 3.71 (s, 3H, OCH3), 2.64 (s, 2H, CH2), 1.33 (s, 6H, C(CH3)2). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 177.5  (s), 159.3 (s), 133.1 (s), 116.0 (s), 113.9 (s), 85.1 
(s), 82.6 (s), 55.4 (s), 52.2 (s), 42.7 (s), 30.7 (s), 24.8 (s). HRMS (AP+) m/z calculated 
for [C15H19O3]+ [M+H]+: 247.1334, found: 247.1324.
4.9d’: Synthesised according to General Procedure 3 using 4-
fluoroiodobenzene (1.27 g, 5.7 mmol, 1 equiv). Rf value: 0.09 
(SiO2, 3:1 hexane/CHCl3). Yield: 934 mg, 3.99 mmol, 70%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.35 (dd, 3JHH = 8.8 Hz, 
4JHF = 5.5 Hz, 2H, Ar-H), 6.97 (t, 3JHH = 8.8 Hz, 2H, Ar-H), 3.71 (s, 
3H, OCH3), 2.64 (s, 2H, CH2), 1.33 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 
K) δ/ppm: 177.3 (s), 162.3 (d, 1JCF = 249 Hz), 133.5 (d, 3JCF = 8.3 Hz), 119.8 (s), 115.6 
(d, 2JCF = 22.0 Hz), 86.4 (s), 81.8 (s), 52.2 (s), 42.7 (s), 30.7 (s), 24.8 (s). 19F NMR
(376 MHz, CDCl3, 298 K) δ/ppm: -111.97 (s, 1F, p-F). HRMS (AP+) m/z calculated for 
[C14H16O2F]+ [M+H]+: 235.1134, found: 235.1125.
4.9e’: Synthesised according to General Procedure 3 using 4-
(trifluoromethyl)iodobenzene (1.55 g, 0.84 ml, 5.7 mmol, 1 
equiv). Rf value: 0.15 (SiO2, 2:1 hexane/CHCl3). Yield: 1.59 g, 
5.6 mmol, 98%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 7.50 
(dd, 3JHH = 8.09 Hz, 3JHH = 8.07 Hz, 4H, Ar-H), 3.72 (s, 3H, 
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OCH3), 2.67 (s, 2H, CH2), 1.34 (s, 6H, C(CH3)2). 19F NMR (376 MHz, CDCl3, 298 K) 
δ/ppm: -62.79 (s, 3F, CF3). 
4.9f‘: Synthesised according to General Procedure 3 using 1-
iodonaphthalene (0.83 ml, 5.7 mmol, 1 equiv.) Rf value: 0.14 (SiO2, 
2:1 hexane/CHCl3). Yield: 505 mg, 1.89 mmol, 33%. 1H NMR (300 
MHz, CDCl3, 298 K) δ/ppm: 8.30 (d, 3JHH = 8.3 Hz, 1H, Ar-H), 7.83 
(d, 3JHH = 7.8 Hz, 1H, Ar-H), 7.79 (d, 3JHH = 8.3 Hz, 1H, Ar-H), 7.62 
(d, 3JHH = 7.1 Hz, 1H, Ar-H), 7.58–7.48 (m, 2H, Ar-H), 7.40 (dd, 3JHH
= 8.1 Hz, 3JHH =  7.3 Hz, 1H, Ar-H), 3.75 (s, 3H, OCH3), 2.83 (s, 2H, CH2), 1.42 (s, 
6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 177.4 (s), 133.6 (s), 133.3 
(s), 130.4 (s), 128.3 (s), 128.3 (s), 126.7 (s), 126.4 (s), 126.3 (s), 125.3 (s), 121.5 (s), 
91.8 (s), 80.9 (s), 52.3 (s), 42.9 (s), 31.2 (s), 25.0 (s). HRMS (EI+) m/z calculated for 
[C18H18O2]+ [M]+: 266.1307, found: 266.1312.
4.9g‘: Synthesised according to General Procedure 3 using 2-
(methoxy)iodobenzene (0.74 ml, 5.7 mmol, 1 equiv). Rf value: 0.18 
(SiO2, 2:1 hexane/CHCl3). Yield: 746 mg, 3.03 mmol, 53%. 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 7.35 (dd, 3JHH = 7.5 Hz, 4JHH = 1.6 
Hz, 1H, Ar-H), 7.25 (td, 3JHH = 7.8 Hz, 4JHH = 1.7 Hz, 1H, Ar-H), 6.89–
6.84 (m, 2H, Ar-H), 3.86 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 2.72 (s, 2H, CH2), 1.35 
(s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 177.5 (s), 160.1 (s), 133.7 
(s), 129.2 (s), 120.5 (s), 113.0 (s), 110.7 (s), 91.0 (s), 79.0 (s), 55.9 (s), 52.1 (s), 42.7 
(s), 31.0 (s), 24.7 (s). HRMS (ES+) m/z calculated for [C15H18O3]+ [M]+: 246.1256, 
found: 246.1250.
4.9h‘: Synthesised according to General Procedure 3 using 1-
bromo-2-iodobenzene (1.61 g, 5.7 mmol, 1 equiv).  Rf value: 0.18 
(SiO2, 2:1 hexane/CHCl3). Yield: 1.20 g, 4.07 mmol, 71%. 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 7.55 (dd, 3JHH = 8.0 Hz, 4JHH = 1.1 
Hz, 1H, Ar-H), 7.42 (dd, 3JHH = 7.7 Hz, 4JHH = 1.6 Hz, 1H, Ar-H), 7.22 (td, 3JHH = 7.6 
Hz, 4JHH = 1.1 Hz, 1H, Ar-H), 7.12 (td, 3JHH = 7.9 Hz, 4JHH = 1.7 Hz, 1H, Ar-H), 3.72 (s, 
3H, OCH3), 2.72 (s, 2H, CH2), 1.38 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 
K) δ/ppm: 177.4 (s), 133.6 (s), 132.4 (s), 129.0 (s), 127.0 (s), 125.9 (s), 125.6 (s), 
91.9 (s), 81.5 (s), 52.3 (s), 42.7 (s), 30.8 (s), 24.9 (s). HRMS (EI+) m/z calculated for 
[C14H15BrO2]+ [M]+: 294.0255, found: 294.0258.
Chapter 6: Experimental
172
General Procedure 4: Methyl 2-iodobenzoate (2.24 ml, 4.00 g, 15.3 mmol, 1 equiv.), 
Pd(PPh3)2Cl2 (220 mg, 0.3 mmol, 2 mol%) and CuI (120 mg, 0.6 mmol, 4 mol%) were 
mixed. NEt3 (50 ml) and THF (20 ml) was subsequently added. The mixture was 
stirred for 5 mins. The terminal alkyne (1.2 equiv.) was added and the reaction was 
heated under reflux for 16 h. After allowing the mixture to cool, the reaction was 
quenched with water (100 ml) and extracted with CH2Cl2 (3 x 60 ml). The combined 
organic layers were dried over MgSO4, filtered, concentrated and purified by flash 
column chromatography using a gradient of EtOAc/hexane (0-5%) as eluent to afford 
the product.
4.9i’: Synthesised according to General Procedure 4 using 
phenylacetylene (1.9 ml, 17.71 mmol, 1.16 equiv). The 
spectroscopic data agrees with literature established values.[175] Rf
value: 0.18 (SiO2, hexane/EtOAc 95:5) Yield: 3.27 g, 13.84 mmol, 
91%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.98 (dd, 3JHH = 7.9 Hz, 4JHH = 0.9 Hz, 
1H, Ar-H), 7.65 (dd, 3JHH = 7.7 Hz, 4JHH = 0.8 Hz, 1H, Ar-H), 7.60–7.56 (m, 2H, Ar-H), 
7.50 (td, 3JHH = 7.6 Hz, 4JHH = 1.4 Hz, 1H, Ar-H), 7.41–7.34 (m, 4H, Ar-H), 3.97 (s, 3H, 
OCH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 166.9 (s), 134.1 (s), 132.0 (s), 
131.9 (s), 131.9 (s), 130.6 (s), 128.7 (s), 128.5 (s), 128.0 (s), 123.8 (s), 123.4 (s), 94.5 
(s), 88.3 (s), 52.4 (s). 
4.9j’: Synthesised according to General Procedure 4 using 4-
ethynyltoluene (2.25 ml, 17.71 mmol, 1.16 equiv). Rf value: 0.29 
(SiO2, 90:10, hexane/EtOAc). Yield: 3.78 g, 15.1 mmol, 99%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.97 (dd, 3JHH = 7.9, 4JHH
= 0.9 Hz, 1H, Ar-H), 7.64 (dd, 3JHH = 7.7 Hz, 4JHH = 0.7 Hz, 1H, 
Ar-H), 7.51–7.45 (m, 3H, Ar-H), 7.37 (td, 3JHH = 7.8 Hz, 4JHH = 1.2 Hz, 1H, Ar-H), 7.17 
(d, 3JHH = 7.9 Hz, 2H, Ar-H), 3.97 (s, 3H, OCH3), 2.38 (s, 3H, CH3). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 166.9 (s), 138.8 (s), 134.0 (s), 131.8 (s), 131.7 (s), 131.7 
(s), 130.5 (s), 129.2 (s), 127.7 (s), 123.9 (s), 120.2 (s), 94.6 (s), 87.6 (s), 52.2 (s), 21.6 
(s). HRMS (ES+) m/z calculated for [C17H14O2]+ [M+H] 250.0994, found 250.0987.
4.9k’: Methyl 3-iodoacrylate (6.00 g, 28.30 mmol, 1 equiv.), 
phenylacetylene (2.96 ml, 26.56 mmol, 1.16 equiv.), Pd(PPh3)2Cl2 (322 
mg, 0.45 mmol, 2 mol%) and CuI (175 mg, 0.92 mmol, 4 mol%) were 
dissolved in NEt3 (50 ml) and THF (20 ml) and stirred over night. The 
black suspension was quenched with saturated NH4Cl (50 mL) and the 
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mixture was extracted with ethyl acetate (3 x 40 ml). After being concentrated in 
vacuo, the residue was purified by flash column chromatography (SiO2, 50:1, 
hexane/EtOAc) to afford the product as an orange oil. The spectroscopic data agrees 
with literature established values.[176] Rf value: 0.07 (SiO2, 50:1, hexane/EtOAc) Yield: 
4.27 g, 22.93 mmol, 81%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.58–7.51 (m, 
2H, Ar-H), 7.36 (s, 3H, Ar-H), 6.37 (d, 3JHH = 11.4 Hz, 1H, =CH), 6.15 (d, 3JHH = 11.3 
Hz, 1H, =CH), 3.81 (s, 3H, OCH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.3 
(s), 132.2 (s), 129.3 (s), 128.4 (s), 127.8 (s), 123.2 (s), 122.6 (s), 101.4 (s), 86.3 (s), 
51.5 (s).
General Procedure 5: In a procedure similar to that outlined by Takaki et al.,[101] to a 
solution of NaOH (5 equiv.) in methanol (20 ml), a solution of methyl ester in methanol 
(25 ml) was added. The mixture was heated at 80 °C for 16 h. After cooling to room 
temperature, the crude mixture was concentrated and then diluted with H2O (25 ml). 
The aqueous mixture was extracted with Et2O (3 x 20 ml). The aqueous layer was 
acidified with concentrated HCl and extracted with Et2O. The combined extracts were 
washed with saturated aqueous NaCl solution, dried over MgSO4, filtered and dried 
in vacuo to give the carboxylic acid. 
4.9a: Synthesised according to General Procedure 5 using 4.9a’ (1.16 
g, 5.4 mmol, 1 equiv.) to give an off-white solid. The spectroscopic data 
agrees with literature established values.[101] Yield: 1.15 g, 5.4 mmol, 
99%. 1H NMR (300 MHz, CDCl3, 298 K) δ/ppm: 7.39 (br. s, 2H, Ar-H), 
7.27 (br. s, 3H, Ar-H), 2.69 (s, 2H, CH2), 1.37 (s, 6H, C(CH3)2). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 182.7 (s), 131.8 (s), 128.3 (s), 127.9 (s), 123.7 (s), 86.4 (s), 
83.1 (s), 42.5 (s), 30.4 (s), 24.6 (s).
4.9b: Synthesised according to General Procedure 5 using 4.9b’
(670 mg, 2.91 mmol, 1 equiv.) to give an off-white solid. Melting 
point: 92–98 °C. Yield: 629 mg, 2.91 mmol, 99%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.29 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 
7.08 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 2.67 (s, 2H, CH2), 2.33 (s, 3H, 
Ph-Me), 1.37 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 183.8 (s), 
137.9 (s), 131.6 (s), 129.1 (s), 120.7 (s), 85.6 (s), 83.1 (s), 42.5 (s), 30.4 (s), 24.6 (s), 
21.6 (s). HRMS (ES+) m/z calculated for [C14H16O2]+ [M]+: 216.1150, found: 216.1151.
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4.9c: Synthesised according to General Procedure 5 using 
4.9c’ (532 mg, 2.17 mmol, 1 equiv.) to give an off-white solid. 
Melting point: 104–108 °C. Yield: 501 mg, 2.17 mmol, 99%. 1H 
NMR (300 MHz, CDCl3, 298 K) δ/ppm: 7.32 (d, 3JHH = 8.0 Hz, 
2H, Ar-H), 6.80 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 3.79 (s, 3H, OCH3), 
2.66 (s, 2H, CH2), 1.36 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 
183.8 (s), 159.3 (s), 133.1 (s), 115.9 (s), 114.0 (s), 84.8 (s), 82.8 (s), 55.4 (s), 42.5 
(s), 30.4 (s), 24.6 (s). HRMS (ES–) m/z calculated for [C14H15O3]– [M-H]–: 231.1021, 
found: 231.1015.
4.9d: Synthesised according to General Procedure 5 using 4.9d’
(934 mg, 3.99 mmol, 1 equiv.) to give an off-white solid. Melting 
point: 77–82 °C. Yield: 879 mg, 3.99 mmol, 99%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.36 (dd, 3JHH = 8.6 Hz, 4JHF = 5.5 
Hz, 2H, Ar-H), 6.96 (t, 3JHH = 8.7 Hz, 2H, Ar-H), 2.67 (s, 2H, CH2), 1.37 (s, 6H, 
C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 182.7 (s), 162.4 (d, 1JCF = 250 
Hz), 133.6 (d, 3JCF = 8.3 Hz), 119.7 (s), 115.6 (d, 2JCF = 22.0 Hz), 86.0 (s), 82.0 (s), 
42.5 (s), 30.4 (s), 24.6 (s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -111.84 (s, 1F, 
p-F). HRMS (EI+) m/z calculated for [C13H13O2F]+ [M]+: 220.0900, found: 220.0898.
4.9e: Synthesised according to General Procedure 5 using 4.9e’
(1.59 g, 5.6 mmol, 1 equiv.) to give an off-white solid.  Melting 
point: 80–86 °C. Yield: 1.51 g, 5.6 mmol, 97%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.53–7.48 (m, 4H, Ar-H), 2.70 (s, 
2H, CH2), 1.37 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 183.2 (s), 132.0 (s), 127.5 (s), 125.3 (q, 3JCF = 3.8 Hz), 123.0 (s), 89.3 (s), 
81.9 (s), 42.5 (s), 30.4 (s), 24.7 (s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -62.80 
(s, 3F, CF3). HRMS (AP+) m/z calculated for [C14H14O2F3]+ [M+H]+: 271.0946, found: 
271.0933.
4.9f: Synthesised according to General Procedure 5 using 4.9f’ (505 
mg, 1.89 mmol, 1 equiv.) to give an off-white solid. Melting point: 
118–122 °C. Yield: 476 mg, 1.89 mmol, 99%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.31 (d, 3JHH = 8.3 Hz, 1H, Ar-H), 7.81 (d, 3JHH
= 8.0 Hz, 1H, Ar-H), 7.77 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 7.62 (d, 3JHH
= 7.0 Hz, 1H, Ar-H), 7.54 (t, 3JHH = 7.1 Hz, 1H, Ar-H), 7.47 (d, 3JHH = 7.1 Hz, 1H, Ar-
H), 7.37 (d 3JHH = 7.7 Hz, 1H, Ar-H), 2.84 (s, 2H, CH2), 1.44 (s, 6H, C(CH3)2). 13C NMR
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(126 MHz, CDCl3, 298 K) δ/ppm: 183.7 (s), 133.6 (s), 133.3 (s), 130.4 (s), 128.3 (s), 
128.3 (s), 126.8 (s), 126.4 (s), 126.4 (s), 125.3 (s), 121.4 (s), 91.5 (s), 81.1 (s), 42.7 
(s), 30.8 (s), 24.8 (s). HRMS (EI+) m/z calculated for [C17H16O2]+ [M]+: 252.1150, 
found: 252.1149.
4.9g: Synthesised according to General Procedure 5 using 4.9g’
(746 mg, 3.03 mmol, 1 equiv.) to give an off-white solid. Melting point 
90–94 °C. Yield: 696 mg, 42.5 mmol, 99%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.36 (dd, 3JHH = 7.6 Hz, 4JHH = 1.5 Hz, 1H, Ar-
H), 7.25 (td, 3JHH = 7.8 Hz, 4JHH = 1.6 Hz, 1H, Ar-H), 6.89–6.83 (m, 
2H, Ar-H), 3.86 (s, 3H, OCH3), 2.75 (s, 2H, CH2), 1.40 (s, 6H, C(CH3)2). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 183.8 (s), 160.2 (s), 133.6 (s), 129.3 (s), 120.5 (s), 112.9 
(s), 110.7 (s), 90.7 (s), 79.3 (s), 55.9 (s), 42.6 (s), 30.6 (s), 24.5 (s). HRMS (EI+) m/z
calculated for [C14H16O3]+ [M]+: 232.1099, found: 232.1095.
4.9h: Synthesised according to General Procedure 5 using 4.9h’
(1.20 g, 4.07 mmol, 1 equiv.) to give an off-white solid. Melting point: 
44–48 °C. Yield: 1.13 g, 4.07 mmol, 99%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.55 (dd, 3JHH = 8.0 Hz, 4JHH = 0.9 Hz, 1H, Ar-H), 7.43 
(dd, 3JHH = 7.7 Hz, 4JHH = 1.5 Hz, 1H, Ar-H), 7.22 (td, 3JHH = 7.6 Hz, 
4JHH = 1.1 Hz, 1H, Ar-H), 7.12 (td, 3JHH = 7.7 Hz, 4JHH = 1.6 Hz, 1H, Ar-H), 2.75 (s, 2H, 
CH2), 1.42 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 182.6 (s), 
133.6 (s), 132.4 (s), 129.1 (s), 127.0 (s), 125.8 (s), 125.6 (s), 91.5 (s), 81.7 (s), 42.5 
(s), 30.6 (s), 24.7 (s). HRMS (EI+) m/z calculated for [C13H13O2Br]+ [M]+: 280.0099, 
found: 280.0090.
General Procedure 6: To a stirred solution of the ester in methanol (60 ml) was added 
aqueous NaOH (1.0 M, 2.7 equiv.) at ambient temperature and the reaction was 
stirred for 14 h. The reaction mixture was concentrated under reduced pressure. This 
was subsequently diluted with water (120 ml) and washed with Et2O (3 x 30 ml). The 
aqueous phase was acidified (pH = 1–2) with HCl (1 M) and extracted with EtOAc (3 
x 50 ml). The combined organic extracts were dried over MgSO4, filtered and 
concentrated under reduced pressure to afford the pure free acid.
Chapter 6: Experimental
176
4.9i: Synthesised according to General Procedure 6 using 4.9i’ (3.27 
g, 13.84 mmol). The spectroscopic data agrees with literature 
established values.[175] Rf value: 0.18 (SiO2, CHCl3). Yield: 2.84 g, 
12.78 mmol, 92%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.15 (dd, 
3JHH = 7.9, 1H, Ar-H), 7.70 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 7.61–7.54 (m, 3H, Ar-H), 7.44 
(td, 3JHH = 7.8, 4JHH = 1.2 Hz, 1H, Ar-H), 7.36–7.28 (m, 3H, Ar-H). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 171.1 (s), 134.2 (s), 132.6 (s), 131.8 (s), 131.4 (s), 130.5 (s), 
128.7 (s), 128.4 (s), 128.0 (s), 124.4 (s), 123.1 (s), 95.5 (s), 88.0 (s).
4.9j: Synthesised according to General Procedure 6 using 4.9j’
(3.78 g, 15.1 mmol). Rf value: 0.23 (SiO2, CHCl3). Yield: 3.47 g, 
15.1 mmol, 93%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.14 
(d, 3JHH = 7.8 Hz, 1H, Ar-H), 7.68 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 7.55 
(t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.47 (d, 3JHH = 7.7 Hz, 2H, Ar-H), 7.42 (t, 3JHH = 7.6 Hz, 
1H, Ar-H), 7.12 (d, 3JHH = 7.7 Hz, 2H, Ar-H), 2.35 (s, 3JHH = 13.8 Hz, 3H, CH3). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 171.8 (s), 138.9 (s), 134.2 (s), 132.7 (s), 131.8 
(s), 131.5 (s), 130.6 (s), 129.3 (s), 127.9 (s), 124.8 (s), 120.2 (s), 95.9 (s), 87.6 (s), 
21.7 (s).
4.9k: Synthesised by dissolving 4.9k’ in THF (50 ml) and treating with 
1M LiOH solution (50 ml, 21.00 mmol 2.38 equiv.). The mixture was 
stirred vigorously overnight. The solution was concentrated under 
vacuum and cooled down to 0 °C. Sulfuric acid (1 M) was added 
dropwise until a pH of 1 is reached. The suspension was extracted with 
ethylacetate (3 x 50 ml) and dried with MgSO4 and concentrated under vacuum to 
obtain the product as bright yellow crystals The spectroscopic data agrees with 
literature established values.[177] Yield: 3.55 g, 20.6 mmol, 98%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.52 (d, 3JHH = 6.9 Hz, 2H, Ar-H), 7.40–7.29 (m, 3H, Ar-H), 6.49 
(d, 3JHH = 11.3 Hz, 1H, Ar-H), 6.19 (d, 3JHH = 11.3 Hz, 1H, Ar-H). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 169.2 (s), 132.2 (s), 129.5 (s), 128.5 (s), 127.3 (s), 125.2 (s), 
122.4 (s), 103.2 (s), 86.2 (s).
General Procedure 7: The carboxylic acid (1 equiv.) was dissolved in CH2Cl2. After 
addition of 4-dimethylaminopyridine (7 mol%) and the alcohol (1–3 equiv.), the 
reaction mixture was cooled down to 0 °C and N,N'-dicyclohexylcarbodiimide (1.1 
equiv.) was added. After 5 minutes the solution was warmed to room temperature, 
and stirred for 3 h. The mixture was filtered to remove the resulting urea. The filtrate 
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was washed twice with aq. HCl (0.5 M), then washed with a saturated aq. NaHCO3
solution and dried using MgSO4. The obtained residue was purified by column 
chromatography (SiO2, 100% chloroform) to give the ester.
4.10a: Synthesised according to General Procedure 7 using 
compound 4.9a (750 mg, 3.7 mmol, 1 equiv.) and 2-propanol (11.1 
mmol, 1.2 g, 3 equiv.) giving a yellow oil. Rf value: 0.64. Yield: 115 
mg, 0.47 mmol, 13%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.43–7.21 (m, 5H, Ar-H), 5.01 (hept, 3JHH = 6.2 Hz, 1H, CH(CH3)2), 2.62 (s, 2H, CH2), 
1.30 (s, 6H, C(CH3)2), 1.23 (d, 3JHH = 6.3 Hz, 6H, OC(CH3)2). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 176.4 (s), 131.7 (s), 128.3 (s), 127.8 (s), 123.9 (s), 87.0 (s), 
82.7 (s), 67.9 (s), 42.5 (s), 30.7 (s), 24.7 (s), 21.9 (s). IR ʋmax (cm-1): 2981 (m), 1723 
(s), 1601 (w), 1491 (m), 1471 (m), 1391 (w), 1385 (m), 1375 (m), 1302 (w), 1249 (w), 
1199 (m), 1143 (m), 1106 (s), 1023 (w), 927 (w), 877 (w), 831 (w), 755 (s), 692 (s), 
526 (m). HRMS (ES+) m/z calculated for [C16H21O2]+ [M+H]+: 245.1542, found: 
245.1536.
4.10b: Synthesised according to General Procedure 7 using 
compound 4.9a (500 mg, 2.5 mmol, 1 equiv.) and allylalcohol (0.80 g, 
7.4 mmol, 3 equiv.) to give a yellow oil. Rf value: 0.67. Yield: 334 mg, 
1.38 mmol, 56%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.42–7.24 
(m, 5H, Ar-H), 5.97–5.88 (m, 1H, -CH=), 5.28 (dd, 2JHH = 61.3 Hz 3JHH = 13.9 Hz 2H, 
=CH2), 4.62 (d, 3JHH = 5.4 Hz 2H, OCH2–), 2.68 (s, 2H, CH2), 1.36 (s, 6H, C(CH3)2). 
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 176.5 (s), 132.4 (s), 131.7 (s), 128.3 (s), 
127.9 (s), 123.8 (s), 117.9 (s), 86.8 (s), 82.9 (s), 65.4 (s), 42.8 (s), 30.7 (s), 24.8 (s). 
IR ʋmax (cm-1): 2977 (w), 1730 (s), 1650 (w), 1597 (w), 1488 (m), 1471 (m), 1388 (w), 
1365 (w), 1322 (m), 1246 (m), 1196 (m), 1130 (s), 1070 (w), 984 (m), 924 (m), 848 
(w), 755 (s), 692 (s), 526 (w). HRMS (ES+) m/z calculated for [C16H19O2]+ [M+H]+: 
243.1385, found: 243.1380.
4.10c: Synthesised according to General Procedure 7 using 
compound 4.9a (2.0 g, 9.89 mmol, 1 equiv.) and benzylalcohol 
(3.2 g, 30 mmol, 3 equiv.) to give a yellow oil. Rf value: 0.85. Yield: 
1.85 g, 6.34 mmol, 64%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.37–7.23 (m, 10H, Ar-H), 5.15 (s, 2H, OCH2–), 2.68 (s, 2H, CH2), 1.35 (s, 6H, 
C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 176.6 (s), 136.2 (s), 131.6 (s), 
128.5 (s), 128.2 (s), 128.0 (s), 127.8 (s), 127.7 (s), 123.6 (s), 86.6 (s), 82.8 (s), 66.5 
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(s), 42.7 (s), 30.6 (s) , 24.7 (s). IR ʋmax (cm-1): 2974 (w), 1730 (s), 1597 (w), 1491 (m), 
1458 (m), 1388 (w), 1319 (w), 1299 (w), 1246 (w), 1193 (m), 1126 (s), 984 (w), 751 
(s), 692 (s), 529 (m). HRMS (ES+) m/z calculated for [C20H21O2]+ [M+H]+: 292.1463, 
found: 292.1452.
4.10d: Synthesised according to General Procedure 7 using 
compound 4.9a (800 mg, 3.96 mmol, 1 equiv.) and 4-
fluorobenzhydrol (840 mg, 4.15 mmol, 1.05 equiv.) giving a white 
solid. Rf value: 0.72. Yield: 605 mg, 1.57 mmol, 40%. Melting 
point: 79–85 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.37–7.25 (m, 12, Ar-H), 
6.98–6.90 (m, 2H, Ar-H), 6.85 (s, 1H, C(H)Ar2), 2.71 (s, 2H, CH2), 1.37 (s, 6H, 
C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 175.7 (s), 162.4 (d, 1JCF = 246 
Hz), 140.2 (s), 136.3 (s), 131.7 (s), 129.1 (d, 4JCF = 8.2 Hz), 128.5 (d, 2JCF = 50.2 Hz), 
128.0 (d, 3JCF = 16.8 Hz), 127.0 (s), 123.6 (s), 115.5 (s), 115.3 (s), 86.5 (s), 83.0 (s), 
42.9 (s), 31.1(s), 30.7 (s), 24.9 (s), 24.8 (s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: 
-114.33 (s, 1F, p-F). IR ʋmax (cm-1): 2977 (w), 1727 (s), 1607 (w), 1511 (s), 1491 (m), 
1468 (w), 1455 (w), 1388 (w), 1368 (w), 1322 (m), 1305 (m), 1226 (m), 1199 (s), 1163 
(s), 1133 (s), 1103 (w), 1073 (w), 1023 (w), 1000 (w), 917 (w), 861 (w), 828 (m), 811 
(w), 788 (m), 758 (s), 741 (m), 692 (s), 645 (w), 629 (w), 582 (m), 556 (s), 506 (m). 
HRMS (ES+) m/z calculated for [C26H24FO2]+ [M+H]+: 387.1759, found: 387.1760.
4.10e: Synthesised according to General Procedure 7 using 
compound 4.9a (900 mg, 4.5 mmol, 1 equiv.) and 4-
chlorobenzhydrol (1.07 g, 4.89 mmol, 1.1 equiv.) to give a white 
solid. Rf value: 0.83. Yield: 452 mg, 1.12 mmol, 26%. Melting 
point: 62–67 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.37–7.27 (m, 14H, Ar-H), 
6.85 (s, 1H, C(H)Ar2), 2.73 (s, 2H, CH2), 1.40 (s, 6H, C(CH3)2). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 175.6 (s), 139.9 (s), 139.0 (s), 133.9 (s), 131.7 (s), 128.8 (s), 
128.7 (s), 128.6 (s), 128.3 (s), 128.2 (s), 127.9 (s), 127.0 (s), 123.6 (s), 86.6 (s), 83.1 
(s), 76.6 (s), 43.0 (s), 30.7 (s), 24.9 (s), 24.9 (s). IR ʋmax (cm-1): 2977 (w), 1723 (s), 
1601 (w), 1494 (s), 1458 (w), 1388 (w), 1302 (m), 1193 (s), 1166 (m), 1133 (s), 1093 
(m), 1020 (m), 997 (m), 987 (m), 914 (q), 858 (q), 814 (m), 788 (m), 758 (s), 721 (m),
698 (s), 642 (w), 622 (w), 582 (m), 549 (w), 516 (m), 489 (m), 413 (w). HRMS (ES+) 
m/z calculated for [C26H24O2Cl]+ [M+H]+: 403.1465, found: 403.1452.
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4.10f: Synthesised according to General Procedure 7 using 
compound 4.9a (800 mg, 3.96 mmol, 1 equiv.) and 4-
bromobenzhydrol (1.1 g, 4.15 mmol, 1.05 equiv.) to give a white 
solid. Rf value: 0.72. Yield: 795 mg, 1.78 mmol, 45%. Melting 
point: 70–76 °C 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.32 (d, 3JHH = 8.3 Hz, 2H, 
Ar-H), 7.27-7.18 (m, 10H, Ar-H), 7.15 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 6.74 (s, 1H, 
C(H)Ar2), 2.64 (s, 2H, CH2), 1.30 (s, 6H, C(CH3)2) 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 175.6 (s), 139.8 (s), 139.5 (s), 131.8 (s), 131.7 (s), 129.0 (s), 128.7 (s), 128.3 
(s), 128.2 (s), 128.0 (s), 127.0 (s), 123.6 (s), 122.0 (s), 86.6 (s), 83.2 (s), 76.6 (s), 43.0 
(s), 30.8 (s), 24.9 (s), 24.9 (s). IR ʋmax (cm-1): 2984 (w), 1727 (s), 1601 (w), 1487 (s), 
1469 (w), 1456 (w), 1444 (w), 1397 (w), 1388 (w), 1325 (w), 1316 (w), 1296 (w), 1195 
(s), 1162 (m), 1135 (s), 1071 (m), 1023 (w), 1001 (m), 916 (w), 859 (w), 814 (w), 785 
(m), 753 (s), 711 (w), 702 (s), 693 (s), 666 (w), 625 (w), 583 (m), 548 (w), 523 (w), 
506 (w), 477 (w).  HRMS (ES+) m/z calculated for [C26H24O2Br]+ [M+H]+: 447.0960, 
found: 447.0962.
4.10g: Synthesised according to General Procedure 7 using 
compound 4.9e (1.0 g, 3.7 mmol, 1 equiv.) and benzylalcohol 
(420 mg, 3.89 mmol, 1.05 equiv.) to give a yellow oil. Rf value: 
0.76. Yield: 805 mg, 2.23 mmol, 61%. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 7.55–7.38 (m, 4H, Ar-H), 7.38–7.28 (m, 5H, Ar-H), 5.16 (s, 2H, OCH2–), 
2.70 (s, 2H, CH2), 1.37 (s, 6H, C(CH3)2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
176.4 (s), 136.2 (s), 132.0 (s), 129.6 (q, 2JCF = 32.6 Hz), 128.6 (s), 128.3 (s), 128.2 
(s), 128.0 (s), 125.2 (q, 3JCF = 3.8 Hz), 89.7 (s), 81.8 (s), 66.6 (s) ,42.8 (s), 42.8 (s), 
30.8 (s) , 24.9 (s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -62.77 (s, 3F, CF3). IR
ʋmax (cm-1): 2977 (w), 1730 (s), 1617 (w), 1471 (w), 1458 (w), 1405 (w), 1322 (s), 1242 
(w), 1166 (m), 1123 (s), 1066 (s), 1017 (w), 841 (m), 741 (w), 695 (m), 599 (w). HRMS
(ES+) m/z calculated for [C21H20O2F3]+ [M+H]+: 361.1415, found: 361.1418.
4.10h: Synthesised according to General Procedure 7 using 
compound 4.9e (1.0 g, 3.70 mmol, 1 equiv.) and 4-
fluorobenzhydrol (790 mg, 3.89 mmol, 1.05 equiv.) to give a white 
solid. Rf value: 0.78. Yield: 405 mg, 1.68 mmol, 24%. Melting 
point: 68–75 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.54–
7.47 (m, 2H, Ar-H), 7.37–7.27 (m, 9H, Ar-H), 7.01–6.92 (m, 2H, Ar-H), 6.86 (s, 1H, 
C(H)Ar2), 2.72 (s, 2H, CH2), 1.38 (s, 6H, C(CH3)2). 13C NMR partial (126 MHz, CDCl3, 
298 K) δ/ppm: 175.4 (s), 162.3 (d, 1JCF = 246 Hz), 140.1 (s), 136.2 (s) 132.0 (s), 129.1 
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(d, 3JCF = 8.1 Hz), 128.7 (s), 128.1 (s), 127.4 (s), 127.0 (s), 125.2 (q, 3JCF = 3.9 Hz), 
115.6 (d, 2JCF = 21.6 Hz), 89.5 (s), 82.0 (s), 76.6 (s), 42.9 (s), 31.1 (s), 30.8 (s), 24.9 
(s), 24.9 (s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -62.78 (s, 3F, CF3), -114.33 
(s, 1F, p-F). IR ʋmax (cm-1): 2974 (w), 1733 (m), 1717 (m), 1611 (w), 1511 (m), 1471 
(w), 1451 (w), 1405 (w), 1322 (s), 1229 (m), 1166 (s), 1126 (s), 1103 (s), 1066 (s), 
1017 (m), 987 (m), 911 (w), 841 (s), 828 (m), 788 (w), 765 (w), 738 (m), 698 (s), 649 
(w), 625 (w), 599 (m), 556 (m), 509 (m).
4.10i: Synthesised according to General Procedure 7 using 
compound 4.9e (1.0 g, 3.7 mmol, 1 equiv.) and 4-
chlorobenzhydrol (850 mg, 3.9 mmol, 1.05 equiv.) to give a white 
solid. Rf value: 0.74. Yield: 750 mg, 1.59 mmol, 43%. Melting 
point: 67–74 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.53 
(br. s, 2H, Ar-H), 7.33–7.29 (m, 11H, Ar-H), 6.87 (s, 1H, C(H)Ar2), 2.74 (s, 2H, CH2), 
1.40 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 175.4 (s), 139.8 (s), 
138.9 (s), 134.0 (s), 131.9 (s), 128.9 (s), 128.8 (s), 128.7 (s), 128.2 (s), 127.0 (s), 89.4 
(s), 76.6 (s), 42.9 (s), 30.8 (s), 25.0 (s), 24.9 (s). 19F NMR (376 MHz, CDCl3, 298 K) 
δ/ppm: -62.69 (s, 3F, CF3). IR ʋmax (cm-1): 2978 (w), 1731 (s), 1614 (w), 1494 (m), 
1471 (w), 1451 (w), 1404 (w), 1394 (w), 1324 (s), 1301 (m), 1194 (m), 1164 (s), 1120 
(s), 1104 (s), 1067 (s), 1020 (m), 1000 (m), 960 (w), 910 (w), 844 (s), 817 (s), 787 
(m), 760 (m), 717 (m), 697 (s), 620 (w), 597 (w), 570 (m), 517 (m), 490 (m). 
4.10j: Synthesised according to General Procedure 7 using 
compound 4.9e (1.0 g, 3.7 mmol, 1 equiv.) and 4-
bromobenzhydrol (3.89 mmol, 1.0 g, 1.05 equiv.) Rf value: 0.61. 
Yield: 577 mg, 1.12 mmol, 31%. Melting point: 74–80 °C. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 7.51 (d, 3JHH = 8.1 Hz, 2H, Ar-
H), 7.39 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.33–7.27 (m, 7H, Ar-H), 7.39 (d, 3JHH = 8.3 Hz, 
2H, Ar-H), 6.82 (s, 1H, C(H)Ar2), 2.72 (s, 2H, CH2), 1.38 (s, 6H, C(CH3)2). 13C NMR
partial (126 MHz, CDCl3, 298 K) δ/ppm: 175.4 (s), 139.8 (s), 139.4 (s), 131.9 (s), 
131.8 (s), 129.0 (s), 128.8 (s), 128.2 (s), 127.0 (s), 125.2 (q, 3JCF = 3.8 Hz), 122.1 (s), 
89.4 (s), 82.0 (s), 76.7 (s), 43.0 (s), 30.8 (s), 25.0 (s), 24.9 (s). 19F NMR (376 MHz, 
CDCl3, 298 K) δ/ppm: -62.77 (s, 3F, CF3). IR ʋmax (cm-1): 2987 (w), 1730 (w), 1617 
(w), 1491 (w), 1475 (w), 1455 (w), 1405 (w), 1388 (w), 1322 (s), 1302 (m), 1196 (m), 
1163 (s), 1116 (s), 1106 (s), 1066 (s), 1017 (m), 997 (m), 957 (w), 914 (w), 841 (s), 
818 (m), 788 (w), 751 (s), 715 (m), 698 (m), 672 (w), 622 (w), 599 (m), 572 (m), 519 
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(w), 506 (m), 493 (m). HRMS (ES)+ m/z calculated for [C26H23O2]+ [M+H]+: 515.0834, 
found: 515.0834.
4.10k: Synthesised according to General Procedure 7 using 
compound 4.9b (0.216 g, 1.07 mmol) N,N’-
dicyclohexylcarbodiimide (0.243 g, 1.18 mmol, 1.1 equiv.),  4-
dimethylaminopyridine (9 mg, 7 mol%) and 1-phenylethanol (0.14 
ml, 0.143 g, 1.17 mmol, 1.1 equiv.) giving a colourless oil. Rf
value: 0.26 (SiO2, 1:1, hexane/CHCl3) Yield: 82 mg, 0.26 mmol, 24%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.42–7.24 (m, 7H, Ar-H), 7.10 (d, 3JHH = 5.8 Hz, 2H, Ar-
H), 5.98–5.89 (m, 1H, C(H)CH3), 2.70 (s, 2H, CH2), 2.36 (s, 3H, CH3), 1.61–1.58 (m, 
3H, CH3), 1.38 (s, 6H). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 176.1 (s), 142.0 
(s), 137.8 (s), 131.6 (s), 129.1 (s), 128.6 (s), 127.8 (s), 126.0 (s), 120.7 (s), 86.0 (s), 
82.9 (s), 72.6 (s), 42.7 (s), 30.7 (s), 24.8 (s), 24.8 (s), 22.5 (s), 21.6 (s). HRMS (ES+) 
m/z calculated for [C22H24O2]+ [M+H]+: 321.1855, found  321.1842.
4.10l: Synthesised according to General Procedure 7 using 
compound 4.9i (0.60 g, 2.7 mmol) and 4-fluorobenzhydrol (0.610 
g, 2.97 mmol, 1.1 equiv.) giving a colourless oil. Rf value: 0.63 
(SiO2, CHCl3). Yield: 0.876 g, 2.16 mmol, 80%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 8.06 (d, 3JHH = 8.0 Hz, 1H, Ar-H), 7.67 (d, 
3JHH = 7.0 Hz, 1H, Ar-H), 7.52 (t, 3JHH = 7.4 Hz, 1H, Ar-H), 7.48–7.27 (m, 13H, Ar-H), 
7.16 (s, 1H, C(H)Ar2), 6.95 (t, 3JHH = 8.1 Hz, 2H, Ar-H). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 165.5 (s), 162.5 (d, 1JCF = 247 Hz), 140.1 (s), 136.2 (d, 4JCF = 3.2 Hz), 
134.6 (s), 132.1 (s), 131.8 (s), 131.6 (s), 131.0 (s), 129.36 (d, 3JCF = 8.2 Hz), 128.7 
(s), 128.6 (s), 128.4 (s), 128.1 (s), 128.1 (s), 127.3 (s), 124.0 (s), 123.3 (s), 115.5 (d, 
2JCF = 21.6 Hz), 94.8 (s), 88.5 (s), 77.4 (s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: 
-114.31 (s, 1F, p-F). HRMS (ES+) m/z calculated for [C28H20FO2]+ [M+H]+: 407.1447, 
found: 407.1441.
4.10m: Synthesised according to General Procedure 7 using 
compound 4.9i (0.60 g, 2.7 mmol) and 4-chlorobenzhydrol 
(0.650 g, 2.97 mmol, 1.1 equiv.) giving a colourless oil. Rf value: 
0.64 (SiO2, CHCl3). Yield: 1.06 g, 2.51 mmol, 93%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 8.06 (d, 3JHH = 7.8 Hz, 1H, Ar-H), 
7.67 (d, 3JHH = 7.6 Hz, 1H, Ar-H), 7.52 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.47–7.21 (m, 16H, 
Ar-H), 7.13 (s, 1H, C(H)Ar2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.4 (s), 
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139.8 (s), 138.9 (s), 134.6 (s), 134.0 (s), 132.1 (s), 131.8 (s), 131.6 (s), 131.0 (s), 
128.9 (s), 128.8 (s), 128.8 (s), 128.7 (s), 128.4 (s), 128.2 (s), 128.2 (s), 127.3 (s), 
124.0 (s), 123.2 (s), 94.8 (s), 88.5 (s), 77.5 (s). HRMS (ES+) m/z calculated for 
[C28H20ClO2]+ [M+H]+: 423.1152, found: 423.1164.
4.10n: Synthesised according to General Procedure 7 using 
compound 4.9i (0.60 g, 2.7 mmol) and 4-bromobenzhydrol 
(0.790 g, 2.97 mmol, 1.1 equiv.) giving a colourless oil. Rf value: 
0.65 (SiO2, CHCl3). Yield: 1.04 g, 2.23 mmol, 83%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 8.05 (d, 3JHH = 7.8 Hz, 1H, Ar-H), 
7.67 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 7.52 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.36 (dd, 3JHH = 
13.8, 3JHH = 7.0 Hz, 16H, Ar-H), 7.11 (s, 1H, C(H)Ar2). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 165.5 (s), 139.7 (s), 139.4 (s), 134.6 (s), 132.1 (s), 131.8 (s), 131.8 (s), 
131.5 (s), 131.0 (s), 129.2 (s), 129.2 (s), 128.8 (s), 128.7 (s), 128.4 (s), 128.2 (s), 
128.2 (s), 127.3 (s), 124.0 (s), 123.2 (s), 122.1 (s), 94.8 (s), 88.5 (s), 77.5 (s). HRMS
(ES+) m/z calculated for [C28H20BrO2]+ [M+H]+: 467.0647, found: 467.0668.
4.10o: Synthesised according to General Procedure 7 using 
compound 4.9j (0.750 g, 3.18 mmol), N,N’-
dicyclohexylcarbodiimide (0.720 g, 3.50 mmol, 1.1 equiv.),  4-
dimethylaminopyridine (27 mg, 7 mol%) and 1-phenylethanol (0.42 
ml, 0.426 g, 3.49 mmol, 1.1 equiv.) giving a very light pink solid. Rf value: 0.25 (SiO2, 
1:1, hexane/CHCl3) Yield: 657 mg, 2.01 mmol, 63%. 1H NMR (400 MHz, CDCl3, 298 
K) δ/ppm: 7.99 (dd, 3JHH = 7.6, 4JHH = 2.7 Hz, 1H, Ar-H), 7.65 (dd, 3JHH = 7.5, 4JHH =2.6 
Hz, 1H, Ar-H), 7.52–7.44 (m, 3H, Ar-H), 7.44–7.25 (m, 7H, Ar-H), 7.15 (d, 3JHH = 5.1 
Hz, 2H, Ar-H), 6.23–6.14 (m, 1H, C(H)CH3), 2.37 (d, 3JHH = 2.9 Hz, 3H, CH3), 1.71–
1.65 (m, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.8 (s), 141.8 (s), 
138.7 (s), 134.3 (s), 132.2 (s), 131.7 (s), 131.7 (s), 130.7 (s), 129.2 (s), 128.6 (s), 
127.9 (s), 127.9 (s), 126.4 (s), 124.0 (s), 120.4 (s), 94.7 (s), 87.9 (s), 73.5 (s), 22.7 
(s), 21.7 (s). HRMS (ES+) m/z calculated for [C24H20O2]+ [M+H]+: 341.1542, found: 
341.1538.
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4.10p: Synthesised according to General Procedure 7 using 
compound 4.9j (0.60 g, 2.54 mmol) and 4-fluorobenzhydrol 
(0.570 g, 2.79 mmol, 1.1 equiv.) giving a colourless oil. Rf value: 
0.65 (SiO2, CHCl3). Yield: 0.725 g, 1.72 mmol, 68%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.98 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 
7.59 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 7.43 (t, 3JHH = 7.3 Hz, 1H, Ar-
H), 7.41–7.15 (m, 10H, Ar-H), 7.08 (s, 1H, C(H)Ar2), 7.03 (d, 3JHH = 7.6 Hz, 2H, Ar-
H), 6.88 (t, 3JHH = 8.3 Hz, 2H, Ar-H), 2.29 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 165.5 (s), 162.5 (d, 1JCF = 247 Hz), 140.1 (s), 138.8 (s), 136.2 (d, 4JCF
= 3.2 Hz), 134.5 (s), 132.0 (s), 131.7 (s), 131.5 (s), 131.0 (s), 129.4 (d, 3JCF = 8.2 Hz), 
129.2 (s), 128.7 (s), 128.1 (s), 127.9 (s), 127.3 (s), 124.2 (s), 120.2 (s), 115.5 (d, 2JCF
= 21.6 Hz), 95.1 (s), 88.0 (s), 77.4 (s), 21.7 (s). 19F NMR (376 MHz, CDCl3, 298 K) 
δ/ppm: -114.36 (s). HRMS (ES+) m/z calculated for [C29H22FO2]+ [M+H]+: 421.1604, 
found: 421.1604.
4.10q: Synthesised according to General Procedure 7 using 
compound 4.9j (0.60 g, 2.54 mmol) and 4-chlorobenzhydrol 
(0.61 g, 2.79 mmol, 1.1 equiv.) giving a colourless oil. Rf value: 
0.67 (SiO2, CHCl3). Yield: 1.07 g, 2.45 mmol, 96%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 8.07 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 
7.68 (d, 3JHH = 7.6 Hz, 1H, Ar-H), 7.53 (t, 3JHH = 7.6 Hz, 1H, Ar-
H), 7.49–7.22 (m, 12H, Ar-H), 7.14 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 7.11 (s, 1H, C(H)Ar2), 
2.39 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 165.5 (s), 139.9 (s), 
138.9 (s), 138.9 (s), 134.5 (s), 133.9 (s), 132.1 (s), 131.7 (s), 131.5 (s), 131.0 (s), 
129.2 (s), 129.0 (s), 128.8 (s), 128.8 (s), 128.2 (s), 128.0 (s), 127.3 (s), 124.2 (s), 
120.2 (s), 95.1 (s), 87.9 (s), 77.5 (s), 21.7 (s). HRMS (ES+) m/z calculated for 
[C29H22ClO2]+ [M+H]+: 437.1309, found: 437.1308.
4.10r: Synthesised according to General Procedure 7 using 
compound 4.9j (0.600 g, 2.54 mmol) and 4-bromobenzhydrol 
(0.740 g, 2.79 mmol, 1.1 equiv.) giving a colourless oil. Rf value: 
0.70 (SiO2, CHCl3). Yield: 1.18 g, 15.1 mmol, 97%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 8.07 (d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.68 
(d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.53 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.49–7.23 (m, 15H, Ar-
H), 7.14 (s, 2H, Ar-H), 7.12 (s, 1H, C(H)Ar2), 2.39 (s, 3H, CH3). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 165.5 (s), 139.8 (s), 139.4 (s), 138.9 (s), 134.5 (s), 132.1 (s), 
131.8 (s), 131.7 (s), 131.5 (s), 131.0 (s), 129.2 (s), 128.8 (s), 128.2 (s), 128.0 (s), 
Chapter 6: Experimental
184
127.3 (s), 124.2 (s), 122.1 (s), 120.2 (s), 95.1 (s), 87.9 (s), 77.5 (s), 21.7 (s). HRMS
(ES+) m/z calculated for [C29H22BrO2]+ [M+H]+: 481.0803, found: 481.0825.
4.10s: Synthesised according to General Procedure 7 using 
compound 4.9k (0.500 g, 2.9 mmol) and 4-fluorobenzhydrol (0.646 g, 
3.19 mmol, 1.1 equiv.) giving a yellow oil. Rf value: 0.44 (chloroform). 
Yield: 0.946 g, 2.65 mmol, 91%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.46–7.27 (m, 12H, Ar-H), 7.01 (s, 1H, C(H)Ar2), 6.97 (t, 3JHH
= 8.2 Hz, 2H, Ar-H), 6.44 (d, 3JHH = 11.7 Hz, 1H, =CH), 6.21 (d, 3JHH = 11.5 Hz, 1H, 
=CH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 163.9 (s), 162.5 (d, 1JCF = 247 Hz), 
140.1 (s), 136.2 (d, 4JCF = 3.1 Hz), 132.1 (s), 129.4 (s), 129.3 (d, 3JCF = 8.2 Hz), 128.7 
(s), 128.5 (s), 128.1 (s), 127.9 (s), 127.3 (s), 123.7 (s), 122.6 (s), 115.5 (d, 2JCF = 21.6 
Hz), 102.1 (s), 86.6 (s), 76.6 (s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -114.30 
(s, 1F, p-F). HRMS (ES+) m/z calculated for [C24H17FO2]+ [M]+: 356.1213, found: 
356.1210.
4.10t: Synthesised according to General Procedure 7 using 
compound 4.9k (0.500 g, 2.9 mmol) and 4-chlorobenzhydrol (0.699 
g, 3.19 mmol, 1.1 equiv.) giving a yellow oil. Rf value: 0.49 (SiO2, 
CHCl3). Yield: 0.797 g, 2.14 mmol, 74%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.41–7.26 (m, 14H, Ar-H), 6.99 (s, 1H, C(H)Ar2), 6.45 
(d, 3JHH = 11.5 Hz, 1H, =CH), 6.21 (d, 3JHH = 11.6 Hz, 1H, =CH). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 163.9 (s), 139.8 (s), 138.9 (s), 133.9 (s), 132.1 (s), 129.4 (s), 
128.8 (s), 128.8 (s), 128.8 (s), 128.5 (s), 128.2 (s), 127.8 (s), 127.3 (s), 123.8 (s), 
122.6 (s), 102.1 (s), 86.6 (s), 76.6 (s). HRMS (ES+) m/z calculated for [C24H17ClO2]+
[M]+: 372.0917, found: 372.0919.
4.10u: Synthesised according to General Procedure 7 using 
compound 4.9k (0.500 g, 2.9 mmol) and 4-bromobenzhydrol (0.841 
g, 3.19 mmol, 1.1 equiv.) giving a yellow oil. Rf value: 0.53 (SiO2, 
CHCl3). Yield: 0.641 g, 1.54 mmol, 53%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.44–7.27 (m, 14H, Ar-H), 6.97 (s, 1H, C(H)Ar2), 6.45 
(d, 3JHH = 11.5 Hz, 1H, =CH), 6.21 (d, 3JHH = 11.5 Hz, 1H, =CH). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 163.7 (s), 139.6 (s), 139.2 (s), 132.0 (s), 131.7 (s), 129.3 (s), 
129.0 (s), 128.6 (s), 128.4 (s), 128.1 (s), 127.6 (s), 127.2 (s), 123.7 (s), 122.4 (s), 
121.9 (s), 102.0 (s), 86.4 (s), 76.5 (s). HRMS (ES+) m/z calculated for [C28H17FO2]+
[M]+: 416.0412, found: 416.0415.
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6.4.3.2 Synthesis of Products
General Procedure 8: Carboxylic acid 4.9 or ester 4.10 (0.1 mmol, 1 equiv.) was 
dissolved in CDCl3 (0.5 ml) with subsequent addition of B(C6F5)3 (0.1 mmol, 1 equiv.). 
After 15 minutes (unless stated otherwise) multinuclear NMR spectroscopy showed 
full conversion at which point solvent was removed in vacuo and the residue was 
washed with cold hexane (2 x 1 ml) to give the compound 4.11.
4.11a: Synthesised according to General Procedure 8 using 4.9a
(20 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give a white 
solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 68 mg, 0.09 mmol, 96%. Melting point: 70–76 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.38–7.30 (m, 3H, Ar-H), 7.07 (d, 3JHH = 7.2 
Hz, 2H, Ar-H), 5.95 (t, 3JHH = 4.0 Hz, 1H, =CH), 2.54 (d, 3JHH = 3.8 Hz, CH2), 1.46 (s, 
6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 150.5 (s), 147.9 (dm, 1JCF ≈ 
240 Hz), 140.3 (dm, 1JCF ≈ 240 Hz), 137.3 (dm, 1JCF ≈ 250 Hz), 130.5 (s), 129.3 (s), 
129.0 (s), 124.4 (s), 103.2 (s), 37.6 (s), 32.8 (s), 24.0 (s). 11B NMR (128 MHz, CDCl3, 
298 K) δ/ppm: 2.0 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -135.04 (d, 3JFF
= 15.9 Hz, 6F, o-F B(C6F5)3), -156.64 (br. s, 3F, p-F B(C6F5)3), -163.63 (br. s, 6F, m-
F B(C6F5)3). IR ʋmax (cm-1): 2982 (w), 2936 (w), 1716 (m), 1678 (m), 1647 (m), 1557 
(m), 1518 (s), 1465 (s), 1389 (m), 1342 (w), 1287 (m), 1275 (m), 1209 (w), 1099 (s), 
1055 (w), 970 (s), 893 (w), 791 (m), 760 (m), 746 (m), 689 (m), 613 (w), 576 (w). 
HRMS (AP+) m/z calculated for [C14H16O2]+ [M+H–(B(C6F5)3)]+: 203.1072, found: 
203.1079.
4.11b: Synthesised according to General Procedure 8 using 
4.9b (22 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give 
a white solid. Yield: 68 mg, 0.09 mmol, 93%. Melting point: 75–
81 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.10 (d, 3JHH
= 7.7 Hz, 2H, Ar-H), 7.01 (d, 3JHH = 7.3 Hz, 2H, Ar-H), 5.87 (t, 
3JHH = 4.5 Hz, 1H, =CH), 2.49 (s, 2H, CH2), 2.35 (s, 3H, p-Me), 1.44 (s, 6H, C(CH3)2). 
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 150.5 (s), 148.0 (dm, 1JCF ≈ 240 Hz), 140.8 
(s), 140.2 (dm, 1JCF ≈ 250 Hz), 137.3 (dm, 1JCF ≈ 250 Hz), 129.6 (s), 126.8 (s), 124.3 
(s), 101.9 (s), 37.5 (s), 32.8 (s), 24.1 (s), 21.4 (s). 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 1.5 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -135.05 (d, 3JFF = 18.5 
Hz, 6F, o-F B(C6F5)3), -156.86 (t, 3JFF = 19.2 Hz, 3F, p-F B(C6F5)3), -163.74 (br. s, 6F, 
m-F B(C6F5)3). IR ʋmax (cm-1): 2955 (w), 2910 (w), 2876 (w), 1726 (w), 1678 (m), 1599 
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(s), 1576 (m), 1510 (m), 1483 (w), 1418 (w), 1368 (w), 1317 (m), 1261 (m), 1171 (s), 
1072 (w), 1032 (w), 1004 (m), 976 (w), 907 (m), 841 (m), 841 (m). HRMS (ES+) m/z
calculated for [C14H16O2]+ [M-B(C6F5)3]+: 216.1150, found 216.1149.
4.11c: Synthesised according to General Procedure 8 using 
4.9c (23 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to 
give a white solid. Yield: 69 mg, 0.09 mmol, 93%. Melting 
point: 80–87 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
6.99 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 6.79 (d, 3JHH = 8.3 Hz, 2H, 
Ar-H), 5.77 (t, 3JHH = 4.3 Hz, 1H, =CH), 3.79 (s, 3H, OCH3), 2.48 (d, 3JHH = 4.2 Hz, 
2H, CH2), 1.43 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.3 (s), 
150.4 (s), 148.0 (dm, 1JCF ≈ 240 Hz), 140.3 (dm, 1JCF ≈ 250 Hz), 137.2 (dm, 1JCF ≈ 250 
Hz), 126.0 (s), 121.8 (s), 114.3 (s), 101.1 (s), 55.5 (s), 37.6 (s), 32.7 (s), 24.0 (s). 11B 
NMR (128 MHz, CDCl3, 298 K) δ/ppm: 1.4 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) 
δ/ppm: -135.03 (d, 3JFF = 19.4 Hz, 6F, o-F B(C6F5)3), -156.84 (t, 3JFF = 20.3 Hz, 3F, p-
F B(C6F5)3), -163.72 (t, 3JFF = 18.2 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 2982 (w), 
2845 (w), 1705 (w), 1647 (m), 1611 (m), 1516 (s), 1460 (s), 1381 (m), 1287 (m), 1271 
(m), 1251 (m), 1238 (m), 1178 (m), 1099 (s), 1033 (w), 972 (s), 891 (m), 864 (m), 835 
(w), 793 (w), 775 (w), 764 (w), 746 (w), 685 (w), 673 (w), 608 (w). HRMS (AP+) m/z
calculated for [C14H17O3]+ [M+H–(B(C6F5)3)]+: 233.1178, found: 233.1183. 
4.11d: Synthesised according to General Procedure 8 using 4.9i
(22 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give a pale 
green solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 33 mg, 0.05 mmol, 45%. 
Melting point: 205–211 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.57 (d, 3JHH = 
8.1 Hz, 1H, Ar-H), 8.09 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.89–7.70 (m, 2H, Ar-H), 7.57–
7.48 (m, 1H, Ar-H), 7.47–7.32 (m, 5H, Ar-H). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 154.7 (s), 148.1 (dm, 1JCF = 244 Hz), 140.0 (dm, 1JCF = 247 Hz) 139.3 (s), 
139.2 (s), 137.2 (dm, 1JCF = 253 Hz), 131.8 (s), 130.9 (s), 130.6 (s), 129.4 (s), 127.0 
(s), 125.6 (s), 117.4 (s), 106.5 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 0.8 (br. 
s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.77 (d, 3JFF = 19.6 Hz, 6F, o-F 
B(C6F5)3), -157.14 (t, 3JFF = 19.9 Hz, 3F, p-F B(C6F5)3), -163.79 (t, 3JFF = 17.7 Hz, 6F, 
m-F B(C6F5)3). IR ʋmax (cm-1): 2160 (w), 1681 (m), 1645 (m), 1606 (m), 1564 (m), 1517 
(s), 1426 (s), 1379 (m), 1344 (w), 1286 (m), 1242 (m), 1159 (w), 1089 (s), 1029 (w), 
968 (s), 879 (w), 798 (w), 765 (m), 688 (s), 673 (s), 621 (w), 574 (w), 538 (w), 524 
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(w). HRMS (ES+) m/z calculated for [C15H11O2]+ [M+H–(B(C6F5)3)]+: 223.0759, found: 
223.0760.
4.11e: Synthesised according to General Procedure 8 using 
4.9j (24 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give 
a pale green solid that was recrystallised by slow evaporation 
of a saturated CH2Cl2/hexane solution. Yield: 39 mg, 0.05 
mmol, 52%. Melting point: 187–192 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
8.55 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 8.07 (t, 3JHH = 7.8 Hz, 1H, Ar-H), 7.85–7.64 (m, 2H, 
Ar-H), 7.38 (s, 1H, =CH), 7.25 (q, 3JHH = 8.3 Hz, 4H), 2.41 (s, 3H, CH3). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 154.9 (s), 147.9 (dm, 1JCF = 241 Hz), 142.5 (s), 140.0 
(dm, 1JCF = 246 Hz), 139.3 (s), 139.2 (s), 137.0 (dm, 3JCF = 253 Hz), 130.5 (s), 130.4 
(s), 130.0 (s), 126.7 (s), 125.3 (s), 117.0 (s), 105.6 (s), 21.5 (s). 11B NMR (128 MHz, 
CDCl3, 298 K) δ/ppm: 0.7 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.76 
(d, 3JFF = 18.0 Hz, 6F, o-F B(C6F5)3), -157.27 (t, 3JFF = 20.3 Hz, 3F, p-F B(C6F5)3), -
163.86 (t, 3JFF = 18.3 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 2362 (w), 2160 (w), 1647 
(m), 1606 (m), 1579 (m), 1558 (m), 1517 (s), 1458 (s), 1381 (m), 1340 (m), 1286 (m), 
1244 (w), 1192 (w), 1163 (w), 1101 (s), 984 (s), 881 (w), 854 (w), 831 (w), 817 (m), 
796 (m), 773 (s), 752 (s), 696 (s), 677 (s), 630 (w), 582 (m), 524 (s). HRMS (ES+) m/z
calculated for [C16H13O2]+ [M+H–(B(C6F5)3)]+: 237.0916, found: 237.0920.
4.11f: Synthesised according to General Procedure 8 using 4.10c (57 
mg, 0.2 mmol) and B(C6F5)3 (100 mg, 0.2 mmol) however, this 
compound was purified by column chromatography after 24 h using 
100% chloroform to yield compound 4.11f as a yellow oil. Rf value: 
0.49 (SiO2, CHCl3). Yield: 48 mg, 0.17 mmol, 84%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 7.54–7.49 (m, 2H, Ar-H), 7.42–7.29 (m, 5H, Ar-H), 7.21–7.15 (m, 3H, Ar-H), 
3.55 (s, 2H, CH2), 2.18 (s, 2H, CH2), 1.26 (s, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 
298 K) δ/ppm: 174.2 (s), 146.8 (s), 138.7 (s), 133.0 (s), 129.1 (s), 128.8 (s), 128.8 (s) 
128.7 (s), 128.5 (s), 112.3 (s), 38.7 (s), 37.8 (s), 36.5 (s), 24.9 (s). IR ʋmax (cm-1): 2980 
(w), 2361 (w), 1717 (m), 1647 (m), 1517 (s), 1460 (s), 1379 (m), 1344 (m), 1287 (m), 
1211 (w), 1101 (s), 1053 (w), 965 (s), 868 (w), 789 (w), 764 (m), 746 (w), 700 (m), 
678 (m), 625 (w), 577 (w), 517 (w), 444 (w). HRMS (ES+) m/z calculated for 
[C20H20O2]+ [M+H]+: 292.1463, found: 292.1462.
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4.11g: Synthesised according to General Procedure 8 using 
4.10k (64 mg, 0.2 mmol) and B(C6F5)3 (100 mg, 0.2 mmol) to 
yield compound as a yellow oil. Yield: 138 mg, 0.17 mmol, 83%. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.26–7.20 (m, 2H, Ar-
H), 7.16 (d, 3JHH = 7.3 Hz, 1H, Ar-H), 7.12 (d, 3JHH = 7.8 Hz, 2H, 
Ar-H), 7.01 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 6.85 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 3.82 (q, 
3JHH = 7.1 Hz, 1H, C(H)(Me)Ar), 2.32 (s, 3H, CH3), 2.23 (d, 2JHH = 17.4 Hz, 1H, CH2), 
1.94 (d, 2JHH = 17.2 Hz, 1H, CH2), 1.36 (d, 3JHH = 7.2 Hz, 3H, C(H)(Me)Ar), 1.29 (s, 
3H, CH3), 1.07 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 147.8 (d, 1JCF
= 239 Hz), 145.8 (s), 141.3 (s), 140.8 (s), 140.1 (d, 1JCF = 249 Hz), 137.1 (d, 1JCF = 
247 Hz), 129.7 (s), 128.9 (s), 128.5 (s), 127.4 (s), 127.2 (s), 126.1 (s), 122.9 (s), 38.3 
(s), 37.3 (s), 32.2 (s), 23.4 (s), 23.2 (s), 21.5 (s), 16.7 (s). 11B NMR (160 MHz, CDCl3, 
298 K) δ/ppm: 1.2 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -135.33 (d, 3JFF
= 17.7 Hz, 6F, o-F B(C6F5)3), -157.45 (t, 3JFF = 20.0 Hz, 3F, p-F B(C6F5)3), -163.84 –
-164.48 (m, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 2976 (w), 1705 (m), 1645 (m), 1605 (w), 
1517 (s), 1458 (s), 1379 (m), 1348 (w), 1286 (m), 1224 (w), 1174 (w), 1099 (m), 1068 
(m), 1024 (w), 989 (s), 869 (w), 804 (w), 773 (m), 738 (w), 700 (m), 678 (m), 617 (w). 
HRMS (EI+) m/z calculated for [C22H24O2]+ [M-B(C6F5)3]+: 320.1776, found: 320.1776.
4.11h: Synthesised according to General Procedure 8 using 
compound 4.10d (39 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 
mmol). Yield: 81 mg, 0.09 mmol, 90%. Melting point: 168–175 °C. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.45 (d, 3JHH = 7.5 Hz, 1H, 
Ar-H), 7.34 (pent., 3JHH = 6.5 Hz, 5H, Ar-H), 7.06–7.03 (m, 6H, Ar-
H), 6.99 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 5.14 (s, 1H, CH(Ar)2), 2.42–2.32 (m, 2H, CH2) 
1.25 (d, 4JHH = 4.0 Hz, 6H, C(CH3)2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.0 
(d, 1JCF = 245 Hz), 148.0 (dm, 1JCF = 250 Hz), 140.4 (s), 140.1 (dm, 1JCF = 245 Hz), 
137.1 (dm, 1JCF = 245 Hz), 136.6 (s), 130.5 (s), 129.01 (s), 129.0 (d, 3JCF = 7.4 Hz), 
128.9 (s), 128.3 (s), 127.6 (s), 50.7 (s), 37.0 (s), 34.6 (s), 23.9 (s), 23.8 (s). 11B NMR
(160 MHz, CDCl3, 298 K) δ/ppm: 1.6 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: 
-114.56 (s, 1F, p-F), -135.31 – -135.36 (m, 6F, o-F B(C6F5)3), -157.08 (t, 3JFF = 20.5 
Hz, 3F, p-F B(C6F5)3), -163.85 (td, 6F, 3JFF = 23.9 Hz, 4JFF = 8.3 Hz, m-F B(C6F5)3). IR
ʋmax (cm-1): 2982 (w), 1763 (w), 1647 (w), 1611 (m), 1518 (m), 1506 (m), 1467 (s), 
1408 (m), 1383 (w), 1366 (w), 1331 (w), 21283 (w), 1227 (m), 1227 (m), 1105 (m)1049 
(w), 976 (s), 937 (w), 885 (w), 856 (w), 841 (w), 831 (w), 808 (w), 789 (m), 775 (w), 
765 (m), 745 (w), 727 (w), 696 (m), 681 (m), 667 (m), 624 (w), 610 (w). HRMS (ES+)
m/z calculated for [C26H24O2F]+ [(M-B(C6F5)3)+H]+: 387.1760, found: 387.1752.
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4.11i: Synthesised according to General Procedure 8 using 
compound 4.10e (40 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 
mmol). Yield: 88 mg, 0.09 mmol, 97%. Melting point: 149–155 °C. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.38 (t, 3JHH = 7.5 Hz, 
1H, Ar-H), 7.30 – 7.22 (m, 7H, Ar-H), 6.99 – 6.90 (m, 4H, Ar-H), 
6.86 (d, 3JHH = 7.3 Hz, 2H, Ar-H), 5.05 (s, 1H, C(H)Ar2), 2.32 (s, 2H, CH2), 1.22 (s,
3H, CH3), 1.19 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 186.2 (s), 
147.8 (dm, 1JCF ≈ 250 Hz), 147.5 (s), 140.0 (dm, 1JCF ≈ 250 Hz), 139.6 (s), 138.6 (s), 
137.1 (dm, 1JCF ≈ 250 Hz), 133.6 (s), 131.0 (s), 130.2 (s), 129.3 (s), 129.2 (s), 129.1 
(s), 128.8 (s), 128.2 (s), 127.9 (s), 119.4 (s), 50.7 (s), 37.4 (s), 34.1 (s), 23.6 (s), 23.4 
(s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 1.4 (br. s). 19F NMR (376 MHz, CDCl3, 
298 K) δ/ppm: -135.31 (d, 3JFF = 18.5 Hz, 6F, o-F B(C6F5)3), -157.03 (t, 3JFF = 20.3 
Hz, 3F, p-F B(C6F5)3), -163.66 – -163.94 (m, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 2982 
(w), 2361 (w), 1647 (w), 1611 (s), 1518 (s), 1491 (m), 1462 (s), 1406 (m), 1381 (m), 
1364 (m), 1331 (w), 1283 (m), 1229 (m), 1091 (s), 1048 (m), 1015 (w), 976 (s), 935 
(w), 885 (w), 856 (w), 839 (w), 824 (w), 789 (m), 766 (m), 698 (s), 681 (m), 665 (m), 
625 (m), 610 (m). HRMS (ES+) m/z calculated for [C26H24O2Cl]+ [(M-B(C6F5)3)+H]+: 
403.1465, found: 403.1455.
4.11j: Synthesised according to General Procedure 8 using 
compound 4.10f (45 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 
mmol). Yield: 92 mg, 0.09 mmol, 96%. Melting point: 154–159 °C. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.43–7.35 (m, 3H, Ar-
H), 7.31–7.19 (m, 5H, Ar-H), 6.96 (d, 3JHH = 7.1 Hz, 2H, Ar-H), 6.87 
(d, 3JHH = 8.4 Hz, 4H, Ar-H), 5.04 (s, 1H, C(H)Ar2), 2.32 (s, 2H, CH2), 1.22 (s, 3H, 
CH3), 1.19 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 147.8 (dm, 1JCF ≈ 
240 Hz), 147.6 (s), 140.2 (dm, 1JCF ≈ 250 Hz), 140.2 (d, 3JCF = 47.6 Hz, 137.1 (dm, 
1JCF ≈ 250 Hz), 132.0 (s), 130.7 (s), 130.26 (s), 129.0 (s), 128.9 (s), 128.9 (s), 128.3 
(s), 127.5 (s), 121.3 (s), 51.1 (s), 36.7 (s), 34.9 (s), 24.1 (s), 24.0 (s). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 1.5 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -
135.32 (d, 3JFF = 16.9 Hz, 6F, o-F B(C6F5)3), -157.02 (t, 3JFF = 20.5 Hz, 3F, p-F 
B(C6F5)3), -163.79 (td, 3JFF = 23.9, 4JFF =8.2 Hz, m-F B(C6F5)3). IR ʋmax (cm-1): 2982 
(w), 2361 (w), 1647 (w), 1611 (s), 1518 (s), 1487 (m), 1462 (s), 1406 (m), 1381 (m), 
1364 (m), 1331 (w), 1283 (m), 1229 (m), 1101 (s), 1047 (m), 1011 (m), 976 (s), 885 
(w), 856 (w), 837 (w), 789 (m), 775 (m), 766 (m), 721 (m), 696 (s), 680 (m), 671 (m), 
624 (w), 610 (w). HRMS (ES+) m/z calculated for [C26H24O2Br]+ [(M-B(C6F5)3)+H]+: 
447.0960, found: 447.0947.
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4.11k: Synthesised according to General Procedure 8 using 
compound 4.10g (45 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 
mmol). Yield: 89 mg, 0.09 mmol, 92%. Melting point: 80–86 °C. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.68 (d, 3JHH = 8.0 
Hz, 2H, Ar-H), 7.38–7.34 (m, 2H, Ar-H), 7.25–7.18 (m, 3H, Ar-
H), 7.10 (d, 3JHH = 7.2 Hz, 2H, Ar-H), 3.52 (s, 2H, CH2Ph), 2.38 (s, 2H, CH2), 1.38 (s, 
6H, C(CH3)2). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 1.7 (br. s). 19F NMR (471 
MHz, CDCl3, 298 K) δ/ppm: -63.30 (s, 3F, CF3), -134.94 (br. s, 6F, o-F-B(C6F5)3), -
156.30 (br. s, 3F, p-F B(C6F5)3), -163.44 (br. s, 6F, m-F B(C6F5)3. IR ʋmax (cm-1): 2936 
(w), 2361 (w), 2332 (w), 1717 (w), 1647 (w), 1618 (w), 1541 (w), 1518 (s), 1461 (s), 
1406 (w), 1381 (w), 1323 (s), 1288 (m), 1169 (m), 1103 (s), 1067 (s), 1018 (w), 972 
(s), 845 (w), 793 (w), 775 (w), 745 (w), 700 (w), 673 (w), 609 (w), 577 (w). HRMS
(ES+) m/z calculated for [C23H23F3NO2]+ [M+MeCN+H-(B(C6F5)3)]+: 402.1681, found: 
402.1674.
4.11l: Synthesised according to General Procedure 8 using 
compound 4.10h (45 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 
mmol). Yield: 89 mg, 0.09 mmol, 92%. Melting point: 165–
171 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.55 (d, 3JHH
= 8.3 Hz, 2H), 7.33–7.27 (m, 3H, Ar-H), 7.19 (d, 3JHH = 6.5 Hz, 
2H, Ar-H), 7.03–6.97 (m, 5H, Ar-H), 5.03 (s, 1H, C(H)Ar2), 2.41–2.39 (m, 2H, CH2), 
1.29 (s, 3H, CH3), 1.28 (s, 3H, CH3). 13C NMR partial (126 MHz, CDCl3, 298 K) δ/ppm: 
148.1 (dm, 1JCF = 245 Hz), 147.9 (s), 140.1 (s), 139.1 (s), 137.3 (dm, 1JCF = 250 Hz), 
134.0 (s), 131.3 (s), 130.1 (s), 129.6 (s), 129.6 (s), 129.5 (s), 129.2 (s), 128.6 (s), 
128.3 (s), 51.1 (s), 37.7 (s), 34.5 (s), 24.0 (s), 23.92 (s). 11B NMR (128 MHz, CDCl3, 
298 K) δ/ppm: 0.0 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -63.04 (s, 3F, -
CF3), -114.76 (m, 1F, p-F Ph), -138.45 (dd, 3JFF = 21.7 Hz, 4JFF = 8.5 Hz, 6F, o-F 
B(C6F5)3), -153.49 (br. s, 3JFF = 20.1 Hz, 4JFF = 6.9 Hz, 3F, p-F B(C6F5)3), -161.81 – -
161.94 (m, 6F, m-F B(C6F5)3).
4.11m: Synthesised according to General Procedure 8 using 
compound 4.10i (47 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 
mmol). Yield: 92 mg, 0.09 mmol, 94%. Melting point: 160–168 
°C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.54 (d, 3JHH = 
8.2 Hz, 2H, Ar-H), 7.26–7.24 (m, 4H, Ar-H), 7.00–6.90 (m, 8H, 
Ar-H), 4.99 (s, 1H, C(H)Ar2), 2.35 (s, 2H, CH2), 1.26 (s, 3H, CH3), 1.23 (s, 3H, CH3). 
11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 2.6 (br. s). 13C NMR (126 MHz, CDCl3, 
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298 K) δ/ppm: 188.0 (s), 146.6 (dm, 1JCF = 240 Hz), 144.8 (s), 140.6 (s), 138.9 (dm, 
1JCF = 245 Hz), 138.5 (s), 137.4 (s), 136.0 (dm, 1JCF = 245 Hz), 132.6 (s), 129.0 (s), 
128.4 (s), 128.2 (s), 128.1 (s), 128.2 (s), 127.6 (s), 127.6 (s), 126.8 (s), 124.9 (q, 3JCF
= 3.5 Hz), 49.7 (s), 36.0 (s), 33.6 (s), 22.6 (s), 22.6 (s). 19F NMR (376 MHz, CDCl3, 
298 K) δ/ppm: -63.39 (s, 3F, CF3), -135.12 (d, 3JFF = 18.3 Hz, 6F, o-F B(C6F5)3), -
156.46 (s, 3F, p-F B(C6F5)3), -163.58 (t, 3JFF = 17.7 Hz, 6F, m-F B(C6F5)3). IR ʋmax
(cm-1): 2982 (w), 2359 (w), 2332 (w), 1716 (m), 1647 (m), 1616 (w), 1518 (s), 1462 
(s), 1406 (m), 1381 (m), 1323 (s), 1288 (m), 1225 (w), 1169 (m), 1101 (s), 1067 (s), 
1016 (m), 972s, 847 (m), 791 (w), 775 (w), 744 (w), 704w, 679 (m), 608 (w), 579 (w), 
561 (w). HRMS (ES+) m/z calculated for [C27H23O2F3Cl]+ [(M-B(C6F5)3)+H]+: 471.1339, 
found: 471.1330.
4.11n: Synthesised according to General Procedure 8 using 
compound 4.10j (51 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 
mmol). Yield: 93 mg, 0.09 mmol, 92%. Melting point: 105–
110 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.48 (d, 3JHH
= 8.2 Hz, 2H, Ar-H), 7.35 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 7.23–
7.21 (m, 3H, Ar-H), 6.94–6.88 (m, 4H, Ar-H), 6.79 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 4.91 
(s, 1H, C(H)Ar2), 2.30 (s, 2H, CH2), 1.21 (s, 3H, CH3), 1.18 (s, 3H, CH3). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 189.2 (s), 147.9 (dm, 1JCF = 245 Hz), 146.3 (s), 141.3 
(s), 140.1 (dm, 1JCF = 245 Hz), 140.0 (s), 136.9 (dm, 1JCF = 245 Hz), 132.1 (s), 130.1 
(s), 129.1 (s), 128.9 (s), 128.8 (s), 127.7 (s), 125.8 (q, 3JCF = 3.8 Hz), 121.4 (s), 51.2 
(s), 36.7 (s), 35.5 (s), 24.3 (s), 24.2 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 
2.6 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -63.26 (s, 3F, -CF3), -134.97 
(br. s, 6F, o-F B(C6F5)3), -156.09 (br. s, 3F, p-F B(C6F5)3), -163.44 (br. s, 6F, m-F 
B(C6F5)3). IR ʋmax (cm-1): 2934 (w), 22361 (w), 1717 (w), 1647 (w), 1618 (w), 1518 (s), 
1462 (s), 1381 (m), 1323 (s), 1288 (m), 1227 (w), 1169 (m), 1126 (s), 1103 (s), 1067 
(s), 972 (s), 847 (m), 791 (w), 775 (w), 745 (w), 704 (w), 673 (m), 608 (w), 577 (w), 
561 (w). HRMS (ES+) m/z calculated for [C27H23O2F3Br]+ [(M-B(C6F5)3)+H]+: 515.0834, 
found: 515.0831.
4.11o: Synthesised according to General Procedure 8 using 4.10l
(41 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give a white 
solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 79 mg, 0.09 mmol, 86%. Melting 
point: 190–195 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.62 
(d, 3JHH = 7.4 Hz, 1H, Ar-H), 7.79 (t, 3JHH = 7.2 Hz, 1H, Ar-H), 7.73 (t, 3JHH = 7.4 Hz, 
Chapter 6: Experimental
192
1H, Ar-H), 7.67 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 7.48 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.34–
7.24 (m, 6H, Ar-H), 7.08–7.00 (m, 4H, Ar-H), 6.97 (t, 3JHH = 8.4 Hz, 4H, Ar-H), 5.81 
(s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 169.3 (s), 161.9 (d, 1JCF
= 247 Hz), 154.2 (s, 148.2 (dm, 1JCF = 245 Hz), 139.8 (dm, 1JCF = 250 Hz), 139.0 (s), 
139.0 (s), 136.9 (dm, 1JCF = 250 Hz), 135.6 (d, 3JCF = 3.3 Hz), 131.5 (s), 131.1 (s), 
130.6 (s), 129.6 (s), 129.2 (s), 129.1 (s), 128.8 (s), 128.6 (s), 127.8 (s), 127.7 (s), 
120.9 (s), 118.3 (s), 116.0 (d, 2JCF = 12.1 Hz), 49.4 (s). 11B NMR (128 MHz, CDCl3, 
298 K) δ/ppm: 0.4 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -114.54 (s, 1F, 
CF), -134.98 (d, 3JFF = 19.2 Hz, 6F, o-F B(C6F5)3), -157.48 (t, 3JFF = 18.0 Hz, 3F, p-F 
B(C6F5)3), -164.03 (br. t, 3JFF = 18.2 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 3032 (w), 
2957 (w), 1645 (m), 1603 (m), 1556 (m), 1452 (s), 1377 (m), 1284 (m), 1228 (m), 
1161 (w), 1099 (s), 1016 (w), 974 (s), 860 (w), 835 (w), 790 (m), 745 (m), 739 (m), 
696 (s), 665 (m), 611 (w), 574 (w). HRMS (ES+) m/z calculated for [C28H20O2F]+ [M+H–
(B(C6F5)3)]+: 407.1447, found: 407.1440.
4.11p: Synthesised according to General Procedure 8 using 4.10m
(42 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give a white 
solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 85 mg, 0.09 mmol, 91%. Melting 
point: 194–200 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.61 
(d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.78 (t, 3JHH = 7.2 Hz, 1H, Ar-H), 7.72 (t, 3JHH = 7.5 Hz, 
1H, Ar-H), 7.64 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 7.47 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.32 (t, 
3JHH = 7.8 Hz, 2H, Ar-H), 7.29–7.17 (m, 4H, Ar-H), 7.05 (d, 3JHH = 7.3 Hz, 2H, Ar-H), 
6.99 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 6.95 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 5.79 (s, 1H, 
C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 169.3 (s), 154.3 (s), 148.0 (dm, 
1JCF = 238 Hz), 140.0 (dm, 1JCF = 250 Hz), 139.4 (s), 138.9 (s), 138.4 (s), 137.07 (dm, 
1JCF = 241 Hz). 133.5 (s), 131.5 (s), 131.1 (s), 130.5 (s), 130.3 (s), 129.5 (s), 129.3 
(s), 129.2 (s), 129.1 (s), 128.8 (s), 128.6 (s), 127.8 (s), 127.7 (s), 120.6 (s), 118.3 (s), 
49.5 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 0.6 (br. s). 19F NMR (471 MHz, 
CDCl3, 298 K) δ/ppm: -134.98 (d, 3JFF = 18.5 Hz, o-F B(C6F5)3), -157.47 (t, 3JFF = 20.0 
Hz, p-F B(C6F5)3), -164.02 (t, 3JFF = 18.3 Hz, m-F B(C6F5)3). IR ʋmax (cm-1): 3059 (w), 
2158 (w), 2027 (w), 1635 (m), 1602 (w), 1564 (m), 1517 (m), 1465 (s), 1408 (m), 1377 
(m), 1284 (m), 1168 (w), 1097 (m), 970 (m), 908 (m), 858 (w), 829 (w), 800 (m), 790 
(m), 767 (m), 696 (s), 611 (w), 513 (w). HRMS (ES+) m/z calculated for [C28H20ClO2]+
[M+H–(B(C6F5)3)]+: 423.1152, found: 423.1151.
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4.11q: Synthesised according to General Procedure 8 using 4.10n
(47 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give a white 
solid that was recrystallised by slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 83 mg, 0.08 mmol, 85%. Melting 
point: 185–189 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.61 
(d, 3JHH = 7.9 Hz, 1H, Ar-H), 7.83–7.69 (m, 2H, Ar-H), 7.64 (d, 3JHH = 8.1 Hz, 1H, Ar-
H), 7.48 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.40 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 7.37–7.21 (m, 
6H, Ar-H), 7.06 (d, 3JHH = 7.3 Hz, 2H, Ar-H), 7.00–6.88 (m, 3H, Ar-H), 5.78 (s, 1H, 
C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 154.3 (s), 148.0 (dm, 1JCF = 245 
Hz), 140.0 (dm, 1JCF = 250 Hz), 139.4 (s), 139.0 (s), 138.8 (s), 137.1 (dm, 1JCF = 247 
Hz), 132.2 (s), 131.5 (s), 131.1 (s), 130.6 (s), 130.5 (s), 129.2 (s), 129.1 (s), 128.8 (s), 
128.6 (s), 127.7 (s), 127.7 (s), 121.5 (s), 49.5 (s). 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 0.4 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.98 (br. s, 6F, o-F 
B(C6F5)3), -157.40 (br. s, 3F, p-F B(C6F5)3), -163.95 (br. s, 6F, m-F B(C6F5)3). IR ʋmax
(cm-1): 3064 (w), 3030 (w), 1645 (m), 1602 (m), 1568 (m), 1518 (m), 1436 (s), 1379 
(m), 1286 (m), 1166 (w), 1099 (s), 1010 (w), 974 (s), 906 (m), 792 (m), 765 (m), 729 
(m), 694 (s), 617 (w), 609 (w), 576 (w). HRMS (ES+) m/z calculated for [C28H20BrO2]+
[M+H–(B(C6F5)3)]+: 467.0647, found: 467.0652.
4.11r: Synthesised according to General Procedure 8 using 4.10o
(68 mg, 0.2 mmol) and B(C6F5)3 (102 mg, 0.2 mmol) to yield 
compound 3f as a yellow solid. Yield: 148 mg, 0.17 mmol, 87%. 
Melting point: 72–78 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
8.51 (s, 1H, Ar-H), 7.70 (s, 1H, Ar-H), 7.61 (s, 1H, Ar-H), 7.45 (s, 1H, Ar-H), 7.24 (t, 
3JHH = 7.6 Hz, 2H, Ar-H), 7.14 (d, 3JHH = 8.0 Hz, 5H, Ar-H), 6.99 (s, 2H, Ar-H), 4.48 (q, 
3JHH = 7.3 Hz, 1H, C(H)(Me)Ar), 2.33 (s, 3H, CH3), 1.72 (d, 3JHH = 7.3 Hz, 3H, 
C(H)(Me)Ar). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm:153.1 (s), 148.1 (d, 1JCF = 
238.1 Hz), 141.9 (s), 141.7 (s), 140.0 (d, 1JCF = 248.4 Hz), 138.4 (s), 138.3 (s), 137.1 
(d, 1JCF = 217.8 Hz), 131.1 (s), 130.2 (s), 130.1 (s), 129.8 (s), 129.2 (s), 128.5 (s), 
128.4 (s), 127.0 (s), 126.9 (s), 126.6 (s), 125.5 (s), 37.3 (s), 21.5 (s), 18.6 (s). 11B 
NMR (160 MHz, CDCl3, 298 K) δ/ppm: 0.9 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) 
δ/ppm: -134.96 (br. s, 6F, o-F B(C6F5)3), -157.81 (br. s, 3F, p-F B(C6F5)3, -164.22 (br. 
s, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 2943 (w), 1645 (m), 1608 (w), 1566 (w), 1516 (s), 
1495 (s), 1377 (m), 1286 (m), 1184 (w), 1099 (s), 1022 (w), 974 (s), 864 (w), 815 (m), 
788 (m), 771 (m), 748 (m), 698 (m), 973 (m). HRMS (EI+) m/z calculated for 
[C24H20O2]+ [M-B(C6F5)3]+: 340.1463, found: 340.1462.
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4.11s: Synthesised according to General Procedure 8 using 
4.10p (42 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to 
give a white solid that was crystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 75 mg, 0.08 mmol, 
81%. Melting point: >230 °C. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 8.59 (d, 3JHH = 7.8 Hz, 1H, Ar-H), 7.79–7.50 (m, 3H, Ar-H), 7.27 (q, 3JHH = 8.2 
Hz, 3H, Ar-H), 7.12 (d, 3JHH = 7.4 Hz, 2H, Ar-H), 7.03–7.01 (m, 4H, Ar-H), 6.95 (t, 3JHH
= 8.1 Hz, 2H, Ar-H), 6.85 (d, 3JHH = 7.2 Hz, 1H, Ar-H), 5.83 (s, 1H, CH(Ar)2), 2.36 (s, 
3H, CH3). 13C NMR (126 MHz, DMSO-d6, 298 K) δ/ppm: 161.7 (s), 160.8 (d, 1JCF = 
243 Hz), 153.9 (s), 147.2 (dm, 1JCF = 239 Hz), 140.7 (s), 140.1 (s), 139.1 (dm, 1JCF = 
251.1 Hz),  137.2 (s), 136.8 (s), 136.8 (s), 136.2 (dm, 1JCF = 246 Hz), 134.0 (s), 130.6 
(s), 130.6 (s), 130.2 (s), 129.2 (s), 129.1 (s), 128.6 (s), 128.0  (s), 126.7 (d, 3JCF = 7.0 
Hz), 121.3 (s), 115.3 (d, 2JCF = 21.3 Hz), 114.2 (s), 48.5 (s), 20.9 (s). 11B NMR (128 
MHz, CDCl3, 298 K) δ/ppm: 0.5 (br. s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -
114.70 (s, 1F, p-F), -134.97 (d, 3JFF = 19.6 Hz, 6F, o-F B(C6F5)3), -157.69 (t, 3JFF = 
19.0 Hz, 3F, p-F B(C6F5)3), -164.16 (t, 3JFF = 18.0 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-
1): 3030 (w), 2158 (w), 1973 (w), 1639 (m), 1606 (w), 1564 (s), 1518 (m), 1506 (m), 
1425 (s), 1371 (m), 1282 (m), 1224 (m), 1161 (w), 1099 (m), 985 (m), 974 (s), 858 
(w), 788 (m), 771 (m), 746 (m), 715 (m), 690 (s), 675 (m), 613 (m). HRMS (ES+) m/z
calculated for [C29H22FO2]+ [M+H–(B(C6F5)3)]+: 421.1604, found: 421.1609.
4.11t: Synthesised according to General Procedure 8 using 
4.10q (44 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to 
give a white solid that was crystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 79 mg, 0.08 mmol, 
84%. Melting point: 207–213 °C. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 8.58 (d, 3JHH = 7.7 Hz, 1H, Ar-H), 7.78–7.66 (m, 2H, Ar-H), 7.62 (d, 
3JHH = 7.7 Hz, 1H, Ar-H), 7.29 (q, 3JHH = 6.3, 5.7 Hz, 3H, Ar-H), 7.25 (d, 3JHH = 8.6 Hz, 
3H, Ar-H), 7.13 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 7.07 (d, 3JHH = 7.4 Hz, 2H, Ar-H), 7.01 
(d, 3JHH = 8.4 Hz, 2H, Ar-H), 6.87 (br. s, 2H, Ar-H), 5.82 (s, 1H, C(H)Ar2), 2.38 (s, 3H, 
CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 154.59 (s), 148.03 (dm, 1JCF = 239 
Hz), 142.2 (s), 140.3 (dm, 1JCF = 246 Hz) 139.6 (s), 139.0 (s), 138.6 (s), 137.1 (dm, 
1JCF = 247 Hz), 133.4 (s), 131.0 (s), 130.3 (s), 129.7 (s), 129.2 (s), 128.8 (s), 128.6 
(s), 127.7 (s), 49.5 (s), 21.6 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 0.5 (br. s). 
19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.98 (d, 3JFF = 17.6 Hz, 6F, o-F 
B(C6F5)3), -157.60 (t, 3JFF = 20.3 Hz, p-F B(C6F5)3), -164.11 (t, 3JFF = 24.2 Hz, m-F 
B(C6F5)3). IR ʋmax (cm-1): 3028 (w), 2158 (w), 1637 (m), 1606 (w), 1564 (s), 1517 (s), 
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1432 (s), 1375 (w), 1280 (m), 1174 (w), 1097 (s), 1014 )m), 987 (m), 974 (s), 906 (w), 
858 (m), 839 (m), 821 (m), 794 (m), 738 (s), 707 (m), 690 (s), 673 (m), 626 (m), 613 
(m). HRMS (ES+) m/z calculated for [C29H22ClO2]+ [M+H–(B(C6F5)3)]+: 437.1308, 
found: 437.1307.
4.11u: Synthesised according to General Procedure 8 using 
4.10r (48 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give 
a white solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 87 mg, 0.09 mmol, 
88%. Melting point: 220–224 °C. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 8.63 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 7.80 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 7.74 
(t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.66 (d, 3JHH = 8.2 Hz, 1H, Ar-H), 7.42 (d, 3JHH = 8.5 Hz, 
2H, Ar-H), 7.31 (dt, 3JHH = 6.9 Hz, 3H, Ar-H), 7.16 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 7.09 
(d, 3JHH = 7.4 Hz, 2H, Ar-H), 6.97 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 6.87 (d, 3JHH = 7.9 Hz, 
2H, Ar-H), 5.83 (s, 1H, C(H)Ar2), 2.41 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 169.3 (s), 154.6 (s), 148.0 (dm, 1JCF = 241 Hz), 142.3 (s), 140.0 (d, 1JCF = 
262 Hz), 139.4 (s), 139.1 (s), 137.1 (d, 1JCF = 249 Hz), 132.2 (s), 131.1 (s), 130.7 (s), 
130.4 (s), 129.7 (s), 129.2 (s), 128.8 (s), 128.5 (s), 127.7 (s), 127.7 (s), 126.6 (s), 
121.5 (s), 120.2 (s), 118.2 (s), 49.6 (s), 21.6 (s). 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 0.5 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.98 (d, 3JFF = 18.2 
Hz, 6F, o-F B(C6F5)3), -157.60 (t, 3JFF = 19.9 Hz, 3F, p-F B(C6F5)3), -164.10 (t, 3JFF = 
18.2 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 3032 (w), 2160 (w), 1638 (m), 1606 (w), 
1564 (m), 1518 (m), 1589 (s), 1377 (m), 1321 (w), 1282 (m), 1172 (w), 1097 (s), 1009 
(m), 985 (s), 974 (s), 935 (w), 906 (w), 856 (m), 821 (m), 790 (s), 773 (s), 740 (m), 
717 (m), 690 (s), 675 (s), 624 (m), 611 (w). HRMS (ES+) m/z calculated for 
[C29H22O2Br]+ [M+H–(B(C6F5)3)]+: 481.0803, found: 481.0810.
4.11v: Synthesised according to General Procedure 8 using 4.10s
(36 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give a pale 
green solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 80 mg, 0.09 mmol, 92%. 
Melting point: 117–123 °C. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 7.92 (br. s, 1H, =CH), 7.57 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.45–7.31 (m, 5H, Ar-
H), 7.11–7.03 (m, 4H, Ar-H), 7.00–6.94 (m, 4H, Ar-H), 6.91 (br. s, 1H, =CH), 5.49 (s, 
1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.2 (d, 1JCF = 248 Hz), 
148.0 (dm, 1JCF = 241 Hz), 140.4 (s), 140.0 (dm, 1JCF = 249 Hz), 137.1 (dm, 1JCF = 
245 Hz), 136.5 (s), 132.4 (s), 130.5 (d, 3JCF = 8.1 Hz), 129.6 (s), 129.2 (s), 128.8 (s), 
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128.5 (s), 128.2 (s), 117.7 (s), 116.5 (d, 2JCF = 21.6 Hz), 113.6 (s), 49.4 (s). 11B NMR
(128 MHz, CDCl3, 298 K) δ/ppm: 0.1 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: 
-113.7 (s, 1F, p-F), -134.7 (d, 3JFF = 17.9 Hz, 6F, o-F B(C6F5)3), -157.6 (t, 3JFF = 20.3 
Hz, 3F, p-F B(C6F5)3), -164.2 (t, 3JFF = 18.3 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 3030 
(w), 2158 (w), 1973 (w), 1639 (m), 1606 (m), 1564 (s), 1517 (s), 1506 (m), 1435 (s), 
137 (m), 1282 (m), 1224 (m), 1161 (w), 1099 (s), 985 (m), 974 (s), 858 (m), 788 (m), 
771 (s), 746 (m), 738 (m), 715 (m), 690 (s), 613 (m). HRMS (ES+) m/z calculated for 
[C24H18O2F]+ [M+H–(B(C6F5)3)]+: 357.1291, found: 357.1293.
4.11w: Synthesised according to General Procedure 8 using 4.10t
(37 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give a pale 
green solid that was recrystallised by slow evaporation of a 
saturated CH2Cl2/hexane solution. Yield: 76 mg, 0.09 mmol, 86%. 
Melting point: 120–126 °C. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 7.95 (d, 3JHH = 9.4 Hz, 1H, =CH), 7.58 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.44–7.32 
(m, 8H, Ar-H), 7.06 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 6.99–6.86 (m, 6H, Ar-H), 5.49 (s, 1H, 
C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 168.6 (s), 162.0 (s), 153.9 (s), 
148.0 (dm, 1JCF = 238 Hz), 140.1 (s), 140.0 (dm, 1JCF = 250 Hz), 139.1 (s), 137.1 (dm, 
1JCF = 248 Hz), 134.2 (s), 132.6 (s), 130.2 (s), 129.7 (s), 129.7 (s), 129.3 (s), 128.8 
(s), 128.5 (s), 128.3 (s), 128.1 (s), 124.7 (s), 113.5 (s), 49.6 (s). 11B NMR (128 MHz, 
CDCl3, 298 K) δ/ppm: 0.1 (br. s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -134.7 
(d,3JFF = 18.6 Hz, 6F, o-F B(C6F5)3), -157.6 (t, 3JFF = 20.1 Hz, 3F, p-F B(C6F5)3), -164.2 
(t, 3JFF = 18.3 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-1): 3028 (w), 2158 (w), 1637 (m), 
1606 (w), 1564 (m), 1517 (m), 1458 (s), 1375 (m), 1280 (m), 1174 (w), 1097 (m), 1014 
(w), 987 (m), 974 (m), 933 (w), 906 (w), 858 (m), 839 (m), 821 (m), 794 (m), 773 (m), 
746 (m), 738 (m), 721 (m), 690 (m), 673 (m). HRMS (ES+) m/z calculated for 
[C24H18O2Cl]+ [M+H–(B(C6F5)3)]+: 373.0995, found: 373.1005.
4.11x: Synthesised according to General Procedure 8 using 
4.10u (42 mg, 0.1 mmol) and B(C6F5)3 (51 mg, 0.1 mmol) to give 
a pale green solid that was recrystallised by slow evaporation of 
a saturated CH2Cl2/hexane solution. Yield: 78 mg, 0.08 mmol, 
84%. Melting point: 92–95 °C. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 7.95 (d, 3JHH = 9.2 Hz, 1H, =CH), 7.58 (t, 3JHH = 7.6 Hz, 1H, Ar-H), 7.50 (d, 
3JHH = 8.5 Hz, 2H, Ar-H), 7.45–7.33 (m, 6H, Ar-H), 7.06 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 
6.97 (d, 3JHH = 6.7 Hz, 3H, Ar-H, =CH), 6.86 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 5.47 (s, 1H, 
C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.9 (s), 147.9 (dm, 1JCF = 238 
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Hz), 140.1 (s), 140.0 (dm, 1JCF = 254 Hz), 139.7 (s), 137.0 (dm, 1JCF = 253 Hz), 132.6 
(s), 130.5 (s), 129.6 (s), 129.3 (s), 128.8 (s), 128.5 (s), 128.2 (s), 122.2 (s), 113.5 (s), 
49.6 (s). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 0.0 (br. s). 19F NMR (471 MHz, 
CDCl3, 298 K) δ/ppm: -134.72 (d, 3JFF = 17.8 Hz, 6F, o-F B(C6F5)3), -157.58 (t, 3JFF = 
20.2 Hz, 3F, p-F B(C6F5)3), -164.14 (t, 3JFF = 18.1 Hz, 6F, m-F B(C6F5)3). IR ʋmax (cm-
1): 3032 (w), 2160 (w), 1637 (m), 1606 (w), 1564 (m), 1516 (m), 1425 (s), 1377 (m), 
1321 (w), 1282 (m), 1172 (w), 1097 (s), 1008 (m), 985 (s), 974 (s), 935 (w), 906 (w), 
856 (m), 821 (m), 790 (m), 746 (m), 740 (m), 717 (m), 690 (s), 675 (s), 625 611 (m), 
576 (m). HRMS (ES+) m/z calculated for [C24H18O2Br]+ [M+H–(B(C6F5)3)]+: 417.0490, 
found: 417.0503.
General Procedure 9: Alkynyl carboxylic acids 4.9 or esters 4.10 (0.1 mmol) were 
dissolved in CDCl3 (0.2 M), then B(C6F5)3 (3 mg, 5 mol%), unless otherwise stated, 
was added and transferred to a sealable J. Young NMR tube. The resultant solution 
was heated for 18 h at 70 °C (unless otherwise indicated). Once the reaction was 
complete as observed by in situ NMR spectroscopy, the solvent was removed in 
vacuo and the residue purified by either recrystallisation or column chromatography 
(SiO2, CHCl3) to obtain the pure product 4.12 after the removal of solvents under 
reduced pressure.
4.12a: Synthesised according to General Procedure 9 using 
4.9c (23 mg, 0.1 mmol) to give a white solid that was 
recrystallised from slow evaporation of a saturated 
CH2Cl2/hexane solution. Yield: 21 mg, 0.09 mmol, 91%. 
Melting point: 68–74 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.53 (d, 3JHH = 8.2 
Hz, 2H, Ar-H), 6.88 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 5.60 (t, 3JHH = 4.4 Hz, 1H, =CH), 3.82 
(s, 3H, OCH3), 2.35 (d, 3JHH = 4.4Hz, 2H, CH2), 1.32 (s, 6H, C(CH3)2). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 160.3 (s), 149.8 (s), 126.0 (s), 114.0 (s), 97.4 (s), 55.5 
(s), 36.6 (s), 34.5 (s), 25.1 (s). IR ʋmax (cm-1): 3067 (w), 2959 (w), 1724 (s), 1676 (s), 
1599 (s), 1576 (m), 1508 (m), 1483 (w), 1467 (w), 1427 (s), 1366 (w), 1306 (w), 1253 
(m), 1170 (m), 1120 (s), 1093 (s), 1028 (s), 995 (m), 974 (m), 916 (w), 874 (w), 835 
(w), 773 (w), 736 (m), 719 (s), 695 (s), 542 (w), 501 (s), 482 (m). HRMS (ES+) m/z
calculated for [C14H17O3]+ [M+H]+: 233.1178, found: 233.1179.
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4.12b: Synthesised according to General Procedure 9 using compound 
4.10c (58 mg, 0.2 mmol, 1 equiv.). Once reacted for 5 d, Removal of 
volatiles after column chromatography gave a pale yellow oil. Rf value: 
0.50. Yield: 19 mg, 0.7 mmol, 33%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.52–7.30 (br. m, 7H, Ar-H), 7.18–7.17 (br. s, 3H, Ar-H), 3.55 (s, 2H, CH2Ph), 
2.18 (s, 2H, CH2), 1.26 (s, 6H, C(CH3)2). Agreeing with values obtained for 4.11f.
4.12c: Synthesised according to General Procedure 9 using 
compound 4.10d (39 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 
mol%). Removal of volatiles after column chromatography gave a 
white solid. A crop of colourless crystals suitable for single crystal X-
ray diffraction were obtained by storing a saturated hexane/CH2Cl2
solution at -40 °C. Rf value: 0.51 (SiO2, hexane/CHCl3 1:2). Yield: 37 mg, 0.95 mmol, 
95%. Melting point: 139–144 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.30–7.17 
(m, 8H, Ph–H), 7.03–6.97 (m, 4H, Ph–H), 6.92 (t, 3JHH = 8.5 Hz, 2H, Ph–H), 5.18 (s, 
1H, C(H)Ar2), 2.20–2.10 (m, 2H, CH2), 1.07 (s, 6H, C(CH3)2). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 173.8 (s), 161.7 (d, 1JCF = 245.8 Hz), 147.9 (s), 141.7 (s), 137.6 
(d, 3JCF = 3.3 Hz), 132.9 (s), 130.6 (d, 3JCF = 7.9 Hz), 129.4 (s), 129.0 (s), 128.6 (s), 
128.6 (s), 128.5 (s), 127.0 (s), 115.4 (d, 2JCF = 21.2 Hz), 114.3 (s), 50.9 (s), 36.4 (s), 
35.9 (s), 24.8 (s), 24.7 (s). 19F NMR (376 Hz, CDCl3, 298 K) δ/ppm: –115.82 (s, 1F, 
p-F). IR ʋmax (cm-1): 2988 (w), 1760 (s), 1671 (w), 1603 (m), 1504 (s), 1493 (m), 1466 
(w), 1445 (m), 1388 (w), 1367 (w), 1344 (w), 1282 (w), 1219 (s), 1189 (w), 1155 (w), 
1132 (w), 1099 (s), 1082 (s), 1070 (s), 1029 (w), 1015 (w), 1003 (w), 926 (w), 876 
(w), 835 (m), 807 (w), 773 (m), 731 (w), 700 (s), 635 (w), 624 (w), 618 (w), 598 (w), 
570 (w), 549 (m), 533 (m), 506 (m). HRMS (EI+) m/z calculated for [C26H24O2F]+
[M+H]+: 387.1760, found: 387.1751.
4.12d: Synthesised according to General Procedure 9 using 
compound 4.10e (40 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 
mol%). Rf value: 0.49 (SiO2, hexane/CHCl3 1:2). Yield: 36 mg, 0.90 
mmol, 90%. Melting point: 104–110 °C. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.39–7.26 (m, 10H, Ar-H), 7.07 (d, 3JHH = 7.6 Hz, 2H, 
Ar-H), 7.04 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 5.23 (s, 1H, C(H)Ar2), 2.23 (s, 2H, CH2), 1.16 
(s, 3H, CH3), 1.15 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 174.1 (s), 
148.0 (s), 141.3 (s), 140.4 (s), 132.8 (s), 132.7 (s), 130.5 (s), 129.5 (s), 129.0 (s), 
128.8 (s), 128.7 (s), 128.6 (s), 128.5 (s), 127.2 (s), 114.2 (s), 51.1 (s), 36.4 (s), 35.8 
(s), 24.8 (s), 24.7 (s). IR ʋmax (cm-1): 2982 (w), 1759 (s), 1668 (w), 1601 (w), 1515 (w), 
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1489 (s), 1464 (s), 1389 (w), 1352 (w), 1277 (w), 1225 (w), 1194 (w), 1179 (w), 1157 
(w), 1134 (w), 1099 (s), 1069 (s), 1013 (s), 976 (w), 921 (w), 870 (w), 833 (w), 773 
(s), 756 (w), 727 (w), 705 (s), 648 (w), 611 (w), 598 (w), 550 (w), 519 (w). HRMS (EI+) 
m/z calculated for [C26H23O2Cl]+ [M]+ 402.1387, found: 402.1399.
4.12e: Synthesised according to General Procedure 9 using 
compound 4.10f (45 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 
mol%). Rf value: 0.44 (SiO2, hexane/CHCl3 1:2). Yield: 42 mg, 0.93 
mmol, 93%. Melting point: 116–121 °C. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 7.37 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.30 (s, 5H, Ar-H), 
7.25–7.18 (m, 3H, Ar-H), 7.01 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 6.92 (d, 3JHH = 8.2 Hz, 2H, 
Ar-H), 5.16 (s, 1H, C(H)Ar2), 2.15 (s, 2H, CH2), 1.09 (s, 3H, CH3), 1.07 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 174.0 (s), 148.1 (s), 141.3 (s), 140.9 (s), 
132.7 (s), 131.7 (s), 130.9 (s), 129.5 (s), 129.1 (s), 128.7 (s), 128.6 (s), 128.5 (s), 
127.2 (s), 120.9 (s), 114.0 (s), 51.2 (s), 36.4 (s), 35.8 (s), 24.8 (s), 24.7 (s). IR ʋmax
(cm-1): 3058 (w), 2981 (s), 1767 (m), 1751 (w), 1684 (w), 1667 (w), 1601 (w), 1487 
(m), 1446 (m), 1386 (m), 1344 (w), 1285 (w), 1217 (w), 1155 (w), 1107 (s), 1091 (m), 
1068 (s), 1029 (w), 1008 (m), 993 (s), 921 (w), 854 (w), 829 (m), 798 (w), 767 (m), 
746 (m), 725 (w), 715 (w), 700 (s), 694 (s), 680 (w), 669 (w), 602 (m), 547 (m), 501 
(w), 487 (m), 474 (m), 424 (w). HRMS (EI+) m/z calculated for [C26H24O2Br]+ [M+H]+: 
447.0960, found: 447.0964
4.12f: Synthesised according to General Procedure 9 using 
compound 4.10j (500 mg, 0.9 mmol) and B(C6F5)3 (3 mg, 5 µmol, 
5 mol%) and was heated for 5 d. Rf value: 0.64 (SiO2, 
hexane/CHCl3 1:2). Yield: 138 mg, 0.3 mmol, 27%. Melting 
point: 125–131 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.64 (d, 3JHH = 8.3 Hz, 
2H, Ar-H), 7.51 (d, 3JHH = 8.2 Hz, 2H, Ar-H), 7.46 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 7.35–
7.29 (m, 3H, Ar-H), 7.07 (d, 3JHH = 7.2 Hz, 2H, Ar-H), 6.98 (d, 3JHH = 8.4 Hz, 2H, Ar-
H), 5.17 (s, 1H), 2.29 (d, 2JHH = 17.1 Hz, 1H, diastereotopic CH2), 2.16 (d, 2JHH = 17.1 
Hz, 1H, diastereotopic CH2), 1.19 (s, 3H, CH3), 1.17 (s, 3H, CH3). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 173.1 (s), 146.7 (s), 140.8 (d, 2JCF = 45.7 Hz), 136.3 (s), 131.9 
(s), 130.8 (s), 129.0 (s), 129.0 (s), 128.9 (s), 127.4 (s), 125.7 (q, 4JCF = 3.8 Hz) 121.1 
(s), 115.5 (s), 51.3 (s), 36.4 (s), 36.2 (s), 29.9 (s), 24.9 (s), 24.8 (s). 19F NMR (471 
MHz, CDCl3, 298 K) δ/ppm: -62.82 (s). IR ʋmax (cm-1): 2981 (w), 2925 (w), 1761 (s), 
1668 (w), 1615 (w), 1487 (m), 1465 (w), 1454 (m), 1424 (w), 1410 (w), 1392 (w), 1323 
(s), 1228 (m), 1225 (w), 1211 (w), 1194 (w), 1178 (w), 1153 (m), 1129 (s), 1100 (s), 
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1075 (s), 1065 (s), 1016 (m), 1009 (m), 910 (w), 877 (m), 857 (s), 827 (m), 788 (m), 
761 (w), 752 (w), 717 (w), 701 (s), 681 (w), 667 (w), 623 (w), 600 (w), 559 (m), 536 
(w), 518 (m), 497 (w), 474 (m), 438 (w). HRMS (ES+) m/z calculated for 
[C27H23O2BrF3]+ [M+H]+: 514.0755, found: 514.0761.
4.12g: Synthesised according to General Procedure 9 using 4.10k 
(32 mg, 0.1 mmol) with B(C6F5)3 (3 mg, 5 mol%) and was heated for 
54 h to give a white oil after filtration and removal of solvent. Rf
value: 0.23 (SiO2, hexane/CHCl3 1:2). Yield: 17 mg, 0.055 mmol, 
55%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm:  7.38 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 
7.31–7.20 (m, 5H, Ar-H), 7.15 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 4.05 (q, 3JHH = 7.0 Hz, 1H, 
C(H)(Me)Ar), 2.39 (s, 3H, CH3), 2.15 (d, 2JHH = 16.8 Hz, 1H, CH2), 1.89 (d, 2JHH = 16.8 
Hz, 1H, CH2), 1.45 (d, 3JHH = 7.1 Hz, 3H, C(H)(Me)Ar), 1.26 (s, 3H, CH3), 1.07 (s, 3H, 
CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 174.2 (s), 145.9 (s), 142.9 (s), 139.0 
(s), 130.4 (s), 129.3 (s), 128.8 (s), 128.4 (s), 127.4 (s), 126.6 (s), 117.5 (s), 38.2 (s), 
36.1 (s), 34.3 (s), 24.7 (s), 24.7 (s), 21.5 (s), 17.3 (s). IR ʋmax (cm-1): 1753 (w), 1448 
(s), 1386 (s), 1170 (s), 1072 (w), 1024 (m), 910 (s), 827 (s), 777 (s), 732 (m), 700 (w), 
410 (s), 401 (m). HRMS (ES+) m/z calculated for [C29H21O2F]+ [M+H]+: 320.1855, 
found: 320.1856.
4.12h: Synthesised according to General Procedure 9 using 4.10l 
(41 mg, 0.1 mmol) and B(C6F5)3 (5 mg, 10 µmol, 10 mol%) and was 
heated for 24 h to give a white oil after filtration and removal of 
solvent. Yield: 29 mg, 0.071 mmol, 71%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 8.39–8.35 (m, 1H, Ar-H), 7.45–7.37 (m, 7H, Ar-H), 7.32–7.26 (m, 3H, 
Ar-H), 7.20–7.14 (m, 5H, Ar-H), 6.99–6.94 (m, 2H, Ar-H), 5.82 (s, 1H, C(H)Ar2). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 162.2 (s), 161.6 (d, 1JCF = 246 Hz), 154.4 (s), 
141.2 (s), 137.2 (s), 137.1 (s), 137.1 (s), 133.9 (s), 133.3 (s), 130.7 (d, 3JCF = 7.9 Hz), 
130.1 (s), 130.1 (s), 129.2 (s), 129.0 (s), 128.8 (s), 128.6 (s), 127.9 (s), 127.2 (s), 
127.0 (s), 122.0 (s), 115.5 (d, 2JCF = 21.3 Hz), 49.3 (s). 19F NMR (376 MHz, CDCl3)
δ/ppm: -115.92 (s, 1F, p-F). IR ʋmax (cm-1): 3059 (w), 1774 (w), 1730 (s), 1624 (w), 
1602 (m), 1560 (w), 1504 (m), 1483 (m), 1448 (m), 1305 (w), 1222 (m), 1159 (m), 
1136 (w), 1093 (s), 1051 (m), 1029 (m), 1002 (m), 905 (w), 873 (w), 831 (m), 792 (w), 
765 (s), 729 (s), 685 (s), 611 (w). HRMS (ES+) m/z calculated for [C28H19O2F]+ [M+H]+
406.1369, found: 406.1366.
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4.12i: Synthesised according to General Procedure 9 using 4.10m 
(43 mg, 0.1 mmol) and B(C6F5)3 (6 mg, 10 µmol, 10 mol%) and was 
heated for 24 h to give a white oil after filtration and removal of 
solvent. Yield: 33 mg, 0.078 mmol, 78%. 1H NMR (400 MHz, CDCl3, 
298 K) δ/ppm: 8.39–8.34 (m, 1H, Ar-H), 7.46–7.35 (m, 8H, Ar-H), 
7.32–7.26 (m, 3H, Ar-H), 7.24 (s, 1H, Ar-H), 7.20–7.11 (m, 5H, Ar-H), 5.81 (s, 1H, 
C(H)Ar2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 162.2. (s), 154.5 (s), 140.9 (s), 
139.9 (s), 137.1 (s), 133.9 (s), 133.3 (s), 132.7 (s), 130.5 (s), 130.1 (s), 130.1 (s), 
129.2 (s), 129.0 (s), 128.8 (s), 128.8 (s), 128.7 (s), 128.0 (s), 127.1 (s), 127.0 (s), 
122.0 (s), 114.9 (s), 49.4 (s). IR ʋmax (cm-1): 3026 (w), 2962 (w), 1778 (w), 1730 (s), 
1602 (m), 1560 (w), 1483 (s), 1404 (w), 1305 (m), 1284 (m), 1261 (m), 1224 (m), 1136 
(w), 1089 (s), 1051 (m), 1029 (s), 1012 (s), 906 (m), 825 (m), 796 (m), 765 (m), 746 
(m), 727 (s), 705 (s), 646 (m), 619 (w), 609 (w). HRMS (ES+) m/z calculated for 
[C29H21O2Br]+ [M+H]+: 422.1082, found: 480.1074.
4.12j: Synthesised according to General Procedure 9 using 4.10n 
(47 mg, 0.1 mmol) and B(C6F5)3 (6 mg, 10 µmol, 10 mol%) and 
was heated for 24 h to give a white solid after filtration and removal 
of solvent. Yield: 35 mg, 0.075 mmol, 75%. Melting point: 85–91 
°C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.31–8.27 (m, 1H, 
Ar-H), 7.37–7.27 (m, 10H, Ar-H), 7.24–7.18 (m, 3H, Ar-H), 7.12–7.08 (m, 2H, Ar-H), 
7.02–6.98 (m, 2H, Ar-H), 5.71 (s, 1H, C(H)Ar2). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 162.2 (s), 154.5 (s), 140.8 (s), 140.4 (s), 137.1 (s), 133.9 (s), 133.3 (s), 131.7 
(s), 130.9 (s), 130.1 (s), 130.1 (s), 129.2 (s), 129.0 (s), 128.8 (s), 128.7 (s), 128.0 (s), 
127.1 (s), 127.04 (s), 121.9 (s), 120.8 (s), 114.8 (s), 49.5 (s). IR ʋmax (cm-1): 2945 (w), 
1778 (w), 1732 (s), 1604 (m), 1560 (w), 1483 (s), 1446 (m), 1398 (w), 1305 (m), 1284 
(m), 1226 (m), 1182 (m), 1136 (w), 1093 (s), 1074 (s), 1051 (m), 1029 (s), 1008 (s), 
908 (w), 825 (m), 792 (w), 765 (m), 744 (m), 695 (s). HRMS (ES+) m/z calculated for 
[C29H21O2Br]+ [M+H]+: 466.0568, found: 466.0570.
4.12k: Synthesised according to General Procedure 9 using 
4.10o (34 mg, 0.1 mmol) with B(C6F5)3 (6 mg, 10 mol%) and was 
heated for 43 h to give a white oil after filtration and removal of 
solvent. Rf value: 0.22 (SiO2, hexane/CHCl3 1:2). Yield: 25 mg, 
0.073 mmol, 73%. 1H NMR (500 MHz, CDCl3) δ/ppm: 8.33 (d, 
3JHH = 7.5 Hz, 1H, Ar-H), 7.49–7.36 (m, 4H, Ar-H), 7.33–7.16 (m, 8H, Ar-H), 4.53 (q, 
3JHH = 7.1 Hz, 1H, C(H)(Me)Ar), 2.36 (s, 3H, CH3), 1.74 (d, 3JHH = 7.3 Hz, 3H, 
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C(H)(Me)Ar). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.6 (s), 153.0 (s), 143.4 
(s), 139.9 (s), 136.6 (s), 133.9 (s), 130.2 (s), 129.4 (s), 129.0 (s), 128.8 (s), 127.6 (s), 
126.8 (s), 126.3 (s), 126.2 (s), 125.3 (s), 122.2 (s), 117.0 (s), 37.2 (s), 21.5 (s), 18.7 
(s). IR ʋmax (cm-1): 1728 (w), 1105 (m), 1483 (s), 1078 (m), 1062 (m), 1022 (m), 812 
(s), 783 (s), 767 (w), 725 (w), 698 (w), 661 (s), 513 (s), 497 (s). HRMS (ES+) m/z 
calculated for [C29H21O2F]+ [M+H]+: 341.1542, found: 341.1530.
4.12l: Synthesised according to General Procedure 9 using 
4.10p (42 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 mol%) 
and was heated for 6 h to give a white solid after filtration and 
removal of solvent. Yield: 41 mg, 0.097 mmol, 97%. Melting 
point: 142–148 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
8.26–8.23 (m, 1H, Ar-H), 7.31–7.22 (m, 4H, Ar-H), 7.20–7.11 (m, 4H, Ar-H), 7.10–
7.03 (m, 7H, Ar-H), 6.88–6.83 (m, 2H, Ar-H), 5.74 (s, 1H, C(H)Ar2), 2.27 (s, 3H, CH3).
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.4 (s), 161.6 (d, 1JCF = 246 Hz), 154.6 
(s), 141.3 (s), 140.3 (s), 137.3 (s), 137.2 (s), 133.8 (s), 130.7 (d, 3JCF = 7.8 Hz), 130.4 
(s), 130.0 (s), 129.3 (s), 129.0 (s), 129.0 (s), 128.7 (s), 127.8 (s), 127.1 (s), 126.9 (s), 
121.9 (s), 115.4 (d, 2JCF = 21.3 Hz), 114.8 (s), 49.3 (s), 21.5 (s). 19F NMR (471 MHz, 
CDCl3, 298 K) δ/ppm: -115.94 – -116.02 (m, 1F, p-F). IR ʋmax (cm-1): 1737 (w), 1625 
(s), 1600 (s), 1504 (w), 1483 (m), 1446 (s), 1224 (w), 1161 (s), 1089 (w), 1051 (s), 
1024 (m), 837 (m), 825 (s), 808 (s), 765 (w), 752 (m), 727 (m), 698 (w), 677 (m), 609 
(s), 526 (w), 509 (s), 497 (s). HRMS (ES+) m/z calculated for [C29H21O2F]+ [M+H]+: 
420.1526, found: 420.1515.
4.12m: Synthesised according to General Procedure 9 using 
4.10q (44 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 mol%)
and was heated for 6 h to give a white solid after filtration and 
removal of solvent. Yield: 42 mg, 0.096 mmol, 96%. Melting 
point: 72–76 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
8.31–8.27 (m, 1H, Ar-H), 7.36–7.32 (m, 2H, Ar-H), 7.30–7.25 (m, 2H, Ar-H), 7.25–
7.14 (m, 6H, Ar-H), 7.12 (d, 3JHH = 8.0 Hz, 4H, Ar-H), 7.07 (d, 3JHH = 8.1 Hz, 2H, Ar-
H), 5.77 (s, 1H, C(H)Ar2), 2.31 (s, 3H, CH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 
162.2 (s), 154.6 (s), 140.8 (s), 140.2 (s), 139.9 (s), 137.1 (s), 133.7 (s), 132.5 (s), 
130.4 (s), 130.3 (s), 129.9 (s), 129.2 (s), 128.9 (s), 128.9 (s), 128.6 (s), 128.6 (s), 
127.7 (s), 127.0 (s), 126.9 (s), 121.8 (s), 114.5 (s), 49.3 (s), 21.5 (s). IR ʋmax (cm-1):
1730 (w), 1606 (s), 1508 (s), 1487 (m), 1448 (s), 1284 (s), 1089 (m), 1051 (s), 1026 
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(s), 1014 (s), 831 (s), 769 (m), 748 (m), 729 (s), 698 (m), 547 (s), 518 (s), 499 (s).
HRMS (ES+) m/z calculated for [C29H21O2Cl]+ [M+H]+: 436.1230, found: 233.1227.
4.12n: Synthesised according to General Procedure 9 using 
4.10r (48 mg, 0.1 mmol) and was heated for 6 h to give a white 
solid after filtration and removal of solvent. Yield: 43 mg, 0.089 
mmol, 89%. Melting point: 56–59 °C. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 8.27–8.23 (m, 1H, Ar-H), 7.32–7.27 (m, 
4H, Ar-H), 7.27–7.22 (m, 3H, Ar-H), 7.20–7.11 (m, 3H, Ar-H), 7.08 (d, 3JHH = 7.9 Hz, 
4H, Ar-H), 6.98 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 5.72 (s, 1H, C(H)Ar2), 2.28 (s, 3H, CH3).
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.3 (s), 154.7 (s), 140.8 (s), 140.5 (s), 
140.3 (s), 137.2 (s), 133.8 (s), 131.7 (s), 130.9 (s), 130.4 (s), 130.0 (s), 129.3 (s), 
129.0 (s) 129.0 (s), 128.7 (s), 127.8 (s), 127.0 (s), 127.0 (s), 121.9 (s), 120.7 (s), 
114.5 (s), 49.5 (s), 21.5 (s). IR ʋmax (cm-1): 2980 (w), 1728 (m), 1483 (m), 1091 (m), 
1074 (s), 1026 (s), 1008 (s), 769 (s), 744 (m), 727 (m), 698 (w), 682 (s), 545 (s), 516 
(s), 497 (s), 468 (s). HRMS (ES+) m/z calculated for [C29H21O2Br]+ [M+H]+: 480.0725, 
found: 480.0725.
4.12o: Synthesised according to General Procedure 9 using 4.10s 
(36 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and was 
heated for 16 h to give a yellow oil after filtration and removal of 
solvent. Yield: 29 mg, 0.080 mmol 80%. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 7.41–7.32 (m, 5H, Ar-H), 7.30–7.27 (m, 1H, Ar-H), 
7.25–7.16 (m, 3H, Ar-H), 6.99–6.93 (m, 6H, Ar-H), 6.22 (d, 3JHH = 9.6 Hz, 1H, Ar-H), 
5.37 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.8 (d, 1JCF = 247 
Hz), 161.7 (s), 159.3 (s), 146.2 (s), 142.1 (s), 138.1 (d, 3JCF = 3.3 Hz), 132.0 (s), 130.6 
(s), 130.6 (s), 130.5 (s), 129.1 (s), 129.0 (s), 128.8 (s), 128.7 (s), 127.4 (s), 117.4 (s), 
115.85 (d, 2JCF = 21.4 Hz), 114.98 (s), 49.21 (s). 19F NMR (471 MHz, CDCl3) δ/ppm: 
-115.24 – -115.32 (m, 1F, p-F). IR ʋmax (cm-1): 2980 (s), 1707 (m), 1548 (s), 1504 (w), 
1490 (m), 1446 (s), 1226 (m), 1157 (m), 1116 (s), 1097 (m), 1076 (s), 991 (s), 852 
(s), 825 (w), 806 (s), 771 (m), 759 (m), 732 (w), 698 (w), 663 (m), 644 (m), 615 (m), 
594 (w), 565 (w), 526 (s), 509 (w). HRMS (ES+) m/z calculated for [C24H17O2F]+
[M+H]+: 356.1213, found: 356.1209.
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4.12p: Synthesised according to General Procedure 9 using 4.10t 
(38 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and was 
heated for 24 h to give a yellow solid after filtration and removal of 
solvent. Yield: 29 mg, 0.078 mmol 78%. Melting point: 45 °C. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.41–7.35 (m, 4H, Ar-H), 
7.31–7.27 (m, 3H, Ar-H), 7.25–7.20 (m, 3H, Ar-H), 7.19–7.16 (m, 1H, Ar-H), 6.98 (d, 
3JHH = 7.1 Hz, 2H, Ar-H), 6.95–6.92 (m, 2H, Ar-H), 6.23 (d, 3JHH = 9.6 Hz, 1H, Ar-H), 
5.37 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 161.6 (s), 159.5 (s), 
146.1 (s), 141.8 (s), 140.9 (s), 133.2 (s), 132.1 (s), 131.9 (s), 130.6 (s), 130.4 (s), 
129.1 (s), 129.1 (s), 129.0 (s), 128.8 (s), 128.7 (s), 117.1 (s), 115.0 (s), 49.4 (s). IR
ʋmax (cm-1): 2980 (s), 1720 (w), 1543 (s), 1489 (w), 1446 (m), 1155 (m), 1089 (m), 
1014 (s), 1002 (s), 991 (s), 819 (m), 752 (m), 734 (m), 696 (w), 663 (s), 615 (s), 594 
(m), 514 (s), 491 (m). HRMS (ES+) m/z calculated for [C24H17O2Cl]+ [M+H]+: 372.0917, 
found: 372.0914.
4.12q: Synthesised according to General Procedure 9 using 4.10u 
(42 mg, 0.1 mmol) and B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and was 
heated for 24 h to give a yellow oil after filtration and removal of 
solvent. Yield: 30 mg, 0.072 mmol 72%. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 7.39–7.32 (m, 6H, Ar-H), 7.25–7.17 (m, 4H, Ar-H), 
7.16–7.12 (m, 1H, Ar-H), 6.94 (d, 3JHH = 7.5 Hz, 2H, Ar-H), 6.86–6.82 (m, 2H, Ar-H), 
6.20 (d, 3JHH = 9.6 Hz, 1H, Ar-H), 5.32 (s, 1H, C(H)Ar2). 13C NMR (126 MHz, CDCl3, 
298 K) δ/ppm: 160.5 (s), 158.3 (s), 144.9 (s), 140.6 (s), 140.3 (s), 130.9 (s), 129.6 (s), 
129.4 (s), 128.0 (s), 127.8 (s), 127.6 (s), 127.6 (s), 126.3 (s), 126.1 (s), 120.1 (s), 
115.9 (s), 113.9 (s), 48.3 (s). IR ʋmax (cm-1): 2980 (s), 1720 (m), 1487 (m), 1155 (s), 
1097 (s), 1072 (m), 1010 (m), 993 (s), 821 (s), 750 (w), 732 (w), 696 (w), 665 (s), 594 
(m), 505 (s), 486 (s). HRMS (ES+) m/z calculated for [C24H17O2Br]+ [M+H]+: 416.0412, 
found: 416.0418.
General synthesis 10: Alkynyl ester 4.10 (0.1 mmol, 1 equiv.) was disolved in CH2Cl2
and combined with B(C6F5)3 (3 mg, 5 μmol, 5 mol%) with subsequent heating to 70 
°C for 8 h. At this time silane (0.1 mmol, 1 equiv.) was added and the reaction mixture 
heated again at 70 °C for 8 h. Removal of solvents in vacuo yielded the pure cyclic 
silylacetal product 6. Note: NMR spectra show both conformations of cyclic 
silylacetals in a ca. 1:1 ratio, however, both diastereomers showed considerable 
overlap with one another so could not be independantly reported. 
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4.13a: Synthesised according to General Procedure 10 using 4.10d 
(39 mg, 0.1 mmol) along with B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and 
HSiPh3 (26 mg, 0.1 mmol, 1 equiv.) to give a white powdery solid 
upon removal of volatiles. Yield: 61 mg, 0.09 mmol, 95%. Melting 
point: 120–127 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.53 (m, 6H, Ar-H), 7.38 
(m, 4H, Ar-H), 7.31–7.17 (m, 9H, Ar-H), 7.10–7.02 (m, 5H, Ar-H), 6.92 (m, 2H, Ar-H), 
6.78 (m, 2H, Ar-H), 5.03 (m, 1H, C(H)O2), 4.98 (m, 1H, C(H)Ar2), 2.08 (d, 2JHH = 17.4 
Hz, 1H, CH2), 1.65 (d, 2JHH = 16.7 Hz, 1H, CH2), 0.97–0.95 (m, 6H, C(CH3)2). 13C NMR
(101 MHz, CDCl3, 298 K) δ/ppm: 161.5 (d, 1JCF = 254 Hz), 145.5 (s), 143.4 (s), 139.4 
(d, 3JCF = 13.0 Hz), 136.0 (s), 136.0 (s), 134.1 (s), 131.0 (s), 130.8 (s), 130.3 (s), 130.1 
(s), 129.5 (s), 129.3 (s), 128.9 (s), 128.4 (s), 128.3 (s), 128.1 (s), 128.0 (s), 126.4 (s), 
115.1 (d, 2JCF = 21.2 Hz), 109.5 (s), 98.6 (s), 51.5 (s), 33.7 (s), 32.0 (s), 25.5 (s), 24.2 
(s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -116.99 (s, 1F, p-F), -117.18 (s, 1F, p-
F). 29Si NMR (79 MHz, CDCl3, 298 K) δ/ppm: -11.7 (s, SiPh3). IR ʋmax (cm-1): 3198 
(w), 3009 (m), 2931 (w), 2854 (m), 2439 (m), 2320 (w), 2229 (s), 2094 (s), 2058 (s), 
2021 (w), 2000 (w), 1948 (s), 1897 (w), 1751 (m), 1705 (m), 1653 (m), 1625 (w), 1537 
(m), 1490 (m), 1395 (s), 1346 (m), 1311 (m), 1274 (m), 1209 (m), 1128 (m), 1051 (s), 
1021 (s), 876 (w), 781 (m), 758 (m), 744 (m). HRMS (ES+) m/z calculated for 
[C44H40FO2Si]+ [M+H]+: 647.2782, found: 647.2781. 
4.13b: Synthesised according to General Procedure 10 using 4.10e
(40 mg, 0.1 mmol) along with B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and 
HSiPh3 (26 mg, 0.1 mmol, 1 equiv.) to give a white powdery solid 
upon removal of volatiles. Yield: 61 mg, 0.09 mmol, 92%. Melting 
point: 70–75 °C. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.63 (d, 3JHH = 7.0 Hz, 6H, 
Ar-H), 7.48 (m, 4H, Ar-H), 7.41–7.26 (m, 10H, Ar-H), 7.21–7.10 (m, 6H, Ar-H), 6.86 
(d, 3JHH = 7.4 Hz, 2H, Ar-H), 5.11 (m, 1H, C(H)O2), 5.07 (m, 1H, C(H)Ar2), 2.16 (t, 2JHH
= 16.7 Hz, 1H, CH2), 1.74 (dd, 2JHH = 16.6 Hz, 1H, CH2), 1.07–1.04 (m, 6H, C(CH3)2). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 145.5 (s), 143.1 (s), 142.2 (s), 135.9 (s), 
135.9 (s), 135.1 (s), 134.0 (s), 131.9 (s), 130.9 (s), 130.6 (s), 130.3 (s), 129.4 (s), 
129.2 (s), 128.7 (s), 128.4 (s), 128.3 (s), 128.2 (s), 128.1 (s), 126.5 (s), 109.0 (s), 98.5
(s), 51.5 (s), 33.6 (s), 31.9 (s), 25.5 (s), 24.1 (s). 29Si NMR (79 MHz, CDCl3, 298 K) 
δ/ppm: -11.7 (s, SiPh3). IR ʋmax (cm-1): 3049 (w), 2972 (w), 2903 (w), 1668 (w), 1599 
(w), 1504 (m), 1490 (w), 1427 (m), 1388 (w), 1359 (w), 1334 (w), 1284 (w), 1221 (m), 
1159 (w), 1114 (s), 1047 (s), 1029 (m), 974 (m), 949 (w), 902 (m), 875 (m), 852 (s), 
827 (m), 813 (w), 727 (s), 695 (s), 603 (m). HRMS (ES+) m/z calculated for 
[C44H40ClO2Si]+ [M+H]+: 663.2486, found: 663.2480.
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4.13c: Synthesised according to General Procedure 10 using 4.10f
(45 mg, 0.1 mmol) along with B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and 
HSiPh3 (26 mg, 0.1 mmol, 1 equiv.) to give a white powdery solid 
upon removal of volatiles. Yield: 64 mg, 0.09 mmol, 90%. Melting 
point: 80–86 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.54 (m, 6H, Ar-H), 7.37 
(m, 4H, Ar-H), 7.28 (m, 8H, Ar-H), 7.20–7.15 (m, 2H, Ar-H), 7.07 (m, 4H, Ar-H), 7.01–
6.96 (m, 2H, Ar-H), 7.01 (m, 2H, Ar-H), 5.00 (m, 2H, C(H)O2, C(H)Ar2), 2.12–2.04 (m, 
1H, CH2), 1.68–1.62 (t, 2JHH = 16.1 Hz, 1H, CH2), 0.97–0.96 (m, 6H, C(CH3)2). 13C 
NMR (126 MHz, CDCl3, 298 K) δ/ppm: 145.6 (s), 143.0 (s), 142.9 (s), 135.9 (s), 134.0 
(s), 131.3 (s), 131.1 (s), 130.3 (s), 129.4 (s), 129.2 (s), 128.7 (s), 128.3 (s), 128.1 (s), 
128.0 (s), 126.5 (s), 120.1 (s), 109.0 (s), 98.5 (s), 51.7 (s), 33.6 (s), 31.8 (s), 25.3 (s), 
24.1 (s). 29Si NMR (99 MHz, CDCl3, 298 K) δ/ppm: -11.8 (s, SiPh3). IR ʋmax (cm-1):
3067 (w), 2903 (w), 1647 (w), 1589 (w), 1518 (w), 1485 (w), 1485 (m), 1468 (m), 1427 
(m), 1391 (w), 1364 (w), 1335 (w), 1287 (w), 1235 (w), 1188 (w), 1157 (w), 1115 (s), 
1047 1115 (s), 1028 1115 (s), 976 1115 (s), 949 (w), 923 (w), 871 (w), 851 (w), 831 
(w), 793 (w), 769 (w), 738 (w), 710 (s), 695 (s), 621 (w), 600 (w), 553 (w), 507 (s). 
HRMS (ES+) m/z calculated for [C44H39BrO2SiNa]+ [M+Na]+: 729.1800, found: 
729.1801.
4.13d: Synthesised according to General Procedure 10 using 4.10d
(39 mg, 0.1 mmol) along with B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and 
HSiEt3 (12 mg, 0.1 mmol, 1 equiv.) to give a pale yellow oil upon 
removal of volatiles. Yield: 47 mg, 0.09 mmol, 93%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.34–7.24 (m, 8H, Ar-H), 7.18–7.09 (4H, Ar-H), 6.99 (m, 
2H, Ar-H), 5.12 (s, 1H, C(H)O2), 4.90 (s, 1H, C(H)Ar2), 2.00 (t, 2J HH = 17.4 Hz, 1H, 
CH2), 1.57 (m, 1H, CH2), 1.01–0.98 (m, 15H, 3 x CH3 (SiEt3), C(CH3)2), 0.70 (m, 6H, 
3 x CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 161.2 (d, 1JCF = 255 Hz) 145.6 
(s), 143.3 (s), 139.5 (d, 2JCF = 28.2 Hz), 139.2 (s), 136.5 (s), 130.9 (s), 130.8 (s), 129.4 
(s), 129.2 (s), 128.7 (s), 128.3 (s), 128.2 (s), 128.1 (s), 126.2 (s), 114.9 (d, 3JCF = 13.9 
Hz), 109.4 (s), 98.3 (s), 51.3 (s), 33.4 (s), 32.2 (s), 24.5 (s), 24.2 (s), 6.9 (s), 5.0 (s).
19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -117.27 (s, p-F), -117.56 (s, p-F). 29Si NMR
(79 MHz, CDCl3, 298 K) δ/ppm: 19.7 (s, SiEt3). IR ʋmax (cm-1): 3067 (w), 2970 (w), 
1962 (w), 1824 (w), 1689 (s), 1599 (w), 1518 (w), 1489 (w), 1468 (m), 1427 (s), 1304 
(m), 1257 (w), 1226 (m), 1205 (w), 1158 (w), 1141 (w), 1117 (s), 1094 (s), 1028 (w), 
997 (w), 974 (w), 945 (w), 920 (w), 854 (w), 758 (m), 737 (m), 711 (s), 695 (s), 594 
(w), 502 (s), 482 (s), 420 (m). HRMS (AP+) m/z calculated for [C32H40FO2Si]+ [M+H]+: 
503.2782, found: 503.2775.
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4.13e: Synthesised according to General Procedure 10 using 4.10e
(40 mg, 0.1 mmol) along with B(C6F5)3 (3 mg, 5 µmol, 5 mol%) and 
HSiEt3 (12 mg, 0.1 mmol, 1 equiv.) to give a pale yellow oil upon 
removal of volatiles. Yield: 47 mg, 0.09 mmol, 91%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.21–7.12 (m, 10H, Ar-H), 7.04–6.95 (m, 4H, Ar-H), 4.98 
(s, 1H, C(H)O2), 4.77 (s, 1H, C(H)Ar2), 1.87 (m, 1H, CH2), 1.44 (m, 1H, CH2), 0.88–
0.85 (m, 15H, 3 x CH3 (SiEt3), C(CH3)2), 0.60–0.55 (m, 6H, 3 x CH2). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 145.8 (s), 143.2 (s), 142.3 (s), 136.5 (s), 131.9 (s), 130.8 
(s), 130.2 (s), 129.4 (s), 129.2 (s), 129.2 (s), 129.1 (s), 128.7 (s), 128.3 (s), 128.2 (s), 
128.2 (s), 126.3 (s), 109.1 (s), 98.4 (s), 51.5 (s), 33.4 (s), 32.3 (s), 24.4 (s), 24.2 (s), 
6.9 (s), 5.0 (s). 29Si NMR (99 MHz, CDCl3, 298 K) δ/ppm: 19.7 (s, SiEt3). IR ʋmax (cm-
1): 2955 (w), 2874 (w), 1761 (w), 1728 (w), 1647 (w), 1601 (w), 1518 (w), 1489 (m), 
1468 (s), 1408 (w), 1389 (w), 1284 (w), 1238 (m), 1179 (w), 1155 (w), 188 (s), 1059 
(s), 1014 (s), 974 (s), 923 (w), 831 (w), 792 (w), 768 (m), 729 (s), 698 (s), 623 (w), 
551 (w), 488 (w). HRMS (ES+) m/z calculated for [C32H40ClO2Si]+ [M+H]+: 519.2486, 
found: 519.2480.
4.13f: Synthesised according to General Procedure 10 using 4.10f
(45 mg, 0.1 mmol) along with B(C6F5)3 (2 mg, 5 mol%) and HSiEt3
(12 mg, 0.1 mmol, 1 equiv.) to give a clear pale yellow oil upon 
removal of volatiles. Yield: 53 mg, 0.09 mmol, 95%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.36 (dd, 3JHH = 7.9 Hz, 2H, Ar-H), 7.26–7.18 (m, 8H, Ar-
H), 7.08 (dd, 3JHH = 7.6 Hz, 2H, Ar-H), 6.98 (dd, 3JHH = 7.9 Hz, 2H, Ar-H), 5.03 (s, 1H, 
C(H)CO2), 4.84 (s, 1H, C(H)Ar2), 1.93 (m, 1H, CH2), 1.50 (m, 1H, CH2), 0.95–0.90 (m, 
15H, 3 x CH3 (SiEt3), C(CH3)2), 0.66–0.62 (m, 6H, 3 x CH2). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 145.8 (s), 143.1 (s), 142.8 (s), 136.5 (s), 131.2 (s), 129.4 (s), 
129.2 (s), 128.3 (s), 128.2 (s), 128.2 (s), 126.3 (s), 120.0 (s), 109.0 (s), 98.4 (s), 51.5 
(s), 33.4 (s), 32.1 (s), 24.5 (s), 24.2 (s), 6.9 (s), 5.1 (s). 29Si NMR (99 MHz, CDCl3, 
298 K) δ/ppm: 19.8 (s, SiEt3), 19.7 (s, SiEt3). IR ʋmax (cm-1): 2955 (w), 2908 (w), 2874 
(w), 1761 (m), 1724 (m), 1647 (m), 1600 (w), 1518 (m), 1485 (s), 1466 (s), 1391 (m), 
1344 (w), 1285 (m), 1238 (m), 1155 (w), 1103 (s), 1070 (s), 1029 (m), 1011 (s), 974 
(s), 831 (w), 802 (w), 768 (m), 739 (s), 695 (s), 621 (w), 551 (m), 480 (m). HRMS
(ES+) m/z calculated for [C32H40BrO2Si]+ [M+H]+: 563.1981, found: 563.1982.
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6.4.5 Computational Studies 
All geometry optimisations were undertaken using the B3LYP functional[152a] and 6-
31G* basis set[154] within Gaussian09.[178] Subsequent single point calculations were 
undertaken using the B3LYP functional and larger 6-311G*+ basis set. 
6.4.6 Crystallographic Studies
Crystallographic studies were undertaken on single crystal mounted in paratone and 
studied on an Agilent SuperNova Dual three-circle diffractometer using Cu-Kα or Mo-
Kα radiation and a CCD detector. Measurements were typically made at 150(1) K with 
temperatures maintained using an Oxford cryostream. Data were collected and 
integrated and data corrected for absorption using a numerical absorption correction 
based on gaussian integration over a multifaceted crystal model within 
CrysAlisPro.[156] The structures were solved by direct methods and refined against F2
within SHELXL-2013.[170] The structures have been deposited with the Cambridge 
Structural Database (CCDC deposition numbers 1417004,1417005, 1480722–
1480724, 1517858–1517863, 1524192–1524195 and 1545638–1545640). 
Table 6.4.1 Crystallographic data for compounds 4.3–4.13.
Compound 4.3a 4.3b 4.5 4.6
Empirical Formula C30H10BF15O2 C28H14BF15O2 C49H24BF15O2 C53H32BF15O2Se
Crystal System Monoclinic Monoclinic Monoclinic Monoclinic
Space Group P21/n P21/n P21/c P21/c
a/Å 10.53693(10) 10.9906(3) 15.9561(6) 17.4913(9)
b/Å 13.77283(16) 10.9906(3) 18.8796(7) 12.8840(7)
c/Å 36.3610(4) 14.4145(3) 13.6604(7) 20.4750(10)
α/o 90 90 90 90
β/o 95.1711(10) 91.562(2) 102.743(4) 96.260(4)
γ/o 90 90 90 90
V/Å3 5255.36(10) 2539.55(10) 4013.8(3) 4586.7(4)
Z 8 4 4 4
T /K 150(2) 150(2) 150(2) 150(2)
Dc/g.cm-3 1.765 1.774 1.556 1.558
Crystal size/mm 0.370 x 0.130 x 0.090 0.170 x 0.060 x 0.040 0.320 x 0.120 x 0.050 0.343 x 0.151 x 0.051
Total data 21738 10428 13686 25867
Unique data 10388 5024 6802 8046
Rint 0.0188 0.0415 0.0337 0.0663
R1[F2>2 σ(F2)] 0.0343 0.0389 0.0500 0.0558
wR2 (all data) 0.0915 0.1235 0.1498 0.1367
GoF 1.041 1.140 1.022 1.054
ρmin/ρmax/eÅ-3 -0.250/0.288 -0.224/0.423 -0.243/0.484 -0.794/0.880
CCDC code 1417004 1417005 1480722 1480723
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Compound 4.7 4.11a 4.11d 4.11e
Empirical Formula C42H29Cl5O2Se3 C31H14BF15O2 C34H12BCl2F15O2 C35H14BCl2F15O2
Crystal System Triclinic monoclinic triclinic triclinic
Space Group P-1 P21/n P-1 P-1 
a/Å 9.1231(4) 13.9659(5) 10.8906(6) 10.2165(4)
b/Å 13.3695(6) 11.7430(5) 11.6131(10) 11.5168(6)
c/Å 16.6564(8) 17.0158(7) 12.4826(7) 14.9858(8)
α/o 73.574(4) 90 90.902(6) 95.385(4)
β/o 83.219(4) 98.501(4) 95.194(5) 94.461(4)
γ/o 87.728(4) 90 98.525(6) 111.742(4)
V/Å3 1934.99(15) 2759.97(19) 1554.20(19) 1618.47(14)
Z 2 4 2 2
T /K 150(2) 150(2) 150(2) 150(2)
Dc/g.cm-3 1.682 1.719 1.750 1.710    
Crystal size/mm 0.360 x 0.110 x 0.030 0.497 x 0.425 x 0.303 0.389 x 0.136 x 0.076 0.227 x 0.171 x 0.081
Total data 13349 15097 10405 10489
Unique data 7599 5996 5660 5710
Rint 0.0458 0.0399 0.0398 0.0304
R1[F2>2 σ(F2)] 0.0357 0.0425 0.0413 0.0368
wR2 (all data) 0.1002 0.1059 0.1214 0.1009
GoF 1.036 1.026 1.016 1.016
ρmin/ρmax/eÅ-3 -0.601/0.850 -0.218/0.331 -0.525/0.380 -0.689/0.274
CCDC code 1480724 1524194 1545638 1545639
Compound 4.11h 4.11i 4.11m 4.11v
Empirical Formula C44H23BF16O2 C44H23BClF15O2 C45H22BClF18O2 C43H17BCl3F16O2
Crystal System monoclinic monoclinic orthorhombic Orthorhombic
Space Group P21/n P 21/c Pbca Pbca
a/Å 16.4273(3) 17.3148(13) 11.6820(3) 16.6460(4)
b/Å 12.13337(18) 11.6132(5) 20.9042(5) 16.9974(5)
c/Å 21.5533(3) 20.9195(13) 33.1030(11) 27.5259(8)
α/o 90 90 90 90
β/o 103.2592(15) 113.426(8) 90 90
γ/o 90 90 90 90
V/Å3 4181.44(11) 3859.7(5) 8083.8(4) 7788.1(4)
Z 4 4 8 8
T /K 100(2) 173(2) 173(2) 150(2)
Dc/g.cm-3 1.426 1.573 1.614 1.683  
Crystal size/mm 0.220 x 0.140 x 0.135 0.070 x 0.030 x 0.020 0.110 x 0.080 x 0.050 0.392 x 0.231 x 0.054
Total data 51694 35904 48324 28641
Unique data 9543 6829 7135 7808
Rint 0.0144 0.0680 0.0539 0.0278
R1[F2>2 σ(F2)] 0.0386 0.0579 0.0674 0.0521
wR2 (all data) 0.1026 0.1366 0.1794 0.1540
GoF 1.066 1.046 1.060 1.044
ρmin/ρmax/eÅ-3 -0.210/0.390 -0.276/0.304 -0.339/0.696 -0.889/0.620
CCDC code 1517858 1517859 1517860 1545640
Chapter 6: Experimental
210
Compound 4.12a 4.12c 4.12f 4.13a
Empirical Formula C14H16O3 C26H23FO2 C27H22BrF3O2 C44H39FO2Si
Crystal System Monoclinic Triclinic Monoclinic Triclinic
Space Group P21/n P-1 P21/n P-1 
a/Å 6.2006(4) 9.8670(7) 10.3127(3) 9.7701(2)
b/Å 7.1664(5) 9.8812(10) 9.3262(3) 18.8537(4)
c/Å 27.3075(16) 11.2904(11) 23.4030(6) 19.9681(4)
α/o 90 69.648(9) 90 87.5026(18)
β/o 94.857(6) 78.120(7) 92.792(2) 83.8723(19)
γ/o 90 86.424(7) 90 81.812(2)
V/Å3 1209.09(13) 1009.92(17) 2248.20(11) 3618.36(15)
Z 4 2 4 4
T /K 150(2) 100(2) 100(2) 150
Dc/g.cm-3 1.276 1.267 1.520 1.186
Crystal size/mm 0.284 x 0.245 x 0.117 0.180 x 0.160 x 0.120 0.100 x 0.050 x 0.010 0.421 x 0.220 x 0.127
Total data 5630 12495 53772 65007
Unique data 2849 4584 5121 14425
Rint 0.0374 0.0185 0.0519 0.0355
R1[F2>2 σ(F2)] 0.0478 0.0395 0.0701 0.0439
wR2 (all data) 0.1222 0.1033 0.1473 0.1182
GoF 1.043 1.008 1.124 1.014
ρmin/ρmax/eÅ-3 -0.282/0.207 -0.214/0.228 -0.798/0.525 -0.500/0.366
CCDC code 1524195 1517861 1517862 1517863
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6.5 Boron Mediated and Catalysed Reduction Reactions: 
Emerging Catalysts, Novel Processing Techniques and 
Transfer Hydrogenation
6.5.1 Tempering Lewis Acidity of Boranes for General Hydroboration 
Reactions
6.5.1.1 Synthesis of Starting Materials
General Procedure 1: Synthesised according to the literature[164] whereby propargyl 
alcohol (0.72 ml, 12.5 mmol, 1 equiv.) was dissolved in 100 ml CH2Cl2 and cooled to 
-78 °C. Tetramethylethylenediamine (TMEDA) (1.12 ml, 7.5 mmol, 0.6 equiv.) was 
added followed by dropwise addition of acyl chloride (13.8 mmol, 1.1 equiv.). After 
stirring at this temperature for 30 minutes the reaction was warmed to room 
temperature and quenched with saturated NH4Cl solution. The aqueous phase was 
extracted with CH2Cl2 (3 x 30 ml) with the combined organic phases being washed 
with H2O then dried over K2CO3 and Na2SO4. Removal of volatiles under reduced 
pressure gave the crude product as a pale yellow oil. This was purified by either 
recrystallisation or column chromatography.
General Procedure 2: According to the literature[20] whereby triethylamine (1.0 equiv.) 
and 4-dimethylaminopyridine (4-DMAP) (0.02 equiv.) were added to a solution of the 
propargyl alcohol (1.0 equiv.) in CH2Cl2 (ca. 20 ml) and was stirred for 5 min. The 
solution was cooled to 0 °C and the acyl chloride (1.0 equiv.) added dropwise. The 
resulting mixture was stirred at this temperature for 30 min and was then allowed to 
warm to room temperature and was stirred for a further 48 h. The reaction was 
quenched with water and the aqueous layer extracted twice with CH2Cl2. The 
collective organic phases were washed with brine, dried with MgSO4, filtered, and the 
solvent was removed under vacuum and the product purified by column 
chromatography or recrystallisation.
Prop-2-yn-1-yl benzoate: Synthesised according to General Procedure 
1 using benzoyl chloride (1.60 ml, 13.8 mmol, 1.1 equiv.). Purification 
via column chromatography (hexane/ethyl acetate, 20:1) gave the pure 
product as a colourless oil. Yield: 1.82 g, 11.4 mmol, 91%. 
Spectroscopic analyses agree with literature established values.[165] 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 8.09 – 8.07 (m, 2H, Ar-H), 7.58 (tt, 3JHH = 7.5 Hz, 4JHH = 
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1.3 Hz, 1H, Ar-H), 7.45 (t, 3JHH = 7.6 Hz, 2H, Ar-H), 4.93 (d, 4JHH = 2.5 Hz, 2H, CH2), 
2.52 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 
Prop-2-yn-1-yl-4-methylbenznoate: Synthesised according to 
General Procedure 1 using p-toluoyl chloride (1.82 ml, 13.8 mmol, 
1.1 equiv.). Recrystallisation from hexane by slow evaporation 
afforded the product as a white crystalline solid. Yield: 2.17 g, 12.5 
mmol, 100%. Spectroscopic analyses agree with literature established values.[20] 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.96 (d, 3JHH = 8.1 Hz, 2H, Ar-H), 7.25 (d, 3JHH
= 8.1 Hz, 2H, Ar-H), 4.91 (d, 4JHH = 2.5 Hz, 2H, CH2), 2.51 (t, 4JHH = 2.5 Hz, 1H, ≡CH), 
2.41 (s, 3H, CH3). 
Prop-2-yn-1-yl-4-methoxybenznoate: Synthesised according to 
General Procedure 2 using p-anisoyl chloride (2.03 ml, 15 mmol, 
1.2 equiv.). Purification via column chromatography (hexane/ethyl 
acetate, 5:1) gave the pure product as a colourless oil. Yield: 1.98 
g, 10.4 mmol, 83%. Spectroscopic analyses agree with literature established 
values.[166] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.02 (dt, 3JHH = 9.0 Hz, 4JHH = 
2.2 Hz, 2H, Ar-H), 6.92 (dt, 3JHH = 9.0 Hz, 4JHH = 2.2 Hz, 2H, Ar-H), 4.89 (d, 4JHH = 2.4 
Hz, 2H, CH2), 3.86 (s, 3H, OCH3), 2.50 (t, 4JHH = 2.4 Hz, 1H, ≡CH). 
Prop-2-yn-1-yl-4-nitrobenznoate: Synthesised according to 
General Procedure 2 using p-nitrobenzoylchloride (2.77 g, 15 
mmol, 1.2 equiv.). Recrystallisation via slow evaporation of CH2Cl2
gave the pure product as a yellow crystalline solid. Yield: 2.36 g, 
11.5 mmol, 96%. Spectroscopic analyses agree with literature established values.[167]
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.30 (dt, 3JHH = 9.0 Hz, 4JHH = 2.2 Hz, 2H, 
Ar-H), 8.23 (dt, 3JHH = 9.0 Hz, 4JHH = 2.2 Hz, 2H, Ar-H), 4.97 (d, 4JHH = 2.5 Hz, 2H, 
CH2), 2.56 (t, 4JHH = 2.5 Hz, 1H, ≡CH). 
General Procedure 3: In accordance with the literature known procedure[179] the 
requisite aldehyde (10 mmol) was dissolved in CH2Cl2 (10 ml) along with 3 Å 
molecular sieves. To this the necessary amine (10 mmol) was added. The reaction 
was left at ambient temperature for 2 h at which point MgSO4 was added with 
subsequent filtration. Volatiles were removed in vacuo to leave the pure imine in 
quantitative yields.
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(E)-N-phenyl-1-(p-tolyl)methanimine: Synthesised in accordance 
with General Procedure 3 using 4-tolualdehyde (1.18 ml, 10 mmol) 
and aniline (0.91 ml, 10 mmol). Spectroscopic analyses agree with 
literature values.[180] Yield: 1.8 g, 9.2 mmol, 92%. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 8.42 (s, 1H, N=CH), 7.80 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.39 (t, 
3JHH = 7.8 Hz, 2H, Ar-H), 7.28 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 7.22 (t, 3JHH = 9.1 Hz, 3H, 
Ar-H), 2.43 (s, 3H, CH3).
(E)-1-mesityl-N-phenylmethanimine: Synthesised in accordance 
with General Procedure 3 using mesitaldehyde (1.47 ml, 10 mmol) 
and aniline (0.91 ml, 10 mmol). Spectroscopic analyses agree with 
literature values.[181] Yield: 2.0 g, 9.1 mmol, 91%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 8.80 (s, 1H, N=CH), 7.43 (t, 3JHH = 7.7 Hz, 2H, Ar-H), 
7.23–7.06 (m, 3H, Ar-H), 6.95 (s, 2H, Ar-H), 2.56 (s, 6H, CH3, mesityl), 2.35 (s, 3H, 
CH3 mesityl).
(E)-1-(4-methoxyphenyl)-N-phenylmethanimine: Synthesised in 
accordance with General Procedure 3 using 4-anisaldehyde (1.22 
ml, 10 mmol) and aniline (0.91 ml, 10 mmol). Spectroscopic 
analyses agree with literature values.[182] Yield: 2.0 mg, 9.4 mmol, 
94%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.44 (s, 1H), 7.91 (d, 3JHH = 8.7 Hz, 
2H, N=CH), 7.44 (t, 3JHH = 7.7 Hz, 2H, Ar-H), 7.30–7.14 (m, 3H, Ar-H), 7.04 (d, 3JHH = 
8.7 Hz, 2H, Ar-H), 3.93 (s, 3H, OCH3).
(E)-1-(2-methoxyphenyl)-N-phenylmethanimine: Synthesised in 
accordance with General Procedure 3 using benzaldehyde (1.21 ml, 
10 mmol) and aniline (0.91 ml, 10 mmol). Spectroscopic analyses 
agree with literature values.[183] Yield: 1.9 g, 9.0 mmol, 90%. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 8.81 (s, 1H, N=CH), 8.05 (d, 3JHH = 5.3 Hz, 1H, Ar-H), 7.26 (s, 
3H, Ar-H), 7.17–7.04 (m, 3H, Ar-H), 6.94–6.70 (m, 2H, Ar-H), 3.72 (s, 3H, OCH3).
(E)-1-(4-fluorophenyl)-N-phenylmethanimine: Synthesised in 
accordance with General Procedure 3 using benzaldehyde (1.07 ml, 
10 mmol) and aniline (0.91 ml, 10 mmol). Spectroscopic analyses 
agree with literature values.[183] Yield: 1.8 g, 9.1 mmol, 91%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 8.43 (s, 1H, N=CH), 7.91 (dd, 3JHH = 8.6, 4JHH = 5.6 
Hz, 2H, Ar-H), 7.40 (t, 3JHH = 7.7 Hz, 2H, Ar-H), 7.30–7.05 (m, 6H, Ar-H).
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(E)-1-(4-nitrophenyl)-N-phenylmethanimine: Synthesised in 
accordance with General Procedure 3 using benzaldehyde (1.51 g, 
10 mmol) and aniline (0.91 ml, 10 mmol). Spectroscopic analyses 
agree with literature values.[181] Yield: 2.1 g, 9.4 mmol, 94%. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.49 (s, 1H, N=CH), 8.26 (d, 3JHH = 8.7 Hz, 
2H, Ar-H), 8.01 (d, 3JHH = 8.7 Hz, 2H, Ar-H), 7.36 (t, 3JHH = 7.7 Hz, 2H, Ar-H), 7.28–
7.17 (m, 3H, Ar-H).
(E)-1-(naphthalen-2-yl)-N-phenylmethanimine: Synthesised in 
accordance with General Procedure 3 using benzaldehyde (1.56 g, 
10 mmol) and aniline (0.91 ml, 10 mmol). Spectroscopic analyses 
agree with literature values.[181] Yield: 2.1 g, 8.9 mmol, 89%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 8.52 (s, 1H, N=CH), 8.09 (dd, 3JHH = 10.4, 4JHH = 1.6 
Hz, 2H, Ar-H), 7.81 (ddd, 3JHH = 8.9, 3JHH = 6.5 Hz, 3H, Ar-H), 7.49–7.41 (m, 2H, Ar-
H), 7.38–7.28 (m, 2H, Ar-H), 7.21–7.13 (m, 3H, Ar-H).
(E)-N-butyl-1-phenylmethanimine: Synthesised in accordance with 
General Procedure 3 using benzaldehyde (1.02 ml, 10 mmol) and 
nbutylamine (0.99 ml, 10 mmol). Spectroscopic analyses agree with 
literature values.[184] Yield: 1.5 g, 9.5 mmol, 95%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 8.19 (s, 1H, N=CH), 7.66–7.55 (m, 2H, Ar-H), 7.33–7.23 (m, 3H, Ar-H), 3.53 
(t, 3JHH = 6.9 Hz, 2H, N–CH2), 1.61 (pent., 3JHH = 7.1 Hz, 2H, CH2), 1.31 (h, 3JHH = 7.2 
Hz, 2H, CH2), 0.87 (t, 3JHH = 7.4 Hz, 3H, CH3).
(E)-N-isopropyl-1-phenylmethanimine: Synthesised in accordance with 
General Procedure 3 using benzaldehyde (1.02 ml, 10 mmol) and 
isopropylamine (0.86 ml, 10 mmol). Spectroscopic analyses agree with 
literature values.[184] Yield: 1.3 g, 8.7 mmol, 87%. 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 8.31 (s, 1H, N=CH), 7.80–7.69 (m, 2H, Ar-H), 7.54–7.32 (m, 
3H, Ar-H), 3.55 (sept, 3JHH = 5.2 Hz, 1H, iPr H), 1.28 (d, 3JHH = 6.3 Hz, 6H, iPr CH3).
(E)-N-cyclopentyl-1-phenylmethanimine: Synthesised in accordance 
with General Procedure 3 using benzaldehyde (1.02 ml, 10 mmol) and 
cyclopentylamine (0.99 ml, 10 mmol). Spectroscopic analyses agree 
with literature values.[185] Yield: 1.5 g, 89 mmol, 89%. 1H NMR (500 MHz, CDCl3, 298 
K) δ/ppm: 8.29 (s, 1H, N=CH), 7.78–7.66 (m, 2H, Ar-H), 7.49–7.28 (m, 3H, Ar-H), 
4.06–3.39 (m, 1H, N–CH), 1.88 (s, 4H, CH2), 1.77–1.59 (m, 4H, CH2).
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(E)-N-benzyl-1-phenylmethanimine: Synthesised in accordance with 
General Procedure 3 using benzaldehyde (1.02 ml, 10 mmol) and 
benzylamine (1.09 ml, 10 mmol). Spectroscopic analyses agree with 
literature values.[182] Yield: 1.8 g, 9.2 mmol, 92%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 8.31 (s, 1H, N=CH), 7.77–7.60 (m, 2H, Ar-H), 7.33 (d, 3JHH = 4.9 Hz, 3H, Ar-
H), 7.31–7.04 (m, 4H, Ar-H), 4.74 (s, 2H, CH2Ph).
(E)-N-(2,6-diethylphenyl)-1-phenylmethanimine: Synthesised in 
accordance with General Procedure 3 using benzaldehyde (1.02 ml, 10 
mmol) and 2,6-diethylaniline (1.65 ml, 10 mmol). Spectroscopic 
analyses agree with literature values.[186] Yield: 2.1 g, 8.7 µmol, 87%. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.23 (s, 1H, N=CH), 7.92 (d, 3JHH = 6.9 Hz, 
2H, Ar-H), 7.52 (d, 3JHH = 6.1 Hz, 3H, Ar-H), 7.11 (d, 3JHH = 7.4 Hz, 2H, Ar-H), 7.07–
7.02 (m, 1H, Ar-H), 2.51 (q, 3JHH = 7.4 Hz, 4H, ethyl CH2), 1.14 (t, 3JHH = 7.5 Hz, 6H, 
ethyl CH3).
(E)-N-mesityl-1-phenylmethanimine: Synthesised in accordance 
with General Procedure 3 using benzaldehyde (1.02 ml, 10 mmol) 
and 2,4,6-trimethylaniline (1.40 ml, 10 mmol). Spectroscopic 
analyses agree with literature values.[182] Yield: 2.1 g, 9.4 mmol, 
94%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.16 (br. s, 1H, N=CH), 7.86 (br. s, 
2H, Ar-H), 7.45 (br. s, 3H, Ar-H), 6.85 (br. s, 2H, Ar-H), 2.24 (s, 3H, p-CH3), 2.08 (s, 
6H, o-CH3).
(E)-1-phenyl-N-(4-(trifluoromethyl)phenyl)methanimine: Synthesised 
in accordance with General Procedure 3 using benzaldehyde (1.02 
ml, 10 mmol) and 4-trifluoromethylaniline (1.26 ml, 10 mmol). 
Spectroscopic analyses agree with literature values.[187] Yield: 2.4 g, 
9.1 mmol, 91%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.40 (s, 1H, N=CH), 7.88 
(d, 3JHH = 7.4 Hz, 2H, Ar-H), 7.62 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 7.47 (q, 3JHH = 7.8 Hz, 
3H, Ar-H), 7.22 (d, 3JHH = 7.0 Hz, 2H, Ar-H).
(E)-N-(2-fluorophenyl)-1-phenylmethanimine: Synthesised in 
accordance with General Procedure 3 using benzaldehyde (1.02 ml, 10 
mmol) and 2-fluoroaniline (0.97 ml, 10 mmol). Spectroscopic analyses 
agree with literature values.[182] Yield: 1.8 g, 9.0 mmol, 90%. 1H NMR
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(500 MHz, CDCl3, 298 K) δ/ppm: 8.53 (s, 1H, N=CH), 7.94 (dd, 3JHH = 7.4, 4JHH = 1.9 
Hz, 2H, Ar-H), 7.52–7.45 (m, 3H, Ar-H), 7.19–7.13 (m, 4H, Ar-H).
6.5.1.2 Synthesis of Products
General Procedure 4: In an NMR tube, pinacol borane (31 mg, 0.22 mmol) and the 
substrate (aldehyde/imine) (0.2 mmol) were combined in CH2Cl2 (0.6 ml). To this, 
tris(2,4,6-trifluorophenyl)borane (2 mg, 2 mol%) was added, and the NMR tube 
sealed. Reactions occurred at 60 °C, while reaction times varied with substrate. Once 
conversion was complete, as measured by in situ 1H NMR spectroscopy, the reaction 
mixtures were reduced under vacuum. The alkoxy/amino-pinacol boronates were 
redissolved in CDCl3 for NMR spectroscopic analysis. Select examples were 
subsequently converted to alcohols/amines by hydrolysis as denoted in the text. 
General Procedure 5: In an NMR tube, pinacol borane (31 mg, 0.22 mmol) and the 
substrate alkyne/alkene (0.2 mmol) were combined in CH2Cl2 (0.6 ml). To this, 
tris(2,4,6-trifluorophenyl)borane (2 mg, 2 mol%) was added, and the NMR tube 
sealed. Reactions occurred at 60 °C, while reaction times varied with substrate. Once 
the reaction was complete, as measured by in situ 1H NMR spectroscopy, the reaction 
mixtures were concentrated under vacuum and subsequently passed through a short 
plug of silica in hexane. The pinacol boronates were redissolved in CDCl3 for NMR 
spectroscopic analysis. 
General Procedure 6: As per General Procedure 5 and 6, at room temperature.
5.2a: Synthesised in accordance with General Procedure 6 using 
phenylacetylene (20 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 6 h. Yield: 47 mg, 198 µmol, 99%. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.42 (d, 3JHH = 7.2 Hz, 2H, 
Ar-H), 7.33 (d, 3JHH = 18.5 Hz, 1H, =CH), 7.30–7.21 (m, 3H, Ar-H), 
6.10 (d, 3JHH = 18.5 Hz, 1H, =CH), 1.24 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 
298 K) δ/ppm: 30.1 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 149.5 (s), 137.5 
(s), 128.9 (s), 128.6 (s), 127.1 (s), 83.4 (s), 24.8 (s). HRMS (ES)+ m/z calculated for 
[C14H2010BO2]+ [M+H]+: 230.1593, found: 230.1600.
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5.2b: Synthesised in accordance with General Procedure 6 using 1-
hexyne (16 mg, 0.2 mmol) as the substrate gave the product as a 
colourless oil after 18 h. Yield: 30 mg, 142 µmol, 71%. Spectroscopic 
data agrees with literature values.[188] 1H NMR (500 MHz, CDCl3, 298 
K) δ/ppm: 6.63 (dt, 3JHH = 17.9 Hz, 3JHH = 6.4 Hz, 1H, =CH), 5.42 (dt, 3JHH = 17.9 Hz,
4JHH = 1.5 Hz, 1H, =CH), 2.17–2.12 (m, 2H, alkyl), 1.42–1.36 (m, 2H, alkyl), 1.35–1.29 
(m, 2H, alkyl), 1.26 (s, 12H, pinacol), 0.88 (t, 3JHH = 7.2 Hz, 3H, alkyl). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 29.7 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 154.8 
(s), 83.0 (s), 35.5 (s), 30.4 (s), 24.8 (s), 22.3 (s), 13.9 (s). 
5.2c: Synthesised in accordance with General Procedure 6 using 1-
octyne (22 mg, 0.2 mmol) as the substrate gave the product as a 
colourless oil after 24 h. Yield: 38 mg, 160 µmol, 80%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 6.63 (dt, 3JHH = 18.1 Hz, 3JHH = 6.4 Hz, 
1H, =CH), 5.41 (d, 3JHH = 18.1 Hz, 1H, =CH), 2.14 (q, 3JHH = 6.9 Hz, 2H, CH2), 1.40 
(quintet, 3JHH = 7.2 Hz, 2H, CH2), 1.32–1.20 (m, 6H, alkyl), 1.26 (s, 12H, pinacol), 
0.87 (t, 3JHH = 6.6 Hz, 3H, CH3). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 29.8 (s). 
13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 154.9 (s), 83.0 (s), 35.9 (s), 31.7 (s), 28.9 
(s), 28.2 (s), 24.8 (s), 22.6 (s), 14.1 (s). HRMS (AP)+ m/z calculated for [C14H2810BO2]+
[M+H]+: 238.2219, found: 238.2226. 
5.2d: Synthesised in accordance with General Procedure 6 using 1-
decyne (28 mg, 0.2 mmol) as the substrate gave the product as a 
colourless oil after 18 h. Yield: 48 mg, 180 µmol, 90%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 6.62 (dt, 3JHH = 17.9 Hz, 3JHH = 6.4 Hz, 
1H, =CH), 5.41 (dt, 3JHH = 17.9 Hz, 4JHH = 1.5 Hz, 1H, =CH), 2.15–2.11 (m, 2H, alkyl), 
1.43–1.36 (m, 2H, alkyl), 1.29–1.22 (m, 10H, alkyl), 1.25 (s, 12H, pinacol), 0.87 (t, 
3JHH = 7.0 Hz, 3H, alkyl). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 29.7 (s). 13C 
NMR (126 MHz, CDCl3, 298 K) δ/ppm: 153.8 (s), 82.0 (s), 34.8 (s), 30.9 (s), 28.4 (s), 
28.2 (s), 27.2 (s), 23.8 (s), 21.7 (s), 13.1 (s). HRMS (EI)+ m/z calculated for 
[C16H3110BO2]+ [M]+: 265.2453, found: 265.2448.
5.2e: Synthesised in accordance with General Procedure 5 using 
prop-2-yn-1-yl benzoate (32 mg, 0.2 mmol) as the substrate gave 
the product as a colourless oil after 18 h. Yield: 33 mg, 114 µmol, 
57%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.03–7.96 (m, 2H, 
Ar-H), 7.48 (t, 3JHH = 7.4 Hz, 1H, Ar-H), 7.36 (q, 3JHH = 7.5 Hz, 2H, 
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Ar-H), 6.66 (dt, 3JHH = 18.1, 4JHH = 4.4 Hz, 1H, =CH), 5.72 (dt, 3JHH = 18.1, 4JHH = 1.8 
Hz, 1H, =CH), 4.87–4.81 (m, 1H, CH2), 1.20 (s, 12H, pinacol). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: 29.6 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 166.1 (s), 
146.0 (s), 133.1 (s), 129.8 (s), 129.7 (s), 128.5 (s), 128.4 (s), 83.5 (s), 75.0 (s), 65.7 
(s), 52.5 (s), 24.8 (s). HRMS (AP)+ m/z calculated for [C16H2211BO4]+ [M+H]+: 289.1611, 
found: 289.1597. 
5.2f: Synthesised in accordance with General Procedure 5 using 
prop-2-yn-1-yl 4-methylbenzoate (35 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 24 h. Yield: 30 
mg, 110 µmol, 55%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.89 
(d, 3JHH = 8.2 Hz, 2H, Ar-H), 7.16 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 6.66 
(dt, 3JHH = 4.4 Hz, 3JHH = 18.2 Hz, 1H, =CH), 5.72 (d, 3JHH = 18.2 Hz, 1H, =CH), 4.83 
(d, 3JHH = 6.0 Hz, 2H, CH2), 2.34 (s, 3H, CH3), 1.20 (s, 12H, pinacol). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 29.7 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 166.2 
(s), 146.2 (s), 143.8 (s), 129.8 (s), 129.1 (s), 127.2 (s), 83.5 (s), 74.9 (s), 65.6 (s), 
52.3 (s), 24.8 (s), 21.7 (s). HRMS (AP)+ m/z calculated for [C17H2410BO4]+ [M+H]+: 
302.1804, found: 302.1792. 
5.2g: Synthesised in accordance with General Procedure 5 using 
prop-2-yn-1-yl 4-nitrobenzoate (41 mg, 0.2 mmol) as the substrate 
gave the product as a colourless oil after 18 h. Yield: 51 mg, 154 
µmol, 77%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.26–8.14 
(m, 4H, Ar-H), 6.65 (dt, 3JHH = 18.1, 3JHH = 4.6 Hz, 1H, =CH), 5.72 
(d, 3JHH = 18.2 Hz, 1H, =CH), 4.90 (dd, 3JHH = 8.2, 4JHH = 3.3 Hz, 
2H, CH2), 1.21 (s, 2H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 29.6 (br. 
s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 164.1 (s), 145.1 (s), 134.9  (s), 131.1 
(s), 123.8 (s), 83.7 (s), 75.9 (s), 66.8 (s), 53.4 (s), 24.9 (s). 
5.2h: Synthesised in accordance with General Procedure 5 using 
prop-2-yn-1-yl 4-methoxybenzoate (38 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 24 h. Yield: 44 
mg, 138 µmol, 69%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.95 
(dd, 3JHH = 8.7, 4JHH = 1.8 Hz, 2H, Ar-H), 6.84 (dd, 3JHH = 8.7, 2H, 
Ar-H), 6.65 (dt, 3JHH = 18.1, 3JHH = 4.3 Hz, 1H, =CH), 5.71 (d, 3JHH = 18.2 Hz, 1H, 
=CH), 4.81 (s, 2H, CH2), 3.78 (s, 3H, OMe), 1.20 (s, 12H, pinacol). 11B NMR (160 
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MHz, CDCl3, 298 K) δ/ppm: 29.6 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm:165.9 
(s), 163.5 (s), 146.4 (s), 131.8 (s), 122.5 (s), 113.7 (s), 83.5 (s), 74.9 (s), 65.6 (s), 
55.5 (s), 52.3 (s), 24.9 (s). HRMS (AP)+ m/z calculated for [C17H2411BO5]+ [M+H]+:
319.1717, found: 319.1704.
5.2i: Synthesised in accordance with General Procedure 5 using 
prop-2-yn-1-yl acrylate (22 mg, 0.2 mmol) as the substrate gave 
the product as a colourless oil after 24 h. Yield: 41 mg, 174 µmol, 
87%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 6.64 (dt, 3JHH = 
18.2 Hz, 4JHH = 4.6 Hz, 1H, =CH), 6.44 (dd, 3JHH = 17.3 Hz, 4JHH = 
1.3 Hz, 1H, =CH), 6.14 (dd, 3JHH = 17.3 Hz, 3JHH = 10.4 Hz, 1H, =CH), 5.85 (dd, 3JHH
= 10.5 Hz, 4JHH = 1.3 Hz, 1H, =CH), 5.70 (dt, 3JHH = 18.1 Hz, 4JHH = 1.7 Hz, 1H, =CH), 
4.75 (dd, 3JHH = 4.6 Hz, 4JHH = 1.8 Hz, 2H, CH2), 1.26 (s, 12H, pinacol). 11B NMR
(128 MHz, CDCl3, 298 K) δ/ppm: 29.6 (s). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
164.6 (s), 144.8 (s), 130.1 (s), 127.2 (s), 82.4 (s), 64.4 (s), 23.8 (s). 
5.2j: Synthesised in accordance with General Procedure 5 using 
ethynyltrimethylsilane (20 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 6 h. Yield: 43 mg, 190 µmol, 95%.
Spectroscopic data agrees with literature values.[126] 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.11 (d, 3JHH = 21.8 Hz, 2H, =CH), 6.23 (d, 3JHH = 21.8 
Hz, 1H, =CH), 1.27 (s, 12H, pinacol), 0.06 (s, 9H, SiMe3). 11B NMR (160 MHz, CDCl3, 
298 K) δ/ppm: 28.9 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 157.9 (s), 83.3 
(s), 24.8 (s), -1.9 (s). 29Si NMR (80 MHz, CDCl3, 298 K) δ/ppm: -6.7 (s). 
5.2k: Synthesised in accordance with General Procedure 5 using 
3-trimethylsilylpropyne (22 mg, 0.2 mmol) as the substrate gave 
the product as colourless crystals after 6 h. Yield: 40 mg, 166 
µmol, 83%. Spectroscopic data agrees with literature values.[189]
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 6.69–6.60 (m, 1H, =CH), 5.22 (d, 3JHH = 
17.7 Hz, 1H, =CH), 1.67 (dd, 3JHH = 8.2 Hz, 4JHH = 1.0 Hz, 2H, CH2), 1.24 (s, 12H, 
pinacol), 0.00 (s, 9H, SiMe3). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 29.6 (s). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 154.0 (s), 84.6 (s), 30.1 (s), 26.6 (s), 0.00 (s). 
29Si NMR (80 MHz, CDCl3, 298 K) δ/ppm: 0.8 (s). 
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5.2l: Synthesised in accordance with General Procedure 5 using 
(3-(prop-2-yn-1-yloxy)prop-1-yn-1-yl)benzene (34 mg, 0.2 mmol) 
as the substrate gave the product as a colourless oil after 18 h. 
Yield: 33 mg, 112 µmol, 56%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.44 (dd, 3JHH = 6.6, 4JHH =3.2 Hz, 2H), 7.30 (dd, 3JHH = 5.1, 
3JHH = 1.9 Hz, 2H), 6.67 (dt, 3JHH = 18.1, 4JHH =4.9 Hz, 1H), 5.76 (dt, 3JHH = 18.1, 4JHH
=1.6 Hz, 1H), 4.38 (s, 1H), 4.22 (dd, 3JHH = 4.9, 4JHH = 1.6 Hz, 2H), 1.27 (s, 12H, 
pinacol). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 29.6 (s). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm:148.5 (s), 131.9 (s), 128.5 (s), 128.4 (s), 122.8 (s), 86.5 (s), 
85.1 (s), 83.4 (s), 71.4 (s), 58.4 (s), 24.9 (s). HRMS (AP)+ m/z calculated for 
[C18H2410BO3]+ [M+H]+: 298.1855, found: 298.1849. 
5.2m: Synthesised in accordance with General Procedure 5
using 1-phenyl-1-propyne (23 mg, 0.2 mmol) as the substrate 
gave the product as a colourless oil after 18 h. Yield: 47 mg, 192 
µmol, 96%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.30 (d, 
3JHH = 7.7 Hz, 2H, Ar-H), 7.25 (t, 3JHH = 7.4 Hz, 2H, Ar-H), 7.16 
(s, 1H, =CH), 7.14 (t, 3JHH = 7.4 Hz, 1H, Ar-H), 1.91 (s, 3H, Me), 1.23 (s, 12H, pinacol). 
11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 30.6 (s). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 141.4 (s), 136.9 (s), 128.4 (s), 127.0 (s), 126.1 (s), 82.5 (s), 23.8 (s), 14.9 
(s). HRMS (ES)+ m/z calculated for [C15H2210BO2]+ [M+H]+: 244.1749, found: 
244.1739. 
5.2n: Synthesised in accordance with General Procedure 5 using 2-
butyne (11 mg, 0.2 mmol) as the substrate gave the product as a 
colourless oil after 6 h. Yield: 35 mg, 192 µmol, 96%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 6.42 (q, 3JHH = 6.5 Hz, 1H, =CH), 1.70 
(d, 3JHH = 6.8 Hz, 3H, CH3), 1.67 (s, 3H, CH3), 1.25 (s, 12H, pinacol). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 30.2 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 140.8 
(s), 83.1 (s), 24.8 (s), 14.3 (s), 13.5 (s). HRMS (EI)+ m/z calculated for [C10H1910BO2]+
[M]+: 181.1514, found: 181.1516.
5.2o: Synthesised in accordance with General Procedure 5 using 
1-trimethylsilylpropyne (22 mg, 0.2 mmol) as the substrate gave 
the product as a colourless oil after 18 h. Yield: 43 mg, 178 µmol, 
89%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.09 (q, 4JHH = 6.7 
Hz, 1H, =CH), 1.89 (d, 4JHH = 6.7 Hz, 3H, Me), 1.24 (s, 12H, pinacol), 0.16 (s, 9H, 
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SiMe3). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 31.4 (s). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 155.9 (s), 82.8 (s), 24.7 (s), 0.8 (s). 29Si NMR (80 MHz, CDCl3, 
298 K) δ/ppm: -8.44 (s). 
5.2p: Synthesised in accordance with General Procedure 5 using 
diphenylacetylene (36 mg, 0.2 mmol) as the substrate gave the 
product as white crystals after 168 h. Yield: 49 mg, 160 µmol, 80%. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.37 (br. s, 1H, Ar-H), 
7.29–7.21 (m, 3H, Ar-H), 7.20–7.14 (m, 2H, Ar-H), 7.14–7.07 (m, 3H, Ar-H and =CH), 
7.09–7.02 (m, 2H, Ar-H), 1.30 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) 
δ/ppm: 30.6 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 143.2 (s), 140.5 (s), 137.0 
(s), 131.6 (s), 130.0 (s), 128.9 (s), 128.3 (s), 127.9 (s), 126.3 (s), 83.8 (s), 24.8 (s). 
HRMS (EI)+ m/z calculated for [C20H2310BO2]+ [M]+: 305.1827, found: 305.1831. 
5.3a: Synthesised in accordance with General Procedure 6 using 
benzaldehyde (21 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 1 h. Conversion: >99%. 
Spectroscopic data agrees with literature values.[190] 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.28–7.17 (m, 5H, Ar-H), 4.85 (s, 2H, CH2), 1.18 (s, 12H, 
pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.3 (s). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 139.2 (s), 128.3 (s), 127.4 (s), 126.7 (s), 83.0 (s), 66.7 (s), 24.6 
(s).
5.3b: Synthesised in accordance with General Procedure 4
using 4-methylbenzaldehyde (24 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 3 h.
Conversion: >99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.16 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.06 (d, 3JHH = 8.0 Hz, 2H, Ar-
H), 4.81 (s, 2H, CH2), 2.25 (s, 3H, CH3), 1.18 (s, 12H, pinacol). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: 22.3 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 137.0 (s), 
136.3 (s), 129.0 (s), 126.9 (s), 82.9 (s), 66.6 (s), 24.6 (s), 21.2 (s). HRMS (EI)+ m/z
calculated for [C14H2110BO3]+ [M]+: 247.1620, found: 247.1614.
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5.3c: Synthesised in accordance with General Procedure 4
using mesitaldehyde (29 mg, 0.2 mmol) as the substrate gave 
the product as a colourless oil after 3 h. Conversion: >99%. 
Spectroscopic data agrees with literature values.[191] 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 6.75 (s, 2H, Ar-H), 4.87 (s, 2H, CH2), 2.30 (s, 6H, 
o-Me), 2.17 (s, 3H, p-Me) 1.18 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) 
δ/ppm: 22.3 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 137.8 (s), 137.6 (s), 132.2 
(s), 128.9 (s), 82.8 (s), 61.2 (s), 22.6 (s), 21.0 (s), 19.5 (s).
5.3d: Synthesised in accordance with General Procedure 4 using 
4-fluorobenzaldehyde (25 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 3 h. Conversion: >99%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 7.26–7.22 (m, 2H, Ar-H), 6.96–
6.91 (m, 2H, Ar-H), 4.80 (s, 2H, CH2), 1.19 (s, 12H, pinacol). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: 22.3 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.2 (d,
1JCF = 245 Hz, C-F), 135.0 (d, 4JCF = 3.1 Hz), 128.6 (d, 3JCF = 8.1 Hz), 115.1 (d, 2JCF = 
21.4 Hz), 83.1 (s), 66.1 (s), 24.6 (s). 19F NMR (565 MHz, CDCl3, 298 K) δ/ppm: -115.3 
(s, 1F). HRMS (EI)+ m/z calculated for [C13H1810BO3F]+ [M]+: 251.1369, found:
251.1363.
5.3e: Synthesised in accordance with General Procedure 4 
using 4-bromobenzaldehyde (37 mg, 0.2 mmol) as the substrate 
gave the product as a colourless oil after 3 h. Conversion: >99%. 
1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.38 (d, 3JHH = 7.6 Hz, 
2H, Ar-H), 7.14 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 4.79 (s, 2H, CH2), 
1.19 (s, 1H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.3 (s). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 138.2 (s), 131.4 (s), 128.4 (s), 121.2 (s), 83.2 (s), 
66.0 (s), 24.6 (s). HRMS (EI)+ m/z calculated for [C13H18O3Br10B]+ [M]+: 311.0569, 
found: 311.0573.
5.3f: Synthesised in accordance with General Procedure 4
using 4-methoxybenzaldehyde (27 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 18 h.
Conversion: >99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 
7.20 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 6.79 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 4.77 (s, 2H, CH2), 
3.72 (s, 3H, OMe), 1.18 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 
22.3 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 158.0 (s), 127.5 (s), 112.6 (s), 
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81.9 (s), 65.4 (s), 54.2 (s), 23.6 (s). HRMS (EI)+ m/z calculated for [C14H2110BO4]+ [M]+:
263.1569, found: 263.1565.
5.3g: Synthesised in accordance with General Procedure 4
using 4-nitrobenzaldehyde (30 mg, 0.2 mmol) as the substrate 
gave the product as a colourless oil after 48 h. Conversion: 
>99%. Spectroscopic data agrees with literature values.[190] 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.12 (d, 3JHH = 8.8 Hz, 
2H, Ar-H), 7.43 (d, 3JHH = 8.8 Hz, 2H, Ar-H), 4.95 (s, 2H, CH2), 1.20 (s, 12H, pinacol). 
11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.4 (s). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 146.2 (s), 145.6 (s), 125.8 (s), 122.6 (s), 82.4 (s), 64.5 (s), 23.6 (s).
5.3h: Synthesised in accordance with General Procedure 4
using 4-(trifluoromethyl)benzaldehyde (35 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 3 h.
Conversion: >99%. Spectroscopic data agrees with literature 
values.[191] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.51 (d, 
3JHH = 8.0 Hz, 2H, Ar-H), 7.37 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 4.90 (s, 2H, CH2), 1.19 (s, 
12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.4 (s). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 143.2 (s), 129.6 (q, 2JCF = 32.3 Hz), 126.6 (s), 125.3 (q,
3JCF = 3.7 Hz), 83.2 (s), 65.9 (s), 24.6 (s). 19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: 
-62.5 (s, 3F, p-CF3). 
5.3i: Synthesised in accordance with General Procedure 6 using 2-
bromobenzaldehyde (37 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 18 h. Conversion: >99%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 7.43 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 
7.23 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.05 (t, 3JHH = 7.7 Hz, 1H, Ar-H), 4.90 (s, 2H, CH2), 
1.20 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.4 (s) 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 138.4 (s), 132.3 (s), 128.6 (s), 127.8 (s), 127.4 (s), 
121.6 (s), 83.2 (s), 66.3 (s), 24.6 (s). HRMS (EI)+ m/z calculated for [C13H18O3Br10B]+
[M]+: 311.0569, found: 311.0564. 
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5.3j: Synthesised in accordance with General Procedure 4 using 2-
methoxybenzaldehyde (27 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 24 h. Conversion: >99%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 7.32 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 
7.15 (t, 3JHH = 7.9 Hz, 1H, Ar-H), 6.86 (t, 3JHH = 7.4 Hz, 1H, Ar-H), 6.74 (d, 3JHH = 8.2 
Hz, 1H, Ar-H), 4.90 (s, 2H, CH2), 3.71 (s, 3H, OMe), 1.18 (s, 12H, pinacol). 11B NMR
(160 MHz, CDCl3, 298 K) δ/ppm: 22.4 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 
156.5 (s), 128.3 (s), 127.7 (s), 127.4 (s), 120.4 (s), 109.8 (s), 82.9 (s), 62.3 (s), 55.2 
(s), 24.6 (s). HRMS (EI)+ m/z calculated for [C14H2110BO4]+ [M]+: 263.1569, found:
263.1559.
5.3k: Synthesised in accordance with General Procedure 4 using 2-
nitrobenzaldehyde (30 mg, 0.2 mmol) as the substrate gave the product
as a colourless oil after 48 h. Conversion: >99%. Compound was allowed 
to hydrolyse, and subsequent filtration through silica afforded a clean NMR spectra 
of the hydrolysed alcohol product. Spectroscopic data agrees with literature 
values.[192] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 8.01 (d, 3JHH = 8.2 Hz, 1H, Ar-
H), 7.68 (d, 3JHH = 7.6 Hz, 1H, Ar-H), 7.58 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 7.39 (t, 3JHH = 
7.8 Hz, 1H, Ar-H), 4.91 (d, 3JHH = 5.2 Hz, 1H, CH2), 2.49 (br. s, 1H, OH). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 136.8 (s), 134.2 (s), 130.0 (s), 128.5 (s), 125.1 (s), 
62.6 (s).
5.3l: Synthesised in accordance with General Procedure 4 using 2-
cyanobenzaldehyde (26 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 4 h. Conversion: >99%. 1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.56–7.50 (m, 3H, Ar-H), 7.29 (t, 3JHH = 
7.4 Hz, 1H, Ar-H), 5.60 (s, 2H, CH2), 1.20 (s, 12H, pinacol). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: 22.4 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 142.8 (s), 
132.9 (s), 132.6 (s), 127.8 (s), 127.4 (s), 117.0 (s), 83.4 (s), 64.4 (s), 24.6 (s). HRMS 
(AP)+ m/z calculated for [C8H8NO]+ [M+2H-(C6H12BO2)]+: 134.0606, found: 134.0600.
5.3m: Synthesised in accordance with General Procedure 6
using 2,3,4,5,6-pentaflourobenzaldehyde (39 mg, 0.2 mmol) as 
the substrate gave the product as a colourless oil after 1 h.
Conversion: >99%. Spectroscopic data agrees with literature 
values.[190] 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 5.00 (s, 2H, 
CH2), 1.27 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.3 (s). 13C 
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NMR (126 MHz, CDCl3, 298 K) δ/ppm: 146.6–144.4 (m), 142.4–140.2 (m), 138.5–
136.3 (m), 112.1 (td, 2JCF = 17.7 Hz, 3JCF = 3.8 Hz), 83.5 (s), 54.2 (s), 24.5 (s). 19F 
NMR (471 MHz, CDCl3, 298 K) δ/ppm: -143.1 – -143.2 (m, 2F, o-F), -154.1 (t, 1F, p-
F), -162.3 – -162.4 (m, 2F, m-F). 
5.3n: Synthesised in accordance with General Procedure 4 using 
2-napthaldehyde (31 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 18 h. Conversion: >99%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 7.76–7.69 (m, 4H, Ar-H), 7.40–
7.31 (m, 3H, Ar-H), 5.01 (s, 2H, CH2), 1.19 (s, 12H, pinacol). 11B NMR (160 MHz, 
CDCl3, 298 K) δ/ppm: 22.4 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 136.7 (s), 
133.4 (s), 132.9 (s), 128.0 (s), 127.9 (s), 127.7 (s), 126.1 (s), 125.8 (s), 125.2 (s), 
124.9 (s), 83.1 (s), 66.8 (s), 24.7 (s). HRMS (EI)+ m/z calculated for [C17H2110BO3]+
[M]+: 283.1620, found: 283.1620.
5.3o: Synthesised in accordance with General Procedure 4 using 3-
pyridinecarboxaldehyde (21 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 24 h. Conversion: >99%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 8.49 (s, 1H, Ar-H), 8.42 (d, 3JHH = 
3.8 Hz, 1H, Ar-H), 7.65 (d, 3JHH = 7.8 Hz, 1H, Ar-H), 7.21 (t, 3JHH = 7.5 Hz, 1H, Ar-H), 
4.85 (s, 2H, CH2), 1.18 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 
22.3 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 148.5 (s), 148.1 (s), 135.1 (s), 
123.5 (s), 83.3 (s), 82.7 (s), 64.3 (s), 24.6 (s). HRMS (AP)+ m/z calculated for 
[C6H8NO]+ [M+2H-(C6H12BO2)]+: 110.0606, found: 110.0602.
5.3p: Synthesised in accordance with General Procedure 4 using 2-
furanaldehyde (19 mg, 0.2 mmol) as the substrate gave the product 
as a colourless oil after 18 h. Conversion: >99%. Spectroscopic data 
agrees with literature values.[193] 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 7.30–7.29 (m, 1H, furan), 6.25–6.21 (m, 2H, furan), 4.75 (s, 2H, CH2), 1.19 
(s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.3 (s). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 152.5 (s), 142.5 (s), 110.2 (s), 108.3 (s), 83.1 (s), 59.2 
(s), 24.6 (s).
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5.3q: Synthesised in accordance with General Procedure 6 using 
acetaldehyde (9 mg, 0.2 mmol) as the substrate gave the product as 
a colourless oil after 1 h. Conversion: >99%. Spectroscopic data 
agrees with literature values.[194] 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 3.89 (q, 3JHH = 7.0 Hz, 2H, CH2), 1.24 (s, 12H, pinacol), 1.21 (t, 3JHH = 7.1 Hz, 
3H, Me), 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 22.1 (s). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 83.2 (s), 60.7 (s), 24.5 (s), 17.2 (s). 
5.3r: Synthesised in accordance with General Procedure 6 using 1-
pentanal (17 mg, 0.2 mmol) as the substrate gave the product as a 
colourless oil after 1 h. Conversion: >99%. Spectroscopic data 
agrees with literature values.[195] 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 3.76 (t, 3JHH = 6.6 Hz, 2H, CH2), 1.50 (pent., 3JHH = 6.5 Hz, 2H, CH2), 1.30–
1.23 (m, 4H, CH2), 1.19 (d, 3JHH = 8.1 Hz, 12H), 0.83 (q, 3JHH = 7.3 Hz, 3H, CH3). 11B 
NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.1 (s). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 82.6 (s), 65.0 (s), 31.1 (s), 27.8 (s), 24.6 (s), 22.4 (s), 14.0 (s). 
5.3s: Synthesised in accordance with General Procedure 6 using 
trimethylacetaldehyde (17 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 18 h. Conversion: >99%. 
Spectroscopic data agrees with literature values.[191] 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 3.51 (s, 2H, CH2), 1.24 (s, 12H, pinacol), 0.88 (9H, s, 
tBu). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 22.1 (s). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 82.6 (s), 74.9 (s), 32.3 (s), 26.0 (s), 24.6 (s).
5.3t: Synthesised in accordance with General Procedure 6 using 
cyclohexanaldehyde (22 mg, 0.2 mmol) as the substrate gave the 
product as a colourless oil after 18 h. Conversion: >99%. 
Spectroscopic data agrees with literature values.[194] 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 3.63 (d, 3JHH = 6.4 Hz, 2H, CH2), 1.75–1.62 (m, 5H, alkyl), 
1.54–1.45 (m, 1H, alkyl), 1.20 (s, 12H, pinacol), 1.19–1.10 (m, 3H, alkyl), 0.96–0.87 
(m, 2H, alkyl). 11B NMR (128 MHz, CDCl3, 298 K) δ/ppm: 22.1 (s). 13C NMR (101 
MHz, CDCl3, 298 K) δ/ppm: 82.6 (s), 70.4 (s), 39.3 (s), 29.3 (s), 26.5 (s), 25.8 (s), 
24.6 (s). 
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5.4a: Synthesised in accordance with General Procedure 4 using (E)-
N,1-diphenylmethanimine (36 mg, 0.2 mmol) as the substrate gave 
the product as a colourless oil after 4 h. Conversion: >99%. 1H NMR
(500 MHz, CDCl3, 298 K) δ/ppm: 7.27–7.23 (m, 4H, Ar-H), 7.18 (t, 
3JHH = 6.7 Hz, 1H, Ar-H), 7.08 (t, 3JHH = 7.3 Hz, 2H, Ar-H), 6.65 (t, 3JHH = 7.2 Hz, 1H, 
Ar-H), 6.56 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 4.24 (s, 2H, CH2), 1.18 (s, 12H, pinacol). 11B 
NMR (160 MHz, CDCl3, 298 K) δ/ppm: 21.1 (s). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 129.3 (s), 128.7 (s), 127.6 (s), 127.3 (s), 83.2 (s), 48.7 (s), 24.6 (s). HRMS
(ES)+ m/z calculated for [C19H2510BNO2]+ [M+H]+: 309.2015, found: 309.2019.
5.4b: Synthesised in accordance with General Procedure 4 using 
(E)-N-phenyl-1-(p-tolyl)methanimine (39 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 18 h.
Conversion: >99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.17 
(d, 3JHH = 7.9 Hz, 2H, Ar-H), 7.10–7.04 (m, 4H, Ar-H), 6.62 (t, 3JHH = 7.3 Hz, 1H, Ar-
H), 6.54 (d, 3JHH = 7.8 Hz, 2H, Ar-H), 4.18 (s, 2H, CH2), 2.25 (s, 3H, o-Me), 1.18 (s, 
12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 21.1 (s). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 148.3 (s), 136.9 (s), 136.4 (s), 129.4 (s), 129.3 (s), 127.6 
(s), 117.5 (s), 112.9 (s), 83.2 (s), 48.1 (s), 24.6 (s), 21.2 (s). HRMS (EI)+ m/z
calculated for [C20H2610BNO2]+ [M]+: 322.2093, found: 322.2094; [C14H15N]+ [M]+ m/z
calculated: 197.1204, found: 197.1206.
5.4c: Synthesised in accordance with General Procedure 4 using 
(E)-1-mesityl-N-phenylmethanimine (44 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 18 h.
Conversion: >99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.12 
(t, 3JHH = 7.3 Hz, 2H, Ar-H), 6.80 (s, 2H, Ar-H), 6.64 (t, 3JHH = 7.2 Hz, 1H, Ar-H), 6.57 
(d, 3JHH = 7.7 Hz, 2H, Ar-H), 4.09 (s, 2H, CH2), 2.25 (s, 6H, o-Me), 2.20 (s, 3H, p-Me), 
1.18 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.3 (s). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 148.6 (s), 137.5 (s), 137.3 (s), 132.2 (s), 129.3 (s), 
129.1 (s), 117.4 (s), 112.6 (s), 83.3 (s), 42.5, 24.5, 21.0, 19.5. HRMS (EI)+ m/z
calculated for [C16H19N]+ [M+2H-(C6H12BO2)]+: 225.1517, found: 225.1517.
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5.4d: Synthesised in accordance with General Procedure 4 using 
(E)-1-(4-methoxyphenyl)-N-phenylmethanimine (42 mg, 0.2 
mmol) as the substrate gave the product as a colourless oil after 
18 h. Conversion: >99%. Compound was allowed to hydrolyse, 
and subsequent filtration through silica afforded clean NMR spectra of the secondary 
amine. Spectroscopic data agrees with literature values.[149b] 1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 7.30 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 7.20–7.16 (m, 2H, Ar-H), 6.89 
(d, 3JHH = 8.6 Hz, 2H, Ar-H), 6.72 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 6.65 (d, 3JHH = 7.7 Hz, 
2H, Ar-H), 4.26 (s, 2H, CH2), 3.95 (br. s, 1H, NH), 3.81 (s, 3H, OMe). 13C NMR (126 
MHz, CDCl3, 298 K) δ/ppm: 158.9 (s), 148.2 (s), 131.4 (s), 129.3 (s), 128.8 (s), 117.5 
(s), 114.0 (s), 112.9 (s), 55.3 (s), 47.8 (s). 
5.4e: Synthesised in accordance with General Procedure 4 using (E)-1-
(2-methoxyphenyl)-N-phenylmethanimine (42 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 4 h. Conversion: >99%. 
Compound was allowed to hydrolyse, and subsequent filtration through 
silica afforded clean NMR spectra of the secondary amine. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 7.23 (d, 3JHH = 7.2 Hz, 1H, Ar-H), 7.20–7.13 (m, 1H, Ar-H), 7.13–7.05 
(m, 2H, Ar-H), 6.87–6.76 (m, 2H, Ar-H), 6.67–6.53 (m, 3H, Ar-H), 4.26 (s, 2H, CH2), 
3.78 (s, 3H, OCH3). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 157.4 (s), 148.4 (s), 
129.2 (s), 128.9 (s), 128.3 (s), 127.3 (s), 120.6 (s), 117.4 (s), 113.1 (s), 110.3 (s), 55.3 
(s), 43.5 (s). HRMS (ES)+ m/z calculated for [C14H16NO]+ [M+H]+: 214.1232, found:
214.1236.
5.4f: Synthesised in accordance with General Procedure 6 using (E)-1-
(4-fluorophenyl)-N-phenylmethanimine (40 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 18 h. Conversion: 
>99%. Compound was allowed to hydrolyse, and subsequent filtration 
through silica afforded clean NMR spectra of the secondary amine.  1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 7.34 (dd, 3JHH = 8.4 Hz, 3JHH = 5.5 Hz, 2H, Ar-H), 7.18 (t, 
3JHH = 7.9 Hz, 2H, Ar-H), 7.03 (t, 3JHH = 8.7 Hz, 2H, Ar-H), 6.73 (t, 3JHH = 7.3 Hz, 1H, 
Ar-H), 6.63 (t, 3JHH = 7.8 Hz, 2H, Ar-H), 4.31 (s, 2H, CH2), 4.02 (br. s, 1H, NH). 13C 
NMR (126 MHz, CDCl3, 298 K) δ/ppm: 162.2 (d, 1JCF = 245 Hz), 148.1 (s), 135.2 (d, 
4JCF = 3.1 Hz), 129.4 (s), 129.1 (d, 3JCF = 8.0 Hz), 117.9 (s), 115.6 (d, 2JCF = 21.4 Hz), 
113.0 (s), 47.8 (s). 19F NMR (377 MHz, CDCl3, 298 K) δ/ppm: -115.7 (s, 1F, p-F).
HRMS (ES)+ m/z calculated for [C13H13NF]+ [M+H]+: 202.1032, found: 202.1024.
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5.4g: Synthesised in accordance with General Procedure 6 using (E)-
1-(4-nitrophenyl)-N-phenylmethanimine (45 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 24 h. Conversion: 
>99%. Compound was allowed to hydrolyse, and subsequent filtration 
through silica afforded clean NMR spectra of the secondary amine.  1H NMR (500 
MHz, CDCl3, 298 K) δ/ppm: 8.19 (d, 3JHH = 8.7 Hz, 2H, Ar-H), 7.54 (d, 3JHH = 8.6 Hz, 
2H, Ar-H), 7.18 (t, 3JHH = 7.9 Hz, 2H, Ar-H), 6.75 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 6.59 (t,
3JHH = 8.4 Hz, 2H, Ar-H), 4.48 (s, 2H, CH2), 4.26 (br. s, 1H, NH). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm:147.5 (s), 147.3 (s), 129.4 (s), 127.7 (s), 123.9 (s), 121.0 (s), 
118.2 (s), 112.9 (s), 47.6 (s). HRMS (ES)+ m/z calculated for [C13H13N2O2]+ [M+H]+:
229.0977, found: 229.0966.
5.4h: Synthesised in accordance with General Procedure 4
using (E)-1-(naphthalen-2-yl)-N-phenylmethanimine (46 mg, 0.2 
mmol) as the substrate gave the product as a colourless oil after 
24 h. Conversion: >99%. 1H NMR (500 MHz, CDCl3, 298 K) 
δ/ppm: 7.73–7.68 (m, 4H, Ar-H), 7.37–7.35 (m, 3H, Ar-H), 7.08 (t, 3JHH = 7.9 Hz, 2H, 
Ar-H), 6.65 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 6.58 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 3.38 (s, 2H, 
CH2), 1.17 (s, 12H, pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 22.3 (s). 13C 
NMR (126 MHz, CDCl3, 298 K) δ/ppm: 133.5 (s), 132.8 (s), 129.3 (s), 128.4 (s), 127.8 
(s), 127.7 (s), 126.2 (s), 125.8 (s), 125.8 (s), 83.2 (s), 48.9 (s), 24.6 (s). HRMS (EI)+
m/z calculated for [C17H15N]+ [M+H-(C6H12BO2)]+: 233.1204, found: 233.1208.
5.4i: Synthesised in accordance with General Procedure 4 using (E)-
N-butyl-1-phenylmethanimine (32 mg, 0.2 mmol) as the substrate 
gave the product as a colourless oil after 18 h. Conversion: >99%. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.25–7.08 (m, 5H, Ar-H), 4.00 (s, 
2H, CH2), 2.70 (t, 3JHH = 6.9 Hz, 2H, alkyl CH2), 1.34–1.23 (m, 4H, alkyl CH2), 1.17 (s, 12H, 
pinacol), 0.79 (t, 3JHH = 7.3 Hz, 3H, CH3). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 24.6 
(s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 141.0 (s), 128.3 (s), 127.8 (s), 126.6 (s), 
82.2 (s), 49.1 (s), 44.4 (s), 30.8 (s), 24.7 (s), 19.8 (s), 14.1 (s). HRMS (ES)+ m/z calculated 
for [C11H18N]+ [M+2H-(C6H12BO2)]+: 164.1439, found: 164.1435.
5.4j: Synthesised in accordance with General Procedure 4 using (E)-
N-isopropyl-1-phenylmethanimine (29 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 18 h. Conversion: 
>99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.19 (br. s, 4H, Ar-
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H), 7.10 (br. s, 1H, Ar-H), 4.01 (s, 2H, CH2), 3.27 (sept, 3JHH = 7.3 Hz, 1H, iPr H), 1.17 
(s, 12H, pinacol), 0.93 (d, 3JHH = 6.6 Hz, 6H, iPr CH3). 11B NMR (160 MHz, CDCl3, 
298 K) δ/ppm: 24.6 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 143.2 (s), 128.1 
(s), 127.4 (s), 126.3 (s), 81.9 (s), 48.1 (s), 48.0 (s), 24.7 (s), 22.7 (s). HRMS (EI)+ m/z
calculated for [C17H16N]+ [M+2H-(C6H12BO2]+: 150.1283, found: 150.1278.
5.4k: Synthesised in accordance with General Procedure 4 using (E)-
N-cyclopentyl-1-phenylmethanimine (35 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 6 h. Conversion: 
>99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.29–7.21 (m, 4H, 
Ar-H), 7.20–7.10 (m, 1H, Ar-H), 4.10 (s, 2H, CH2), 3.53–3.36 (m, 1H, NCH 
cyclopentyl), 1.61–1.36 (m, 8H, cyclopentyl), 1.22 (s, 12H, pinacol). 11B NMR (160 
MHz, CDCl3, 298 K) δ/ppm: 24.6 (s). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 143.0 
(s), 128.1 (s) (s), 127.0 (s), 126.2 (s), 81.9 (s), 58.9 (s), 48.7 (s), 31.2 (s), 24.7 (s), 
23.7 (s). HRMS (ES)+ m/z calculated for [C12H18N]+ [M+2H-(C6H12BO2)]+: 176.1439, 
found: 176.1446. 
5.4l: Synthesised in accordance with General Procedure 4 using (E)-
N-benzyl-1-phenylmethanimine (39 mg, 0.2 mmol) as the substrate 
gave the product as a colourless oil after 18 h. Conversion: >99%. 1H 
NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.22 (dd, 3JHH = 7.9, 3JHH = 6.4 
Hz, 4H, Ar-H), 7.14 (td, 3JHH = 8.2, 4JHH = 4.1 Hz, 6H), 3.85 (s, 4H, CH2), 1.22 (s, 12H, 
pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 24.9 (s). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 140.2, 128.4, 128.1, 126.8, 82.7, 48.5, 24.8. HRMS (ES)+ m/z
calculated for [C14H16N]+ [M+2H-(C6H12BO2)]+: 198.1283, found: 198.1288. 
5.4m: Synthesised in accordance with General Procedure 6 using 
(E)-N-(2,6-diethylphenyl)-1-phenylmethanimine (47 mg, 0.2 mmol) 
as the substrate gave the product as a colourless oil after 18 h.
Conversion: >99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.09 
(s, 3H, Ar-H), 7.01–6.92 (m, 5H, Ar-H), 4.15 (s, 2H, CH2), 2.35–2.31 (m, 2H, CH2), 
2.06–2.01 (m, 2H, CH2), 1.21 (br. s, 6H, pinacol), 1.07 (br. s, 6H, pinacol), 0.91 (t, 
3JHH = 7.1 Hz, 6H, CH3). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 24.1 (s). 13C NMR
(126 MHz, CDCl3, 298 K) δ/ppm: 142.6 (s), 140.8 (s), 140.0 (s), 129.6 (s), 127.9 (s), 
126.9 (s), 126.2 (s), 126.1 (s), 82.6 (s), 54.9 (s), 24.6 (s), 23.9 (s), 14.8 (s). HRMS
(EI)+ m/z calculated for [C23H3210BNO2]+ [M]+: 364.2562, found: 364.2556.
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5.4n: Synthesised in accordance with General Procedure 6 using 
(E)-N-mesityl-1-phenylmethanimine (45 mg, 0.2 mmol) as the 
substrate gave the product as a colourless oil after 18 h.
Conversion: >99%. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.11–
7.03 (m, 3H, Ar-H), 7.02–7.01 (m, 2H, Ar-H), 6.68 (s, 2H, Ar-H), 4.12 (s, 2H, CH2), 
2.12 (s, 3H, p-Me) 1.78 (s, 6H, o-Me), 1.23 (br. s, 6H, pinacol), 1.09 (br. s, 6H, 
pinacol). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: 23.8 (s). 13C NMR (126 MHz, 
CDCl3, 298 K) δ/ppm: 140.6 (s), 139.7 (s), 136.3 (s), 134.9 (s), 129.5 (s), 129.0 (s), 
128.0 (s), 126.8 (s), 82.5 (s), 53.7 (s), 24.6 (s), 21.0 (s), 18.2 (s). HRMS (ES)+ m/z
calculated for [C22H3010BNO2]+ [M]+: 350.2406, found: 350.2411; HRMS (ES)+ m/z
calculated for [C16H19N]+ [M+H-(C6H12BO2)]+: 225.1517, found: 225.1517.
5.4o: Synthesised in accordance with General Procedure 6 using 
(E)-1-phenyl-N-(4-(trifluoromethyl)phenyl)methanimine (50 mg, 
0.2 mmol) as the substrate gave the product as a colourless oil 
after 18 h. Conversion: >99%. 1H NMR (400 MHz, CDCl3, 298 K) 
δ/ppm: 7.30 (d, 2H, 3JHH = 8.5), 7.27–7.26 (m, 5H, Ar-H), 6.54 (d, 3JHH = 8.5 Hz, 2H, 
Ar-H), 4.27 (s, 2H, CH2), 1.19 (s, 12H, pinacol). 11B NMR (128 MHz, CDCl3, 298 K) 
δ/ppm: 22.3 (s). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 150.1 (s), 138.1 (s), 130.2 
(s), 128.8 (s), 127.5 (s), 127.4 (s), 126.6 (q, 4JCF = 3.8 Hz), 125.1 (q, 1JCF = 270 Hz), 
119.0 (q, 2JCF = 32.6 Hz), 83.3 (s), 47.8 (s), 24.5 (s). 19F NMR (377 MHz, CDCl3, 298 
K) δ/ppm: -61.0 (s, 3F, CF3). HRMS (ES)+ m/z calculated for [C14H13NF3]+ [M+H-
(C6H12BO2)]+: 252.1000, found: 252.1001.
5.4p: Synthesised in accordance with General Procedure 6 using (E)-N-
(2-fluorophenyl)-1-phenylmethanimine (40 mg, 0.2 mmol) as the substrate 
gave the product as a colourless oil after 24 h. Conversion: >99%. 
Compound was allowed to hydrolyse, and subsequent filtration through 
silica afforded clean NMR spectra of the secondary amine.  1H NMR (500 MHz, 
CDCl3, 298 K) δ/ppm: 7.31–7.15 (m, 5H, Ar-H), 6.92–6.85 (m, 2H, Ar-H), 6.61–6.52 
(m, 2H, Ar-H), 4.28 (s, 2H, CH2), 4.24 (br. s, 1H, NH). 13C NMR (126 MHz, CDCl3, 298 
K) δ/ppm: 151.6 (d, 1JCF = 238 Hz), 139.1 (s), 136.7 (d, 3JCF = 11.5 Hz), 128.8 (s), 
127.5 (s), 124.7 (d, 4JCF = 3.5 Hz), 116.9 (d, 3JCF = 7.0 Hz), 114.5 (d, 2JCF = 18.4 Hz), 
112.4 (s), 48.0 (s). 19F NMR (377 MHz, CDCl3, 298 K) δ/ppm: -136.5 (s, 1F). HRMS
(ES)+ m/z calculated for [C13H13NF]+ [M+H]+: 202.1032, found: 202.1026.
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6.5.2 Novel Processing Methods in the Hydrosilylation of Aldehydes, 
Ketones and Imines
6.5.2.1 Synthesis of Products
General Procedure 7: A stock solution of triphenylsilane (1.0 equiv.) and aldehyde or 
ketone (1.0 equiv.) in toluene (0.4 M) was prepared along with a separate solution of 
tris(pentafluorophenylborane) (2 mol%) in toluene. 5 ml aliquots of B(C6F5)3 and 
reagent/silane solution were combined using a T-piece adapter via syringe pump 
using a flow rate of 0.083 ml/min. The mixed reaction stream then proceeded to a 5 
ml reaction coil where it was heated to 60 °C and left for 30 minutes to reach steady-
state before being passed through a short plug of silica gel and collected in a flask for 
12 minutes (Scheme 6.5.1). The solvent was removed in vacuo followed by 
characterisation via NMR spectroscopy with percent conversion being measured as 
a ratio between Me (acetophenone) or H (aldehyde) of starting material and product.
Scheme 6.5.1: General flow schematic for hydrosilylation of ketones and aldehydes.
5.5a: Synthesised in accordance with General Procedure 7 using 
acetophenone as starting material. Spectroscopic analyses agree with 
literature known values.[196] Conversion: 98%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.60 (d, 3JHH = 7.5 Hz, 6H, Ar-H), 7.40 (d, 3JHH = 7.0 Hz, 3H, 
Ar-H), 7.36–7.24 (m, 11H, Ar-H), 5.04 (q, 3JHH = 6.3 Hz, 1H, CH), 1.43 (d, 3JHH = 6.2 
Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  146.01 (s), 135.6 (s), 134.7 
(s), 130.0 (s), 128.2 (s), 127.9 (s), 127.0 (s), 125.6 (s), 72.13 (s), 27.04 (s).
5.5b: Synthesised in accordance with General Procedure 7 using 4-
fluoroacetophenone as starting material. Conversion: 97%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm:  7.59 (d, 3JHH = 6.7 Hz, 6H, Ar-H), 
7.44–7.33 (m, 11H, Ar-H), 6.94 (d, 3JHH = 8.2 Hz, 2H, Ar-H), 5.02 (q, 3JHH = 6.3 Hz, 
1H, CH), 1.42 (d, 3JHH = 6.3 Hz, 3H, CH3). 13C NMR (75 MHz, CDCl3, 298 K) δ/ppm:  
161.6 (s), 135.5 (s), 134.5 (s), 130.1 (s), 128.7 (d, 1JCF = 81.2 Hz), 127.9 (s), 127.1 
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(d, 3JCF = 8.0 Hz), 115.0 (d, 2JCF = 21.3 Hz), 71.5 (s), 27.1 (s). 19F NMR (376 MHz, 
CDCl3, 298 K) δ/ppm:  -116.2 (s, 1F, CF).
5.5c: Synthesised in accordance with General Procedure 7 using 
4-methylacetophenone as starting material. Conversion: 95%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.60 (d, 3JHH = 6.7 Hz, 6H, 
Ar-H), 7.41–7.32 (m, 9H, Ar-H), 7.21 (d, 3JHH = 7.8 Hz, 2H, Ar-H), 7.08 (d, 3JHH = 7.6 
Hz, 2H, Ar-H), 5.01 (q, 3JHH = 6.1 Hz, 1H, CH), 2.33 (s, 3H, CH3), 1.41 (d, 3JHH = 6.4 
Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  143.0 (s), 136.4 (s), 135.5 
(s), 134.7 (s), 129.9 (s), 128.8 (s), 127.8 (s), 125.4 (s), 71.9 (s), 26.9 (s), 21.2 (s).
5.5d: Synthesised in accordance with the General Procedure 7
using 2’,4’,6’-trimethylacetophenone as starting material. 
Conversion: measured using mesityl Ar-H C–H of reagent and 
product. Conversion: 87%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.54 (d, 3JHH = 
7.4 Hz, 6H, Ar-H), 7.38–7.36 (m, 3H, Ar-H), 7.30 (t, 3JHH = 7.2 Hz, 6H, Ar-H), 6.71 (br. 
s, 2H, Ar-H mes), 5.37 (q, 3JHH = 6.5 Hz, 1H, CH), 2.34–2.15 (br. m, 9H, 3 x CH3), 
1.44 (d, 3JHH = 6.6 Hz, 3H C(CH3)). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 137.7 
(s), 135.4 (s), 135.0 (s), 134.6 (s), 130.2 (s), 129.9 (s), 128.0 (s), 127.8 (s), 69.0 (s), 
22.9 (s), 20.8 (s), 20.5 (s).
5.5e: Synthesised in accordance with General Procedure 7 using 
4-(trifluoromethyl)acetophenone as starting material. Conversion: 
92%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm:  7.49 (d, 3JHH = 7.4 
Hz, 6H, Ar-H), 7.51 (d, 3JHH = 7.8 Hz, 2H, Ar-H), 7.42–7.39 (m, 5H, Ar-H), 7.37–7.33 
(m, 6H, Ar-H), 5.08 (q, 3JHH = 6.3 Hz, 1H, CH), 1.44 (d, 3JHH = 6.3 Hz, 3H, CH3). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 150.0 (s), 135.6 (s), 135.5 (s), 134.3 (s), 130.2 
(s), 128.0 (s), 125.2 (q, 3JCF = 3.8 Hz), 71.6 (s), 26.9 (s). 19F NMR (283 MHz, CDCl3, 
298 K) δ/ppm: –62.4 (s, 3F, CF3).
5.5f: Synthesised in accordance with General Procedure 7 using 4-
bromoacetophenone as starting material. Conversion: 77%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm:  7.61 (d, 3JHH = 7.4 Hz, 6H, 
Ar-H), 7.42–7.35 (m, 11H, Ar-H), 7.18 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 5.01 (q, 3JHH = 6.4 
Hz, 1H, CH), 1.42 (d, 3JHH = 6.3 Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm:  145.1 (s), 135.5 (s), 134.4 (s), 131.3 (s), 130.1 (s), 128.0 (s), 127.4 (s), 120.7 
(s), 71.5 (s), 26.9 (s).
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5.5g: Synthesised in accordance with General Procedure 7 using 
4-methoxyacetophenone as starting material. Conversion: 78%. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.66–7.63 (m, 2H, Ar-
H), 7.61–7.58 (m, 6H, Ar-H), 7.44–7.32 (m, 9H, Ar-H), 6.81 (d, 3JHH = 8.7 Hz, 2H, Ar-
H), 5.00 (pent., 3JHH = 6.3 Hz, 1H, CH), 3.78 (s, 3H, OMe), 1.42 (d, 3JHH = 6.3 Hz, 3H, 
CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 158.6 (s), 135.6 (s), 135.1 (s), 134.8 
(s), 130.0 (s), 129.2 (s), 128.4 (s), 128.2 (s), 127.9 (s), 113.6 (s), 71.7 (s), 55.4 (s), 
27.0 (s).
5.5h: Synthesised in accordance with General Procedure 7 using 
4-nitroacetophenone as starting material. Conversion: 92%. 1H 
NMR (400 MHz, CDCl3, 298 K) δ/ppm:  8.12 (d, 3JHH = 8.3 Hz, 2H, 
Ar-H), 7.62 (d, 3JHH = 7.2 Hz, 6H, Ar-H), 7.47–7.42 (m, 5H, Ar-H), 7.38–7.35 (t, 3JHH = 
7.2 Hz, 6H, Ar-H), 5.14 (q, 3JHH = 6.2 Hz, 1H, CH), 1.47 (d, 3JHH = 6.2 Hz, 3H, CH3). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm:  153.4 (s), 147.0 (s), 135.4 (s), 134.0 (s), 
130.3 (s), 128.0 (s), 126.3 (s), 123.6 (s), 71.3 (s), 26.8 (s).
5.5i: Synthesised in accordance with General Procedure 7 using 2-
acetonaphthone as starting material. Conversion: 93%. 1H NMR 
(400 MHz, CDCl3, 298 K) δ/ppm: 7.85–7.72 (m, 4H, Ar-H), 7.66 (d, 
3JHH = 6.5 Hz, 6H, Ar-H), 7.55 (d, 3JHH = 8.3 Hz, 1H, Ar-H), 7.48–7.42 (m, 6H, Ar-H), 
7.39–7.35 (m, 5H, Ar-H), 5.23 (pent., 3JHH = 6.1 Hz, 1H, CH), 1.54 (d, 3JHH = 6.4 Hz, 
3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 143.4 (s), 135.6 (s), 134.6 (s), 
133.4 (s), 132.8 (s), 130.1 (s), 129.2 (s), 128.4 (s), 128.1 (s), 128.0 (s), 127.9 (s), 
127.7 (s), 126.0 (s), 125.6 (s), 124.2 (s), 124.1 (s), 72.3 (s), 26.9 (s).
5.5j: Synthesised in accordance with General General 
Procedure 7 using 1,3-diacetylbenzene as starting material. 
Conversion: 98%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
7.58–7.55 (m, 12H, Ar-H), 7.40–7.24 (m, 22H, Ar-H), 4.96 (dd, 3JHH = 6.1 Hz, 4JHH = 
1.9 Hz, 2H, CH), 1.37 (dd, 3JHH = 6.3 Hz, 4JHH = 2.8 Hz, CH3). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 145.9 (s), 135.6 (s), 134.7 (s), 130.0 (s), 128.4 (s), 127.9 (s), 
124.3 (s), 124.2 (s), 122.9 (s), 122.8 (s), 72.2 (s), 26.9 (s).
5.5k: Synthesised in accordance with General Procedure 7 using 
4-phenyl-2-butanone as starting material. Spectroscopic analyses 
agree with literature known values.[197] Conversion: 99%. 1H NMR
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(400 MHz, CDCl3, 298 K) δ/ppm: 7.67–7.64 (m, 6H, Ar-H), 7.46–7.36 (m, 9H, Ar-H), 
7.26–7.14 (m, 3H, Ar-H), 7.04 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 4.04 (sext., 3JHH = 5.7 Hz, 
1H, CH), 2.73–2.51 (m, 2H, CH2), 1.94–1.71 (m, 2H, CH2), 1.22 (dd, 3JHH = 6.1 Hz, 
4JHH = 0.9 Hz, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 142.5 (s), 135.6 
(s), 135.1 (s), 130.0 (s), 128.5 (s), 128.4 (s), 127.9 (s), 125.7 (s), 69.6 (s), 41.3 (s), 
31.9 (s), 23.7 (s).
5.6a: Synthesised in accordance with General Procedure 7 using 
benzaldehyde as starting material. Spectroscopic analyses agree with 
literature known values.[198] Conversion: 98%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm:  7.66 (d, 3JHH = 7.4 Hz, 6H, Ar-H), 7.46–7.32 (m, 14H, Ar-H), 
4.91 (s, 2H, CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 140.7 (s), 135.6 (s), 
134.1 (s), 130.2 (s), 128.4 (s), 128.1 (s), 127.2 (s), 126.5 (s), 65.7 (s).
5.6b: Synthesised in accordance with General Procedure 8 using 4-
fluorobenzaldehyde as starting material. Conversion: 95%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm:  7.65 (d, 3JHH = 6.7 Hz, 6H, Ar-H), 
7.47–7.37 (m, 11H, Ar-H), 7.20 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 4.84 (s, 2H, CH2). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 162.1 (d, 1JCF = 245 Hz), 136.4 (d, 3JCF = 3.1 
Hz), 135.5 (s), 134.0 (s), 130.3 (s), 129.2 (s), 128.1 (s), 115.2 (d, 2JCF = 21.4 Hz), 65.2 
(s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -115.8 (s, 1F, CF).
5.6c: Synthesised in accordance with General Procedure 7 using 4-
methylbenzaldehyde as starting material. Spectroscopic analyses 
agree with literature known values.[199] Conversion: 94%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm:  7.60–7.58 (m, 6H, Ar-H), 7.33–7.31 (m, 9H, Ar-H), 
7.16 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.05 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 4.79 (s, 2H, CH2), 
2.26 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 135.9 (s), 135.6 (s), 
134.2 (s), 130.2 (s), 129.0 (s), 128.2 (s), 128.0 (s), 126.6 (s), 65.6 (s), 21.3 (s). 
5.6d: Synthesised in accordance with General Procedure 7 using 
mesitaldehyde as starting material. Conversion: 62%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm: 7.49 (d, 3JHH = 7.2 Hz, 8H, Ar-H), 7.33–
7.30 (m, 7H, Ar-H), 6.72 (s, 2H, Ar-H), 4.72 (s, 2H, CH2), 2.16 (s, 3H, p-CH3), 2.12 (s, 
6H, o-CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 137.6 (s), 135.6 (s), 135.1 (s), 
134.4 (s), 133.4 (s), 130.1 (s), 129.0 (s), 127.9 (s), 60.1 (s), 21.1 (s), 19.6 (s).
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5.6e: Synthesised in accordance with General Procedure 7 using 
4-(trifluoromethyl)benzaldehyde as starting material. Conversion: 
97%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.67 (d, 3JHH = 8.4 
Hz, 2H, Ar-H), 7.58 (d, 3JHH = 8.1 Hz, 7.47–7.38 (m, 11H, Ar-H), 4.95 (s, 2H, CH2). 
13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 144.7 (s), 135.5 (s), 133.8 (s), 130.4 (s), 
129.4 (d, 2JCF = 32.3 Hz), 128.2 (s), 126.5 (s), 125.3 (q, 3JCF = 3.8 Hz), 124.4 (d, 1JCF
= 260 Hz), 65.1 (s). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -62.3 (s, 3F, CF3).
5.6f: Synthesised in accordance with General Procedure 7 using 4-
bromobenzaldehyde as starting material. Conversion: 77%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm: 7.66 (d, 3JHH = 6.4 Hz, 6H, Ar-H), 
7.45–7.38 (m, 10H, Ar-H), 7.21 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 4.84 (s, 2H, CH2). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 139.9 (s), 135.5 (s), 133.9 (s), 132.6 (s), 131.4 
(s), 130.3 (s), 128.2 (s), 128.1 (s), 65.1 (s). 
5.6g: Synthesised in accordance with General Procedure 7 using 
4-methoxybenzaldehyde as starting material. Conversion: 58%. 
1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.67 (d, 3JHH = 8.0 Hz, 
6H, Ar-H), 7.41–7.38 (m, 9H, Ar-H), 7.25 (d, 3JHH = 8.5 Hz, 2H, Ar-H), 6.86 (d, 3JHH = 
8.6 Hz, 2H, Ar-H), 4.85 (s, 2H, CH2), 3.78 (s, 3H, OCH3). 13C NMR (101 MHz, CDCl3, 
298 K) δ/ppm: 158.9 (s), 135.5 (s), 134.2 (s), 133.4 (s), 130.2 (s), 128.1 (s), 128.0 (s), 
113.8 (s), 65.5 (s), 55.3 (s).
5.6h: Synthesised in accordance with General Procedure 7 using 
4-nitrobenzaldehyde as starting material. Sepctroscopic analyses 
agree with literature values.[200] Conversion: 95%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm:  8.18 (d, 3JHH = 8.0 Hz, 2H, Ar-H), 7.66 (d, 3JHH = 7.5 Hz, 
6H, Ar-H), 7.51–7.46 (m, 5H, Ar-H), 7.43–7.39 (t, 3JHH = 7.0 Hz, 6H, Ar-H), 4.99 (s, 
2H, CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 148.2 (s), 147.2 (s), 135.5 (s), 
133.4 (s), 130.5 (s), 128.2 (s), 126.7 (s), 123.7 (s), 64.8 (s).
5.6i: Synthesised in accordance with General Procedure 7 using 
naphthaldehyde as starting material. Conversion: 97%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm: 7.65 (d, 3JHH = 7.3 Hz, 7H, Ar-H), 
7.47–7.37 (m, 11H, Ar-H), 7.28 (t, 3JHH = 6.8 Hz, 2H, Ar-H), 6.99 (t, 3JHH = 8.4 Hz, 2H, 
Ar-H), 4.86 (s, 2H, CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 136.3 (s), 136.0 
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(s), 135.6 (s), 135.1 (s), 134.0 (s), 130.3 (s), 130.0 (s), 129.2 (s), 128.4 (s), 128.3 (s), 
128.2 (s), 128.1 (s), 127.9 (s), 65.1 (s).
General Procedure 8: A solution of the aldehyde (0.4 M) and dimethylphenylsilane 
(0.48 M, 1.2 equiv.) in dry toluene was prepared. This solution was loaded into the 
sample loop of stream A (Scheme 6.5.2). A solution of the aniline (0.48 M, 1.2 equiv.) 
in dry toluene was loaded into the sample loop of stream B (Scheme 6.5.2) and a 
solution of B(C6F5)3 (0.008 M, 2 mol%) in dry toluene was loaded into the sample loop 
of stream C (Scheme 6.5.2). The pumps were set to a flow rate of 0.17 mlmin-1 and 
the temperature of the heated coil set to 150 °C. Streams A and B were set to inject, 
followed by stream C after 41 s. After waiting for 7 ml (14 min) to be collected as 
waste (to allow the system to reach steady-state), the output was directed through a 
plug of silica (to remove the catalyst) and solution collected for 8 min (4 ml). The 
solvent was removed under reduced pressure and mesitylene (74 μl, 0.064 g, 0.53 
mmol) added as an internal standard. NMR yields were determined by comparing the 
-CH2 benzylic peak to the mesitylene CH3 peak at 2.5 ppm.
Scheme 6.5.2: General flow schematic for the multistep synthesis of secondary amines.
5.7a: Synthesised in accordance with General Procedure 8 from 
benzaldehyde and aniline. Spectroscopic analyses agree with 
literature known values.[201] Conversion: 69%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.43 (m, 5H, Ar-H), 7.25 (t, 3JHH = 7.9 Hz, 2H, 
Ar-H), 6.80 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 6.71 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 4.40 (s, 2H, 
CH2), 4.08 (br. s, 1H, NH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 148.3 (s), 139.5 
(s), 129.4 (s), 128.7 (s), 127.6 (s), 127.3 (s), 117.6 (s), 112.9 (s), 48.4 (s). HRMS (EI+) 
m/z calculated for [C13H13N]+ [M]+: 183.1048, found: 183.1043.
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5.7b: Synthesised in accordance with General Procedure 8 from 
p-tolaldehyde and aniline. Spectroscopic analyses agree with 
literature known values.[201] Conversion: 66%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.42–7.35 (m, 6H, Ar-H), 6.94 (t, 3JHH = 7.3 
Hz, 1H, Ar-H), 6.83 (d, 3JHH = 7.7 Hz, 2H, Ar-H), 4.45 (s, 2H, CH2), 3.58 (br. s, 1H, 
NH), 2.56 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 137.7 (s), 133.1 
(s), 129.3 (s), 129.3 (s), 127.5 (s), 127.0 (s), 117.5 (s), 112.9 (s), 48.1 (s), 21.3 (s). 
HRMS (EI+) m/z calculated for [C14H15N]+ [M]+: 197.1204, found: 197.1204.
5.7c: Synthesised in accordance with General Procedure 8 from 
p-anisaldehyde and aniline. Spectroscopic analyses agree with 
literature known values.[201] Conversion: 78%. 1H NMR (400 MHz, 
CDCl3, 298 K) δ/ppm: 7.45 (d, 3JHH = 8.7 Hz, 2H, Ar-H), 7.36 (dd, 
3JHH = 8.5, 3JHH = 7.4 Hz, 2H, Ar-H), 7.06 (d, 3JHH = 8.6 Hz, 2H, Ar-H), 6.91 (t, 3JHH = 
7.3 Hz, 1H, Ar-H), 6.80 (d, 3JHH = 7.6 Hz, 2H, Ar-H), 4.40 (s, 2H, CH2), 3.95 (s, 3H, 
OCH3), 3.59 (br. s, 1H, NH). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 159.0 (s), 
148.3 (s), 129.4 (s), 128.9 (s), 127.0 (s), 117.7 (s), 114.2 (s), 113.0 (s), 55.4 (s), 48.0 
(s). HRMS (EI+) m/z calculated for [C14H15NO]+ [M]+: 213.1154, found 213.1150.
5.7d: Synthesised in accordance with General Procedure 8 from 
4-bromobenzaldehyde and aniline. Spectroscopic analyses agree 
with literature known values.[201] Conversion: 89%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm:  7.53 (d, 3JHH = 8.3 Hz, 2H, Ar-H), 
7.32–7.24 (m, 4H, Ar-H), 6.82 (t, 3JHH = 7.3 Hz, 1H, Ar-H), 6.68 (d, 3JHH = 8.1 Hz, 2H, 
Ar-H), 4.35 (s, 2H, CH2), 4.11 (s, 1H, NH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
147.9 (s), 138.6 (s), 131.7 (s), 129.4 (s), 129.1 (s), 120.9 (s), 117.8 (s), 112.9 (s), 47.7 
(s). HRMS (EI+) m/z calculated for [C13H12NBr]+ [M]+: 261.0153, found: 261.0150.
5.7e: Synthesised in accordance with General Procedure 8 from 
benzaldehyde and p-toluidine. Spectroscopic analyses agree 
with literature known values.[201] Conversion: 65%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm:  7.58–7.52 (m, 5H, Ar-H), 7.19 (d, 
3JHH = 8.4 Hz, 2H, Ar-H), 6.75 (d, 3JHH = 8.4 Hz, 2H, Ar-H), 4.46 (s, 2H, CH2), 3.53 (br. 
s, 1H, NH), 2.45 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 145.9 (s), 
137.7 (s), 129.8 (s), 128.6 (s), 127.6 (s), 127.0 (s), 113.2 (s), 48.7 (s), 21.3 (s). HRMS
(EI+) m/z calculated for [C14H15N]+ [M]+: 197.1204, found: 197.1204.
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5.7f: Synthesised in accordance with General Procedure 8 from 
benzaldehyde and 4-methoxyaniline. Spectroscopic analyses 
agree with literature known values.[201] Conversion: 45%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm:  7.53–7.38 (m, 5H, Ar-H), 6.93 
(d, 3JHH = 8.9 Hz, 2H, Ar-H), 6.74 (d, 3JHH = 8.9 Hz, 2H, Ar-H), 4.40 (s, 2H, CH2), 3.87 
(s, 3H, OCH3), 3.41 (br. s, 1H, NH). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 152.3 
(s), 142.4 (s), 139.7 (s), 128.6 (s), 127.9 (s), 127.6 (s), 115.0 (s), 114.3 (s), 55.8 (s), 
49.3 (s). HRMS (EI+) m/z calculated for [C14H15NO]+ [M]+: 213.1154, found: 213.1155.
5.7g: Synthesised in accordance with General Procedure 8 from 
benzaldehyde and 4-(trifluoromethyl)aniline. Spectroscopic 
analyses agree with literature known values.[202] Conversion: 
34%.1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.57–7.48 (m, 7H, 
Ar-H), 6.76 (d, 3JHH = 7.9 Hz, 2H, Ar-H), 4.46 (s, 2H, CH2), 3.97 (br. s, 1H, NH). 13C 
NMR (101 MHz, CDCl3, 298 K) δ/ppm: 150.6 (s), 137.8 (s), 128.9 (s), 127.4 (s), 127.0 
(s), 126.7 (q, 3JCF = 3.8 Hz), 119.0 (q, 2JCF = 34 Hz) 112.1 (s), 65.1 (s), 47.8 (s). 19F 
NMR (376 MHz, CDCl3, 298 K) δ/ppm: -60.7 (s). HRMS (EI+) m/z calculated for 
[C14H12NF3]+ [M]+: 251.0922, found: 251.0920.
5.7h: Synthesised in accordance with General Procedure 8 from 
benzaldehyde and 4-bromoaniline. Spectroscopic analyses agree 
with literature known values.[203] Conversion: 77%. 1H NMR (400 
MHz, CDCl3, 298 K) δ/ppm:  7.58–7.49 (m, 7H, Ar-H), 6.61 (d, 3JHH
= 8.8 Hz, 2H, Ar-H), 4.40 (s, 2H, CH2), 3.59 (br. s, 1H, NH). 13C NMR (101 MHz, 
CDCl3, 298 K) δ/ppm: 147.1 (s), 137.7 (s), 131.9 (s), 128.7 (s), 127.9 (s), 127.4 (s), 
116.8 (s), 114.5 (s), 48.2 (s). HRMS (EI+) m/z calculated for [C13H12NBr]+ [M]+: 
261.0153, found: 261.0142.
6.5.3 Biologically Inspired Borohydride Sources and Subsequent 
Transfer Hydrogenation Reactions
6.5.3.1 Synthesis of Starting Materials
5.8a: Synthesised in accordance with previously outlined procedures.[204]
Pyridine (2.0 ml, 25.3 mmol) was dissolved in acetonitrile (30 ml), then 
benzyl bromide (3.0 ml, 25.3 mmol) was added. The reaction mixture was 
stirred under reflux at 80 °C for 12 h. The solution was then cooled and 
diethyl ether (50 ml) was added to precipitate the crude product. After filtering off the 
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supernatant and washing the solid with diethyl ether (3 x 10 ml), the bromide salt was 
obtained as a yellow solid (1.9 g, 7.6 mmol, 30%). A suspension of water (70 ml) and 
toluene (50 ml) containing sodium dithionite (10.0 g, 60.0 mmol) and sodium 
carbonate (8.0 g, 70.0 mmol) was stirred vigorously under a nitrogen atmosphere and 
was heated to 100 °C. 1-Benzyl pyridinium bromide (2.5 g, 10.0 mmol) dissolved in 
water (100 ml) was then added in small portions over a period of 10 mins. After reflux 
for 10 minutes, the organic solution was separated and was washed with saturated 
sodium bicarbonate solution (3 x 10 ml), followed by water (3 x 10 ml) with the organic 
layer being dried with Na2SO4. The solvent was removed under reduced pressure to 
yield the product as a yellow/red oil. Analytical data agrees with previously reported 
values.[204] Yield: 0.63 g, 3.7 mmol, 37%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 
7.33–7.23 (m, 5H, Ar-H), 5.73 (d, 3JHH = 7.9 Hz, 2H, NCH), 4.36–4.33 (m, 2H, =CH), 
4.08 (s, 2H, N-CH2), 2.95 (br. s, 2H, CH2). 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 
139.0 (s), 131.6 (s), 128.7 (s), 127.3 (s), 127.3 (s), 97.9 (s), 56.9 (s), 22.6 (s).
5.8b: Synthesised in accordance with previously outlined 
procedures.[205] To a solution of nicotinamide (4.9 g, 40.0 mmol) in a 
mixture of 1,4-dioxane (100 ml) and methanol (25 ml), benzyl bromide 
(4.8 ml, 40.0 mmol) was added. The reaction mixture was stirred 
under reflux at 80 °C for 4 h. The solution was then cooled and 1,4-dioxane (50 ml) 
was added to precipitate the crude product. After filtering off the supernatant and 
washing the solid with 1,4-dioxane (3 x 10 ml), the bromide salt was obtained as a 
white solid (7.5 g, 25.7 mmol, 64%). 1-benzyl-3-carbamoyl pyridinium bromide (0.40 
g, 1.4 mmol) was dissolved in water (15 ml) and sodium bicarbonate (0.78 g, 9.4 
mmol) was added. Under a nitrogen atmosphere, sodium dithionite (1.63 g, 9.4 mmol) 
was added in small portions over a period of 10 mins. The reaction mixture was stirred 
at room temperature for 3 h in the dark, during which time the solution turned from 
orange to yellow as the yellow product precipitated. The solid was filtered, washed 
with cold water (2 x 10 ml) and then dissolved in chloroform (20 ml). The organic 
phase was extracted with water (2 x 10 ml) and was subsequently dried over Na2SO4
and evaporated under vacuum to obtain a bright yellow powder. Analytical data 
agrees with previously reported values.[205] Yield: 0.21 g, 1.0 mmol, 70%. 1H NMR
(400 MHz, CDCl3, 298 K) δ/ppm: 7.35 (t, 3JHH = 7.2 Hz, 2H, Ar-H), 7.29 (d, 3JHH = 7.2 
Hz, 1H, Ar-H), 7.24 (d, 3JHH = 7.0 Hz, 2H, Ar-H), 7.15 (s, 1H, NCH), 5.73 (dq, 3JHH = 
7.8 Hz, 4JHH = 1.6 Hz, 1H, NCH), 5.66 (br. s, 2H, NH2), 4.74 (dt, 3JHH = 3.5 Hz, 4JHH = 
8.0 Hz, 1H, =CH), 4.28 (s, 2H, N-CH2), 3.16 (br. s, 2H, CH2). 13C NMR (101 MHz, 
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CDCl3, 298 K) δ/ppm: 170.5 (s), 139.9 (s), 137.4 (s), 129.0 (s), 128.9 (s), 127.8 (s), 
127.2 (s), 103.3 (s), 98.9 (s), 57.4 (s), 22.9 (s).
5.8c: A small portion of compound 5.8b was dissolved twice in 
methanol-d4, which was removed under reduced pressure, to yield a 
bright yellow powder. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.36–
7.28 (m, 3H, Ar-H), 7.23–7.21 (m, 2H, Ar-H), 7.12 (d, 4JHH = 1.4 Hz, 
1H, NCH), 5.71 (dq, 3JHH = 8.2 Hz, 4JHH = 1.6 Hz, 1H, NCH), 4.72 (dt, 3JHH = 7.9 Hz, 
3JHH = 3.4 Hz, =CH), 4.25 (s, 2H, N-CH2), 3.13 (q, 3JHH = 3.0 Hz, 4JHH = 1.4 Hz, 2H, 
CH2). 
5.8d: Synthesised in accordance with previously outlined 
procedures.[205] Nicotinic acid (2.46 g, 20 mmol) was dissolved in a 
minimal amount of ethanol and diluted with acetonitrile (40 ml). 
Benzyl bromide (2.4 ml, 20 mmol) was then added and stirred under 
reflux at 80 °C for 12 h. The solution was cooled and diethyl ether (50 ml) was added 
to precipitate the crude product. After filtering off the supernatant and washing the 
solid with diethyl ether (3 x 10 ml), the bromide salt was obtained as a white powder 
(3.5 g, 11.9 mmol, 60%). A suspension of 1-benzyl-3-carboxy pyridinium bromide (2.9 
g, 10 mmol) in water (200 ml) and dichloromethane (100 ml) was cooled to 0 °C and 
stirred under a nitrogen atmosphere. Sodium carbonate (6.4 g, 60 mmol) was added 
in small portions over a period of 10 minutes. Sodium dithionite (7 g, 40 mmol) was 
then added slowly over a period of 15 minutes. Stirring was continued over a period 
of 1 h under a nitrogen stream at 0 °C. The organic layer was washed with water (3 x 
100 ml), dried over Na2SO4 and the volatiles evaporated under vacuum to afford the 
yellow product. Analytical data agrees with previously reported values.[205] Yield: 0.55 
g, 2.6 mmol, 26%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 7.36–7.30 (m, 3H, Ar-
H), 7.25–7.23 (m, 3H, Ar-H), 7.22 (d, 3JHH = 1.4 Hz, 1H, NCH), 5.68 (dq, 3JHH = 8.1 
Hz, 4JHH = 1.7 Hz, 1H, NCH), 4.82 (dt, 3JHH = 8.1 Hz, 4JHH = 3.5 Hz, 1H, =CH), 4.29 
(s, 2H, N-CH2), 3.12 (d, 3JHH = 3.2 Hz, 2H, CH2).  13C NMR (101 MHz, CDCl3, 298 K) 
δ/ppm: 173.6 (s), 143.6 (s), 137.1 (s), 129.0 (s), 128.2 (s), 128.0 (s), 127.3 (s), 106.1 
(s), 96.7 (s), 57.6 (s), 21.9 (s).
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6.5.3.2 Synthesis of Products
5.9: Compound 5.8a (17 mg, 0.1 mmol, 1 equiv.) was dissolved in 
CDCl3 (0.5 ml) to give a dark red solution to which B(C6F5)3 (51 mg, 
0.1 mmol, 1 equiv.) was added. This was transferred to an NMR tube 
to monitor reaction progress. After 30 minutes the reaction showed almost complete 
conversion to the hydridoborate product 5.9 as observed by in situ NMR 
spectroscopy, at this point removal of solvents in vacuo gave a dark red viscous oil. 
Yield:  63 mg, 92 μmol, 91%. 1H NMR (400 MHz, CDCl3, 298 K) δ/ppm: 8.64 (t, 3JHH
= 5.8 Hz, 2H, o-H), 8.43 (t, 3JHH = 7.8 Hz, 1H, p-H), 7.97 (t, 3JHH = 7.1 Hz, 2H, m-H), 
7.46–7.39 (m, 3H, Ar-H), 7.27 (d, 3JHH = 7.1 Hz, 2H, Ar-H), 5.67 (s, 2H, N-CH2). Note: 
B-H not observed. 13C NMR (101 MHz, CDCl3, 298 K) δ/ppm: 148.2 (dm, 1JCF = 240 
Hz), 146.2 (s), 143.7 (s), 136.7 (dm, 1JCF = 250 Hz), 131.2 (s), 130.4 (s), 130.3 (s), 
129.2 (s), 128.9 (s), 66.0 (s). 11B NMR (128 MHZ, CDCl3, 298 K) δ/ppm: -25.3 (d, 1JBH
= 66 Hz). 19F NMR (376 MHz, CDCl3, 298 K) δ/ppm: -133.82 (br. s, 6F, o-F), -162.92 
(br. s, 3F, p-F), -166.34 (br.s, 6F, m-F). IR νmax (cm-1): 3091 (w), 2378 (w), 2156 (w), 
1641 (m), 1570 (w), 1508 (s), 1487 (w), 1451 (s), 1373 (w), 1273 (m), 1213 (w), 1089 
(s), 1028 (w), 974 (s), 910 (m), 787 (w), 760 (m), 743 (m), 700 (m), 679 (m), 617 (w), 
601 (w), 567 (w). HRMS (ES–) m/z calculated for [M]– [C18F15BH]–: 511.9968, found 
511.9984, (ES+) [M]+ [C12H12N1]+ m/z calculated: 170.0970, found: 170.0963.
5.10: Compound 5.8b (42 mg, 0.2 mmol, 1 equiv.) was 
dissolved in CDCl3 (0.5 ml) to which B(C6F5)3 (102 mg, 0.2 
mmol, 1 equiv.) was added, yielding an orange solution. This 
was transferred to a J-Youngs NMR tube and heated for 12 h 
at 70 °C. A white crystalline solid precipitated out of solution which was isolated and 
measured by X-ray diffractometry. The mother liquor was retained for isolation of 5.11
(see below). The remaining solid was washed with cold CH2Cl2 (2 x 2 ml) and dried 
in vacuo to garner a white powdery solid. Yield: 63 mg, 87.0 μmol, 44%. Melting point: 
124–130 °C. 1H NMR (500 MHz, DMSO-d6, 298 K) δ/ppm: 9.48 (s, 1H, Ar-H), 9.15 
(d, 3JHH = 4.9 Hz, 1H, Ar-H), 8.98 (d, 3JHH = 7.5 Hz, 1H, Ar-H), 8.19 (t, 3JHH = 6.5 Hz, 
1H, Ar-H), 7.71 (s, 1H, Ar-H), 7.54 (d, 3JHH = 5.3 Hz, 2H, Ar-H), 7.43 (d, 3JHH = 6.1 Hz, 
3H, Ar-H), 5.85 (s, 2H, CH2), 5.74 (s, 1H, NH). 13C NMR (126 MHz, DMSO-d6, 298 K) 
δ/ppm: -162.9 (s), 147.8 (dm, 1JCF = 240 Hz), 145.2 (s), 144.5 (s), 143.4 (s), 137.6 
(dm, 1JCF = 240 Hz), 136.9 (s), 135.6 (dm, 1JCF = 240 Hz), 134.1 (s), 129.4 (s), 129.3 
(s), 129.0 (s), 127.9 (s), 63.4 (s), 54.9 (s). 11B NMR (160 MHZ, DMSO-d6, 298 K) 
δ/ppm: -11.5 (s). 19F NMR (471 MHz, DMSO-d6, 298 K) δ/ppm: -133.31 (d, 3JFF = 22.4 
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Hz, 6F, o-F), -161.93 (d, 3JFF = 21.4 Hz, 3F, p-F), -166.23 (t, 3JFF = 20.8 Hz, 6F, m-F). 
IR νmax (cm-1): 3454 (w), 3071 (w), 1665 (m), 1645 (m), 1625 (w), 1512 (m), 1487 (m), 
1458 (s), 1379 (w), 1277 (m), 1180 (w), 1082 (s), 1030 (w), 974 (s), 947 (s), 887 (w), 
813 (w), 771 (m), 758 (m), 739 (m), 704 (m), 675 (m), 623 (w), 574 (m), 548 (w). 
HRMS (ES–) m/z calculated for [M–H]– [C31H11N2OBF15]–: 722.0761, found: 722.0769.
5.11: The mother liquor from the formation of 5.10 was retained 
with the solvents being subsequently removed under reduced 
pressure. The yellow/green solid was then washed with cold 
pentane (2 x 2 ml) and dried in vacuo to yield a yellow/green 
powdery solid. Yield: 61 mg, 83.4 μmol, 42%. Melting point: 101–
110 °C. 1H NMR (500 MHz, CDCl3, 298 K) δ/ppm: 7.92 (s, 1H, C=CH), 7.39–7.33 (m, 
3H, Ar-H), 7.20 (d, 3JHH = 7.2 Hz, 2H, Ar-H), 5.52 (br. s, 2H, NH2), 4.42 (s, 2H, CH2), 
3.15 (t, 3JHH = 4.9 Hz, 2H, CH2), 2.11 (t, 3JHH = 5.7 Hz, 2H, CH2), 1.91 (br. pent., 3JHH
≈ 5 Hz, 2H, CH2). 13C NMR (126 MHz, CDCl3, 298 K) δ/ppm: 169.6 (s), 151.5 (s), 
147.9 (dm, 1JCF = 245 Hz), 139.9 (dm, 1JCF = 245 Hz), 137.0 (dm, 1JCF = 245 Hz), 
134.5 (s), 129.3 (s), 129.2 (s), 128.8 (s), 128.4 (s), 128.0 (s), 125.5 (s), 90.5 (s), 61.3 
(s), 45.7 (s), 20.5 (s), 18.9 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -2.8 (br. s). 
19F NMR (471 MHz, CDCl3, 298 K) δ/ppm: -133.92 (d, 3JFF = 21.0 Hz, 6F, o-F), -
158.14 (t, 3JFF = 20.2 Hz, 3F, p-F), -163.93 (t, 3JFF = 19.0 Hz, 6F, m-F). IR νmax (cm-1): 
3524 (w), 3420 (w), 1643 (m), 1618 (m), 1558 (w), 1510 (s), 1458 (s), 1418 (m), 1354 
(m), 1319 (w), 1279 (m), 1211 (m), 1089 (s), 1028 (w), 976 (s), 877 (m), 806 (m), 773 
(m), 764 (m), 750 (m), 734 (m), 696 (m), 675 (m), 625 (w), 609 (w), 574 (w), 556 (w). 
HRMS (ES+) m/z calculated for [M+H(–B(C6F5)3)]+ [C13H17N2O]+: 217.1341, found: 
217.1339.
5.12: Compound 5.8c (44 mg, 0.2 mmol, 1 equiv.) was dissolved 
in CDCl3 (0.5 ml) to which B(C6F5)3 (102 mg, 0.2 mmol, 1 equiv.) 
was added, yielding an orange solution. This was transferred to 
a J-Youngs NMR tube and heated for 12 h at 70 °C. A white 
crystalline solid precipitated out of solution which was isolated and washed with cold 
pentane (2 x 2 ml) and dried in vacuo to garner 5.12 as a white powdery solid. The 
mother liquor was retained for isolation of 5.13 (see below). Yield: 58 mg, 80.0 μmol, 
40%. Melting point: 119–125 °C. 1H NMR (500 MHz, DMSO-d6, 298 K) δ/ppm: 9.47 
(br. s, 1H, NCH), 9.15 (s, 1H, NCH), 8.96 (br. s, 1H, =CH), 8.19 (t, 3JHH = 6.8 Hz, 1H, 
=CH), 7.53 (d, 3JHH = 6.7 Hz, 2H, Ar-H), 7.43 (d, 3JHH = 6.2 Hz, 3H, Ar-H), 5.85 (s, 2H, 
N-CH2). 13C NMR (126 MHz, DMSO-d6, 298 K) δ/ppm: 162.8 (s), 147.8 (dm, 1JCF = 
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240 Hz), 145.2 (s), 144.5 (s), 143.4 (s), 137.5 (dm, 1JCF = 240 Hz), 136.9, 135.5 (dm, 
1JCF = 250 Hz), 134.0 (s), 129.4 (s), 129.3 (s), 128.9 (s), 127.9 (s), 63.4 (s). 11B NMR 
(160 MHz, DMSO-d6, 298 K) δ/ppm: -11.5 (s). 19F NMR (471 MHz, DMSO-d6, 298 K) 
δ/ppm: -133.31 (d, 3JCF = 22.9 Hz, 6F, p-F), -161.9 (t, 3JCF = 21.4 Hz, 3F, p-F), -166.3 
(t, 3JCF = 20.8 Hz, 6F, m-F). IR νmax (cm-1): 3464 (w), 2359 (w), 2164 (w), 1665 (m), 
1624 (w), 1514 (m), 1487 (m), 1451 (s), 1379 (m), 1279 (m), 1199 (w), 1178 (w), 1082 
(s), 976 (s), 962 (s), 947 (s), 908 (s), 883 (w), 825 (w), 771 (m), 764 (s), 704 (m), 657 
(m).  
5.13: The mother liquor from the formation of 5.12 was retained 
with the solvents being subsequently removed under reduced 
pressure. The orange solid was then washed with cold pentane 
(2 x 2 ml) and dried in vacuo to yield an orange powdery solid. 
Yield: 56 mg, 76.6 μmol, 38%. Melting point: 112–116 °C. 1H NMR (500 MHz, CDCl3, 
298 K) δ/ppm: 7.91 (s, 1H, =CH), 7.40–7.34 (m, 3H, Ar-H), 7.20 (d, 3JHH = 7.0 Hz, 2H, 
Ar-H), 4.42 (s, 2H, N-CH2), 3.14 (d, 3JHH = 5.4 Hz, 2H, CH2), 2.10 (d, 3JHH = 6.1 Hz, 
2H, CH2), 1.91 (pent., 3JHH = 6.1 Hz, 1H, CHD). 13C NMR (126 MHz, CDCl3, 298 K) 
δ/ppm: 169.5 (s), 151.5 (s), 147.9 (dm, 1JCF = 240 Hz), 139.8 (dm, 1JCF = 250 Hz), 
137.1 (dm, 1JCF = 255 Hz), 134.5 (s), 130.4 (s), 129.3 (s), 128.8 (s), 128.0 (s), 61.3 
(s), 45.7 (s), 22.5 (s), 20.5 (s). 11B NMR (160 MHz, CDCl3, 298 K) δ/ppm: -2.78 (br. 
s). 19F NMR (471 MHz, CDCL3, 298 K) δ/ppm: -133.93 (d, 3JFF = 22.1 Hz, 6F, o-F), -
158.14 (t, 3JFF = 20.4 Hz, 3F, p-F), -163.92 (t, 3JFF = 18.7 Hz, 6F, m-F). IR νmax (cm-1): 
3082 (w), 2160 (w), 2035 (w), 1687 (s), 1647 (m), 1516 (m), 1425 (s), 1386 (m), 1342 
(m), 1275 (m), 1198 (w), 1182 (m), 1083 (s), 1033 (w), 975 (s), 934 (m), 906 (m), 881 
(m), 812 (m),773 (m), 758 (s), 724 (s), 706 (s), 677 (s), 665 (s), 650 (m).
5.14: Compound 5.8d (44 mg, 0.1 mmol, 1 equiv.) was 
dissolved in CDCl3 (0.5 ml) to which B(C6F5)3 (102 mg, 0.1 
mmol, 1 equiv.) was added, yielding an orange solution. This 
was transferred to a J-Youngs NMR tube and heated for 12 h 
at 70 °C. An orange precipitate formed which was separated 
from the supernatant and washed with pentane (2 x 2 ml) then dried in vacuo to garner 
a light orange powdery solid. Yield: 52 mg, 71.7 μmol, 36%. Melting point: 137–144 
°C. 1H NMR (500 MHz, DMSO-d6, 298 K) δ/ppm: 9.5 (s, 1H, NCH), 9.31 (d, 3JHH = 5.9 
Hz, 1H, NCH), 8.89 (d, 3JHH = 7.9 Hz, 1H, =CH), 8.27 (t, 3JHH = 7.0 Hz, 1H, =CH), 7.55 
(br. s, 2H, Ar-H), 7.41 (br. s, 3H, Ar-H), 5.92 (s, 2H, N-CH2). 13C NMR (126 MHz, 
DMSO-d6, 298 K) δ/ppm: 147.1 (dm, 1JCF = 245 Hz), 146.8 (s), 145.3 (s), 144.9 (s), 
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117.4 (dm, 1JCF = 250 Hz), 135.7 (dm, 1JCF = 245 Hz), 133.6 (s), 133.4 (s), 129.4 (s), 
129.0 (s), 128.6 (s), 63.5 (s). 11B NMR (160 MHZ, DMSO-d6, 298 K) δ/ppm: -4.1 (br. 
s). 19F NMR (471 MHz, DMSO-d6, 298 K) δ/ppm: -134.10 (d, 3JFF = 22.0 Hz, 6F, o-F), 
-160.65 (t, 3JFF = 21.2 Hz, 3F, p-F), -165.57 (t, 3JFF = 20.2 Hz, 6F, m-F). IR νmax (cm-
1): 2978 (w), 2872 (w), 1645 (w), 1514 (m), 1456 (s), 1275 (m), 1182 (m), 1082 (s), 
976 (s), 906 (m), 808 (m), 772 (w), 758 (w), 731 (m), 706 (m), 675 (m), 623 (m).
6.5.4 Computational Studies
All geometry optimisations were undertaken using the B3LYP functional[152a] and 6-
31G* basis set[154] within Gaussian09.[178] Subsequent single point calculations were 
undertaken using the B3LYP functional and larger 6-311G*+ basis set. 
6.5.5 Crystallographic Studies
Crystallographic studies were undertaken on single crystal mounted in paratone and 
studied on an Agilent SuperNova Dual three-circle diffractometer using Cu-Kα or Mo-
Kα radiation and a CCD detector. Measurements were typically made at 150(2) K with 
temperatures maintained using an Oxford cryostream. Data were collected and 
integrated and data corrected for absorption using a numerical absorption correction 
based on gaussian integration over a multifaceted crystal model within 
CrysAlisPro.[156] The structures were solved by direct methods and refined against F2
within SHELXL-2013.[170] The structures have been deposited with the Cambridge 
Structural Database (CCDC deposition numbers 1556722–1556723, 1532113). 
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Table 6.5.1 Crystallographic data for compounds 5.2k, 5.2p and 5.10.
Compound 5.2k 5.2p 5.10
Empirical Formula C12H25BO2Si C21H25BCl2O2 C31H12BF15N2O, CHCl3
Crystal System Monoclinic Monoclinic Triclinic
Space Group P21/n P21/n P-1 
a/Å 6.5494(4) 18.5123(8) 12.5821(9)
b/Å 21.5345(13) 6.02084(19) 12.6326(8)
c/Å 10.8938(7) 19.3786(9) 12.9076(8)
α/o 90 90 88.937(5)
β/o 94.458(6) 107.955(5) 79.854(5)
γ/o 90 90 66.759(6)
V/Å3 1531.81(17) 2054.75(15) 1852.7(2)
Z 4 4 2
T /K 150(2) 150(2) 150(2)
Dc/g.cm-3 1.042     1.264  1.512
Crystal size/mm 0.236 x 0.182 x 0.095 0.488 x 0.102 x 0.090 0.289 x 0.187 x 0.122
Total data 5536 7867 12937
Unique data 2883 4058 7276
Rint 0.0446 0.0460 0.0463
R1[F2>2 σ(F2)] 0.0685 0.0688 0.0478
wR2 (all data) 0.2004 0.1984 0.1409
GoF 1.044 1.050 1.026
ρmin/ρmax/eÅ-3 -0.391/0.614 -0.926/0.852 -0.778/0.449
CCDC code 1556722 1556723 1532113
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